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Abstract
The bioactivation of arylamines was investigated in hepatic microsomal and 
cytosolic fractions.
The bioactivation of 6-aminochrysene to mutagenic intermediates in the Ames test 
was demonstrated for the first time in cytosol from Aroclor 1254-induced rat. 
Substantial evidence was obtained to demonstrate that this activity was not a 
consequence of microsomal contamination, including the inhibition of cytosol- 
mediated bioactivation by the addition of microsomal protein. Investigation of 
substrate specificity demonstrated that the cytosolic activation of promutagens 
requires an exocyclic amino group and consequently bioactivation probably involves 
N-hydroxylation. Extrahepatic cytosol cannot bioactivate either 6AC or 2AA to 
mutagens and therefore the major site for this activity is the liver. No constitutive 
hepatic bioactivating activity was demonstrated by rat, mouse, hamster, ferret or pig 
hepatic cytosol but, moderate bioactivation of 2-aminoanthracene was carried out by 
human hepatic cytosol.
The cytosolic protein responsible for the bioactivation of arylamines was only 
induced by polychlorinated biphenyls and the be^ induction was accomplished by 
highly-substituted planar PCB congeners. However, Aroclor 1254 could not induce 
cytosol-mediated bioactivation of arylamines in Ah receptor non-responsive (DBA2) 
mice. Therefore induction of this enzyme system requires the cytosolic Ah receptor
II
Purification of the cytosolic amine oxidase was undertaken with partial success and a 
protein with an approximate molecular weight of approximately 65.5kDa was 
identified as the most likely candidate for the cytosolic enzyme.
Microsomes isolated from Aroclor 1254-treated rat could bioactivate arylamines to 
mutagens in the presence of either NADH or NADPH. In these investigations 
NADH-dependent bioactivation of IQ and 6-aminochrysene was demonstrated for 
the first time. Investigation of arylamine bioactivation in the presence of these two 
cofactors demonstrated sufficient differences to suggest these activities are carried 
out by different microsomal enzymes. However, both NADPH- and NADH- 
dependent bioactivation probably involves N-hydroxylation. Two microsomal 
enzyme systems which may perform this metabolism are the cytochromes P450 and 
the flavin-monooxygenases. However, the complete oxidation of xenobiotics by 
cytochrome P450 in the presence of NADH had not been demonstrated previously. In 
these investigations the cytochrome P450-dependent dealkylation of ethoxy- and 
methoxy-resorufin were performed in the presence of NADH by Aroclor 1254- 
induced microsomes. However, there is insufficient evidence to determine whether a 
cytochrome P450 isoform is responsible for the bioactivation of arylamine but like 
CYPl isoforms induction of the mjcrosofvja\ enzyme was regulated by the cytosolic Ah 
receptor.
I l l
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CHAPTER 1
An introduction to chemical carcinogenesis
1.1. Chemical carcinogenesis
Currently, in most western cultures, almost a quarter of the population will develop 
cancer during their lifetime. Cancerous tissue develops when a stem cell diverts from 
normal differentiation to unrestrained growth, forming a mass of cells 
(tumourigenesis). For this to take place, changes must occur within the genetic 
information of the cell, the DNA.
Epidemiological studies show that the environment plays a major role in determining 
the geographical distribution of cancers. For example, Japan has a very low incidence 
of both breast and colon cancers but a marked prevalence for stomach cancer, while 
in the United States the reverse is true, including the descendants of Japanese 
immigrants (Doll, 1977). Factors responsible for the induction of cancer include 
carcinogenic chemicals, radiation (including UV and X-rays), hormones (e.g. 
oestrogen-dependent breast cancer), inheritance (e.g. retinoblastoma), tumour viruses 
(e.g. Papilloma virus), and chronic irritation and cell damage (e.g. asbestos).
Carcinogenic chemicals are widespread in the environment and can be natural or 
synthetic. Natural carcinogens vary considerably, ranging from dietary components, 
such as natural plant defences and pyrolysis products generated through cooking 
(Ames and Gold, 1991), to metals, or radon gas which induces lung cancer through 
inhalation or ingestion in drinking water.
Numerous synthetic chemicals contaminate the environment, including industrial 
intermediates, pesticides, dyes, drugs and the complex mixtures of chemicals found 
in cigarette smoke and exhaust fumes, many of which are mutagenic. With over 50,
000 synthetic chemicals being manufactured in significant quantities and more than 
1000 new chemicals being produced annually, thorough testing and the study of 
chemical carcinogenesis have become crucial.
The first ‘chemical’ cause of cancer was described in 1700 by Ramazzini (Wright, 
1940) who noticed the increased incidence of breast cancer in nuns, but failed to 
make the cormection between the cancer and the responsible hormonal imbalance. 
Sixty years later, a London physician Dr. John Hill observed increased nasal polyps 
in patients taking snuff (Redmond, 1970), and in 1775 a surgeon, also from London, 
Percival Pott published a paper putting forward the hypothesis that soot was the 
agent responsible for cancer in patients with scrotal cancer who had been chimney 
sweeps in their youth (Pott, 1963). Over a hundred years later, Rehn (Rehn, 1895) 
recognised bladder cancer as an occupational hazard of workers in the manufacture 
of the dye fuchsin (magenta). Case and co-workers (Case et al, 1954) demonstrated 
that this was a result of the prolonged exposure to the aromatic amines 2- 
naphthylamine, benzidine and 4-aminobiphenyl.
Earnest Kennaway and his colleagues were the first to use a pure synthetic chemical, 
dibenz[a,h]anthracene, to induce cancer in experimental animals (Kennaway and 
Hieger, 1930). They also demonstrated the potent carcinogenicity of benzo[a]pyrene, 
a chemical they extracted firom coal tar (Cook et al, 1932). These discoveries 
changed the perspectives of people towards cancer, which was considered to be an 
unavoidable consequence of growing old, into a disease which was, in principle, 
avoidable. Since 1940 an ever-increasing number of both synthetic and natural 
chemicals have been evaluated for their carcinogenicity using animal models and
epidemiological investigations. A major breakthrough in carcinogenesis research 
occurred in 1969 when the highly reactive intermediate N-hydroxy-2- 
acetylaminofluorene was identified. Generation of this intermediate was critical for 
the carcinogenicity of 2-acetylaminofluorene (Miller and Miller, 1969) indicating 
that some chemical carcinogens required metabolism before exerting their 
carcinogenicity.
1.2. The metabolism of chemical carcinogens
1.2.1. Introduction
Chemical carcinogens undergo biotransformation to a number of metabolites usually 
involving an initial fimctionalisation, e.g. hydroxylation, followed by an 
estérification, e.g. sulphation or glucuronidation. However, occasionally chemical 
carcinogens are metabolised to unstable intermediates which spontaneously degrade 
to highly reactive metabolites, that react with cellular nucleophiles, i.e. hioactivation. 
The majority of metabolites are non-carcinogenic, and are highly stable and more 
water soluble than the parent compound; this increased solubility facilitates their 
excretion, i.e., deactivation. The majority of enzymes involved in detoxication 
reactions are localised in the liver.
To encourage the rapid removal of potentially hazardous chemicals, many chemicals 
increase the activity of enzymes (induction) responsible for their own detoxication. 
Unfortunately, many carcinogens also induce the enzymes responsible for their
bioactivation to reactive electrophiles. The balance of these two opposing activities 
determines the carcinogenic potential of xenobiotics.
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The Millers demonstrated that 2-acetylaminofluorene undergoes metabolism to the 
more carcinogenic N-hydroxylamine which, following estérification, generates 
highly reactive compounds capable of direct interaction with cellular nucleophiles. 
They proposed that the majority of chemical carcinogens are procarcinogens
requiring bioactivation to reactive proximate carcinogens and eventually to electron- 
pair deficient electrophilic reactants capable of covalent binding with cellular 
macromolecules: these final products they named ultimate carcinogens (another class 
of highly reactive carcinogenic intermediates, produced both enzymically and non- 
enzymically are the single electron deficient firee radicals). This discovery opened the 
way for extensive research into the metabolism of chemical carcinogens; 
investigation of their metabolism has revealed that many are metabolised or 
converted non-enzymically to one or more ultimate carcinogens. These carcinogens 
are consequently known as indirect-acting carcinogens.
Other carcinogens already exist in their ultimate form and are known as direct-acting 
carcinogens. These compounds, because of their alkylating or acylating ability, react 
with nucleophilic sites on proteins and nucleic acids. For example, 
methylmethanesulphonate or p-propiolactone act mainly at the 7-position of guanine 
in DNA and RNA but also react with positions N% and of adenine and of 
cytosine.
Therefore the balance of deactivating and activating enzymes is important in 
determining the susceptibility of different tissues, species and even individuals to 
chemical carcinogens.
1.2.2. Polycyclic aromatic hydrocarbons
Polycyclic aromatic hydrocarbons (PAHs) are a large and important group of 
environmental pollutants arising mainly firom the incomplete combustion of organic 
chemicals, especially in power stations and refuse disposal sites (Dipple, 1983). The
identification of the proximate carcinogen of PAHs was difficult because of the 
absence of functional groups attached to their aromatic nucleus. However, Jerina 
established that epoxides of PAHs could react with cellular proteins and nucleic acids 
in the absence of metabolising enzymes (Jerina et al, 1970).
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Figure, 1,2. The K  and bay regions of benzo[a]pyrene
Sims correctly proposed that the diol-epoxide of benzo[a]pyrene, later identified as 
(+) fl«ft-benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide, as the ultimate carcinogen 
(Sims et al, 1974; Yagi et a l, 1975), which was shown to react with exocyclic 
amino groups of guanine residues in DNA (King et al, 1976; Jeffrey et a l, 1976). In 
the liver aryl hydrocarbon hydroxylase, a mixed-frmction oxidase, metabolises 
benzo[a]pyrene to the 7,8-epoxide, proximate carcinogen. A second microsomal 
enzyme, epoxide hydrolase, then hydrolyses the epoxide to the 7,8-diol which enters 
a second cycle of oxidative metabolism leading to the production of the highly 
carcinogenic 7,8-diol-9,10-epoxide (figure. 1.3). This diol-epoxide is very labile and 
quickly binds via the 10-carbon to the N^ position of deoxyguanine in DNA (King et 
al, 1976; Jeffrey et a l, 1976). Bioactivations of PAHs generally involve the 
formation of electrophilic epoxides, and with few exceptions an epoxide of a benzo-
ring that forms part of the bay region (figure. 1.2) is the most likely PAH ultimate 
carcinogen.
Oxidation of PAHs by aryl hydrocarbon hydroxylase in the liver is responsible for 
both activation and deactivation, with almost every double-bond undergoing 
oxidation to form an epoxide. The abundance of an individual epoxide metabolite is 
dependent upon, firstly, its stability. Le. how readily it rearranges to the phenol and, 
secondly, on its accessibility for further metabolism by epoxide hydrolase or 
glutathione S-transferase.
In addition to the cytochrome P450 mixed-function oxidase system, oxidation of the 
proximate carcinogen benzo[a]pyrene-7,8-diol to the 7,8-diol-9,10-epoxide is also 
catalysed by extrahepatic prostaglandin H-synthase (PHS). However, PHS- 
dependent activation proceeds via a free radical mechanism and the resultant diol- 
epoxide differs stereochemically from that produced by cytochrome P450 (Dix and 
Mamett, 1983). PHS only generates the anti-diol epoxides whereas cytochrome P450 
is responsible for metabolism to both the anti- and jy^-diol epoxides. PHS also plays 
a role in the detoxication of PAHs (Eling and Curtis, 1992).
1.2.3. Aromatic amines
Aromatic amines are, like polycyclic aromatic hydrocarbons, metabolised to both 
highly soluble detoxication products and activated metabolites capable of DNA- 
adduct formation. Generally, the bioactivation of planar aromatic amines involves N- 
hydroxylation, though diol-epoxides are also sometimes involved (Beland and 
Kadlubar, 1990). The deactivation of aromatic amines involves hydroxylation of the 
aromatic nucleus and can occur at several different ring positions.
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Both ring- and N-hydroxylated intermediates are substrates for conjugation enzymes, 
UDP-glucuronosyltransferase, sulphotransferase, glutathione-S-transferase and 
acetyltransferase. As with PAH, conjugation with glutathione is usually a 
detoxication pathway, but the major route of detoxication is UDP-glucuronidation 
(Beland and Kadlubar, 1990). Enterohepatic circulation of glucuronides is common.
however, and p-glucuronidase activity in bladder epithelia, or the acidity of urine 
within the bladder can reform the parent arylamine. These phenomena are important 
in the targeting of the bladder by aromatic amine carcinogens. Of the phase II 
enzymes both sulphotransferase and acetyltransferase have been implicated in the 
bioactivation of aromatic amines.
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Figure.1.4. Deactivation and bioactivation o f 
dimethylaminoazobenzene
The most extensively investigated amino compound is the amide 2- 
acetylaminofluorene which is metabolised by cytochrome P450 oxidases to the 
proximate carcinogen, the N-hyroxylamine (Miller and Miller, 1969), which is a 
substrate for both sulphotransferase and acetyltransferase. These conjugates are very
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good leaving groups and heterolytic cleavage leads to the formation of the nitrenium 
ion ultimate carcinogen. Deactivation proceeds via ring hydroxylation followed 
mainly by glucuronide conjugation. The metabolism of 2-AAF will be discussed later 
in more detail.
Another extensively studied compound is dimethylaminoazobenzene which, 
similarly to aromatic amines undergoes bioactivation via N-hydroxylation and 
deactivation by ring hydroxylation; however, activation is also accomplished by 
déméthylation (figure 1.4), also catalysed by the cytochromes P450, followed by N- 
hydroxylamine (Kadlubar et a l, 1976). Further demethylated leads to the formation 
of the non-mutagenic aminoazobenzene.
The majority of aromatic amine carcinogens undergo bioactivation, catalysed by the 
mixed-fimction oxidase systems, via their N-hydroxylamine. 2-Aminofiuorene, 2- 
naphthylamine, 4-aminobiphenyl, 3,2’-dimethyl-4-aminobiphenyl, 2-acetylamino 
phenanthrene and 4-acetylaminostilbene are all metabolised to N-hydroxylamines 
and this constitutes the principal pathway of their activation (Beland and Kadlubar,
1990); however in some instances alternative activation routes are also available.
Increasing the number of aromatic rings increases the hydrocarbon characteristic of 
an aromatic amine and epoxidation becomes more important as a route of 
bioactivation. 6-Aminochrysene (four aromatic rings), a chemotherapeutic agent used 
in the treatment of breast cancer, has two routes of bioactivation (Delclos et al, 
1988), N-hydroxylation and formation of the //*aw^-l,2-dihydrodiol-3,4-epoxide 
(figure 1.5). The relative amounts of the enzymes involved in each reaction (CYPIA 
and CYP2B) determines which route predominates (Yamazaki et. al, 1993).
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The mixed-function oxidases are not the only enzymes responsible for the activation 
of aromatic amines. 2-Naphthylamine, in addition to the carcinogenic 
hydroxylamine, is also metabolised by prostaglandin H synthase (PHS) to the 
electrophilic 2-imino-l-naphthoquinone which can also form DNA adducts 
(Kadlubar et al, 1982). PHS is a membrane4)ound microsomal enzyme, whose 
involvement in carcinogenesis was first described in the concomitant activation of N- 
hydroxy-2-acetylaminofluorene (Wong et al, 1982) to the nitroso free radical with 
the endoperoxidation of arachidonic acid to prostaglandin in rat mammary gland cells 
(figure. 1.8).
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Benzidine is another carcinogen oxidised by various extrahepatic peroxidases 
including prostaglandin H synthase and lactoperoxidase (Josephy et al, 1983). The 
benzidine diimine product is, however, unstable at physiological pH where it is found 
as the nitrenium ion, the DNA binding, ultimate carcinogen (figure 1.6).
L2.4. Heterocyclic aromatic amines
Carcinogenic heterocyclic amines are found in foods cooked at high temperatures as 
a result of the of proteins and amino acids (Sugimara and Sato, 1986), and
in cigarette smoke condensate (Yamashita et al., 1986). In rodents, these amines are
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responsible for inducing tumours in many organs including the liver and the small 
and large intestines (Sugimura, 1988).
Bioactivation of heterocyclic amines, such as 2-amino-3-methylimidazo(4,5- 
f)quinoline (IQ), involves hydroxylation of the amino group (Yamazoe et a l, 1983). 
In the liver N-hydroxylation is performed by the cytochrome P450 oxidases 
especially the CYPlAl and CYP1A2 isoforms (Yamazoe et al, 1983; Boobis et al., 
1994; Kato 1986; Shimada and Nakamura, 1987). Extrahepatically prostaglandin H 
synthase is also responsible for the conversion of heterocyclic amines to mutagens 
(Wild and Degen, 1987; Petry et al, 1988). In the absence of microsomes rat hepatic 
cytosol can also convert IQ, MelQ and Trp-P-2 (3-amino-l-methyl-5H-pyrido[4,3- 
b]indole) to mutagens by a mechanism thought to consist of an initial oxidation 
followed by reduction with DT-diaphorase to form the N-hydroxylamine (DeFlora et 
a l, 1994).
IQ is more mutagenic in the presence of hepatic S9 than microsomes (Abu-Shakra et 
al, 1986) and further metabolism of microsomal intermediates by cytosolic enzymes 
is responsible for this increased mutagenic response. Heterocyclic amines are not 
directly N-acetylated by acetyltransferase but 0-acetylation of N-hydroxylamine 
intermediates is responsible for an increase in DNA-binding of N-hydroxy-Glu-P-1 
and N-hydroxy-IQ (Kato and Yamazoe, 1994). However no acetylated residues are 
identified as DNA-adducts so the acetoxyarylamines probably break down to form 
the nitrenium ion ultimate carcinogen (Saito et a l, 1985; Turesky et a l, 1991). 
Mutagenic sulphate esters of N-hydroxy Glu-P-1 and, to a lesser extent, N-hydroxy- 
IQ have also been demonstrated (Yamazoe et al, 1989; Abu-Zeid et a l, 1992). Trp-
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P-2 and N-hydroxy-Tip-P-2 also form more mutagenic intermediates after 
conjugation with glutathione but this metabolite has not been identified (Saito et al,
1983).
1.3. The metabolism of 2-acetyIaminofluorene and 2- 
aminofluorene
1.3.1. Historical
2-Acetylaminofluorene (2AAF) and 2-aminofluorene (2AF) were patented in 1940 
by the U.S. Department of Agriculture for use as insecticides against mosquito larvae 
and tobacco homworm. No acute toxicity was demonstrated by these compounds in 
experimental animals (Wilson et al, 1941). The carcinogenic potential of 2- 
acetylaminofluorene was, however demonstrated in 1941 with the discovery of 
tumours in various organs and tissues of rats fed for 100 days with diets containing 
2AAF (Wilson et al, 1941). Ring-hydroxylated metabolites, found in the urine, were 
scrutinised by the Weisburgers (Weisburger and Weisburger, 1958), and identified 
as 1-, 3-, 5-, 6-, 7-, and 8-hydroxy 2AAF. Several years later the proximate 
carcinogen, N-hydroxy-2-acetylaminofluorene (N-0H-2AAF) was isolated as the 
glucuronide conjugate in rat urine (Miller and Miller, 1969).
By the early 1970s the hydroxylamine N-0H-2AAF was considered to have five 
pathways of fiirther metabolism: (1) Deacetylation to the 2-aminofluorene 
hydroxylamine, N-0H-2AF (Irving, 1966). (2) Conjugation with glucuronide, the 
predominant conjugation reaction of 2AAF (Irving et al, 1967). (3) Formation of N-
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sulphonoxyl-AAF by sulphotransferase enzymes (Debaun et al, 1968). (4) One- 
electron addition by peroxidases to yield the nitroxide radical which spontaneously 
dismutates to N-acetoxy-AAF and 2-nitrosofluorene (Bartsch and Hecker, 1971), and 
(5) Transfer of the acetyl groups from the amino-group nitrogen to the hydroxyl 
oxygen with the formation of 2-acetoxy-2AF by cytosolic acetyltransferase, (Bartsch 
et al, 1972). Of all these reactions, deacetylation is the most important in the 
activation of N-0H-2AAF because the hydroxylamine of 2AF is 200-fold more 
carcinogenic.
The rate limiting step in 2AAF carcinogenesis is N-hydroxylation and has, therefore 
been extensively investigated.
L3.2. Phase I  metabolism of 2AAF and 2AF
Phase I or functionalisation reactions constitute the initial reactions in the 
metabolism of xenobiotics. With 2AAF and 2AF, phase I metabolism mainly 
involves hydroxylation. Enzymes that carry out these functionalisation reactions 
include the cytochrome P450- and flavin-containing monooxygenases and a cytosolic 
NADPH-dependent oxidase found in the liver of rats treated with Aroclor 1254. 
Prostaglandin H synthase (PHS) is also responsible for the bioactivation of 2AF 
though this extrahepatic enzyme is concerned with one-electron addition and not 
hydroxylation.
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1.3.3. The cytochrome P450 mixed-function oxidases
The superfamily of isoenzymes collectively known as the cytochrome P450 mixed- 
function oxidases consists of 74 gene families including 14 families, comprising 26 
sub-families, which are expressed in all mammals (Nelson et al, 1996). The 
cytochromes P450 (CYP) are membrane bound, haem-containing enzymes found 
within the endoplasmic reticulum and, to a lesser extent, the nuclear envelope and 
mitochondria of the majority of mammalian cell types. CYPs have also been isolated 
from most eukaryotic and many prokaryotic cells (Nebert et al, 1991). In mammals 
the CYPs play an important role in the endogenous metabolism of steroids, bile 
acids, fatty acids, prostaglandins, leukotrienes and biogenic acids. However, certain 
subfamilies are also concerned with the metabolism of a wide range of xenobiotics 
including pharmaceuticals, pollutants, natural plant products, insecticides and 
alcohols. These isoforms are members of the CYPIA, CYP2A, CYP2B, CYP2C, 
CYP2D, CYP2E, and CYP3A subfamilies. CYPs are responsible for both the 
bioactivation and the detoxication of carcinogens, teratogens and other toxins. In 
many instances different isoforms act antagonistically, one responsible for the 
activation while another is responsible for the detoxication of a chemical carcinogen. 
2AAF and 2AF are excellent examples of this duality, with CYPs catalysing both N- 
and ring-hydroxylation.
2-Acetylaminofluorene is oxidised, by the CYPs to 1-, 3-, 5-, 7-, 8-, 9-, and N- 
hydroxy-2AAF (Smith and Thorgeirsson, 1981). Activation via N-hydroxylation is 
accomplished by the CYPlAl and CYP1A2 isoforms in both rat and human tissues 
(Astrom and DePierre, 1985; Rudo et al, 1987). In liver from untreated rat, the 
contribution by each of these isoforms is comparable, but in 3-methylcholanthrene-
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pretreated rats CYPlAl is responsible for the majority of the N-hydroxylation 
(Goldstein, et a l, 1984). In contrast, human CYP1A2 is the preferred hepatic 
isoform because CYPlAl expression is extremely low in human liver, while in non- 
hepatic tissues, such as mammary gland, bioactivation by the CYPlAl isoform 
predominates (McManus et a l, 1990). In both mouse and rabbit only CYP1A2 
catalyses the N-hydroxylation of 2AAF.
The CYPIA family is also responsible for the detoxication of AAF. In rat hepatic 
microsomes the total 2AAF metabolism by CYPlAl is 10 to 16 times greater than 
CYP1A2 which is 30-fold greater than all the other isoforms (Astrom and DePierre, 
1985; Goldstein et a l, 1984). Each isoform is capable of oxidising 2AAF at more 
than one position. CYPlAl can oxidise 2AAF at the 3-, 5-, 7-, and 9-ring positions, 
in addition to N-hydroxylation, and the CYP1A2 isoform is responsible for N-, 7-, 5- 
, 9-, and 3-hydroxylation (McManus et a l, 1990). The most abundant metabolite in 
rat hepatic microsomes is 7-hydroxy-2AAF, being the predominant product of the 
CYPlAl, 2B2,2C6, and 3A1 isoforms and the second most abundant CYP1A2- and 
CYP2B1-dependent metabolite (Astrom and DePierre, 1985). Similarly, in human 
only 15% of the CYPlAl-dependent 2AAF metabolism involves formation of the N- 
hydroxylamine. CYPlAl is mainly responsible for detoxication, and oxidises 75% of 
2AAF to 7-OH-2AAF. In contrast, CYP1A2 catalyses the formation of equal 
amounts of both N- and 7-OH-2AAF but the predominant metabolite is 1-0H-2AAF.
Cytochrome P450-dependent oxidation of 2AF is similar to that of its acetylated 
derivative. N- and ring-oxidations were performed by purified rat CYPlAl, 1A2, 
2B1, 2B2, 2D1 and 2C11 (Hammons et a l, 1985). Similarly, the most active
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isoforms in the oxidation of 2AF are CYPlAl, 1A2, and 2B1 with CYP1A2 the 
principal isoform concerned with N-hydroxylation (Hammons et al., 1985). In the 
lung, 2AF is also metabolised by CYP4B1 (Verschoyle et a l, 1993), a form 
important in 2AF metabolism by the rabbit along with CYP2B4 and CYPlAl 
(Vanderslice etal, 1985).
Members of the CYPIA subfamily are only found in low concentrations in untreated 
animals, but can constitute the major isoform in tissues after pretreatment with many 
planar xenobiotics, such as 3-methylcholanthrene, polychlorinated biphenyls and 
polycyclic hydrocarbons. The induction process responsible for the marked increase 
in CYPIA expression, and the expression of a number of other important enzymes, 
involves the aryl-hydrocarbon receptor.
The ethanol inducible, CYP2E1 enzyme is also linked to chemical carcinogenesis, 
and after chronic feeding of ethanol, hamster S9 had increased 2AF and 2AAF 
mutagenic-bioactivation (Traynor er a/., 1991).
1.3.4. The Aryl-hydrocarbon receptor
The aryl-hydrocarbon, or Ah, receptor mediates the induction of a number of 
enzymes by planar aromatic xenobiotics, and is of importance to the 
biotransformation of 2AAF and 2AF. The receptor is found in the cytosolic fraction 
and the nucleus of cells from the majority of tissues, including lung, liver, kidney, 
heart, brain, and muscle (Li et a l, 1994). It is a multi-subunit receptor of 280kDa, 
and in the cytosol it is associated with an hsp90 protein (Hankinson 1993).^Lung
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cytosol has the highest concentration of Ah receptors, 5-10-fold more than the liver, 
kidney or heart (Li et al., 1994).
Many environmentally important carcinogens (PAHs, PCBs, and aromatic amines) 
bind to the Ah receptor. Preferred ligands are planar, and bind non-covalently to the 
aryl-hydrocarbon receptor ligand binding sub-unit (ALBS). Ligands may be parent 
compounds or their metabolites (Bigelow and Nebert, 1982) .
When the ligand binds to the Ah receptor, hsp90 is released allowing the binding of 
the aryl hydrocarbon receptor nuclear transferase (ARNT) protein to the ligand- 
receptor complex (Guengerich, 1996). This complex enters the nucleus and binds to 
sequences of the DNA called xenobiotic responsive elements (XREs). XREs are 
found in multiple copies upstream of many genes and binding of the Ah receptor 
results in transcriptional activation, by genomic derepression, of structural genes, 
leading to an increase in the synthesis of a number of enzymes including CYPlAl, 
CYP1A2, CYP IB 1, UDP-glucuronosyltransferase, NAD(P)Hquinoneoxido
reductase, ornithine decarboxylase, glutathione S-transferase and aldehyde oxidase 
(Nebert and Jensen, 1979). Some of these enzymes are involved in the metabolism of 
planar carcinogens. Protein kinase c, the enzyme responsible for phosphorylation 
essential for receptor-ligand binding and for gene activation, is also induced (Nebert 
and Jensen, 1979).
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1.3.5. Flavin-containing monooxygenase
The flavin-containing monooxygenases, mixed-function amine oxidases or Ziegler 
enzymes, have been demonstrated in several mammalian species and are localised in 
the microsomes of many tissues (Cashman, 1995). These enzymes are adapted to
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catalyse the detoxication of structurally diverse, lipophilic, soft nucleophiles to polar, 
readily excreted oxygenated metabolites. Flavin-monooxygenases (FMOs) have a 
broad substrate specificity. Substrates usually contain either sulphur, nitrogen or 
phosphorus and are metabolised to products with lower toxicity. FMOs have this 
broad substrate specificity because oxygen binds to the flavin prosthetic group before 
the substrate, forming a hydroperoxyflavin, then any compound that can be 
subsequently oxidised by this hydroxyflavin is a possible substrate for FMO. Over a 
thousand substrates have been identified including several amines and 
hydroxylamines (Cashman, 1995).
Five flavin monooxygenase isoforms have been identified, FMOl, FM02, FM03, 
FM04 and FM05, three of which are found in adult human livers. FM03 is the 
major hepatic form and there are low concentrations of both FM02 and FM04. 
Human foetal liver also expresses FMOl activity, the isoform that predominates in 
adult human kidney (Cashman, 1995). FMO can facilitate both activation and 
deactivation reactions but is specific for N-oxidation of aromatic amines including 
2AF (Frederick et al, 1982). FMO has been isolated fi-om a number of non-hepatic 
organs and may have an important role in the metabolism of 2AF in tissues with only 
poor CYP activities. However, 2-AAF is non-mutagenic in the Ames test employing 
purified FMO (Pelroy and Gandolfi, 1980) so this carcinogen is probably not a 
substrate for this enzyme.
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1.3.6. Prostaglandin H synthase
Prostaglandin H synthase (EC.l.14.99.1) is an extrahepatic glycoprotein complex of 
two identical haem-containing subumts, found in the endoplasmic reticulum, and 
nuclear membranes. Physiologically, prostaglandin H synthase (PHS) initiates the 
metabolism of arachidonic acid to functionally active eicosanoids, prostaglandins, 
thromboxanes and prostacyclin. It has two distinct catalytic activities, a 
cyclooxygenase and a peroxidase. The cyclooxygenase component oxygenates 
arachidonic acid to an unstable cyclic hydroperoxy endoperoxide, prostaglandin Gi 
(PGG2), then the peroxidase component reduces PGG2 to the hydroxy endoperoxide, 
prostaglandin H2, (PGH2).
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Figure.1.8. The role of prostaglandin H  synthase in carcinogen 
oxidation (taken from Boyd et al, 1983)
The concomitant conversion of xenobiotics to free radicals can occur with PHS- 
dependent metabolism of arachidonic acid by three mechanisms. (I) The direct 
oxidation of xenobiotics by peroxidase. (II) PHS-generated peroxyl radicals can act
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as.oxidising agents and oxygenate xenobiotics. (Ill) The formation of a secondary 
oxidant species derived from a metabolite, catalysed by the peroxidase (Eling and 
Curtis, 1992).
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Many compounds act as reducing co-substrates for peroxidase-catalysed one electron 
oxidation. Co-substrates, including phenols and aromatic amines, can yield activated 
metabolites. PHS-dependent DNA adducts are found in a number of non-hepatic 
tissues, especially bladder urothelium and renal medulla, where CYP expression is 
low. Stable products of PHS metabolism of 2AF are 2,2’-azobisfluorene, 2-
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nitrosofluorene and 2-aminodifluorenylamine (Eling et al, 1988). 2-AAF is not a 
substrate for PHS.
1.3.7. Cytosol-dependent oxidation
It was believed that the subcellular location of phase I metabolism of aromatic 
amines was restricted to the endoplasmic reticulum (microsomes), with the cytosol 
responsible only for some phase II reactions, but this view no longer appears to be 
true. Hepatic cytosol has a potentiating effect on the microsomal activation of 
mutagens in the Ames and other mutagenicity tests, in the absence of cofactors 
required for phase II metabolism. The microsome-mediated mutagenicity of 
benzidine (Smith and loannides, 1987), 2-amino-3-methylimidazo[4,5-f]quinoline 
(Abu-Shakra et al, 1986), N-nitrosopiperidine (Ayrton et al, 1987), aflatoxin Bi, 2- 
aminofluorene and benzo[a]pyrene (Saccone and Pariza, 1981) were all sigmficantly 
enhanced by supptoentation with untreated rat hepatic cytosol. Cytosol from rats 
pretreated with Aroclor 1254, phénobarbital or 3-methylcholanthrene also potentiated 
the bioactivation of several aromatic amines by untreated microsomes, and the 
further addition of cytosol to control rat liver S9 increased the mutagenicity of 2AAF 
(Forster et al., 1981a). Initially it was postulated that these observations are the 
consequence of the soluble fraction diffusing into the bottom agar, so that the 
addition of supplementary SI05 is necessary to simply restore the cytosol lost by 
diffusion (Forster et a l, 1981a). Other hypotheses include the further metabolism of 
promutagens formed by the microsomal fraction or, as is the case with 
benzo[a]pyrene, cytosol-dependent conjugation can enhance the mutagenic response
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by removing quinone metabolites which are potent inhibitors of microsomal 
activation (Nemoto et a l, 1978; Shen et a l, 1979) or, alternatively, there may be a 
soluble component required for the microsomal electron transfer chain.
Intrigued by the differences between the activation of aromatic amines by S9 from 
Aroclor 1254 and untreated rat livers Forster et al, (1981a and 1981b), investigated 
the role of the soluble fraction in bioactivation and noted that the hepatic cytosolic 
fraction (SI05), could not only supplement microsomal activation but also 
metabolised 2AF, 2AAF and 2-aminoanthracene to mutagenic intermediates in a 
microsome-free system. 2-Naphthylamine also exhibited limited microsome- 
independent bioactivation by cytosol (Ami et al, 1980). This cytosolic system was 
NADPH-dependent and resistant to repeated ultra-centrifugation. Other bacterial 
mutagens, such as benzo[a]pyrene, ethidium bromide and dimethylaminoazobenzene, 
whose bioactivation by the microsomal fraction to reactive metabolites was 
potentiated by the addition of the SI05 fraction, were not bioactivated by the 
cytosolic fraction (Forster et al, 1981b). Therefore the cytosolic-potentiating and 
bioactivating systems are two separate systems because, apart from different 
substrate specificity, the two systems also have different responses to the comutagen 
norharman. Norharman inhibits microsome-independent bioactivation by cytosol but 
increases the enhancing effect of cytosol on bioactivation by the microsomal fraction 
(Forster e/a/., 1981a).
For ten years following these initial observations this cytosolic system did not attract 
any attention. Then a more detailed investigation of the bioactivation of 2AF was 
undertaken using cytosol from Aroclor 1254-pretreated rats (Leist et al, 1992 ).
26
These workers established that the cytosolic activity was resistant to dialysis, was 
abolished by heating or by incubation with proteinase k, had a requirement for both 
oxygen and NADPH and was refractive to repeated centrifugation.
The possible involvement of the cytosolic molybdenum oxidases; aldehyde oxidase 
and xanthine oxidase, was disproved by the resistance of this activity to inhibition by 
xanthine, phthalazine and allopurinol. (+)-Catechin also had no effect so rejecting 
any involvement of cytochrome P450 reductase (Ayrton et al., 1992; Leist et al., 
1992).
This cytosol-dependent bioactivation of 2AF was depressed by the oxygen radical 
scavengers dimethyl sulphoxide and retinol; any role for a free radical mechanism is, 
however, unclear because the incorporation of superoxide dismutase, catalase or 
ascorbic acid had no effect. PurtkcT: demonstrated identical
characteristics for the cytosolic bioactivation of 2-aminoanthracene (Ayrton et al,
1992). Other investigators have however demonstrated the oxidation of aromatic 
amines by H2O2 and various peroxidases and catalase (Yagi, 1979).
DeFlora et al demonstrated the NADPH-dependent mutagenicity of the food 
mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), 2-amino-3,4-dimethyl 
imidazo[4,5-f]quinoline (MelQ) and 3-amino-l-methyl-5H-pyrido[4,5-b]indole (Trp- 
P-2), in addition to 2AF, 2AAF and 2-aminoanthracene in the cytosol of Sprague 
Dawley rats (DeFlora et al, 1994). This activity was inducible by Aroclor 1254 and
3-methylcholanthrene but not phénobarbital. Notably this bioactivation was inhibited 
by the addition of dicoumarol, an inhibitor of cytosolic DT-diaphorase, an FAD- 
containing flavoprotein induced by both 3-methylcholanthrene and Aroclor 1254.
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This group also demonstrated that SI2, SI05 and purified DT-diaphorase could 
support both the NADPH- and NADH-dependent bioactivation of heterocyclic 
amines (DeFlora et a l, 1994). A role for DT-diaphorase is, hoivever, difficult to 
interpret because amino compounds do not accept electrons, and are consequently 
not substrates for this enzyme. The mutagenic responses in the same study, in the 
presence of cytosol, were less profound using the N,0-acetyltransferase deficient, 
TA98-l,8-DNPe, Salmonella strain, which suggests oxidation of the amino group is 
required for bioactivation^ but unchanged with the nitroreductase deficient TA98NR. 
Therefore this group proposed an initial cytosolic or microsomal oxidation followed 
by DT-diaphorase-catalysed formation of an N-hydroxyamino derivative.
Marginal induction of the bioactivation of 2AAF but not 2AF, in the presence of 
cytosol, was also observed in rats after chronic ethanol ingestion (Traynor et al,
1991), and a very slight mutagenic response was observed for 2AF with cytosol from 
rats fed beef tallow or kept on a low fat diet (Tsai and Pence, 1992).
The N-hydroxylation of 2AF, 2AAF and 2AA has also been detected in the cytosol 
of human red blood cells (Duverger-van Bogaert et al, 1991 and 1992) in both the 
presence and absence of methylene blue. Methylene blue is used as an exogenous 
electron carrier, to increase NADPH levels via activation of the pentose phosphate 
shunt. Haemoglobin is probably involved in this mutagenicity by reducing 
hydroxylated metabolites of arylamines to the nitroso derivative with the concurrent 
formation of methaemoglobin. A unique enzyme is probably involved in the initial 
N-hydroxylation of these compounds because red blood cells have no cytochrome 
P450 or flavin monooxygenase.
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Despite the fact that cytosol-dependent activation of 2AAF, 2AF and 2AA has been 
demonstrated; the mechanism has not been identified, though from the current 
evidence N-hydroxylation appears to be the most likely route of activation. It is 
relevant to point out that hydroxylation of 3-methylcholanthrene has been previously 
demonstrated in the cytosol but this activity did not require any cofactors (Flesher 
and Myers, 1985). \
In the microsomal fraction, CYPlAl and CYP1A2 are the proteins most active in the 
N-hydroxylation of aromatic amines, however CYPlA-like activity has also been 
identified in hepatic cytosol isolated from the human foetus and rat conceptus (Yang 
et al, 1995). This activity consisted of ethoxyresorufin-O-deethylase (EROD), used 
as a marker for CYPlAl activity (Namkung et ah, 1988). |n the foetus EROD 
activity was markedly higher in cytosol than in microsomes. Other dealkylation 
activities detectable in embryonic liver cytosol which are usually associated with the 
cytochromes P450 were; methoxyresorufin 0-demethylase (CYP1A2), 
pentoxyresorufin 0-depentylase (CYP2B) and benyloxy 0-debenzylase (CYP3A). In 
the foetus benzyloxy 0-debenzylase expressed the greatest activity in the cytosol, 
followed by ethoxy-, pentoxy- and methoxy-dealkylase activities, whereas in the 
microsomes only ethoxy- and to a lesser extent benzyloxy- dealkylase activities were 
detectable. Surprisingly, cytosolic EROD activity was unaffected by both anti- 
CYPlAl antibodies and 7,8-benzofiavone, which inhibited the microsomal EROD 
by 72 and 77% respectively. Interestingly, it has previously been demonstrated that 
the CYPIA inhibitors, a-naphthoflavone, 9-hydroxyellipticine and anthraflavic acid 
abolished both microsomal and cytosolic bioactivation of 2-aminoanthracene, while
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the CYP2B and CYP3A inhibitor metyrapone removed cytosolic, but had no effect 
upon microsomal activation (Ayrton et al, 1992). Therefore a haem-containing 
enzyme structurally related to CYP may be responsible for this activity.
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1.3.8. Phase II metabolism of 2AAF and 2AF
In the liver the phase I deactivating metabolism of 2AAF and 2AF involves ring 
hydroxylation mainly at position 7 but also l-,3-,5-,8- and 9-positions catalysed by 
CYPlAl and a number of other CYPs (Smith and Thorgeirsson, 1981; Hammons et 
al., 1985). Hydroxylation increases the aqueous solubility of compounds allowing 
their ready excretion, and conjugation of phase I metabolites increases still further 
this solubility. However, occasionally conjugation leads to highly unstable, reactive
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metabolites, and these reactions are an essential step towards the generation of the 
ultimate carcinogen.
The major phase II enzymes involved in 2AAF and 2AF metabolism are deacetylase, 
UDP-glucuronosyltransferase, sulphotransferase, and
acetyltransferase.
1.3.9. Deacetylase
Non-specific microsomal deacetylase activity is exhibited by most tissues but the
highest activity is associated with the liver and kidney. Aroclor 1254 induces
deacetylation of both 2AAF and N-0H-2AAF, with deacetylation of the latter 30-40
times greater than the parent (Schut et al, 1978). Deacetylation is the most important
reaction in the mutagenicity of N-0H-2AAF because N-0H-2AF is 200-300 fold
more mutagenic (Schut ûr/., 1978) | A
oiosancie. of ^  .
1.3.10. UDP-glucuronosyltransferase
The UDP-glucuronosyltransferases (EC 2.4.1.17) are quantitatively the most 
important conjugation enzymes in the metabolism of N-OH-AF and N-OH-AAF. 
They are hepatic microsomal enzymes and catalyse the N-glucuronidation of 2AF 
and N-0H-2AF and the 0-glucuronidation of 2AAF; both activities are induced by 
prototype inducers e.g. phénobarbital and 3-methylcholanthrene (Bock, 1991). Of the 
two families of UDP-glucuronosyltransferases, UGT-1 and UGT-2, it is the latter that 
is responsible for aromatic amine glucuronide-conjugation.
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The glucuronidation of N-oxidised metabolites of aromatic amines has two roles. (1) 
Formation of a soluble, transport form of the proximate carcinogen and (2) 
Detoxication (Bock, 1991). The N-glucuronide of N-0H-2AF is excreted in urine 
but, under acidic conditions, such as those found in dog urine, the N-glucuronide is 
lysed releasing the hydroxylamine proximate carcinogen. N-Glucuronides therefore 
play an important transport role in the bladder carcinogenesis of aromatic amines.
The 0-glucuronides of N-0H-2AAF and N-OH-2AF are also excreted in urine, but 
do not induce DNA repair synthesis in the absence of p-glucuronidase (Wang et aL,
1984). p-Glucuronidase activity is low in bladder and therefore 0-glucuronidation is 
usually a detoxication pathway. Both N- and O-glucuronides are excreted in both the 
bile and urine (Irving et al, 1967).
In the rat only 10% of a dose of 2AAF and 21% of a dose of N-0H-2AAF are 
excreted in bile as the N-OH-AAF-O-glucuronide within 24 hours,This low rate o f fueco i 
excretion being probably a consequence of enterohepatic circulation. Only 1-1.5% of 
the same dose is excreted in the urine. In contrast, the excretion of ring-hydroxylated 
metabolites of 2AAF and 2AF are found in much higher quantities as O- 
glucuronides, with the glucuronides of 3-, 5-, and 7-OH-AAF being detected at 
significant levels in rat urine.
L3.1L Sulphotransferase
Bioactivation of N-OH-AAF by sulphotransferases was the first example of a phase 
II enzyme-mediated activation step to be described (Kato and Yamazoe, 1994). 
Sulphotransferases are cytosolic enzymes and require 3’-phosphoadenosine-5’-
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phosphosulphate (PAPS) as a sulphate donor. Human, mouse, guinea pig, hamster, 
rabbit, dog and, most significantly, rat all conjugate N-0H-2AF and N-OH-AAF to 
sulphonoxy metabolites (Abu-Zeid et al, 1992).
Of the three human sulphotransferases so far identified; namely thermostable phenol 
sulphotransferase (TS-PST), thermolabile phenol sulphotransferase (TL-PST), and 
dehydroepiandrosterone sulphotransferases (DHEA-ST), only TS-PST is involved in 
aromatic amine sulphate conjugation. The large human inter-individual differences in 
sulphate conjugation suggest that TS-PST demonstrates genetic polymorphism. This 
polymorphism may be important in the susceptibility of certain individuals to 
aromatic amine carcinogens. Contrary to in vivo studies, incorporation of PAPS in 
vitro with either rat liver cytosol (Mulder et al, 1977) or purified sulphotransferases 
(Wirth and Thorgeirsson, 1981) resulted in decreased N-OH-AAF mutagenicity. This 
is probably a result of the very short half-life of this conjugate. Sulphotransferase is 
therefore likely to be less important in aromatic amine activation than 
acetyltransferase.
1.3.12. Acetyltransferase
Cytosolic acetyltransferases are responsible for both acetyl CoA-dependent N- and
5'
O-acetyltransferase, and N,0-acetyltransferase activity. Acetyltraijferase exists as 
two isoenzymes, ATI and ATII, the latter being polymorphic in many species 
including man (Kato and Yamazoe, 1994).
Acetyltransferase I is able to catalyse the acetyl CoA-dependent N-acetylation of 
2AF, both N- and 0-acetylation of N-OH-AF to N-OH-AAF and 2-acetoxy 2AF,
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the 0-acetylation of N-0H-2AAF to 2-acetoxy-AAF andN,0 acetyltr^fer of N-OH- 
2AAF to 2-acetoxy-AF (Lotlikar and Luha, 1971). ATI also carries out N- and O- 
acetylation independent of acetyl Co A, where acetylated arylhydroxamic acids act as 
acetyl donors to N-hydroxylamines to give the highly mutagenic N-acetoxyarylamine 
(Bartsch el ûf/., 1972).
ATII cannot acetylate aromatic amines in the absence of acetyl CoA but does N- 
acetylate 2AF and 0-acetylate N-OH-AF in many tissues, including rat liver, urinary 
bladder and colon. ATII activity is dependent upon the acetylator phenotype, and 
consequently, slow acetylator phenotypes have an increased incidence of urinary 
bladder cancer while fast acetylators show increased incidences of colon cancer 
(Chou et al, 1995). Individuals with slow acetylator phenotype have a 
predisposition for glucuronidation of N-OH-AF. Excretion of this conjugate in bile, 
followed by cleavage catalysed by A-glucuronidase present in the gut microflora, 
may explain the increased incidence of colon cancer in these individuals (Hein et al,
1993). N-acetylation is a detoxication reaction because 2AAF and N-OH-AAF are 
considerably less carcinogenic than 2AF and N-OH-AF, but 0-acetylation of N-OH- 
AF and N,0-acetyltransfer of N-OH-AAF are activation steps giving mutagenic N- 
acetoxyarylamine derivatives that degenerate to the nitrenium ion, the ultimate 
carcinogen. Acetyltransferase is the most important conjugation enzyme in the 
activation of 2AF.
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1.3.13. Further metabolism by prostaglandin H-synthase
N-OH-AF and 2-nitrosofluorene metabolites of 2AF phase I metabolism are 
substrates for prostaglandin H synthase and are both oxygenated to 2-nitrofluorene 
(Boyd et al, 1983). N-0H-2AAF is metabolised by rat mammary gland cells to the 
unstable nitroso free radical, which spontaneously dismutates to generate 
nitrosofluorene and N-acetoxyacetylaminofluorene (Wong et aL, 1982).
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Figure.1.11. Phase II metabolism of 2AAF and 2AF hydroxylamines
1.3.14. Glutathione conjugation
Conjugation with glutathione is a detoxication reaction. Glutathione can readily 
conjugate with free radicals generated by peroxidases o r ,alternatively, glutathione-S- 
transferase can catalyse the formation of soluble 0-glutathione metabolites of ring-
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and amino-hydroxylated metabolites. The significance of glutathione in 
detoxification of 2AF and 2AAF is unclear. Salmonella strains expressing human 
glutathione-S-transferase used in bacterial mutagenicity tests showed no change in 
the mutagenicity of 2AF and only slightly reduced N-0H-2AF mutagenicity 
compared to the original strain (Simula et al, 1993), probably because glutathione 
removes nitroso free radicals produced by PHS.
1.4. Objectives
The aims of this work are to increase the understanding of the cytosolic and 
microsomal oxidation of aromatic amines, to identify and quantitate the products of 
these activities and investigate the role of the Ah-receptor and individual 
polychlorinated biphenyl congeners in the induction process. Emphasis will be 
placed on the characterisation of the cytosolic activity culminating in its purification.
Recent experimental evidence indicates that an NADH-dependent system which can 
also carry out the activation of 2AA and 2AF also exists in the microsomes of rats 
treated with Aroclor 1254 (Leist et al, 1992; Ayrton et al, 1992). This activity will 
be investigated in more detail using 2AA as a model substrate, in the Ames test.
The aryl-hydrocarbon (Ah) receptor is known to co-ordinate the induction of many 
enzymes involved in chemical carcinogenesis. The relevance of the Ah receptor to 
aromatic amine metabolism by the microsomes, both NADPH- and NADH-
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dependent, and cytosol will be investigated using strains of mice that are either Ah- 
responsive (C57bl6) or Ah-non-responsive (DBA2).
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CHAPTER 2
Materials and methods
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2.1. Materials
Kochlight laboratories Ltd, 
Coinbrook,
Bucks
2-Aminochrysene
Commission of European 
Communities, Brussels, 
Belgium
2-Methylchrysene and 6-methylchrysene
Aldrich Chemical Co, 
Gillingham,
Dorset
Chrysene, 2,3-diaminonaphthalene, 1,8- 
diaminonaphthalene, o-aminoazotoluene, 3- 
methoxy-4-aminoazobenzene, 2,4-diamino 
toluene, 2,6-diaminotoluene and 2- amino 
fluorene
Wako Fine Chemicals, 
Neuss,
Germany
2-Amino-3-methylimidazo[4,5-f]quinoline 
(IQ), 2-amino-3,4-dimethylimidazo[4,5-f] 
quinoline (MelQ) and 2-amino-6-methyl 
dipyrido[l,2-a:3’,2’- d]imidazole (Glu-P-1).
Ralph and Emmanuel Ltd, 
Wembley,
Middlesex
1 -Aminoanthracene
Rohens Institute, 
University of Surrey, 
Guildford,
Surrey
Aroclor 1254
ICI Pharmaceuticals PLC, 
Macclesfield,
Lancs
BDH,
Poole,
Dorset
Clofibrate
Phenobarbitone, methylene blue and reduced 
glutathione
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Sigma Co,
Poole,
Dorset
Benzo[a]pyrene, dexamethasone, isoniazid, 
3,3’-diaminobenzidine, 2-aminoanthracene, 
6- aminochrysene, 2-acetylaminofluorene, 
hydroxylamine, 2,4,6-tripyridyl-S-triazine, 
(+)-catechin, No-nitro-l-arginine-methyl 
ester (NAME), cobalt(III)chloride, 
cytochrome c, methylene blue, 
streptozotocin (2-deoxy-2-[([methylnitroso 
amino] carbonyl)amino}- D-glucopyranose), 
Folin and Ciocalteau’s phenol reagent, 
sodium dodecyl sulphate (SDS), bovine 
serum albumin (Fraction V), N,N,N',N- 
tetramethyl-ethylenediamine (TEMED), 
ammonium persulfate, P-mercapto ethanol, 
coomasie blue R250, bromophenol blue, 
hydrogen peroxide, peroxidase linked 
donkey anti-sheep antibody, NADP, 
NADPH, NADH, glucose-6-phosphate and 
glucose-6-phosphate dehydrogenase
Beckton and Dickinson, 
Cowley,
Oxford
Vogel-Bonner E plates
British Greyhound chromatography 
and allied chemicals,
Birkenhead,
Merseyside
All polychlorinated biphenyl congeners
Molecular Frohes, 
Eugene,
Oregon, USA
Resorufin, methoxyresorufin, ethoxy 
resorufin and pentoxyresorufin
FSA,
Loughborough,
Leics
DMSO, methanol, 
magnesium sulphate
ethyl acetate and
Gentest Corporation, 
Woburn,
USA
Anti-rat cytochrome P450 reductase
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Midwest Research Institute, 
Kansas City,
Missouri
Ring-pH]-2-acetylaminofluorene(2AAF, 
3.26mCi/mg), l-hydroxy-2-AAF, 3-hydroxy 
-2AAF, 5-hydroxy-2AAF, 7-hydroxy- 
2AAF, 8-hydroxy-2AAF, 9-hydroxy-2AAF 
and N-hydroxy-2AAF
Whatman Inc, 
Clifton,
New Jersey
Partisil lO-ODS hplc column
Wallac Scientific Products, 
Milton Keynes
Optiphase ‘safe’
Schleicher and Schuell, 
Dassel,
Germany
Protran BA 85 nitrocellulose sheets
National Diagnostics, 
Aylesbury,
Bucks
Acrylagel and Bis-acrylagel
Pharmacia Biotech, 
Uppsala,
Sweden
Sephacryl S-300 High resolution and 
sephacryl S-100 High resolution.
Salmonella typhimurium strains, except TA98-1,8-DNP6 (kindly donated by 
Professor H. Rosenkranz, Cleveland, USA), were gifts from Professor B.N. Ames 
(Berke^ California). l-Hydroxy-2-aminofluorene, 3-hydroxy-2-aminofluorene, 7- 
hydroxy-2-aminofluorene and N-hydroxy-2-aminofluorene were gifts from Professor 
J.W. Gorrod (Kings College, London). Human hepatic cytosol was a gift from Dr. 
A.R. Boobis (Hammersmith Hospital, London).
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1-Aminobenzotriazole (lABT) was kindly synthesised by Mr P. Kentish by the 
method of Campbell, C.D. and Rees, C.W. (1969).
Antibodies to CYPIA were produced by Rodrigues (Rodrigues et aL, 1987). The 
antigen was rat CYPlAl and the antibodies were raised in sheep. Antibodies 
recognised both members of the CYPIA family, CYPlAl and CYP1A2, but did not 
cross react with proteins from other families.
2.2 Methods
2.2.1. Pretreatment of animals
Male Wistar albino rats (The Experimental Biology Unit, University of Surrey), 
male golden Syrian hamsters (Wrights, Essex), male albino ferrets (Graystons, 
Ringwood, Hants), male Sprague Dawley rats (Harlan-Olac UK Ltd, Bicester, Oxon) 
and male C57BL6 and DBA2 mice (B and K Universal Ltd, Hull, North 
Humberside) were all purchased. All animals were housed in cages with sawdust 
bedding and were allowed food and water ad libitum, and were kept in a 12 hour 
light-dark cycle (0700-1900 light) at 20°C and 50% humidity.
Animals were treated with a single intraperitoneal injection of either Aroclor 1254 
(250mg/ml dissolved in com oil) at a dose of 500mg/kg of body weight, or individual 
polychlorinated biphenyls (70mmol/ml dissolved in com oil) at a dose of 70mmol/kg 
of body weight. Animals were sacrificed by cervical dislocation on the fifth day after 
injection.
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Alternatively, induction of the cytochromes P450 was achieved by dosing for three 
consecutive days with either benzo[a]pyrene (25mg/kg of body weight, dissolved in 
com oil), phenobarbitone (80mg/kg of body weight, dissolved in distilled water), 
clofibrate (80mg/kg of body weight, dissolved in 0.9% saline), by intraperitoneal 
injection, or dexamethasone (lOOmg/kg of body weight, dissolved in distilled water), 
and isoniazid (lOOmg/kg of body weight, dissolved in distilled water) by oral gavage. 
Animals were sacrificed 24 hours after the last treatment by cervical dislocation.
2.2.2. Preparation of subcellular fractions
Hepatic subcellular firactions were prepared, with some slight modifications, as 
described previously (loannides and Parke, 1975). The livers were excised and 
immediately washed in ice-cold, sterile KCl (1.15% w/v) to remove excess blood. 
Subsequently the livers were weighed, scissor minced and homogenized in 3 
volumes of ice-cold, sterile KCl (1.15% w/v) using a motor-driven Potter-Elvehjem 
glass-teflon homogeniser. The homogenate was adjusted to 25% (w/v) by further 
addition of 1.15% (w/v) KCl and was centrifuged at 9,000g for 20 minutes at 4°C in 
a Beckman J2-21 centrifuge using a JAH 14 x 50ml aluminium angle-head rotor. The 
supematants (S9)k/cf^ decanted off and stored as 2ml aliquots at -20°C until required. 
89 was prepared firom rat brain in the same way as hepatic 89, but heart, lung and 
kidney homogenates were homogenised using a Polytron PI1000 homogeniser.
Ultracentrifugation, using a Beckman L8-7 ultracentrifuge with either a TY65 (8 x 
10ml titanium angle-head rotor) or a T170.1 (12 x 10ml titanium angle-head rotor), at 
45,000rpm (105,000g) for 2 x 60 minutes separated the 89 into the cytosolic
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(supernatant) and microsomal (pellet) fractions. The microsomal pellet was 
resuspended in sterile 1.15% (w/v) KCl using a motor driven Potter-Elvehjem teflon 
homogeniser. All solutions and equipment were sterilised in an autoclave at 120°C, 
prior to use.
2.2.3. Protein determination using the Lowry procedure
Measurement of protein concentrations in subcellular fractions was determined by 
the Lowry procedure (Lowry et al, 1951), with bovine serum albumin (fraction V) 
used as standards.
The Lowry “Copper reagent” was prepared immediately prior to use by mixing 
copper sulphate (l%w/v), sodium potassium tartrate (2% w/v) and sodium carbonate 
(25% w/v) solutions (1:1:100).
Protein samples were diluted 25-fold for microsomes and 50-fold for cytosols and 
protein standards were diluted with NaOH (0.5N) to give a range of concentrations of 
bovine serum albumin (0-25Opg) per tube. Samples, standards and blanks were then 
further diluted 1:1 with NaOH (0.5N), prior to the addition of copper reagent (5ml). 
Samples were mixed and allowed to stand at room temperature for 10 minutes.
Folin Ciocalte(A. ’s phenol reagent was diluted 1:1 with distilled water and then added 
(0.5ml) to each tube and immediately mixed. The mixture was allowed to stand at 
room temperature for 30 minutes before the absorbance at 720nm was recorded using 
a Kontron Uvikon 860 spectrophotometer. The protein concentrations were 
determined from the standard curve. Samples, blanks and standards were all 
determined in triplicate.
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2.2.4. Spectrophotometric determination of microsomal 
cytochrome P450 concentration
Determination of microsomal cytochrome P450 concentration was essentially as 
described by Omura and Sato (1964), using the difference spectrum, recorded 
between 390-500nm, of the reduced-carbon monoxide bound complex with reduced 
cytochrome P450.
The microsomal suspension (25% w/v) was diluted 1:6 with potassium phosphate 
buffer (O.IM, pH 7.6). Reduction of cytochrome P450 was achieved by the addition 
of a few milligrams of sodium dithionite. After mixing, the reduced suspension was 
divided between two plastic cuvettes and placed into the reference and sample beams 
of a Kontron Uvikon 860 spectrophotometer. A baseline was recorded between 390 
and 500nm, then carbon monoxide was gently bubbled into the sample cuvette at a 
rate of about a bubble a second for 30 seconds, and the difference spectrum recorded 
between 390 and 500nm. Total cytochrome P450 concentration was calculated from 
the difference in absorbance at 450nm and 490mn employing an extinction 
coefficient of 91mM'* cm* .^
2.2.5. Spectrophotometric determination of aromatic amine 
N-hydroxylation
The N-hydroxylation of aromatic amines by rat hepatic subcellular fractions was 
determined by the Lolodmetric method of Belanger et aL, (1981), essentially as 
modified by Vanderslice et aL, (1987). The method is based on the reduction, by 
hydroxylamines, of free ferric ions to ferrous ions which when coupled with 2,4,6- 
tripyridyl-S-triazine give a purple colour with maximum absorbance at 595nm.
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Colour Reagent: Sodium acetate (5M) containing 2,4,6-tripyridyl-s-triazine
(0.24M) and ferric chloride (0.08M). The pH was adjusted to 
pH5.5 with glacial acetic acid.
The incubation mixture (2ml), was prepared in duplicate in 10ml tubes and consisted 
of:
Microsomal protein (50pg) 
or, cytosolic protein (lOOpg)
Aromatic amine (SOpmol)
NADPH or NADH (2mM in l%w/v NaHCOs)
Sodium phosphate buffer (0. IM, pH7.4).
The mixture was incubated at 37°C in a shaking waterbath for 10 minutes. At the end 
of the incubation, the reaction was terminated by placing the tubes on ice. To 0.5ml 
of incubation mixture was added 2.5 ml of colour reagent and mixed thoroughly. The 
mixture was left to stand at room temperature for 30 minutes to allow the colour to 
develop; and finally was centrifuged at 3000rpm for 10 minutes in a bench 
centrifuge. The absorbance was measured at 595mn with the absorbance of blanks, 
treated the same as samples, but in the absence of cofactors, subtracted. The 
concentration of N-hydroxylated metabolites was determined using hydroxylamine 
standards (5-40pmol).
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2.2.6. Fluorimetric determination of alkoxyresorufin O- 
dealkylase activity
The methods used were principally as described previously by Burke and Mayer, 
(1974) and Lubet et ah, (1985).
The dealkylation of three alkoxyresorufins, methoxy-, ethoxy-, and pentoxy- 
resorufins were determined by following the generation of resorufin fluorimetrically, 
using a Perkin Elmer LS5 luminescence spectrophotometer.
Spectrophotometer settings
excitation wavelength 510nm excitation slit width lO.Onm
emission wavelength 586nm emission slit width 2.5nm
To a 3ml quartz fluorimeter cuvette were added the following reagents;
Tris HCl buffer, O.IM, pH 7.8, at 3TC  2.00ml
Microsomal suspension (25%w/v) 0.01-0.05ml
or, cytosol* 0.20ml
and either ethoxyresorufin 0.53mM 0.003ml
pentoxyresorufin 1 .OOmM 0.005ml
or methoxyresorufin l.OOmM 0.005ml
* When measuring dealkylation in cytosol, dicoumarol was added to inhibit DT-
diaphorase, at a final concentration of lOpM.
After the baseline was recorded, the reaction was initiated by the addition of lOpl 
NADPH (50mM in 1% NaHCOs). The increase in fluorescence was monitored and
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the initial rate of resorufin generation was calculated from the slope. Calibration was 
achieved by adding aliquots (5pl) of resorufin (0.0 ImM) to an incubation mixture 
comprising all components except substrate.
Ethoxy-, methoxy-, and pentoxy-resorufin 0-dealkylase activities are considered to 
be markers for CYPlAl, CYP1A2 and CYP2B respectively (Namkung et aL, 1988).
2.2.7. The Ames Salmonella mutagenicity test
Mutagenicity was determined ,essentially, by the method of Ames et aL, (1975). All 
consumables and heat stable solutions were previously autoclaved at 120°C for 20 
minutes, and all procedures were performed in a class 2 flow cabinet.
Bacterial tester strains
Salmonella typhimurium strains TA98, TA98-1,8 DNPa and TA1530 were stored as 
permanent frozen cultures at -80°C incorporating DMSO as a cryopreservative 
(0.09ml in 1ml of overnight culture). Working cultures were prepared by inoculating 
nutrient broth, for TA1530, or nutrient broth containing ampicillin (25pg/ml), for 
strains TA98 and TA98-1,8-DNP6, with frozen culture using a platinum loop. The 
inoculated broth was incubated in a shaking waterbath at 37°C for 12 hours.
Testing for strain properties
The Salmonella strains have a requirement for histidine because they have lesions in 
the His operon which makes them unable to synthesise histidine. Different lesions
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enable strains to detect different types of mutagens, for example TA98 detects 
frameshift mutagens. These Salmonella strains also have two other mutations which 
increase their susceptibility and, therefore, their ability to detect mutagens. These 
mutations are the loss of their excision repair system {uvrE) and the inability to 
synthesise the lipopolysaccharide cell wall {rfa) which allows free entry of larger 
compounds into the bacteria. TA98 has further increased sensitivity because a 
plasmid (pKMlOl) has been introduced, which confers both ampicillin resistance and 
an error prone repair system (R-factor). Strain TA98-l,8-DNPô is deficient in several 
enzymes including a nitroreductase specific for nitropyrenes, and conjugation 
enzymes including sulphotransferase and O-acetyltransferase (McCoy et aL, 1983).
Table 2.1. Genotype of Salmonella strains used in the Ames test
Histidine mutation LPS Repair R-factor
hisD3052 hisG46
TA98 rfa AuvrB +R
TA98-1,8-DNP6 rfa SmrB +R
TA1530 gal AwrB -R
The deletion (A) through uvrB also includes the nitrate reductase(chl) and biotin (bio) genes. The 
gal and uvrB strains have a single deletion through gal chi uvrB. R =  pKMlOl.
Each frozen permanent culture was routinely tested for viability and spontaneous 
reversion rate to ensure that all strain characteristics were maintained. All tests were 
performed in duplicate.
Test for histidine requirement
Onto the surface of a Vogel Bonner E plate was spread lOOpl of high histidine/biotin 
solution (O.IM histidine and 0.5mM biotin). The bacterial culture was then streaked
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onto the plate with a platinum wire loop. Bacterial culture was also streaked onto 
histidine-free plates. Plates were incubated overnight at 37°C. If bacterial colonies 
were only observed on plates with histidine then the histidine mutation is still 
present.
Tests for rfa mutation and the R-factor
To 2ml of agar (agar 0.6%w/v and NaCl 0.5%w/v containing 5mM histidine and 
25pM biotin) was added lOOpl of bacterial culture, mixed and poured onto Vogel 
bonner E plates. Once the agar had solidified, a sterile filter paper disc (1cm in 
diameter) was added to the centre of the plate. To the filter paper disc was added 
either crystal violet (lOOpl of a 1 mg/ml solution), to test for the rfa mutation, or 
ampicillin (lOOpl of an 8mg/ml solution in 0.02N NaOH solution), to test for the R- 
factor. The plates were incubated overnight at 37°C. The presence of a clear zone of 
inhibition around the filter paper disc indicates the presence of the mutation or the 
plasmid.
Test for bacterial viability
To ensure that the overnight bacterial culture has sufficient viable bacteria, the 
bacterial culture was diluted serially 1 in 10® with nutrient broth and then 0.1ml of 
diluted culture was added to 2ml of agar (as above), mixed and poured onto Vogel 
Bonner E plates. The plates were incubated overnight at 37°C and the total number 
of colonies was counted so that the viability (number of bacteria/ml) of the original 
culture could be calculated.
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Test for spontaneous reversion rates
The spontaneous reversion rate, the number of reversions of histidine mutations in 
the absence of mutagens, was determined by incorporating a blank le., solvent only, 
into the Ames test.
The plate incorporation method
To 2ml of top agar (agar 0.6% w/v, NaCl 0.5% w/v containing histidine 0.05mM and 
biotin 0.05mM) in sterile, capped polyethylene tubes (10ml) in a 45°C waterbath, 
were added fresh overnight bacterial culture (0.1ml), mutagen (0.1ml) and an 
activation system (0.5ml). The plates were incubated at 37°C for 48 hours, and the 
number of revertant colonies were then counted manually using a Gallenkamp colony 
counter. Experiments were carried out in triplicate.
The preincubation method
To activation system (0.5ml/tube) were added fresh overnight bacterial culture 
(0.1ml) and mutagen (0.1ml), mixed and then incubated at in a shaking 
waterbath for various time intervals. Once the duration of incubation had elapsed, top 
agar (2ml) was added to the contents of the tubes, mixed thoroughly and poured onto 
Vogel Bonner E plates. The plates were then incubated at 37°C for 48 hours, and the 
resulting colonies were counted manually using a Gallenkamp colony counter. 
Experiments were performed in triplicate.
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Any modifications to either the plate incorporation or preincubation methods are 
described with the relevant data.
The activation system
Subcellular fractions were prepared as described earlier, and a 10% (v/v) activation 
system was prepared as follows:
Subcellular fraction 10% (v/v)
KC1(0.33M) 10% (v/v)
MgCl (0.08M) 10% (v/v)
Sodium Phosphate buffer (0.2M, pH7.4) 50% (v/v)
Cofactor solution* 20% (v/v)
* In the course of these investigations different cofactor solutions were employed. 
The standard solution was composed of NADP^ (4mM) and glucose-6-phosphate 
(5mM) which was supplemented with glucose 6-phosphate dehydrogenase (lU/plate) 
if the microsomes were the subcellular fraction under investigation. On other 
occasions the cofactor solutions consisted of either NADPH (8mM) or NADH 
(8mM).
This activation mixture containing 10% (v/v) subcellular fraction is the system 
employed most frequently, and is termed a 10% activation system. To alter the % 
composition of subcellular fraction, the volume of fraction added was changed and 
the volume of phosphate buffer was altered to maintain a constant volume.
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2.2.8 Discontinuous sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE), and 
Western blotting of proteins
Solubilisation o f microsomes
Microsomal proteins were solubilised by the addition of lOpl of solubilisation buffer 
(O.IM Potassium phosphate buffer pH 7.4, containing 10% w/v sodium cholate and 
2% w/v Emulgen 911) per milligram of protein, and mixing for 40 minutes.
SDS-PAGE
The separation of proteins was achieved at room temperature using the method of 
Laemmli (1970).
Reagents 
Lower gel buffer: Tris-HCl (1.5M, pH 8.8) containing 0.4% (w/v) sodium 
dodecyl sulphate (SDS).
Upper gel buffer: Tris-HCl (0.5M, pH 6.8) containing 0.4% (w/v) SDS.
Electrode buffer: Tris-HCl (25mM, pH 8.3) containing 192mM glycine and
0.1% (w/v) SDS.
Sample buffer: Tris-HCl (60mM, pH 6.8) containing 25% (v/v) glycerol, 2%
(w/v) SDS, 14.4mM p-mercaptoethanol and 0.1% (w/v) 
bromophenol blue.
Acrylagel: Commercially available.
Bis-acrylagel: Commercially available.
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Prestained molecular weight markers.
Protein Approximate molecular
weight (Daltons)
CL2 Macroglobulin 190 000
P Galactosidase 125 000
Fructose-6-phosphate kinase 88 000
Pyruvate kinase 65 000
Fumarase 56 000
Lactic dehydrogenase 38 000
Triose phosphate isomerase 33 500
Vertical slab gel apparatus, either from Hoefer Scientific Instruments (model SE400) 
or from Bio-Rad (mini-Protean II), used. Gels were cast between glass plates 
with polyvinyl chloride spacers in the assembly apparatus, clamped in place. The 
dimensions of the gels were either 120mm x 110mm x 15mm or 73 x 80mm x 1mm.
Before use the glass plates were washed in Decon detergent, rinsed with distilled 
water and cleaned with acetone and left to dry. The cassettes assembled and 
clamped vertically.
The lower gel (10% w/v) was prepared by mixing:
120 X 110 X 15mm 73 x 80 x 1mm
Lower gel buffer 12.5ml 6.25ml
Bis acrylagel 16.76ml 3.38ml
Acrylagel 16.22ml 8.11ml
Distilled water 14.28ml 7.14ml
Ammonium persulphate (10% w/v)* 0.25ml 0.125ml
* Freshly prepared immediately prior to use.
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Polymerisation was initiated by the addition of 40pl (20pl for the smaller gel) of 
NjNjN’jN'-teramethylethylenediamine (TEMED) and, after mixing, the solution was 
poured into the cassette to a height of 8cm (5cm for smaller gel). A thin layer of 
water-saturated butanol was added to ensure a flat interface between the lower and 
upper gels. After the gel had polymerised, the water-saturated butanol was removed 
by three washes with distilled water.
The upper gel (3% w/v) was prepared by mixing:
120 X 110 X 15mm 73 X 80 X 1mm
Upper gel buffer 5.0ml 2.5ml
Bis-acrylagel 0.8ml 0.4ml
Acrylagel 2.0ml 1.0ml
Distilled water 12.0ml 6.0ml
Ammonium persulphate (10% w/v)* 0.2ml 0.1ml
* Freshly prepared solution.
Again polymerisation was initiated by the addition of 40pl (20pl for the smaller gel) 
of TEMED and, after mixing, was poured onto the lower gel. A teflon comb was 
introduced to form the sample wells in the upper gel. After polymerisation the comb 
was removed and, to maintain their integrity, the wells were filled with electrode 
buffer.
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Solubilised microsomes and cytosol were diluted with an equal volume of sample 
buffer and boiled for 3 minutes in a waterbath, centrifuged in a bench centrifuge for 3 
minutes and then loaded into the wells. The upper and lower (or inner and outer for 
Bio-Rad equipment), reservoirs of the electrophoresis tanks were filled with 
electrophoresis buffer. Alongside the samples were run prestained molecular weight 
markers (5-15pl).
Electrophoresis was carried out immediately after loading the samples using either a 
Pharmacia EPS500/400 or a Bio-Rad Power Pac 300 power pack at a constant 
current of 20mA until the bromophenol blue band had migrated onto the lower gel. 
Subsequently the current was increased to 40mA until the bromophenol blue band 
reached the bottom of the gel, at which time the power was switched off. The cassette 
was removed from the electrophoresis tank, the glass plates separated, and the upper, 
stacking gel discarded. The lower gel was then either stained for protein with 
Cooma^e blue or used to transfer proteins to a nitrocellulose sheet for Western blot 
analysis for CYPIA proteins.
Staining of SDS-PA GE gels for proteins
Protein staining of SDS-PAGE gels required the following solutions:
Fixing solution: Glacial acetic acid, methanol and distilled water mixed in a
ratio of 1:1:1 solution.
Staining solution: 40% (v/v) methanol solution containing 10% (w/v)
trichloracetic acid and 0.1% (w/v) coomaae blue R-250. 
Filtered through whatman no 1 filter paper.
Destaining solution: 10% (w/v) Trichloracetic acid solution.
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The lower gel was placed in a tray containing fixing solution (200ml) for 30 minutes. 
The gel was then stained in coomasie blue solution (200ml) for 6 hours or overnight. 
After staining, the staining solution was poured off and the gel washed gently in 
distilled water before adding destaining solution (200ml). The gel remained in this 
solution until a clear background was observed, though destaining was assisted if  the 
destain was replaced with fresh solution every 2 hours.
The destained gel was stored in 10% (v/v) glycerol solution at 4°C, which removes 
the acetic acid from the gel and prevents cracking, so that the gel could be 
photographed, and the UV absorbance of the protein bands measured using a 
Shimadzu CS-9000 dual wavelength flying spot scanner.
Western blotting
The following buffers were required for Western blotting:
Transfer buffer: Tris-HCl (20mM), glycine (150mM) and methanol
(15% v/v).
Phosphate buffered saline: Sodium chloride (8.0% w/v), potassium dihydrogen
orthophosphate (0.2% w/v), disodium hydrogen 
orthophosphate (2.9% w/v) and potassium chloride 
(0.2% w/v).
Wash buffer: Phosphate buffered saline (1.0% w/v), bovine serum
albumin, fraction V (1.0% w/v), triton XlOO (0.2%v/v).
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Figure 2.1 Transfer cassette construction
The lower gel was placed into transfer buffer (50ml) for 30 minutes so that it replaces 
electrode buffer which had permeated into the gel. Transfer buffer also preshrinks the 
gel prior to transfer. The gel was placed into the transfer cassette, with a 
nitrocellulose sheet, sandwiched between sheets of filter paper (figure 2.1). The 
assembly of the cassette was undertaken in transfer buffer, ensuring all air bubbles 
were removed by rolling with a test tube.
The cassette was placed in transfer buffer in the transfer tank and the transfer was 
carried out at a constant voltage of 60V for 1 hour. After transfer, the nitrocellulose 
sheet was removed and placed in wash buffer (50ml) and rocked gently for 2 hours. 
Next the wash buffer was removed and replaced with the primary antibody, sheep 
anti-CYPlA, diluted (1:10 000) in wash buffer (50ml), for 1 hour. The nitrocellulose
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sheet was washed twice for 15 minutes with wash buffer (50ml) before adding the 
secondary antibody. This peroxidase-linked donkey anti-sheep antibody was diluted 
(1:10000) with wash buffer (50ml) and added to the nitrocellulose sheet for 1 hour. 
Excess antibody was removed by a fiirther two 15-minute washes with wash buffer 
(50ml), before the nitrocellulose sheet was gently rocked in 100ml of phosphate- 
buffered saline (1% v/v) for 10 minutes. The substrate (lOOmg 3,3' diaminobenzidine 
in 100ml of O.IM tris-HCl buffer, pH 7.5 containing 40pl of a 30% hydrogen 
peroxide solution) was added to the nitrocellulose sheet until bands appeared; the 
sheet was then washed several times with ice-cold distilled water.
2.2.9 In vitro metabolism of 2-acetyIaminofluorene and 2- 
aminofluorene by hepatic subcellular fractions
Preparation o f incubation mixtures
The metabolism of 2-acetylaminofluorene (2AAF) and 2-aminofluorene (2AF) by rat 
hepatic microsomal and cytosolic fractions was investigated using a method based 
principally on that described by Coombs et al., (1980).
In a total volume of 10ml the incubation mixtures consisted of:
Potassium phosphate buffer (O.IM, pH 7.4)
* NADP+ (4mM)
* Glucose 6 phosphate (5mM)
t  ring-pH] 2AAF or ring-fH] 2AF (Img)
** Microsomes or cytosol (from Ig of liver)
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* Alternatively NADH (8mM) replaced the NADPH generating system.
** If microsomal metabolism was under investigation, incubation mixtures were 
supplemented with 20 units of glucose-6*phosphate dehydrogenase.
t  Ring pH] 2AAF (728 mCi/mmol) was diluted 1:100 with unlabelled 2AAF, and 
ring pH] 2AF (728 Ci/mmol) was prepared by deacetylation, and is also 
diluted 1:100 with unlabelled 2AF, as described below.
Incubations were performed in 250ml conical flasks, at 37°C for 2 hours, in a 
shaking waterbath. Metabolism was terminated by placing the flasks on ice.
Analysis o f the in vitro metabolites o f 2AAF and 2AF
Incubation mixtures were extracted six times with equal volumes of ice-cold ethyl
acetate. The extracts were dried over magnesium sulphate and evaporated to dryness 
under reduced pressure in a rotary evaporator. The residues were resuspended in 
DMSO (0.25ml), and aliquots (O.Ol-O.lml) were subjected to reverse-phase hplc on 
either a Whatman partisil lO-ODS semi-preparative column (50cm x 1.9cm) or a 
Beckman ultrasphere ODS column (25cm x 4.6mm). Separation was achieved using 
a methanol/HiO linear gradient of 30-100% methanol over 1 hour and maintained at 
100% methanol for 30 minutes. The parent aromatic amines and their metabolites 
were detected using a Waters 440 absorbance detector, set at 254nm.
The UV absorbing peaks were collected and their UV spectra were recorded between 
200 and 400nm. UV Spectra were also obtained after the addition of 0.1ml of NaOH
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(0.5N), to demonstrate whether the metabolite^a phenol by its shift in absorbance, 
and after reduction by sodium borohydride (a few milligrams). Tentative 
identification of metabolites was achieved by comparison with UV spectra and hplc 
retention times of authentic metabolites and with published UV spectra.
To determine the identity of unknown metabolites after incubation with cytosol, 
metabolites were collected after multiple injections, evaporated to dryness and 
analysed by mass spectrometry.
The mutagenicity of the metabolites of 2AAF and 2AF
Metabolites were collected after multiple injections onto the hplc reverse-phase
column, evaporated to dryness, and then resuspended in DMSO to give a 
concentration, where possible, of lOpg/ml. The mutagenicity of these metabolites 
was investigated using the Ames mutagenicity test as described earlier. Activation 
mixtures employed either hepatic microsomes (10% v/v), hepatic cytosol (10% v/v) 
or no subcellular fi*action.
Deacetylation o f ring PH] 2~acetylaminofluorene
The deacetylation of 2AAF was performed by acid hydrolysis, essentially by the 
method described by Miller and McQueen, (1985).
A toluene solution containing 0.25mg ring-fH] 2AAF (7.28 mCi/mmol) was 
evaporated to dryness under a stream of nitrogen. The radiolabel was diluted 1 in 100 
with unlabelled 2AAF, resuspended in 10ml of 2N HCl, and refluxed in a nitrogen
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atmosphere for 2 hours. The solution was allowed to cool to room temperature, was 
neutralised to pH 7 with NaHCOs and subsequently extracted twice with 
dichloromethane (50ml). The extracts were dried over magnesium sulphate and 
evaporated to dryness in a rotary evaporator under reduced pressure. The residue was 
resuspended in 0.5ml DMSO and the radioactivity was measured in an aliquot 
(lOpl), so that the yield could be determined and the solution diluted further with 
DMSO to give a lOmg/ml solution.
The identity of the product was determined by NMR spectrometry in deuterated 
chloroform, UV spectrometry and hplc retention time by comparison with authentic 
2AF.
2.2.10. Protein purification
Packing sephacryl columns
Pharmacia columns were cleaned and assembled, then clamped into a vertical 
position in a LKB Bromma 2021 Maxicoldlab chromatography cabinet maintained at 
4°C. The gel, which was stored at 4°C, was gently agitated until thoroughly mixed. 
The slurry was then poured down the column slowly, but continuously, until the 
column was filled to the brim, to prevent the formation of air pockets. The top of the 
column was assembled and the gel packed using a flow rate of 2ml min'  ^of mobile 
phase [sodium phosphate buffer (16mM, pH7.4), MgCli (8mM), KCl (33mM), P- 
mercaptoethanol (0.25ml 1’*)] for 60 minutes followed by 4ml min'  ^ for 4 hours or 
until the height of the packed gel remained constant. The top adapter was then
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adjusted so that it rested on the top of the gel allowing the sample to be loaded 
directly onto the sephacryl. All procedures were performed at 4°C.
Separating cytosolic proteins by column chromatography
Before loading cytosol onto the column, mobile phase was run at a flow rate of 1ml
min'^ for 2 hours. Buffer eluting from the column was initially passed through an 
LKB Bromma 2138 uvicord s detector to monitor the presence of protein by the 
absorbance at 206nm. When a stable baseline was maintained, up to 2ml of cytosol 
was introduced onto the column and was separated using a flow rate of 1ml min"\ An 
LKB Bromma 2070 ultrorac fraction collector was set to collect fractions for 5 
minute periods and fractions were selected for further investigation by their 
absorbance at 206nm.
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CHAPTERS
The bioactivation of 6-ammochrysene to mutagens in 
the Ames test by rat hepatic subcellular fractions
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3.1. Introduction
6-Aminochiysene (6AC) is a relatively non-toxic arylamine, which was investigated 
initially for its potential use as a chemotherapeutic drug in the treatment of 
splenomegaly, myeloid leukaemia and advanced breast cancer (Lambelin et al, 
1967). Roe et al, (1969) reported the induction of hepatomas and pulmonary 
adenomas in neonatal mice after intraperitoneal injection of 6AC. These observations 
were not widely accepted, but further investigation also identified 6AC as a 
carcinogen in preweanling mice (Lambelin et a l, 1975), where topical skin 
application induced the formation of liver, lung and skin tumours. Currently, 6AC is 
considered as one of the most potent environmental mutagens, being highly 
carcinogenic in mice, and to a lesser extent in rats ( Lambelin et a l, 1975; Lambelin 
et ah, 1967).
6-Aminochrysene is a strong bacterial mutagen in the presence of mammalian 
hepatic S9 fractions (El-Bayoumy et al, 1989; Delclos and Heflich, 1992; Yamazaki 
et a l, 1993; Yamazaki et al, 1994). However, some researchers have reported a 
mutagenic response even in the absence of a mammalian activation system (El- 
Bayoumy et al, 1989). This arylamine is mutagenic to Salmonella typhimurium 
strain TA98 in the presence of S9 or hepatocytes from control rats and from rats 
pretreated with inducers of the cytochrome P450 mixed-function oxidase system 
such as phénobarbital, 3-methylcholanthrene, p-naphthoflavone, dexamethasone and 
also with mixtures of polychlorinated biphenyls, e.g. Aroclor 1254 and Kanechlor 
500 (Yamazaki and Shimada, 1992). These chemicals are established inducing agents 
of various isoforms of the cytochrome P450 mixed-frmction oxidases; phénobarbital
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induces CYP2B1, CYP2B2, CYP2C6 and CYP3A1, dexamethasone induces 
CYP3A1 and CYP3A2, both 3-methylcholanthrene and p-naphthoflavone induce the 
CYPIA subfamily and the polychlorinated biphenyl mixtures, Aroclor 1254 and 
Kanechlor 5000, are ‘mixed-type’ inducers, inducing both the CYPIA and CYP2B 
subfamilies. 6-Aminochrysene displays the highest mutagenic response when in the 
presence of activation systems derived from phenobarbital-treated rats, and 
consequently CYP2B1 and CYP2B2 are considered to be the principal cytochrome 
P450 isoforms responsible for 6AC bioactivation in the rat, with CYPlAl, 1A2 and 
3A2 playing only a minor role (Yamazaki et al., 1994). The most active human 
isoforms in 6AC bioactivation are CYP3A4 and CYP2B6 with CYPlAl and 
CYP1A2 demonstrating only limited activation (Yamazaki et a l, 1993). Purified 
human CYP2B6 supports activation of 6AC in reconstituted systems (Yamazaki et 
al, 1993), but in an investigation of 50 different liver samples only 12 had detectable 
concentrations of this isoform, and only a third of these had relatively high levels of 
CYP2B6 expression (Mimura et al, 1993).
6-Aminochrysene has more hydrocarbon character than many mutagenic aromatic 
amines and its activation pathways reflect this. The majority of aromatic amines are 
metabolised to activated metabolites via N-hydroxylation catalysed in the case of 
planar molecules by CYPlAl and especially CYP1A2, but 6-AC is N-hydroxylated 
principally by rat CYP2B1 and CYP2B2 (Yamazaki and Shimada, 1992) and the 
human CYP3A4 and CYP2B6 (Yamazaki, et al, 1993) isoforms. Both human and 
rat CYPlAl and CYP1A2 isoforms are responsible for the polycyclic hydrocarbon- 
type epoxidation of 6AC and 6AC-diol, leading to the formation of the bay-region
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diol-epoxide, and one of the candidate ultimate carcinogens, l,2-dihydrodiol-3,4- 
epoxide-6AC (figure 3.1). The rat CYP3A2, and human CYP3A6 isoforms also 
contribute to the epoxidation-activation of 6AC (Yamazaki and Shimada, 1992).
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Recently a number of researchers have demonstrated the bioactivation of a limited 
number of aromatic amines by the rat hepatic, soluble (SI05) fraction (Forster et al, 
1981a and b; Traynor et al, 1991; Leist et al, 1992; Ayrton et al, 1992).This 
system is inducible by Aroclor 1254, is NADPH-dependent and requires oxygen. 
Cytosolic activity is unaffected by (+)-catechin (Leist et al, 1992), but is inhibited by 
a-naphthoflavone and 9-hydroxyellipticine (Ayrton et al, 1992). Bioactivation by 
this fraction is also unaltered by inhibitors of cytosolic molybdenum oxidases or by 
addition of superoxide dismutase, catalase or ascorbic acid (Leist et al, 1992). 
Recent evidence also indicates that the inhibitor of cytosolic DT-diaphorase, 
dicoumarol, can inhibit aromatic and heterocyclic amine bioactivation by cytosol 
(DeFlora et al, 1994). DT-Diaphorase is^  howeve^ unable to metabolise amines 
directly and so any role for this enzyme in amine metabolism still requires initial 
activation presumably through N-hydroxylation by another enzyme.
The present study vyas undertaken in order to: (a) Establish whether 6AC is a 
substrate for the cytosolic enzyme system and identify its cofactor requirements; (b) 
Determine the substrate specificity of the cytosolic system; (c) Compare the cytosolic 
activation system with the microsomal cytochrome P450 oxidases in the activation of 
6AC (d) Evaluate if the cytosolic system is inducible by cytochrome P45(Xinducing 
agents and thus, related to this system; (e) Identify any species or strain differences 
and determine whether this enzyme is present in human hepatic cytosol, and finally, 
(f) Establish whether the cytosolic system is expressed extrahepatically.
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3.2. Methods
5.2.i. Pretreatment o f animals
Male Wistar-albino rats (150-200g) were obtained from The Experimental Biology 
Unit, University of Surrey, male Sprague-Dawley rats (200g) were purchased from 
Harlan-Olac UK Ltd, Bicester, Oxon, male Syrian hamsters (100-120g) from 
Wrights, Essex and male albino ferrets from Grayston (Ringwood, Hants). Fresh 
male pig liver was obtained from a local abattoir and samples of human liver cytosol 
were a gift from Dr. Alan Boobis (Hammersmith Hospital, London).
The induction of rat hepatic mixed-fimction oxidases was achieved either by a single 
intraperitoneal injection of Aroclor-1254 (500mg/kg), dissolved in com oil, with 
animals being sacrificed on the fifth day after administration, or by dosing daily for 
three consecutive days with either benzo[a]pyrene (25mg/kg), dissolved in com oil, 
and administered intraperitoneally, intraperitoneal injection of phenobarbitone 
(80mg/kg) in distilled water, isoniazid (lOOmg/kg) in distilled water administered by 
oral gavage or intraperitoneal injection of clofibrate (80mg/kg) in 0.9% saline. All 
animals were killed 24 hours after the last administration. Administration of cobalt 
(III) chloride (50mg/kg) by subcutaneous injection 24 and 48 hours after a single 
dose of Aroclor 1254 (500mg/kg) was employed to suppress haem-containing 
enzymes. Insulin-dependent diabetes was induced by intraperitoneal injection of 
streptozotocin (65mg/kg), the animals being killed 21 days later.
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3.2.2. Determination of total microsomal cytochrome P450 
concentration
Hepatic fractions were prepared as described previously in Chapter 2. The 
determination of total microsomal cytochrome P450 concentrations was by the 
difference-spectra method (Omura and Sato, 1964) and is expressed as a frmction of 
protein concentration, measured by the method of Lowry (Lowry et al, 1951) as 
described in detail in Chapter 2.
3.2.3. Mutagenicity testing
The generation of mutagenic metabolites from 6-aminochrysene, other amines and 
structurally related compounds e.g., 6-methylchrysene, was determined using the 
Ames test employing the Salmonella typhimurium TA98 tester strain which is 
sensitive to frameshifr mutations. Unless otherwise stated, the activation systems 
employed contained 10% (v/v) of the specific subcellular fractions (25% w/v) and an 
NADPH-generating system (NADP, 20pmoles/ml, and glucose-6-phosphate, 
25pmoles/ml). When the microsomal fraction was investigated, activation systems 
were supplemented vdth glucose-6-phosphate dehydrogenase (lunit/plate). All 
carcinogens studied were dissolved in DMSO such that lOOpl of this solvent was 
added to every plate.
70
3.3. Results
3.3.1. Substrate specificity of the cytosolic bioactivation system
Using the Ames mutagenicity test, the ability of hepatic cytosol to bioactivate a range 
of aromatic and heterocyclic amines was investigated. The amines selected were all 
known mutagens in the Ames test, in the presence of hepatic S9 activation systems.
Table 3.1. Substrate specificity of cytosolic bioactivation
Histidine revertants/plate
Compound Concentration
(pg/plate)
Microsomes Cytosol
2,4-DiaminotoIuene* 5 209 ±21 10±6
2,6-Diaminotoluene^ 40 543 ±81 nd
1,8-Diaminonaphthalene 200 43 ± 9 16 ± 8
2^-DiaminonaphthaIene 200 99±11 63 ± 8
3,3’-Diaminobenzidine 100 206 ±15 nd
I-Aminoanthracene 5 41 ±37 5 ± 4
2-Aminoanthracene 5 2266 ±147 354 ±23
6-Aminochrysene 1 248 ±38 282 ±35
3-Methoxy-4-aminoazobenzene* 25 1649 ±413 12±3
o-Aminoazotolnene* 50 36± 2 nd
IQ 0.04 455 ±21 11±8
GIu-P-1 1 3905 ± 373 12±10
systems (10% v/v) were derived from the livers of Aroclor 1254-pretreated rats. With some 
compounds (*), activation system, mutagen and bacteria werepreincubatedfor 30 minutes at 37°C 
in a shaking waterbath. The spontaneous reversion rate of25± 14 has been subtracted. Results are 
presented as mean ± standard deviation of triplicates, nd represents a reversion rate lower than the 
spontaneous reversion rate.
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Only 6-aminochrysene, 2-aminoanthracene and, to a lesser extent, 2,3- 
diaminonaphthalene displayed a clear mutagenic response in the presence of hepatic 
cytosol from Aroclor 1254-treated rat (table 3.1). No cytosolic bioactivation of the 
other amines was evident even when microsomal bioactivation was marked. In the 
case of 6-aminochrysene a similar mutagenic response was observed in the presence 
of microsomes or cytosol.
Another class of chemical carcinogens, the nitrosamines, were only very poorly 
mutagenic in the presence of the cytosolic fraction but displayed a clear mutagenic 
response in the presence of microsomes from isoniazid-treated rats (table 3.2).
Table.3.2. Bioactivation of two nitrosamines by microsomal and 
cytosolic fractions from isoniazid-treated rats
Histidine revertants/plate
Compound Concentration Microsomes Cytosol
Nitrosopyrrolidine 4mg/plate 104 ± 6 14± 4
Nitrosopiperidine 4mg/plate 109 ±22 11±6
typhimurium TA1530 were preincubatedfor 30 minutes in a shaking waterbath at 37°C. Results are 
expressed as the mean ± standard deviation of triplicates. The spontaneous reversion rate of 7 ± 2
has been subtracted.
3.3.2. The effect of repeated centrifugation on the cytosolic 
activation of 6-aminochrysene
In order to ensure the mutagenic response induced by the cytosol not due to 
contaminating microsomes, additional centrifugations were carried out.
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The mutagenicity of 6AC (0,8]ig/plate) by cytosol from Aroclor 1254-pretreated rats 
was decreased, but not abolished, by a second centrifugation (table 3.3). The 
mutagenicity was not reduced further following a third centrifugation.
Table. 3.3. The effect o f repeated centrifugation on the mutagenicity 
o f 6-aminochrysene
Number of centrifugations Histidine revertants/plates
1 X 105,000g 1932 ±465
2 X 105,000g 859 ±261
3 X 105,000g 992 ±257
pretreated rats (10% v/v) comprised the activation mixture. The results are expressed as the mean ± 
standard deviation of triplicates. The spontaneous reversion rate was 20 ±3.
3.3.3. Microsome- and cytosol-mediated activation of 
chrysene and its methyl and amino derivatives
The present study was undertaken in order to evaluate the importance of the amino 
group in the mutagenicity of 6AC in the Ames test. S9, microsomes or cytosol from 
Aroclor 1254-treated rats were capable of bioactivating 6AC (l.Opg/plate) to 
mutagenic intermediates but, at the same concentration, could not activate chrysene 
(table 3.4).
6-Aminochrysene and, more effectively, 2-aminochrysene were bioactivated in a 
concentration-dependent fashion by Aroclor 1254-pretreated microsomal and 
cytosolic hepatic fractions to produce a marked mutagenic response (table 3.5). 
However, at the range of concentrations under investigation (0.4-1.0pg/plate), neither
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2- nor 6-methylchrysene, the corresponding methyl analogues, showed any 
mutagenicity with either subcellular fraction serving as the activation system.
Table.3.4. The mutagenicity o f 6-aminochrysene and chrysene
Histidine revertants/plate
Mutagen S9 Microsome Cytosol
Spontaneous reversion rate 16±6 16 ± 4 17±3
0.4pg/plate chrysene 20±5 13±3 17±0
l.Opg/plate chrysene 18±1 22±1 15 ±1
l.Opg/plate 6-aminochrysene 86±7 285 ±4 239 ±27
activation mixtures (10%v/v) and mixed with bacterial suspension (TA98) and mutagen. Results are 
expressed as mean ± standard deviation of triplicates.
3.3.4. Inhibition of 6-aminochrysene and 2- 
aminoanthracene bioactivation by structurally related 
compounds
6-Methylchrysene and 1-aminoanthracene are both non-mutagenic in the presence of 
hepatic microsomes or cytosol (Cheung et ah, 1992; tables 3.1 and 3.5). This 
investigation was undertaken to determine whether 6-methylchrysene and 1- 
aminoanthracene are substrates for the enzymes responsible for the bioactivation of 
6AC and 2AA to mutagenic intermediates, by their abilities to inhibit the 
bioactivation of these related compounds. It is conceivable that these compounds are 
also metabolised by the cytosolic system but do not generate mutagens and 
consequently cannot be detected by the Ames test.
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Table.3.5. Activation o f amino- and methyl-chrysenes by hepatic 
microsomal and cytosolic fractions
Histidine revertants/plate
Mutagen and 
concentration
Microsomes Cytosol
Spontaneous reversion rate 30±1 32±3
6-Aminochrysene
0.4pg/plate 54±4 175 ±18
0.6|ig/plate 118±3 291 ±26
O.Spg/plate 267 ±72 329 ±47
l.Opg/plate 387 ±138 341 ±60
2-Aminochrysene
0.4pg/plate 97 ± 6 217 ±48
0.6pg/plate 309 ± 2 302 ±17
0.8pg/plate 595 ± 69 492 ± 72
l.Opg/plate 494 ±79 537 ±106
6-Methylchrysene
0.4pg/plate 30±2 33±4
0.6pg/plate 28 ±5 29±1
0.8pg/plate 22±3 33 ±3
l.Opg/plate 25±2 37±6
2-Methylchrysene
0.4pg/plate 21 ± 6 35 ± 7
0.6pg/plate 24±2 32±5
0.8pg/plate 28 ± 6 33 ±10
l.Opg/plate 34±8 34±4
with Aroclor 1254, Salmonella typhimurium TA98 and mutagens (dissolved in DMSO) were mixed 
and poured on minimal agar plates. Results are expressed as the mean ± standard deviation of 
triplicates.
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Table 3.6. Inhibition of 6-aminochrysene and 2-aminoanthracene 
bioactivation by structurally related compounds
Inhibitor Histidine revertants/plate
Mutagen 1-Aminoanthracene
(pg/plate)
Microsomes Cytosol
0 379 ±69 947 ±55
2-Ammoaiithracene 2 338 ±69 575 ±183
(Spg/plate) 4 245 ±29 752 ±283
6 204 ±13 590 ±66
8 262 ±39 633 ±70
6-Methylchiysene
(H^plate)
0 1027 ±94 499 ±116
6-Ammochrysene 1 1122 ±81 368 ±23
(Ijig/plate) 2 1037 ±120 300 ±16
3 856 ±34 218 ±23
4 870 ±74 196 ±40
expressed as mean ± standard deviation of triplicates. Spontaneous reversion rates were 23 ± 8  and 
have been subtracted
2-Aminoanthracene mutagenicity ' modestly suppressed by the addition of its non- 
mutagenic isomer 1-aminoanthracene, in the presence of microsomes or cytosol but 
no concentration-dependent effect evident (table 3.6). Similarly, 6-methylchrysene 
also reduced the mutagenic response of 6-aminochrysene in the presence of either 
subcellular fraction (table 3.6). With both carcinogens, in h ib i t io n w ea k  in the 
microsomal fraction butw  more marked in the cytosol, especially inhibition of 6AC 
mutagenicity by 6-methylchrysene (table 3.6).
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3.3.5. Bioactivation of 6-ammochrysene by S9, microsomal 
and cytosolic fractions
All three hepatic subcellular ftactions from Aroclor 1254-pretreated rats could 
convert 6AC to mutagens in the Ames test in a concentration-dependent manner 
(table 3.7). Surprisingly, at all carcinogen concentrations, the cytosol vyas clearly 
more effective than microsomes and S9 in metabolically activating 6AC to genotoxic 
intermediates.
Table 3.7. 6-Aminochrysene activation by rat hepatic subcellular
fractions
Mutagen and 
concentration
S9 MICROSOME CYTOSOL
Spontaneous reversion rate 
0.05ng/plate 6AC 
O.lOpg/plate 6AC 
0.20|Lig/plate 6AC 
0.3pg/plate 6AC 
0.4pg/plate 6AC 
0.5|ig/plate 2AA
23 ±1 
33 ± 7  
29±1 
34±7 
105 ±26 
600 ±131 
2831 ±381
18±7 
17±7 
16±3 
36 ±13 
329 ±45 
944 ±216 
1919±137
21± 4  
129±11 
349 ±34 
703 ±28 
1125 ±76 
1124 ±71 
1332 ±375
rats were mixed with Salmonella typhimurium strain TA98 and either the positive control 2- 
aminoanthracene (2AA), or various concentrations of 6-aminochrysene (6AC). Results are 
expressed as the mean ± standard deviation of triplicates.
The S9-mediated activation of 6AC vyas unexpectedly lower than that catalysed by 
the cytosol or the microsomes (table 3.7), showing there was no additive effect 
between the cytosolic and microsomal activation systems. In contrast, when 2AA
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was used as the promutagen, microsomes and cytosol elicited a similar mutagenic 
response and S9 demonstrated the largest mutagenic response.
3.3.6. Inter-relationships between cytosolic and microsomal 
activation of 6-aminochrysene
The observation that S9 was clearly less effective than its components, microsomes 
and cytosol, in converting 6AC to mutagens, raised the possibility that products of 
the microsomal metabolism may be subjected to further cytosolic metabolism and 
vice versa.
Microsomes, in the absence of cytosol, activated 6AC to the same extent as S9 (table 
3.8). Moreover, incorporation of increasing amounts of cytosol to the microsomes 
did not cause significant, concentration-dependent effects. Cytosol in the absence of 
microsomes, gave rise to a profoundly higher degree of mutagenicity when compared 
to microsomes or S9. Addition of increasing amounts of microsomes, however, gave 
rise to a concentration-dependent decrease in the cytosol-mediated mutagenic 
response, indicating that microsomal enzymes deactivate the genotoxic metabolites 
generated by the cytosol.
3.3.7. Dependence of microsomal and cytosolic bioactivation 
of 6-aminochrysene on protein concentration
In order to ensure that the mutagenicity elicited by the two activation systems i.e. 
isolated microsomes and cytosol, was linear at the protein concentrations used, the
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mutagenicity of 6AC (0.8pg/plate) was investigated in the presence of increasing 
amounts of microsomes and cytosol.
When microsomes served as the activation system, maximum mutagenicity was 
achieved at a concentration of 10% (v/v), but then rapidly declined (table 3.9). In 
contrast, the mutagenicity mediated by the cytosol was still increasing at the highest 
concentration studied (20% v/v)
Table.3.8. The interactions of hepatic microsomes and cytosol in the 
bioactivation of 6-aminochrysene
Hepatic subcellular fraction Histidine revertants/plate
S9 10% 166 ±15
Microsomes (10%)
Cytosol 0% 144 ±29
2.5% 206 ± 22
5.0% 218 ±14
7.5% 166 ±5
10.0% 125 ± 2
Cytosol (10%)
Microsomes 0% 1277 ±126
0.5% 2771± 294
5.0% 844 ±99
7.5% 389 ±50
10.0% 164 ±34
Salmonella typhimurium TA98 and 6-aminochrysene (0.6ng). Results are expressed as mean ± the 
standard deviation of three plates. The spontaneous reversion rate was 20 ± 7. The procedure was 
repeated and similar results were obtained
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Table.3.9. The effect o f protein concentration on the activation o f 6- 
aminochrysene in the Ames test
Histidine revertants/plate
Concentration
(%v/v) Microsomes
Cytosol
0 24±3 22±4
2.5 210 ±96 330 ±148
5.0 300 ±75 510±131
10.0 360 ±64 1391± 84
20.0 70 ±22 1956 ±363
activation system from rats pretreated with Aroclor 1254. The results are expressed as the mean ± 
standard deviation o f three plates.
3.3.8. Cofactor requirements for the microsomal and 
cytosolic bioactivation of 6-aminochrysene
Both the cytosolic and microsomal-mediated bioactivations of 6AC (0.8pg/plate) 
were supported successfiilly by an NADPH-generating system (figure 3.2). Addition 
of NADH (8mM) to the NADPH-generating system, with either subcellular fraction, 
failed to further enhance the mutagenicity of 6AC, but in fact decreased the 
mutagenicity induced by the NADPH-generating system alone (figure 3.2).
When NADH was added to microsomes, in the absence of NADPH, it provoked a 
mutagenic response comparable to that supported by NADPH (figure 3.2), but 
NADH (8mM) alone could not support cytosol-mediated activation. A mutagenic 
response was also evident with NADP"" in the absence of glucose-6-phosphate with 
both activation systems.
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Figure.3.2. Cofactor requirements for the bioactivation of 6- 
aminochrysene
Ames mutagenicity tests were performed using activation mixtures (10% v/v) containing either 
microsomes ( ^ )  or cytosol ( U )  preparedfrom livers isolated from rats pretreated with Aroclor 
1254. Each plate also contained 6-aminochrysene (O.Spg) and Salmonella typhimurium TA98. 
Results are expressed as the mean ± standard deviation o f triplicates. The spontaneous reversion 
rate was 32 ±3.
3.3.9. Support of cytosol-mediated bioactivation of 6- 
aminochrysene by methylene bine
The livers used in the present study, although washed of excess blood, were not 
perfused so that cytosol was contaminated with blood. It is conceivable that blood 
may contribute to the cytosol-mediated activation of 6AC. Mutagenic intermediates
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of 2-acetyl aminofluorene, 2-aminofluorene and 2-aminoanthracene are generated in 
the presence of red blood cell cytosol and methylene blue (1.33pM) after 
preincubation for 60 minutes at 37 “ C (Duverger-van Bogaert et al., 1991). The role 
of methylene blue in this system is to stimulate the pentose phosphate shunt to 
produce more NADPH, and to maintain haemoglobin in its reduced state required 
for the bioactivation of aromatic amines. To determine if blood contributes to the 
observed cytosolic activation of 6AC, cytosol was incubated for 60 minutes in the 
presence of methylene blue.
In the absence of NADPH, methylene blue (1.33pM) could only support the 
cytosolic activation of 6-aminochrysene poorly, and much less effectively than 
NADPH (8mM). After incubation at 37 °C NADPH-dependent mutagenicity was 
markedly depressed whereas that mediated by methylene blue was completely 
abolished.
Table.3.10. Cytosolic activation of 6-aminochrysene by methylene 
blue
Histidine revertants/plate
Activation system No incubation With incubation
Spontaneous reversion rate 12±2 10 ±1
NADPH 754 ±16 66±7
Methylene blue 49±7 10±1
containing rat hepatic cytosol, prepared from animals pretreated with Aroclor 1254, and either 
NADPH (8mM) or methylene blue (1.33\i\^. To each plate was also added 6-aminochrysene 
(0.8]Xg) and lOO l^ of bacterial suspension (TA98). Results are expressed as mean ± standard 
deviation of triplicates.
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By itself, methylene blue only supported modest bioactivation of 6AC by Aroclor 
1254-treated cytosol (table 3.10), but it is conceivable that methylene blue may have 
a potentiating effect on metabolism in the presence of NADPH. However, no 
increase in mutagenicity was detected (table 3.11) and consequently haemoglobin 5 
not responsible for the bioactivation of 6AC by hepatic cytosol.
Table, 3,11. Potentiation of cytosolic bioactivation o f 6-aminochrysene 
by methylene blue
Activation system Histidine revertants/plate
Spontaneous reversion rate 30±4
NADPH 1807 ±337
NADPH + Methylene blue 1823 ±325
suspension (TA98) and either NADPH (8mM) or NADPH (8mM) + methylene blue (1.33\iM). 
Results are expressed as mean ± standard deviation o f triplicates.
The effect of methylene blue on the bioactivation of 2AA and 2AF, two promutagens 
known to be bioactivated by red blood cell cytosol (Duverger-van Bogaert et al., 
1991), in addition to 6ÀC, was investigated further using a range of concentrations, 
to determine whether methylene blue could increase the metabolism of these amines 
to mutagenic intermediates, and therefore whether cytosolic activitionw^ a 
consequence of contamination with blood.
The addition of increasing concentrations of methylene blue to cytosolic activation 
systems evoked a marked decrease in aromatic amine mutagenicity with the majority 
of the mutagenic response abolished after the addition of O.Spg/plate methylene blue.
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At lower methylene blue concentrations, 6AC bioactivation was less affected than 
either 2AA or 2AF (table 3.12).
Table 3.12. Inhibition o f cytosol-mediated aromatic amine 
mutagenicity by methylene blue
Histidine revertants/plate
Methylene blue 
Concentration 
(pg/plate)
2-Aminoanthracene
(Spg/plate)
2-Aminofluorene
(5pg/plate)
6-Aminochrysene
(Ipg/plate)
0.0 516 ±32 53 ±13 303 ± 69
0.2 74 ±12 9±11 274 ±15
0.4 11±7 2±6 137 ±28
0.8 15±3 1±6 36 ±14
activation mixtures from Aroclor 1254-induced rats (10% v/v). The spontaneous reversion rate was 
24 ± 8  and has already been subtracted. Results are the mean ± standard deviation of triplicates.
3.3.10. Mutagenicity of aromatic amines in the presence of 
Aroclor 1254-treated cytosol and an N,0-acetyItransferase- 
deficient 5'a/flfo/ic//a strain
The Salmonella typhimurium test strain TA98-1,8-DNPô has reduced N,0- 
acetyltransferase activity (McCoy et ah, 1983). Further metabolism of N-hydroxy-2- 
aminofluorene includes 0-acetylation to generate the mutagenic 
acetoxyaminofluorene (Bartsch et ah, 1972), which spontaneously breaks down to 
the highly electrophilic nitrenium ion. This strain was employed to investigate the 
importance of bacterial N,0-acetyltransferase to the mutagenicity of aromatic amines 
in the Ames test, and to demonstrate indirectly that bioactivation in the cytosol 
involves an initial N-hydroxylation.
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Table 3.13. Cytosol-mediated aromatic amine mutagenicity in 
Salmonella typhimurium TA98 and the N,0-acetyltransferase 
deficient TA98-1,8-DNPô
Histidine revertants/plate
Activation system Mutagen(pg/plate) TA98 TA98-1,8-DNP6
Microsomes
2-Aminoanthracene 5 707 ±97 238 ±32
2-Aminofluorene 5 620 ±74 90±5
6-Aminochrysene 1 533 ± 5 295 ±21
Cytosol
2-Aminoanthracene 5 1008 ±75 104 ± 6
2-Aminofluorene 5 108 ± 9 2 ± 2
6-Aminochrysene 1 1046± 16 8 ± 5
1254-treated rat. Results are expressed as mean ± standard deviation o f triplicates. The 
spontaneous reversion rates were 25 ± 5 for TA98 and 25 ^ 4 for TA98-1,8-DNP6, and have 
alreacfy been subtracted.
In the presence of microsomes or cytosol the mutagenicity of the aromatic amines 
was much lower when the acetyltransferase-deficient bacterial strain was used 
implicating the presence of hydroxylamines. However, because a significant 
microsome-mediated mutagenic response is still evident in this strain, it is possible 
that other mutagenic intermediates may be present e.g., diol epoxides of 6AC. In 
contrast, no or very little mutagenic response was evident in the acetyltransferase- 
deficient strain when cytosol was employed for the bioactivation of these amines. 
This indicates that, compared to microsomes, the cytosol is unlikely to produce 
mutagenic intermediates through pathways that do not involve N-hydroxylation.
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3.3.11. The effect of 3'-phosphoadenosine-5'-phospho 
sulphate on the bioactivation of aromatic amines
Conjugation of hydroxylamines by cytosolic sulphotransferase requires 3 - 
phosphoadenosine-5'-phosphosulphate (PAPS) as a source of sulphate. Sulphate 
conjugation is thought to be one mechanism by which hydroxylamines are further 
metabolised to form unstable esters that break down forming the ultimate 
carcinogen, the nitrenium ion. This investigation was undertaken to demonstrate that 
the bioactivation, in both the microsomes and cytosol, involves an initial N- 
hydroxylation and to determine whether conjugation with sulphate potentiates the 
mutagenic response, and therefore is a possible route of bioactivation for 2AA, 2AF 
and 6AC.
Table 3.14. Modulation o f aromatic amine bioactivation by PAPS
Histidine revertants/plate
Mutagen (pg/plate) S9 Cytosol
2-AA(5) 1135±119 2551± 122
2-AA(5) + PAPS 1323 ±47 2859 ±196
2-AF (5) 339 ±15 582 ±81
2-AF(5) + FAPS 426 ±17 775 ±112
6-AC (0.6) 369 ±67 1604 ±47
6-AC (0.6) + PAPS 62 ± 2 692 ±24
Activation mixtures comprised either cytosol (10% v/v) or S9 (10% microsomes supplemented with 
5% cytosol because bioactivation o f 6AC by cytosol is reduced in the presence o f microsomes, see 
chapter 3) from Aroclor 1254-treated rats. Salmonella typhimurium strain TA98 and 3 -  
phosphoadenosine-5-phosphosulphate (PAPS, 0.1 mg/plate). Results are expressed as mean ± 
standard deviation of triplicates. The spontaneous reversion rate 27 ± 5 has already been 
subtracted.
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The addition of PAPS had only minimal effects on the mutagenicity of 2AA in the 
presence of either S9 or cytosol (table 3.14). In contrast, 2AF mutagenicity was 
modestly increased by the addition of PAPS to a similar extent using either activation 
mixture. However, the mutagenic response observed with each activation system in 
the presence of 6 AC was decreased.
With each mutagen, the mutagenic responses were highest in the presence of cytosol, 
so it is unlikely that contamination with microsomal enzymes is responsible for 
mutagenicity in this subcellular fraction. Therefore N-hydroxylating activity is 
present in both microsomes and cytosol.
3.3.12. Induction of 6-aminochrysene bioactivation by 
various mixed-fnnction oxidase inducers
The aim of the present experiment was to establish whether the microsomal and 
cytosolic systems responsible for the activation of 6AC respond in the same way to 
cytochrome P450 inducing agents.
Microsomes from control animals elicited a strong mutagenic response whereas, in 
contrast, a poor mutagenic response was observed in the presence of cytosol (table
3.15). The maximum mutagenic response was seen in the presence of microsomes at 
the lower 6AC concentrations used. It was felt, however, that the use of lower 
concentrations, in order to obtain a linear response, could compromise the ability to 
detect any mutagenic response vyith the cytosolic fractions.
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Table.3.15. Effect o f cytochrome P450 inducers on the bioactivation 
of 6-aminochrysene by hepatic preparations
Histidine revertants/plate
Inducing agent and 
6AC concentration 
(pg/plate)
Cytochrome P450 
concentration 
(nmol/mg protein)
Microsomes Cytosol
Control
0.25
0.79
1867 ±22 16±3
0.50 1819 ±248 40 ±12
0.75 1613 ±165 4 6± 4
1.00 1197 ±165 42±5
Aroclor 1254
0.25
1,35
4 ± 2 186 ±17
0.50 16 ± 9 361 ±34
0.75 28 ±14 401 ±27
1.00 154 ±21 525 ±20
Benzo[a]pyrene
0.25
1.18
4 ± 3 13±4
0.50 35 ± 6 41 ± 6
0.75 119±4 38 ±12
1.00 296 ±30 44 ±3
Phenobarbitone
0.25
1.12
1309 ±140 44 ±15
0.50 1175 ±174 62± 4
0.75 867 ±42 95±3
1.00 673 ±46 101 ±3
Isoniazid
0.25
0.71
759 ±176 18±8
0.50 1171 ±71 31 ±10
0.75 1379 ±79 56±7
1.00 1190 ±125 4 8 ± 4
Dexamethasone
0.25
0.81
1009 ±33 33 ± 5
0.50 1422 ±213 65 ±20
0.75 1893 ±260 82 ±11
1.00 1895 ±160 69 ± 6
Clofîbrate
0.25
0.72
960 ±215 1±1
0.50 1497 ±216 9 ± 3
0.75 1665 ±153 17±11
1.00 2186 ±97 28 ±3
All tests employed 10% (v/v) activation mixtures irrespective of subcellular fraction or treatment 
group. The spontaneous reversion rate for TA98 was 20 ± 5 and has already been subtracted. 
Results are expressed as the mean ± standard deviation of three plates. The study was repeated with 
subcellular samples preparedfrom different, but similarly-treated animals, with similar findings
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When isolated microsomes served as the activation system, treatment of the rats with 
clofîbrate and dexamethasone did not give rise to major, consistent effects (table
3.15). Treatment with isoniazid suppressed mutagenic response at the lower mutagen 
concentrations. Treatment with phenobarbitone also suppressed mutagenicity, but at 
the higher mutagen concentrations only. The most striking effect was a marked 
reduction in mutagenic response following treatment with benzo[a]pyrene and 
Aroclor 1254, despite the much higher cytochrome P450 concentrations in the latter 
animals compared with controls (table 3.15). When cytosol served as the activation 
system the only major effect was a marked enhancement of the mutagenic response 
following treatment with Aroclor 1254 and to a much lesser extent phenobarbitone 
(table 3.15).
Clearly the behaviour of microsomes and cytosol in the activation of 6AC following 
treatment of the animals with cytochrome P450 inducing agents is very dissimilar. 
Cytosolic activation of 6AC was clearly induced by Aroclor 1254 which, in contrast, 
suppressed the microsomal activation.
3.3.13. The effect of streptozotocin-mduced diabetes on the 
hepatic bioactivation of aromatic amines
In addition to inducing insulin-dependent diabetes, treatment with streptozotocin has 
previously been demonstrated to increase the S9-mediated bioactivation of 
nitrosopiperidine, nitrosopyrrolidine, Glu-P-1, Trp-P-1, Trp-P-2 and MelQ and to 
reduce the bioactivation of 2AF, but had no effect on the mutagenicity of 4-
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aminobiphenyl, benzo[a]pyrene, 3-methylcholanthrene or IQ (loannides et al., 1988; 
Flattera/., 1989).
Table 3.16, The bioactivation of 2-aminoanthracene and 2- 
aminofluorene by untreated and streptozotocin-pretreated hepatic
subcellular fractions
Histidine revertants/plate
Treatment Mutagen concentration 
(pg/plate)
Microsomes Cytosol
Untreated 2-Aminoanthracene
1 48± 9 9 ± 5
2 76 ±19 7 ± 4
3 215 ±54 4 ± 7
4 397 ±95 14±7
Untreated 2-Aminofluorene
1 83 ± 14 nd
2 164 ±21 nd
3 263 ±50 11±3
4 389 ±53 5 ± 4
Streptozotocin 2-Aminoanthracene
1 181±37 2 4 ± 2
2 257 ±42 2 2 ± 6
3 304 ±37 23 ±1
4 442 ±46 2 9 ± 4
Streptozotocin 2-Aminofluorene
1 160 ± 7 nd
2 294 ±16 9 ± 6
3 386 ±26 7 ± 5
4 552 ±92 9 ± 3
results are expressed as mean ± standard deviation of triplicates. The spontaneous reversion rate 
was 23 ± 5  and has been subtracted from these values. nd=  a mutagenic response lower than the 
spontaneous reversion rate
The mechanism through which streptozotocin achieves these changes is thought to be 
due to a change in the hepatic cytochrome P450 isoform composition (loannides et 
al., 1988). This investigation was undertaken to observe whether streptozotocin-
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treatment similarly perturbed the bioactivation of 2AA and 2AF by hepatic 
microsomes and cytosol.
Microsome-mediated mutagenic responses were increased, especially at low mutagen 
concentrations, after the induction of diabetes by streptozotocin-pretreatment. 
However, streptozotocin-treatment was unable to induce cytosol to metabolise either 
amine to mutagenic intermediates (table 3.16).
The total cytochrome P450 concentrations of the streptozotocin-treated microsomes 
(0.29nmols mg*^  protein) was lower than that demonstrated by microsomes firom 
untreated animals (0.33nmol mg‘‘ protein).
3.3.14. The role of haemoproteins in the bioactivation of 
aromatic amines by cytosol from Aroclor 1254-treated rat
Treatment with cobalt (III) chloride can be used to decrease hepatic cytochrome P450 
concentrations (Maines and Kappas, 1975). This is achieved by the inhibition of ô- 
aminolaevulinate synthase, the rate limiting step in haem synthesis, and the induction 
of haem oxygenase, the rate limiting enzyme in haem catabolism (Drummond and 
Kappas, 1982). Cobalt (III) chloride was given to rats after they were treated with 
Aroclor 1254, to demonstrate whether the cytosolic enzyme(s) concerned with the 
bioactivation of aromatic amines contain a haem prosthetic group.
Treatment of Aroclor 1254-pretreated rats with cobalt (III) chloride produced a 
marked decline in total cytochrome P450 concentration and in EROD enzyme 
activity (table 3.17). Bioactivation of 2AF and 6AC were not greatly influenced by
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the treatment with cobalt (III) chloride (table 3.18). The mutagenic response elicited 
by 2AA, however, at the two higher concentrations only, was markedly suppressed 
by the cobalt treatment.
Table 3.17. Cytochrome P450 concentrations after Cobalt (III) 
chloride treatment of Aroclor 1254-induced rats
Treatment Total cytochrome P450 (nmol mg'* protein)
EROD activity 
(nmol min"* mg'* 
protein)
Aroclor 1254 1.25 3.08
Aroclor 1254 + Cobalt chloride 0.81 2.18
1-Aminobenzotriazole (ABT) is a suicide substrate of cytochrome P450 (Ortiz de 
Montellano and Mathews, 1981). Oxidation of ABT by cytochrome P450 isoforms, 
yields benzyne which irreversibly binds to haem protoporphyrin IX inactivating these 
enzymes and chloroperoxidase (Ortiz de Montellano et al., 1984).This investigation 
was carried out to determine whether ABT can inhibit the bioactivation of the 
aromatic amines 2AA, 2AF and 6AC, and of the heterocyclic amine IQ, catalysed by 
microsomes or the cytosol.
Addition of ABT (lOmM) to Aroclor 1254-pretreated microsomes caused an 87% 
reduction in cytochrome P450 concentration, from 1.39 to 0.18nmoles mg‘‘ protein, 
after 3 minutes preincubation at 37®C in the presence of NADPH (ImM).
When a higher concentration of ABT (20mM) was added to activation mixtures 
containing microsomes the mutagenicity of 2AA and, to a greater extent, 6AC were 
depressed but remained marked and the bioactivation of 2AF was unaffected (table 
3.19). However, the mutagenicity of IQ was completely abolished (table 3.19). IQ is 
exclusively metabolised by cytochrome P450 oxidases and the complete removal of
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the bioactivation of IQ but not 2AA, 6AC or 2AF suggests that enzymes other than 
the cytochromes P450 are responsible for the bioactivation of aromatic amines. This 
observation is in agreement with the absence of any effect on 2AA mutagenicity 
(table 4.1) and the decrease in 6AC mutagenicity (table 3.15) after pretreatment with 
Aroclor 1254, a potent inducer of cytochrome P450.
Table 3.18. The effect of pretreatment with cobalt (III) chloride on the 
Aroclor 1254-induced cytosol-mediated mutagenicity o f aromatic
amines
Histidine revertants/plate
Mutagen Concentration(pg/plate) Aroclor 1254
Aroclor 1254 + 
Cobalt chloride
2-Aminoanthracene
1 1044 ±40 955 ± 100
2 1080 ±75 1083 ±70
3 1128 ±125 305 ±22
4 1423 ±314 466 ±59
2-Aminofluorene
1 66 ±24 55 ±13
2 87±8 81 ±10
3 132 ±18 74±6
4 182 ±45 131 ±15
6-Ammochrysene
0.25 397 ±55 393 ± 34
0.50 861 ± 77 706 ± 33
0.75 1062 ± 67 870 ± 66
1.00 1350±116 1234 ±208
Mutagenicity tests were performed using activation mixtures derived from Aroclor 1254-induced 
rat liver (10% v/v) and Salmonella typhimurium strain TA98. Results are expressed as mean ± 
standard deviation of three observations. The spontaneous reversion rate was 23 ± 3 and has 
alrea(fy been subtracted.
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Mutagenic response in the presence o^cytosol differed considerably from that of 
microsomes, demonstrating that these are two independent mechanisms responsible 
for the bioactivation of aromatic amines. Firstly, as observed previously (Abu-Shakra 
et al., 1986; chapter 3) IQ did not elicit a mutagenic response in the presence of 
cytosol and the addition of ABT completely inhibited the mutagenicity of 2AA, 2AF 
and 6AC (table 3.19). The cytosolic enzyme concerned with the bioactivation of 
aromatic amines appears to be a haemoprotein able to metabolise ABT to benzyne 
which inactivates the haem prosthetic group. However, without knowing the nature 
of the cytosolic enzyme the possibility that ABT inhibits this enzyme through an 
unrelated mechanism cannot be excluded.
Table. 3.19. The effect o f 1-aminobenzotriazole (ABT) bn aromatic 
amine mutagenicity
Histidine revertants/plate
Activation system 
and mutagen
Mutagen
concentration
(pg/plate)
-ABT + ABT
Microsomes
2-Aminoanthracene 4 1088 ±47 767 ±27
2-Aminofluorene 4 112±14 91 ±23
6-Aminochrysene 0.25 1561 ±43 683 ± 9
IQ 0.04 311 ±73 33 ±10
Cytosol
2-Aminoanthracene 4 1081± 193 38 ±15
2-Aminofluorene 4 103 ± 7 8 ± 7
6-Aminochrysene 0.25 470 ±55 3 ± 8
IQ 0.04 nd nd
ABT was dissolved in DMSO, added to activation mixtures and incubated at 37°C for 3 minutes. An 
equal volume of DMSO was added to the -ABT samples. Salmonella typhimurium strain TA98, 
mutagen and molten agar were added, vortexed thoroughly, and poured onto minimal agar plates. 
Results are expressed as the mean ± standard deviation of triplicates. The spontaneous reversion 
rate was 19 ± 6  and has alreacfy been subtracted, nd = a reversion rate lower than the spontaneous 
reversion rate..
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3.3.15. Inhibition of aromatic amine bioactivation by 
cytochrome c
Cytochrome P450 accepts electrons from NADPH through the flavoprotein 
cytochrome P450 reductase. Cytochrome c also functions as an electron acceptor 
from NADPH cytochrome P450 reductase and therefore inhibits cytochrome P450 as 
a result of competition for the electrons. In the present investigation cytochrome c 
was employed to compare its effect in the cytosolic and microsomal metabolism of 
aromatic amines.
Table 3.20. Inhibition o f the mutagenicity of aromatic amines by
cytochrome c
Histidine revertants/ plate
Mutagen Cytochrome c 
(O.lmM)
Microsomes Cytosol
2-Aminoanthracene - 214 ±45 174 ±29
+ 68 ±38 98 ±15
2-Aminofluorene - 871 ±64 54±6
+ 376 ±27 24±8
6-Aminochrysene - 1216 ±17 91 ±10
+ 363 ± 17 27±4
Mutagenicity tests were performed with S. typhimurium strain TA98 and 10% (v/v) activation 
mixtures from Aroclor 1254-induced animals. The results are expressed as mean ± standard 
deviation o f triplicates. The spontaneous reversion rate for TA98 was 14 ± 4 and has been 
subtracted
Cytochrome c (O.lmM) decreased considerably the mutagenic response of 2AA, 2AF 
and 6AC in microsomes, in the presence of NADPH (table 3.20). The bioactivation 
of all aromatic amines to mutagenic intermediates by the cytosol was markedly 
inhibited by cytochrome c (table 3.20).
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To verify the inhibition of cytosol-mediated bioactivation, a range of concentrations 
of cytochrome c (0.05-0.2mM) were incorporated into Ames tests and a 
concentration-dependent decrease in the mutagenicity of 2AA and 6AC was observed 
(figure 3.3).
3.3.16. Inhibition of 2-aminoanthracene bioactivation by 
(+)-catechin in hepatic subcellular fractions from Aroclor 
1254-pretreated rats
(+)-Catechin is an inhibitor of NADPH-cytochrome P450 reductase and consequently 
depresses cytochrome P450 activity. The effect of (+)-catechin on the 2AA 
mutagenicity in microsomes and cytosol was investigated to determine whether 
cytochrome P450, or other enzymes which also function through a reductase are 
involved in the metabolism of 2AA to mutagenic intermediates. Enzyme systems are 
susceptible to inhibition by (+)-catechin because it prevents the flow of electrons 
from the reductase. Inhibition by (+)-catechin was also employed to demonstrate 
differences between the microsomal and cytosolic activation systems.
Microsomal bioactivation of 2AA was unaffected at the lowest (+)-catechin 
concentration (10"^  M), but was virtually completely inhibited at the highest (+)- 
catechin concentration (10'  ^M) (figure 3.4). However, bioactivation by the cytosol 
was more resistant to inhibition by (+)-catechin, being unaffected at both lO"® and 10*^  
M concentrations, and still maintained a marked, though much reduced, mutagenic 
response at the highest (+)-catechin concentration (figure 3.4).
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Figure 3,3. Inhibition of cytosol-mediated bioactivation o f aromatic 
amines by cytochrome c
Activation mixtures containing Aroclor 1254-induced cytosol (10% v/v) were mixed with 
S.typhimurium strain TA98 and either 2-aminoanthracene (5\ig/plate) (D), 2-aminofluorene 
(5\ig/plate) (U), or 6-aminochrysene (l\ig/plate) (6). The results are expressed as mean ± standard 
deviation of triplicates. The spontaneous reversion rate was 24 ± 8 and has already been 
subtracted.
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Figure 3.4. Inhibition o f 2-aminoanthracene bioactivation by (+)- 
catechin
(+)-Catechin was mixed with 2-aminoanthracene (5\ig/plate), S. typhimurium strain TA98 and 
activation mixtures (10% v/v) employing either microsomes (U), or cytosol (0). Results are 
expressed as mean ± standard deviation of triplicates. The spontaneous reversion rate was 31 ^ 4  
and has alreacfy been subtracted.
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3.3,17. The effect of dimethyl sulphoxide on 2- 
aminoanthracene bioactivation by hepatic microsomes and 
cytosol
Dimethyl sulphoxide (DMSO) is a free radical scavenger and may be used to 
demonstrate the existence of free radical mechanisms in the bioactivation of 2AA to 
mutagenic intermediates. The effect of DMSO on the bioactivation of 2AA by 
hepatic microsomal and cytosolic preparations was investigated.
Table.3.2L The effect o f dimethyl sulphoxide on 2-aminoanthracene 
bioactivation
Histidine revertants/plate
DMSO (p.1) 0 50 100 200
Activation system
1654 ±84 
505 ±94
1684 ±116 
526 ±19
1582 ±108 
444 ±76
1258 ±202 
401 ± 88
Microsomes
Cytosol
(5\ig/plate) and 10% (v/v) activation mixtures from Aroclor 1254-induced animals. The results are 
expressed as mean ± standard deviation o f triplicates. The spontaneous reversion rate was 15 ± 3  
and has already been subtracted.
DMSO had only minimal effects on the activation of 2AA producing only a 
moderate decrease in 2AA mutagenicity by microsomes (table 3.21). Cytosolic 
activation was not significantly modulated by this treatment.
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3.3.18. The effect of Nco-Nitro-L-arginine methyl ester on 
the bioactivation of aromatic amines by microsomes and 
cytosol
Nco-Nitro-L-arginine methyl ester (NAME) is a specific inhibitor of nitric oxide 
synthase (Rees et al., 1990). Nitric oxide synthase is a cytosolic enzyme with its own 
reductase activity, and has been described as a cytochrome P450-type haemoprotein 
(White and Marietta, 1992). NAME was used to determine if the enzyme responsible 
for the bioactivation of aromatic amines by hepatic cytosol, from Aroclor 1254- 
treated rats, is related to nitric oxide synthase. However, the addition of NAME 
(lOOpM) had no effect on the bioactivation of 2-AA (5pg/plate), 2-AF (5pg/plate) or 
6-AC (Ipg/plate) to mutagenic intermediates by either microsomes or cytosol in the 
presence of NADPH (table 3.22).
Table 3.22. The effect o f NAME on aromatic amine mutagenicity
Histidine revertants/plate
Mutagen Inhibitor Microsomes Cytosol
2-Aminoanthracene - 1571± 157 435 ±43
NAME 1411 ±22 466 ±45
2-Ammofluorene - 974 ±31 51±7
NAME 929 ±117 61 ±7
6-Ammochiysene - 872 ±203 417±11
NAME 974 ±118 488 ±81
Mutagenicity tests were performed using 10%(v/v) activation mixtures from Aroclor 1254-induced 
animals, Salmonella typhimurium strain TA98, in the presence or absence o f NAME (N(ù-Nitro-L- 
arginine methyl ester) (100\xh .^ Results are expressed as mean ± standard deviation of triplicates. 
The spontaneous reversion rate was 15 ± 3  and has alreacfy been subtracted
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3.3.19. The effect of reduced glutathione on 2- 
aminoanthracene mutagenicity
Strong electrophiles react with reduced glutathione to form non-toxic conjugates, the 
reaction being catalysed by glutathione-S-transferase. This is an important 
detoxication mechanism for many mutagens. The TA98 tester strain has significant 
amounts of glutathione and glutathione-S-transferase (Meyer et al., 1980), and 
therefore bacterial enzymes may be responsible for further metabolism of mutagenic 
intermediates formed by S9 in the Ames test. Rat cytosol also has high 
concentrations of glutathione, and glutathione-S-transferase is induced by Clophen 
A50, and to a lesser extent, phenobarbitone and 3-methylcholanthrene (Summer et 
ah, 1980). Addition of glutathione decreases the mutagenic responses of 2AAF, 2AF, 
and N-hydroxy-2AAF (Hongslo et a l, 1983), but increases the mutagenicity of Trp- 
P-2 and N-hydroxy-Trpf2 (Saito et a l, 1983).
To determine whether glutathione interacts with microsome- and cytosol-generated 
metabolites of 2AA, the mutagenicity of 2AA was investigated in the presence and 
absence of glutathione. Differential response to glutathione by the two activation 
systems would suggest that different mutagenic intermediates are produced. Reduced 
glutathione itself was non-mutagenic in the presence of subcellular firactions firom 
Aroclor 1254-pretreated rats (table 3.23). However, it haÂa. potentiating effect on 
2AA mutagenicity. In the presence of either microsomes or cytosol, an increase in 
mutagenic response was observed.
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Table 3,23. Potentiation of 2-aminoanthracene mutagenicity in 
hepatic fractions by glutathione
Histidine revertants/plate
2-Ammoanthracene and glutathione 
concentrations
Microsomes Cytosol
Glutathione (lOmM)
2-AA (5pg)
2AA (5pg) + glutathione (1.25mM) 
2AA (5pg) + glutathione (2.5mM) 
2AA (5pg) + glutathione (S.OmM) 
2AA (5pg) + glutathione (lO.OmM)
nd 
386 ±113 
321 ± 87 
426 ±104 
716 ±104 
698 ±17
18 ±17 
1259 ±35 
1265 ± 154 
1455 ± 83 
1303 ± 69 
1713 ± 164
Salmonella typhimurium strain TA 98. The spontaneous reversion rate was 17 ± 6  and has already 
been subtracted. Results are expressed as mean ± standard deviation o f triplicates.
3.3.20. Tissue distribution of microsomal and cytosolic 
activation of 2-aminoanthracene and 6-aminochrysene
All previous studies on the cytosolic metabolism of chemical carcinogens have 
concentrated on the liver and the contribution of other tissues, if any, has been 
ignored. In the present study cytosolic fractions from various tissues were incubated 
with 6AC and 2AA and the production of mutagenic metabolites monitored using the 
Ames test.
Bioactivation of 2AA and 6AC was demonstrated by hepatic microsomes and by 
hepatic cytosol after pretreatment with Aroclor 1254. No activation of either mutagen 
was detected in any of the other tissues at the mutagen concentrations studied (table 
3.24 and 3.25).
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Table.3.24. Tissue distribution of cytosolic enzyme system(s) that
activate 2-aminoanthracene, Comparison with the microsomal system
Histidine revertants/plate
Untreated Aroclor 1254-treated
Tissue and 2-AA 
concentration
Microsomes Cytosol Microsomes Cytosol
LIVER
Ipg/plate 63 ±20 11±7 248 ±30 101 ± 7
4pg/plate 248 ±52 36±1 544 ±101 257 ±28
KIDNEY
Ipg/plate 8 ± 2 1± 4 5 ± 2 6 ± 2
4|ig/plate 11±6 7 ± 3 14±4 10±2
LUNG
Ipg/plate 7 ± 5 5 ± 5 11±2 6 ± 6
4|Lig/plate 27±5 8±1 17±3 8 ± 3
HEART
Ipg/plate 7 ± 2 5 ± 4 11±3 6 ± 5
4|ig/plate 10±1 7 ± 5 17±10 11±8
BRAIN
Ipg/plate 9± 3 3 ± 4 5 ± 6 6 ± 4
4pg/plate 7 ± 7 5± 1 17±5 11±4
spontaneous reversion rate was 10 ± 2 and has been subtracted from these values. Results are 
expressed as mean ± standard deviation of triplicates.
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Table,3.25. Tissue distribution of cytosolic enzyme system(s) that
activate 6-aminochrysene, Comparison with the microsomal system
Histidine revertants/plate
Untreated Aroclor 1254-treated
Tissue and 6-AC 
concentration
Microsomes Cytosol Microsomes Cytosol
LIVER
0.25pg/plate 458 ±101 14±1 87±8 821 ±38
l.OOpg/plate 1578 ±342 21 ± 6 1687 ±303 1773 ±66
KIDNEY
0.25pg/plate 1±1 3 ± 4 0 ± 3 8 ± 3
1.00|Lig/plate 6 ± 6 2 ± 4 6 ± 5 11±4
LUNG
0.25pg/plate 4 ± 2 4 ± 3 7 ± 6 6 ± 4
l.OOpg/plate 5 ±10 4 ± 3 8 ± 4 10±7
HEART
0.25pg/plate 5 ± 4 0 ± 1 8± 3 6 ± 7
l.OOpg/pIate 13±3 0±1 5 ± 4 10±3
BRAIN
0.25pg/plate 3±1 0 ± 5 8 ± 4 0 ± 4
l.OOpg/plate 2 ± 2 nd 10±5 7 ± 2
Tests were carried out using 10% (v/v) activation systems and S. typhimurium strain TA98. Results 
are presented as mean ± standard deviation of triplicates. The spontaneous reversion rate was 12 ± 2  
and has alreacfy been subtracted from these values, nd represents fewer revertants/plate than the 
spontaneous reversion rate.
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3.3.21. Strain differences in the bioactivation of amines by 
hepatic cytosol from Aroclor 1254-pretreated rats
De Flora et al., (1994) have demonstrated the bioactivation of heterocyclic amines by 
rat hepatic cytosol. This is in contrast to the results reported earlier in this Chapter 
and to the findings of Abu-Shakra et a l, (1986). In these studies hepatic cytosol firom 
Aroclor 1254-pretreated Wistar albino rats was employed in standard Ames test 
procedures, whereas De Flora et al., (1994) used Aroclor 1254-treated Sprague- 
Dawley rats and incorporated a preincubation step in the Ames test procedure. The 
observed bioactivation of heterocyclic amines by hepatic cytosol may therefore be a 
consequence of strain differences between Sprague-Dawley and Wistar albino rats or 
the incorporation of a preincubation step.
The ability of cytosolic firactions firom Aroclor 1254-treated Wistar albino and 
Sprague-Dawley rats to activate amines was investigated. Two studies were 
conducted, the first involving the standard Ames test procedure, whereas in the 
second a 30 minute preincubation step was incorporated, to allow further metabolism 
of the mutagens and consequently increased mutagenic response (table 3.26). 
Without preincubation, cytosol firom Sprague-Dawley, but not Wistar albino, rats 
bioactivated MelQ. Sprague-Dawley cytosol also produced a greater mutagenic 
activation in the presence of 2AF, than Wistar albino. There were no major strain 
differences in the mutagenic responses with either 2-AA or 6AC. After 
preincubation, Sprague-Dawley rat liver cytosol was generally a more efficient 
activating system compared with the Wistar albino rat cytosol. 2-Aminoanthracene, 
2-AF and MelQ exhibited significantly higher mutagenicity whereas 6-AC was less
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mutagenic in Sprague-Dawley liver cytosol compared with cytosol from Wistar 
albino rats. IQ was non-mutagenic in both strains of rat, irrespective of 
preincubation, even though it was present at the concentration which has previously 
demonstrated a mutagenic response (De Flora et al., 1994).
Table. 3.26. A comparison of aromatic amine bioactivation by hepatic 
cytosol from Wistar albino and Sprague-Dawley rats
Histidine revertants/plate
Rat strain and mutagen 
(pg/plate)
No preincubation With preincubation
Wistar-Alblno
2-Aminoanthracene (5) 1347 ±479 1374 ±425
2-Aminofluorene (5) 91 ±12 92 ±23
6-Aminochrysene (0.5) 181 ±120 1063 ±193
IQ (0.008) 9±9 4±2
MelQ (0.002) 9 ±5 52±11
Sprague-Dawley
2-Aminoanthracene (5) 907 ±333 2254 ±128
2-Aminofluorene (5) 209 ±56 236 ±13
6-Aminochrysene (0.5) 144 ±88 224 ±85
IQ (0.008) 12±11 9±14
MelQ (0.008) 93 ±18 279 ±14
Cytosol, mutagen and bacteria (TA98) were preincubated for 30 minutes at 37°C and activation 
was then initiated by the addition of the NADPH-generating system. Results are presented as the 
mean ± standard deviation of triplicates. The spontaneous reversion rate of 43 ± 15 has already 
been subtracted.
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3.3.22. Species differences in the microsomal and cytosolic 
activation of 2-aminoanthracene and 6-aminochrysene to 
mutagens in the Ames test
Cytosolic activation of aromatic amines has only been demonstrated in the rat and no 
studies have been carried out in other animals or human. Using 2AA and 6AC as 
model mutagens the ability of cytosol from other animals to catalyse their
activation was investigated.
Table.3.27. Species differences in the bioactivation o f 6- 
aminochrysene and 2-aminoanthracene
Animal Promutagen Microsomal Cytosolic
Species (pg/plate) activation activation
Rat 6AC
0.6 885 ±103 26±7
1.0 1315±119 29±3
2AA
5.0 121±31 26±9
Hamster 6AC
0.6 418 ±39 20±8
1.0 856 ±17 25±4
2AA
5.0 179 ±49 30±8
Ferret 6AC
0.6 41 ±7 20 ±2
1.0 60 ±10 14±3
2AA
5.0 43 ±18 22±7
Pig 6AC
0.6 33 ±6 25 ±9
1.0 49 ±16 37±8
2AA
5.0 28 ±9 24±2
and either 6-aminochrysene (6AC) or 2-aminoanthracene (2AA).The spontaneous reversion rate 
was 16 ±5. Results are presented as means ± standard deviation of triplicates.
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Of the four animal species investigated, namely rat, hamster, pig and ferret, the rat 
microsomes demonstrated the most pronounced 6AC-mutagenicity followed by the 
hamster. In contrast, only weak mutagenicity was demonstrated by the pig and ferret 
microsomes (table 3.27).
An almost identical pattern of mutagenicity was evident with 2-aminoanthracene, but 
with this aromatic amine the mutagenic response was generally much lower than that 
observed for 6AC (table 3.27). Once more activation was only achieved by the rat 
and hamster, but contrary to 6AC activation, 2-aminoanthracene induced a slightly 
stronger mutagenic response in the hamster. Only untreated animals were used in this 
investigation, and no animal species showed any cytosol-mediated bioactivation of 
either aromatic amine.
Table 3.28. Bioactivation of 6-aminochrysene and 2-aminoanthracene 
by microsomes and cytosol from Aroclor 1254-treated hamster
Histidine revertants/plate
Mutagen Concentration
(pg/plate)
Microsomes Cytosol
6-Ammochiysene 0.25 13 ±5 8±3
0.50 94 ±42 15±9
0.75 278 ±48 11±5
1.00 652 ±58 23±4
2-Ammoanthracene 5.00 1339 ±243 9±3
Mutagenic activation was investigated employing 10%(v/v) activation mixtures, S. typhimurium 
strain TA98. Results are expressed as mean ± standard deviation of triplicates. The spontaneous 
reversion rate was 13 ± 3  and has alreacfy been subtracted from these values.
In addition to rat, hamster demonstrated a high degree of microsomal metabolism of 
6AC and 2AA to mutagenic intermediates (table 3.27); consequently cytosolic
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activation of aromatic amines to mutagens was also investigated, in this species, after 
pretreatment with Aroclor 1254. In marked contrast to the rat, Aroclor 1254-treated 
cytosol from the hamster did not convert 6AC or 2AA to mutagenic metabolites 
(table 3.28).
3.3.23. Metabolic activation of 6-aminochrysene and 2- 
aminoanthracene by human hepatic cytosols
Hepatic cytosolic fractions from three individuals were investigated for their ability 
to activate 6-aminochrysene and 2-aminoanthracene to mutagenic intermediates. 
Inter-individual variation was large but all three cytosols a clear mutagenic
response Avith 2-aminoanthracene (table 3.29). When 6AC was used as the mutagen, 
a positive response, as judged by a doubling of the spontaneous reversion rate, was 
seen with all three cytosolic samples but the mutagenic response was much lower 
than that elicited by 2AA.
Table.3.29. Metabolic activation o f 2-aminoanthracene and 6- 
aminochrysene to mutagens in the Ames test by human hepatic cytosol
Histidine revertants/plate
Mutagen Cytosol A Cytosol B Cytosol C
Spontaneous reversion rate 
6-Aminochrysene (Ipg/plate) 
2-Aminoanthracene (5pg/plate)
17±1 
37±3 
217 ±59
21 ±1 
84 ±23 
166 ±53
26±5  
68 ±5  
326 ±47
microsomes and 10%(v/v) activation systems prepared. Mutagenic potential was monitored using 
Salmonella typhimurium strain TA98 and the model mutagens 6-aminochrysene (l[ig/plate) or 2- 
aminoanthracene (5\ig/plate). Results are expressed as mean ± standard deviation o f triplicates.
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3.4. Discussion
Forster et ah, (1981b) were the first to observe that the hepatic cytosolic fraction 
could convert 2-acetylaminofluorene, 2-aminoanthracene and 2-aminofluorene to 
reA.ch\/< intermediates that provoked a mutagenic response in the Ames test. These 
authors, however, did not investigate the nature of this enzyme system and the 
possibility that it represented microsomal contamination of the cytosol was not 
addressed. Subsequent studies (Ayrton et ah, 1992; Leist et ah, 1992) using 2AA and 
2AF confirmed the presence of this system in the cytosol, demonstrated its 
requirement for NADPH and O2 and provided evidence that it is unlikely to 
constitute microsomal contamination. In the present investigation these studies have 
been extended and this enzyme system has been further characterised with respect to 
its substrate specificity and inducibility by xenobiotics. Moreover, additional, strong 
evidence is presented that this system is truly cytosolic in nature and differs 
markedly from the microsomal enzymes known to activate aromatic amines. 
Furthermore, its tissue distribution was studied in the rat and its presence in the liver 
of other animal species investigated. Finally, for the first time, the presence of this 
enzyme system(s) in human cytosol is demonstrated.
Substrate specificity o f a hepatic cytosolic activity responsible for the 
bioactivation o f promutagens
Certain aromatic amines, including 2-acetylaminofluorene, 2-aminofluorene, 2,7- 
diaminofluorene and 2-aminoanthracene undergo biotransformation to mutagenic 
intermediates by a soluble component of hepatic S9 from Aroclor 1254-pretreated
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rats (Forster e/a/., 1981a and b;Traynor et al, 1991; Leist era/., 1992; Ayrton et 
al, 1992). Further investigation of the substrate specificity of the cytosolic activity 
has shown that many compounds which are mutagenic in the presence of the 
microsomal firaction, e.g., benzidine, 4-aminobiphenyl and IQ (Smith and loannides, 
1987; Abu-Shakra et a l, 1986; Leist et a l, 1992) are not mutagenic in the presence 
of cytosol. The ability of hepatic cytosol, firom Aroclor 1254-treated rats, to 
bioactivate several, structurally diverse aromatic amines, and the potent heterocyclic 
amine IQ (figure 3.5) to mutagenic intermediates was investigated and compared to 
bioactivation by microsomes.
In the presence of hepatic cytosol, 2-aminoanthracene, a known substrate for the 
cytosolic system, expressed the most marked mutagenic response. A positive 
mutagenic response was also observed with 6-aminochrysene and, more modestly, 
2,3-diaminonaphthalene (table 3.1). The metabolism to mutagenic intermediates of 
neither 6-aminochrysene nor 2,3-diaminonaphthalene has been previously detected in 
cytosol. The remaining aromatic amines and the potent heterocyclic amine mutagen 
IQ elicited no mutagenic response in the presence of cytosol (table 3.1). The 
substrate specificity of the cytosolic and microsomal bioactivation systems are 
markedly different with some mutagens eliciting a potent mutagenic response in the 
presence of microsomes but not in the presence of cytosol e.g. Glu-P-1, 3-methoxy- 
4-aminoazobenzene and 2,6-diaminotoluene. Moreover, hepatic cytosol isolated firom 
isoniazid-treated rats did not readily convert either N-nitrosopiperidine or N- 
nitrosopyrrolidine to mutagenic intermediates, but both nitrosamines induced a clear 
mutagenic effect in the presence of microsomes (table 3.2). In the microsomes.
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activation of these two nitrosamines to mutagens is catalysed by CYP2E1 
(Kokkinakis et al., 1985; Yang et al., 1985) and for this reason animals were induced 
with isoniazid, a CYP2E1 inducer (Ryan et al., 1985) rather than with Aroclor 1254. 
All the above observations argue strongly against the cytosolic enzyme system being 
merely a microsomal contaminant.
Role ofN-hydroxylation in the cytosolic activation o f aromatic amines
The bioactivation of planar aromatic amines, including 6-aminochrysene, to
mutagens by the microsomal fraction involves N-hydroxylation. The significant 
hydrocarbon character of 6AC, however, also facilitates formation of the bay-region 
l,2-dihydrodiol-3,4-epoxide which is also mutagenic (Delclos et al, 1988). 
Similarly, the parent hydrocarbon, chrysene, exhibits a positive mutagenic response 
with Aroclor 1254-induced microsomes in the Ames test after metabolism to the 
dihydrodiol-epoxide (Cheung et al, 1993). However, chrysene could not induce a 
mutagenic response at the same concentration as 6AC (table 3.4.) Also, in agreement 
with previous reports (Cheung, et al, 1993), 2- and 6-methyl chrysenes were non- 
mutagenic at these concentrations (table 3.5). However, 2-aminochrysene has a 
pronounced mutagenic response comparable to that displayed by 6AC (table 3.5). It 
appears, therefore, that Aroclor 1254-induced microsomes preferentially activate 
aminochrysenes through oxidation of the amino group and not ring-oxidation. The 
previously reported prevalence of N-hydroxylamine-derived hepatic DNA-adducts 
supports this hypothesis (Delclos et al, 1987).
Hepatic cytosol also induced a mutagenic response with aminochrysenes but not 
methylchrysenes or chrysene (tables 3.4. and 3.5), leading to the conclusion that
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bioactivation by cytosolic enzymes also requires the presence of an amino group and 
probably involves N-oxidation. Further evidence for this route of activation was 
obtained using an N,0-acetyltransferase-deficient strain of Salmonella, TA98-1,8- 
DNPe (table 3.13). There was no mutagenic response with 6-aminochrysene, 2- 
aminoanthracene or 2-aminofluorene using the deficient strain demonstrating that O- 
acetylation is important in the mutagenicity of these amines. The most likely route of 
activation for these amines is an initial N-hydroxylation followed by 0-acetylation 
forming the acetoxyamine, which may spontaneously break down releasing the 
electrophilic nitrenium ion. The mutagenicity of 2- and 6-aminochrysenes is 
comparable in microsomes and cytosol, an observation not consistent with the 
hypothesis that cytosolic bioactivation of aromatic amines is a consequence of 
microsomal contamination. Therefore microsomes and cytosol both contain distinct 
enzymes responsible for the N-oxidation of aminochrysenes.
In addition to acétylation N-hydroxylamines can also undergo further metabolism by 
sulphotransferase to form unstable sulphate esters which spontaneously break down 
releasing the nitrenium ion. The role of sulphotransferase in the bioactivation of 
aromatic amines was investigated by supplementing activation mixtures with, the 
sulphate donor, 3’ phosphoadenosine-5’-phosphosulphate (PAPS). In increasing the 
mutagenicity of 2AF, the addition of PAPS further demonstrates that this mutagen 
undergoes N-hydroxylation in both the S9 and the cytosol and, that sulphate 
conjugation of the hydroxylamine to the sulphate-ester is responsible for an increase 
in mutagenic response (table 3.14). Under identical conditions the mutagenic 
response of 6AC was markedly reduced (table 3.14) suggesting that the microsomes
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are mainly responsible for ring oxidation of 6AC with subsequent sulphate 
conjugation yielding only non-mutagenic metabolites, or that sulphate conjugation of 
the hydroxylamine is a route of detoxication. The less pronounced effects of PAPS 
on 6AC bioactivation in the cytosol may demonstrate the absence of ring oxidation in 
this fraction. The absence of any effect on 2AA mutagenicity by PAPS suggests that 
either the sulphate ester is stable and does not break down to release the nitrenium 
ion or conversely, that the sulphate conjugate is very unstable and breaks down 
before it can enter the bacteria and bind to DNA.
Earlier it was demonstrated that 1-aminoanthracene and 6-methylchrysene are non- 
mutagenic (tables 3.1 and 3.5), therefore the bioactivation to mutagens is dependent 
upon both the possession of, and the position of, an amino group. There are two 
possibilities why these compounds are non mutagenic. They are either not substrates 
for the enzymes concerned with the bioactivation to mutagenic intermediates, or the 
metabolites produced are non-mutagenic. 1 -Aminoanthracene and 6-methylchrysene 
inhibited the bioactivation of 2AA and 6AC respectively to mutagens. Inhibition 
occurred in both the microsomes and, to a greater extent, the cytosol, but required 
relatively high concentrations of inhibitor, compared to the mutagen concentration, to 
give only modest inhibition of the mutagenic response and consequently, 1- 
aminoanthracene and 6-methylchrysene are probably only poor substrates. Inhibition 
of the cytosolic fraction is much more pronounced with 30% inhibition by 1- 
aminoanthracene and 60% inhibition by 6-methylchrysene (table 3.6). Inhibition in 
the cytosol may be greater because the enzyme responsible has a greater affinity for 
1-aminoanthracene and 6-methylchrysene than the microsomal enzymes.
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DeFlora et. al have reported the cytosolic bioactivation of the heterocyclic amine 
MelQ by Sprague-Dawley rats, by including preincubation in the Ames test 
(DeFlora et. al 1994). Hepatic cytosols from Aroclor 1254-pretreated Sprague- 
Dawley and Wistar albino rats have different substrate specificity (table 3.26). For 
example, without incubation, neither IQ nor MelQ were metabolised to mutagenic 
intermediates by cytosol from Wistar albino rats, and, after preincubation, only a 
modest mutagenic response was observed with MelQ. In contrast, MelQ gave a good 
mutagenic response with cytosol from Sprague-Dawley rats without and, more 
noticeably, after preincubation. No mutagenic response was observed for IQ in the 
presence of cytosol from either strain. Aromatic amines also displayed different 
mutagenic responses in the two strains. After preincubation 2AA and 2AF were both 
activated much more effectively by cytosol from Sprague-Dawley rats but 6AC, in 
contrast, was bioactivated considerably more by cytosol from the Wistar albino rats. 
Hence Aroclor 1254-pretreatment of both Sprague-Dawley and Wistar albino rats 
induces cytosolic enzymes which can metabolise aromatic and heterocyclic amines to 
mutagenic intermediates. The different substrate specificity, however, suggests that 
these enzymes exhibit some inter-strain differences. DT-diaphorase has already been 
hypothesised to participate in the bioactivation of amines by hepatic cytosol (DeFlora 
et. al, 1994). Amines are not substrates for DT-diaphorase but it is possible that this 
enzyme is acting in conjunction with a cytosolic oxidase to metabolise amines to 
mutagenic intermediates. Alternatively, though no evidence exists, it is conceivable 
that these two strains possess different isozymes of the same system.
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Table 3.30. Structural dimensions o f amines bioactivated by Aroclor 
1254-pretreated hepatic cy tosol
Compound Length (A) Width (A) Depth (A)
2-Aminoanthracene 12.723 7.356 3.200
2-Aminochiysene 14.530 7.876 3.705
6-Aminochrysene 13.851 8.627 4.186
2,7-Diaminofluorene 13.340 7.451 4.219
2-Aminofluorene 12.404 7.451 4.219
2-Acetylaminofluorene 14.156 7.451 4.219
MelQ 11.762 9.273 4.205
2,3-Diaminonaphthalene 10.263 7.361 4.181
Data supplied by Dr. DFV Lewis, University o f Surrey, Guildford
Table 3.31. Structural dimensions o f some amines not bioactivated by 
Aroclor 1254-pretreated hepatic cytosol
Compound Length (A) Width (A) Depth (A)
2,4-Diaminotoluene 9.15 8.09 4.2
2,6-DiaminotoIuene 9.01 8.18 4.2
o-Aminoazotoluene 14.80 7.95 4.2
Glu-P-1 12.20 8.00 4.0
IQ 11.44 7.98 4.2
Data supplied by Dr. DFV Lewis, University o f Surrey, Guildford
Figure 3.5. shows the structures of the amines which elicit mutagenic responses in 
the presence of Aroclor 1254-treated cytosol. All are planar aromatics, and are 
similar in size. As a consequence of their similar size and planarity it is possible to 
assume these mutagens are all substrates for the same enzyme. Therefore, in addition 
to having an amino group, mutagens also have to be planar to be metabolised by 
cytosol. The size of the mutagen is an important determinant of the observed
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mutagenic response. The weakly mutagenic amines, in the presence of cytosol, MelQ 
and 2,3-diaminonaphthalene are shorter in length than the more mutagenic amines 
(table 3.30), and the most mutagenic amines, 2-aminoanthracene, 2-aminochrysene 
and 6-aminochrysene have the lowest depths i. e., are most planar (table 3.30).
2-Aininoanthracene
6-Aminochrysene
2-Aminochrysene 
2,3-Diaminonaphthalene
COCH,
2-Acetylaminofluorene 2-Aminofluorene
N = -
MelQ 2,7-Diaminofluorene
Figure 3.5. Structures of aromatic amines which are converted to 
mutagenic intermediates by Aroclor 1254-treated cytosol
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However, these are not the only characteristics required which determine whether an 
amine is metabolised by the cytosol to mutagens, and investigation of other amines is 
required. Investigation of some of the amines which are non-mutagenic in the 
presence of Aroclor 1254-induced cytosol (table 3.31) clearly demonstrates that 
these amines are also planar and of similar overall dimensions to the mutagenic 
amines. However, it is also apparent that these amines are not as planar as the highly 
mutagenic 2AA, 6AC and 2AC (tables 3.30. and 3.31).
1-Aminoanthracene and 1,8-diaminonaphthalene were not mutagenic in the presence 
of cytosol, therefore the position of the amino group is also important in determining 
the susceptibility of an amine to metabolism by this system (table 3.1). This is not 
unexpected, similar observations have been made previously with the microsomal 
activation of naphthylamines. Even though 2-naphthylamine is a urinary bladder 
carcinogen (Kriek, 1979; Radomsky, 1979), 1-naphthylamine has been shown not to 
be carcinogenic in several animal species (Radomsky, et al,. 1980). Hammons et al, 
(1985), demonstrated that the carcinogenic 2-naphthylamine, but not the non- 
carcinogenic 1-naphthylamine, is N-oxidised by microsomal enzymes to the N- 
hydroxylamine. Similarly, 2- but not 1-naphthylamine is mutagenic in the Ames test 
(McCann et al., 1975). In addition, not only the position of the amino group but also 
the presence of neighbouring functional groups is also important because they may 
prevent access to the amino group.This may explain the absence of a mutagenic 
response with o-aminoazotoluene, 1,8-diaminonaphthalene, and 2,4-, and 2,6- 
diaminotoluene.
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Enzyme characteristics of a system present in Aroclor 1254-induced 
cytosol responsible for the bioactivation o f aromatic amines
S9, microsomes and cytosol from Aroclor 1254-pretreated rats could metabolise 6AC 
to mutagenic intermediates (table 3.7). In contrast to 2AF and 2AA (Ayrton et ah, 
1992; Leist et ah, 1992), bioactivation of 6AC by S9 is considerably lower than by 
either of its components, microsomes or cytosol. The viability of the S9 was verified 
by the marked mutagenicity of 2AA in the presence of this fraction. 6- 
Aminochrysene mutagenicity was greatest in the presence of cytosol and least in the 
S9, and the extent of the mutagenic response with cytosol once again cannot be 
explained by microsomal contamination.
Aroclor 1254-treated rat hepatic S9 is routinely employed in mutagenicity testing. 
6AC is only weakly mutagenic using S9, unlike 2-aminofluorene (Leist et al., 1992), 
but it elicits a much higher mutagenic response in the presence of either microsomes 
or cytosol. It is therefore important that the components of S9 are used in the 
mutagenicity testing of amino compounds, in addition to S9. In contrast to other 
aromatic amines, where the soluble fraction has a potentiating effect on microsomal 
bioactivation (Smith and loannides, 1987; Saccone and Pariza, 1981), cytosol- 
mediated 6AC mutagenicity is inhibited by the presence of the microsomal fraction 
and vice versa. In order to study the interaction of these two subcellular fractions, 
cytosol-induced mutagenicity was investigated in the presence of increasing amounts 
of microsomes until the S9 was reconstituted. Cytosolic bioactivation of 6AC 
experienced a concentration-dependent decrease with the addition of microsomes 
until activation was at a level consistent with S9, where the concentration of 
microsomes and cytosol is the same, z.e., as in S9 (table 3.8). The microsomes
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showed an initial increase in mutagenicity followed by a concentration-dependent 
decrease with the addition of cytosol, but the mutagenic potential of microsomes 
(10%) and S9 (10%) were not significantly different. It appears that mutagenic 
intermediates produced by hepatic cytosol are deactivated by microsomal 
components with a subsequent reduction in mutagenicity. It is also conceivable that 
microsomes direct the metabolism of 6AC towards the formation of non-mutagenic 
intermediates, making it unavailable for cytosolic activation. The pronounced 
mutagenicity of 6AC in cytosol and its removal by the addition of isolated 
microsomes discredits the possibility that cytosolic bioactivation of aromatic amines 
may be the consequence of microsomal contamination.
Even though the mutagenic potential of the cytosol was diminished by a second 
centrifugation, the remaining mutagenic response is still considerable and is 
unaffected by a further centrifugation (table 3.3), indicating once again the cytosolic 
nature of the activity. All subsequent experiments adopted two centrifugations for the 
preparation of cytosol.
Further investigation into the bioactivation of 6AC to mutagens demonstrated 
differences between the microsomal and cytosolic systems, (a) Increasing the 
concentration of microsomes in the activation mixture produced a concentration- 
dependent increase in the number of revertant bacterial colonies until a maximum 
was reached (10% v/v), but any further increase in microsomal protein (20% v/v) 
caused a rapid decrease in the number of revertant colonies (table 3.9), presumably 
because the increased generation of reactive metabolites had become toxic to the 
bacteria. In contrast, in addition to the cytosol producing mutagenic responses in
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considerable excess of those produced by the microsomes, mutagenicity continued to 
increase at 20% (v/v) cytosol, (b) Microsomes and cytosol demonstrated different 
cofactor requirements (figure 3.2). The microsomes could utilise either NADPH or, 
more efficiently, NADH to generate 6AC mutagens, but cytosol-mediated activation 
of 6AC, in contrast, was only supported by NADPH.
Inhibition o f NADPH cytochrome P450 reductase and its effect upon 
the bioactivation o f aromatic amines by microsomes and cytosol from  
Aroclor 1254-treated rats
Inhibitors of cytochrome P450 reductase were employed to determine the importance 
of the cytochrome P450 oxidase system in the bioactivation of amines by the 
microsomal fraction and to demonstrate differences in the microsome- and cytosol- 
mediated activation mechanisms. NADPH cytochrome P450 reductase is present at 
much lower concentrations than other components of the mixed-function oxidase 
system (Estabrook et al., 1971) and is required by all isoforms of cytochrome P450, 
so inhibition of the reductase is an effective method of inhibiting cytochrome P450. 
A decrease in the reductase activity was achieved using (+)-catechin and cytochrome 
c, which inhibit cytochrome P450 by accepting electrons from NADPH cytochrome 
P450 reductase. (+)-Catechin is an inhibitor of both the microsome- and cytosol- 
mediated metabolism of 2AA to mutagenic intermediates (figure 3.4); however, 
whereas microsomal bioactivation was almost completely abolished, the inhibition of 
cytosol was less marked. The addition of cytochrome c also caused a significant 
decrease in the mutagenic response of aromatic amines in the presence of either 
microsomes or cytosol (figure 3.3). Cytochrome P450 reductase is a microsomal, 
membrane-bound enzyme so inhibition of cytosolic activation suggests microsomal
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contamination is responsible for activity in this subcellular fraction. However 
microsomal contamination of the cytosol is only expected to be small, and 
consequently, inhibition should be greater in this fraction and not lower as 
experienced here. Two possible explanations can be put forward to explain why there 
is inhibition of the cytosol-dependent mechanism. Firstly (+)-catechin is not a 
specific inhibitor of NADPH-cytochrome P450 reductase, it is an antioxidant and a 
free radical scavenger (Steele et al., 1985; Fraga et al., 1987), inhibits 
lipooxygenase, cyclooxygenase and lipid peroxidation (Nakayama et al., 1993) and 
can interact directly with proximate carcinogens (Steele et al, 1985), and therefore 
may be acting in a non-reductase dependent manner. Secondly, some cytosolic 
enzymes have their own reductase activity, such as nitric oxide synthase (White and 
Marietta, 1992), and a soluble cytochrome P450 found in Bacillus magabacterium 
(Nahri and Fulco, 1986). These enzymes have sufficient homology with NADPH 
cytochrome P450 reductase to suggest there is non-specific inhibition of a cytosolic 
enzyme which has its own reductase subunit and is responsible for the bioactivation 
of aromatic amines by cytosol.
Possible role of blood in the cytosolic bioactivation o f amines
Previous studies employing the cytosol of red blood cells supplemented with
methylene blue have generated mutagens from 2-aminoanthracene, 2-aminofluorene 
and 2-acetylaminofluorene (Duverger Van Bogaert et al, 1991 and 1992). It is 
conceivable that, because the livers were not perfused, contamination with blood is 
responsible for hepatic cytosolic bioactivation. However, addition of methylene blue 
to hepatic cytosol, in place of NADPH, only supported modest 6AC bioactivation, 
constituting only 5% of that produced by NADPH. The use of the same concentration
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of methylene blue, but in addition to NADPH, also had no effect on the bioactivation 
of 6AC by Aroclor 1254-pretreated cytosol. Increasing concentrations of methylene 
blue completely abolished the mutagenicity of 2AA and 2AF and produced a dose- 
dependent decrease in the mutagenicity of 6AC. Methylene blue supports the 
bioactivation of aromatic amines by red blood cell cytosol by maintaining 
haemoglobin in its reduced state and by stimulating NADPH production by the 
cytosolic pentose phosphate pathway. The conversion of 2AF to the N- 
hydroxylamine by red blood cell cytosol (Duverger Van Bogaert et al., 1992) is 
modestly reduced by methylene blue, and inhibition of the hepatic system may 
indicate that indeed contamination with red blood cell cytosol is responsible for the 
activation in this tissue. However, not only are the mutagenic responses more 
pronounced in hepatic cytosol but they are also inhibited far more effectively, and at 
a much lower concentration, by methylene blue. In addition, haemoglobin is 
maintained in its reduced form not only by NADPH but also, and more effectively, 
by NADH, yet this cofactor was unable to support the bioactivation of aromatic 
amines by hepatic cytosol. Therefore contamination with red blood cell cytosol is 
probably not responsible for hepatic cytosol-mediated bioactivation of aromatic 
amines. Methylene blue functions as an exogenous electron carrier and can mediate 
the transport of electrons to cytochrome c from various enzymes (McCord and 
Fridovich, 1970). Therefore, in inhibiting the cytosolic bioactivation of aromatic 
amines, methylene blue is probably acting in a similar way to cytochrome c i.e., by 
drawing electrons away from a cytosolic oxidase.
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Relationship o f cytosolic amine oxidase to nitric oxide synthase
Methylene blue is also a direct inhibitor of nitric oxide synthase (Mayer et al., 1993;
Shimizu et al, 1993). Nitric oxide synthase (NOS) is a cytosolic enzyme found in 
many cells, including rat Kupffer cells (Curran et al, 1989) and is capable of forming 
mutagenic nitrosamines from amines (Wu et al, 1993). NOS requires NADPH and 
molecular oxygen, has sequence homology with NADPH cytochrome P450 reductase 
and has been described as a cytochrome P450-type haemoprotein (White and 
Marietta, 1992), so is a good candidate for the enzyme responsible for the cytosol- 
dependent bioactivation of aromatic amines. However, the specific NOS inhibitor 
Nm-nitro-arginine methyl ether (Rees et al, 1990) had no effect on either 
microsomal or cytosolic activation of aromatic amines (table 3.22), and therefore 
NOS is not responsible for the bioactivation of aromatic amines to mutagenic 
intermediates.
Modulation o f the cytosol-mediated mutagenicity o f aromatic amines 
by glutathione
One route for the detoxication of carcinogens is conjugation with glutathione. Both 
glutathione and glutathione S-transferase are present at high concentrations in the 
Salmonella typhimurium tester strains (Meijer et al, 1980; Summer et a l, 1980), 
and the presence of functional levels of glutathione usually leads to an increase in 
deactivation and consequently a reduction in mutagenicity (Kerklaan et al, 1985). In 
agreement with previous studies, glutathione itself is not mutagenic at the 
concentrations employed in these investigations, but addition of reduced glutathione 
was responsible for an increase in mutagenicity in the presence of microsomes or 
cytosol (table 3.23). Certain classes of xenobiotic are activated by glutathione e.g.
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halomethanes, and 1,2 dihaloethanes (Anders, 1991) but this has not been 
demonstrated previously with 2AAF or 2AF (Hongslo et.al, 1983). However, the 
heterocyclic amine Trp-P-2 is metabolised by glutathione S-transferase and rat liver 
cytosol to a metabolite more mutagenic than N-hydroxy-Trp-P-2 possibly the N^- 
conjugate (Kato, 1986). Alternatively glutathione may be acting simply as a reducing 
agent causing the reduction of oxidised metabolites to more toxic intermediates. For 
example the weaker nitroso or nitro mutagens may be reduced to the N- 
hydroxylamine.
Neither microsomal nor cytosolic activation of 2AA involves free radical formation 
since the addition of DMSO, a free radical scavenger, to the cytosol had no 
significant effect on the bioactivation of 2AA, and only produced a modest decrease 
in bioactivation by microsomes.
Response of microsomal and cytosolic bioactivation systems to 
inducing agents
A. MICROSOMAL
The role of the cytochrome P450 mixed-function oxidases in the microsome- 
mediated bioactivation of 6AC is complex. Previous investigators have demonstrated 
bioactivation of 6AC by purified proteins belonging to the CYPIA, 2B and 3A 
subfamilies (Yamazaki et al., 1993). Rat CYP2B1 and CYP2B2, and human 
CYP3A4 are the predominant isoforms believed to be responsible for the activation 
of 6AC. In this investigation the microsomes from untreated rat demonstrated the 
greatest activation, showing the importance of constitutive forms of cytochrome 
P450 in the activation of 6AC. FAD monooxygenase (FMO) can conceivably N- 
hydroxylate this amine. The fact, however, that the pig, an animal endowed with a
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high FMO activity, could not activate 6AC (table 3.27), suggests that this enzyme 
system does not make a major contribution to 6AC activation. Neither the CYP4A 
inducer clofibrate nor the CYP3A inducer, dexamethasone could facilitate an 
increase in the microsome-mediated bioactivation of 6AC and, moreover, 
mutagenicity was decreased after pretreatment with isoniazid (CYP2E) or 
phenobarbitone (CYP2B). Interestingly, treatment with the polychlorinated biphenyl 
mixture Aroclor 1254 and with benzo[a]pyrene produced a significant decrease in 
microsomal 6AC mutagenicity. Both of these treatments induce the CYPIA 
subfamily of cytochrome P450, responsible for 6AC epoxidation and diol formation 
(Yamazaki et al., 1993). The reduction in the mutagenicity of 6AC by these hepatic 
fractions may be a result of induced detoxication activity or the mutagenic diol 
epoxide may be less mutagenic than the N-hydroxylamine. However, when the 
bioactivation of 6AC was reinvestigated using various tissues from control and 
Aroclor 1254-treated rats, Aroclor 1254 had no effect on hepatic bioactivation (table 
3.25). Therefore the effect of Aroclor 1254 on the bioactivation of 6AC by 
microsomes is unclear. CYP2B isoforms are responsible for N-hydroxylation of 
6AC (Yamazaki et al, 1993), and consequently phenobarbitone-pretreated and 
control microsomes demonstrated the greatest mutagenicity at the lower 6AC 
concentrations. Both untreated and phenobarbitone-treated microsomes demonstrated 
a reduction in mutagenicity at the higher mutagen concentrations, probably as a 
consequence of toxicity. Lower mutagen concentrations were not employed to obtain 
a linear concentration-dependent increase because it was felt this would compromise 
the investigation of the cytosolic system. The absence of an increase in mutagenicity 
after pretreatment with phenobarbitone is in contrast to the results of other workers
126
(Yamazaki et al, 1993) who, however, employed a Salmonella typhimurium strain 
modified for over-expression of 0-acetyltransferase, an important phase II enzyme 
responsible for further metabolism of N-hydroxylamines leading to the formation of 
the nitrenium ion. It is possible that without this over-expression the effects of 
pretreatment are less pronounced. Indeed, the bioactivation of 6AC by microsomes 
firom phenobarbitone- or p-naphthoflavone-treated rats showed a less marked 
mutagenic response with TA1535/pSK1002 than the 0-acetyltransferase-over- 
expressing strain, NM2009 (Yamazaki and Shimada, 1992).
Diabetes, induced by streptozotocin-pretreatment, modulates the microsome- 
mediated bioactivation of mutagens by changing the population of cytochrome P450 
isoforms (loannides et al, 1988). Streptozotocin increases the expression of 
CYP1A2, CYP2B, CYP2E, CYP3A and CYP4A, and increases the activity of 
NADPH cytochrome P450 reductase (loannides et ah, 1988; loannides et al, 1996). 
In addition streptozotocin-treatment induces flavin monooxygenase which can also 
carry out the bioactivation of promutagens (Rouer et al., 1988). In contrast to 
previous observations, however, where treatment with streptozotocin caused a 
decrease in 2AF activation (Flatt et al, 1989), in this investigation no significant 
increase in microsomal 2-aminoanthracene mutagenicity and only a modest increase 
in 2-aminofluorene mutagenicity were observed. Similar observations have been 
made previously where, even though CYPIA expression is elevated, the 
bioactivation of polycyclic aromatic hydrocarbons, e.g., benzo[a]pyrene, were 
unaffected by streptozotocin-pretreatment (Flatt et al, 1989; loannides et al, 1988; 
Peng et al, 1983); however these mutagens are bioactivated primarily by CYPlAl
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and their bioactivation is unaffected because this treatment selectively induces 
CYP1A2 (Barnett et al., 1990). CYP1A2 is the isoform primarily responsible for the 
bioactivation of aromatic amines and the absence of any increase in mutagenic 
response suggests that other enzymes are involved in the bioactivation of these 
aromatic amines. In addition to increased expression of CYP1A2 and other 
cytochrome P450 isoforms, streptozotocin-treatment increases the expression of 
flavin monooxygenase, epoxide hydrolase and glutathione -S-transferase (Rouer et 
al., 1981 and 1988). Streptozotocin-treatment also reduces acetyltransferase activity 
(Lindsey and Baty, 1990) and has substrate specific effects on UDP- 
glucuronyltransferase and sulphotransferase (Rouer et al., 1981; Price and follow, 
1982), but these enzymes cannot have an effect in the Ames test without the addition 
of cofactors. Therefore there may be a role for CYP1A2 in the bioactivation of 
aromatic amines but the effect of inducing CYP1A2 by streptozotocin is masked by 
the induction of other drug metabolising enzymes.
Incubation with the suicide substrate of cytochrome P450, ABT, was employed to 
investigate the importance of the cytochrome P450 oxidases to the bioactivation of 
aromatic amines by microsomes. Treatment with ABT reduced the mutagenicity of 
IQ by approximately 90%, a reduction comparable to the decrease in total 
cytochrome P450 (87%). However the effect on the mutagenic responses with 
aromatic amines was less pronounced. ABT inhibits all cytochrome P450 isoforms 
but it inhibits some isoforms preferentially, for example, CYP2B is inhibited more 
than CYPlAl, CYP1A2 or CYP3A (Knickle and Bend, 1992). 6-Aminochrysene 
bioactivation proceeds via two pathways, CYPl A-dependent diol-epoxide formation
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and CYP2B-dependent N-hydroxylation (Yamazaki et al, 1993) which may make it 
more resistant to inhibition by ABT. It is also conceivable that the other aromatic 
amines are likewise substrates for several isoforms. However, IQ is exclusively 
bioactivated by the cytochrome P450 oxidases and the mutagenicity of this amine 
was completely abolished after treatment with ABT. It is possible that the 
bioactivation of aromatic amines can be undertaken by other enzyme systems.
B. CYTOSOLIC
Cytosol prepared from animals treated with the various inducers of cytochrome P450 
isoforms, or with streptozotocin, were unable to metabolise 6AC to mutagenic 
intermediates and, in marked contrast to microsomes, cytosol from untreated animals 
was devoid of any activity. The only treatment to markedly induce the mutagenic 
response was Aroclor 1254, though moderate activation was observed with 
phenobarbitone and with dexamethasone. The different responses of the cytosolic 
and microsomal enzyme systems responsible for the bioactivation of 6AC, after 
treatment with cytochrome P450 inducers, demonstrate once again the existence of a 
unique cytosolic system which is independent of microsomal contamination. 
However, the bioactivation of 6AC, 2AA and 2AF by the cytosol was completely 
abolished by ABT, a suicide substrate for cytochrome P450 and chlorooxygenase 
(table 3.19) which inactivates haem prosthetic groups, therefore the enzyme 
concerned is probably a haemoprotein. It is also conceivable that in this system ABT 
is acting in a mechanism unrelated to being a suicide substrate of haemoproteins. 
Indeed, cytosolic bioactivation 6-aminochrysene was unchanged, 2-aminofluorene 
mutagenicity only modestly affected, and 2-aminoanthracene mutagenicity only 
noticeably decreased at higher mutagen concentrations after treatment with cobalt
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(Ill) chloride which causes a reduction in haem content and subsequently a decrease 
in the activity of haem-containing enzymes. After cobalt (III) chloride-treatment, 
2AA no longer gave a concentration-dependent increase in mutagenicity, with higher 
concentrations of 2AA demonstrating a marked decrease in mutagenic response, 
possibly as a consequence of bacterial toxicity. It is possible that metabolism within 
the cytosol has been shifted towards production of more toxic intermediates because 
of the inhibition of a haem containing enzyme or because, like members of the 
CYPIA subfamily, the cytosolic enzyme is not susceptible to inhibition by cobalt 
(III) chloride and in the absence of competition for the substrate, activity is increased 
to give toxic levels of mutagenic intermediates.
Tissue and species differences in the cytosolic activation o f aromatic 
amines
No attempts have previously been undertaken to investigate the cytosolic 
bioactivation of aromatic amines in extrahepatic tissues. Cytosol from heart, lung, 
kidney and brain, in addition to liver, from untreated and Aroclor 1254-treated rats 
were employed to activate 2AA and 6AC to mutagenic intermediates. The 
bioactivation of both amines, by the microsomal and cytosolic fractions, was only 
encountered in the liver, and hepatic cytosolic activation was only demonstrated after 
pretreatment with Aroclor 1254 (tables 3.24 and 3.25).
To establish whether this cytosolic activation system is unique to the rat, or is present 
in other animal species, which may be better models for studying this activity, 
untreated hepatic preparations from different species were investigated for their 
ability to transform 2-aminoanthracene and 6-aminochrysene to mutagenic 
metabolites. Both mutagens were activated considerably by microsomes from both
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rat and hamster, but ferret and pig microsomes were only modestly effective in 
activating 6AC to mutagenic intermediates. Pig microsomes possess high FAD- 
monooxygenase activity, and the absence of significant activation by this species 
demonstrates that this enzyme does not play a major role in the bioactivation of these 
amines. No cytosolic fractions supported the mutagenic activation of either 2- 
aminoanthracene or 6-aminochrysene, so these species do not constitutively express 
the activity responsible for cytosolic bioactivation of 6AC or 2AA. Similar to rat, 
hamster microsomes markedly activate 2AA and 6AC to mutagens, but Aroclor 
1254-induced hamster cytosol, in contrast to the rat, displayed no bioactivation of 
either compound (tables 3.27 and 3.28). The absence of any cytosolic bioactivation in 
hamster even though in this species activation by the microsomes is very 
pronounced, indicates once again that microsomal contamination cannot be 
responsible for the activation observed after Aroclor 1254-pretreatment of rat.
When three human hepatic cytosols were investigated, all three catalysed the 
bioactivation of 2-aminoanthracene, and to a lesser degree 6AC, to mutagens. 
Therefore the proteins responsible for cytosolic bioactivation of aromatic amines are 
also expressed in human hepatic cytosol. In rat this activity was only expressed after 
pretreatment with Aroclor 1254 whether human cytosolic activity is constitutively 
expressed or is a result of exposure to environmental or dietary inducing agents 
cannot be evaluated at present. However the presence of a novel enzyme responsible 
for the bioactivation of aromatic amines to mutagenic intermediates in humans 
demands further investigation.
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3.5. Conclusions
In addition to hepatic S9 and microsomes, the cytosol of rats pretreated with Aroclor 
1254 can metabolise 6AC and other aromatic amines to mutagenic intermediates. 
This investigation was undertaken to characterise the bioactivation of aromatic 
amines, principally 6AC, by cytosol and to draw comparisons with the microsome- 
mediated bioactivation.
These investigations indicate that:
(i). Cytosol-dependent bioactivation has a limited substrate specificity compared to 
microsomes, with many mutagens, which induce a marked mutagenic response in the 
presence of microsomes, being non-mutagenic in the presence of cytosol.
(ii). In addition to substrate specificity, bioactivation of 6AC to mutagenic 
intermediates by microsomes and cytosol possess different characteristics. These two 
systems differ in their response to cytochrome P450 inducing agents, to increases in 
protein concentration and in their cofactor requirements.
(iii). The activation of 6AC to mutagenic intermediates by cytosol is not detectable in 
the liver of untreated rats, but is enhanced following treatment with Aroclor 1254.
(iv). The cytosolic enzyme(s) responsible for the conversion of aromatic amines to 
mutagenic intermediates are localised in the liver and no mutagenic responses were 
observed in the presence of cytosol from extrahepatic tissues.
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(v). Human liver cytosol contains enzyme(s) which can metabolise 6AC and 2AA to 
mutagens.
(vi). Strong evidence is presented that the microsomal and cytosolic enzymes 
catalysing the activation of 6AC are distinct and any microsomal contamination 
cannot explain the marked cytosolic activation.
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CHAPTER 4
Hepatic microsomal NADH-dependent bioactivation
of 2-aminoanthracene
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4.1. Introduction
Aromatic amines are a diverse group of industrial chemicals and environmental 
pollutants used extensively as model compounds to investigate the metabolism of 
procarcinogens to genotoxic intermediates (bioactivation). The bioactivation of 
aromatic amines frequently involves N-hydroxylation. Enzymes which carry out this 
bioactivation include the cytochromes P450 (loannides and Parke, 1990), FAD- 
containing monooxygenase (Poulsen and Zieger, 1979; Pelroy and Gandolfi, 1980), 
and an unidentified enzyme present in the hepatic cytosol of Aroclor 1254-treated 
rats (Forster et a l, 1981a and 1981b; Ayrton et a l, 1992).
The aromatic amine 2-aminoanthracene (2-anthramine) is a potent carcinogen, acting 
as a complete carcinogen in rat skin (Arcos and Argos, 1974), routinely employed as 
a positive control in Ames mutagenicity tests where, in the presence of hepatic S9, it 
elicits a mutagenic effect with all Salmonella typhimurium tester strains. However, 
although 2AA is widely employed in mutagenicity studies, knowledge of its 
metabolisni to mutagenic intermediates is limited. It is documented however that 
2AA bioactivation is responsible for the formation of three major DNA-adducts 
(Gupta et al, 1988), and it is assumed that these are derived from the N- 
hydroxylamine. Surprisingly, 2AA bioactivation is as pronounced in hepatic 
preparations from rat, a relatively poor N-hydroxylator, as in other species with much 
greater N-hydroxylation activities (Phillipson and loannides, 1983).
The rat hepatic bioactivation of 2AA is induced by treatment with p-naphthofiavone 
and 3-methylcholanthrene but is decreased after pretreatment with phenobarbitone or 
dexamethasone (Lubet et a l, 1989; Carrière et a l, 1992) which implies that CYPIA
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isoforms of the cytochrome P450 mixed-function oxidase system are important in 
2AA bioactivation, whereas CYP2B1, CYP2B2 and CYP3A proteins may have a 
role in detoxication. In addition, 2AA mutagenicity and ethoxyresorufin O- 
deethylase activity, a marker enzyme for CYPlAl activity, are induced by 
pretreatment vdth 2AA (Steele and loannides, 1986; Ziegler et al., 1979), and 2AA 
bioactivation is inhibited by anti-CYPlAl and to a greater extent anti-CYPlA2 
antibodies (Lubet et al, 1989; Shimada and Nakamura, 1987) and by (+)-catechin, an 
inhibitor of cytochrome P450 reductase (Steele et al, 1985). Alternatively, 
metyrapone, an inhibitor of CYP2B and CYP3A had no effect on the bioactivation of 
2AA (Lubet et al 1989), but antibodies to CYP2B increased the metabolism of 2AA 
to mutagenic intermediates (Shimada and Nakamura, 1987). Therefore, it is assumed 
CYPlAl and CYP1A2 are responsible for the bioactivation of 2AA via N- 
hydroxylation, while the CYP2B1 and CYP2B2 proteins are primarily concerned 
with detoxication, probably through ring-oxidation.
Surprisingly, even though Aroclor 1254-pretreatment induces CYPlAl and 
CYP1A2, it causes a decrease in the S9- and microsome-mediated metabolism of 
2AA to mutagens (Ziegler et al., 1979; Steele and loannides, 1986; Carrière et a l, 
1992). However, Aroclor 1254-pretreatment enhances the mutagenic responses of 4- 
aminobiphenyl, 2-naphthylamine and IQ, which also require N-hydroxylation by 
CYPIA isoforms. This discrepancy has previously been attributed to inhibitive 
binding of certain polychlorinated biphenyl congeners to CYP1A2 (Miller et al., 
1988) but does not explain why the mutagenicity of other amines is unaffected. 
Another possibility is the involvement of constitutive monooxygenases in the 
bioactivation of 2AA which are suppressed by treatment with Aroclor 1254.
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Alternatively, treatment with Aroclor 1254 also induces the CYP2B isoform 
concerned primarily with detoxication of 2AA and this induction may be sufficient to 
nullify the effect of CYPIA and constitutive enzymes to metabolise 2AA to 
mutagenic intermediates. The flavin-containing monooxygenases are also capable of 
the N-hydroxylation of many aromatic amines including 2-aminoanthracene (Pelroy 
and Gandolfi, 1980), but methimazole, an inhibitor of FMO, had no effect upon 2AA 
bioactivation in Aroclor 1254-induced S9 (Rodriguez-Ariza et al., 1995). Further 
metabolism of N-hydroxylamines may involve acétylation, the reduced mutagenicity 
of 2AA in the N,0-acetyltransferase-deficient Salmonella strain, TA98-l,8-DNPe, 
(DeFlora et al, 1994), is an indication that acétylation is very important in 2AA 
mutagenicity.
Hepatic cytosol from rats treated with Aroclor 1254 also transforms 2AA to 
mutagenic intermediates and this cytosolic activity demonstrates considerable 
differences to the microsome-mediated mutagenic activation and, consequently, is 
not the product of microsomal contamination (Ayrton et al, 1992).
In the presence of NADH, Aroclor 1254-pretreated hepatic microsomes also 
metabolise 2AA to mutagenic intermediates (Ayrton et al, 1992). The bioactivation 
of chemical carcinogens in the presence of NADH, and absence of NADPH, is an 
important consideration for mutagenicity testing. When evaluating the mutagenic 
hazard of a chemical in the Ames test, activation mixtures routinely contain an 
NADPH-generating system (Maron and Ames, 1983), but if the bioactivation of 
some carcinogens is enhanced in the presence of NADH, or can only utilise NADH, 
the current test system would generate false negatives. Previously, NADH-dependent 
bioactivation of 2-aminofluorene, dimethylnitrosamine and nitrosopiperidine to
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mutagens, in the Ames test, has been demonstrated (Leist et al., 1992; Fong et al., 
1982; Ayrton et al., 1987). However, with each of these mutagens the mutagenic 
response in the presence of NADH was reduced in comparison to the mutagenic 
response in the presence of NADPH or an NADPH-generating system (Leist et al., 
1992; Fong gf al., 1982; Ayrton et al., 1987). Therefore the role of NADH in the 
reactive metabolism of 2AA, by various subcellular fractions, requires further 
investigation. To determine its importance as either a unique enzyme system or as 
one which also uses NADPH, bioactivation in the presence of NADH will be 
compared to that supported by NADPH. To characterise these mechanisms, they will 
be investigated for their responses to (a) Changing protein and cofactor 
concentrations, (b) Preincubation at 37°C. (c) Pretreatment with various 
monooxygenase inducers, (d) N-hydroxylation of 2-aminoanthracene. (e) Induced 
insulin-dependent diabetes, and (f) Inhibition by cytochrome P450 reductase 
inhibitors.
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4.2. Methods
4.2.1. Pretreatment o f animals
Male Wistar albino rats (150-200g) were obtained from The Experimental Biology 
Unit, University of Surrey and pretreated to induce the hepatic mixed-frmction 
oxidases. Pretreatment involved either a single intraperitoneal injection of Aroclor- 
1254 (500mg/kg) in com oil, with animals sacrificed five days later, or single 
intraperitoneal injection for three consecutive days with benzo[a]pyrene (25mg/kg) in 
com oil, phenobarbitone (80mg/kg) in distilled water, or clofibrate (80mg/kg) in 
0.9% saline or with isoniazid (lOOmg/kg), or dexamethasone (lOOmg/kg) in distilled 
water, by oral gavage. Animals were killed 24 hours after the last administration. 
Diabetes was induced by intraperitoneal injection of streptozotocin (65mg/kg) and 
animals were killed 21 days later. Livers were excised, homogenised and the S9, 
microsomal and cytosolic fractions prepared as described previously in Chapter 2.
4.2.2. Determination of microsomal cytochrome P450 concentration
Microsomal fractions were prepared as described previously (Chapter 2). The
measurement of total microsomal cytochrome P450 concentration was performed by 
the difference-spectra method (Omura and Sato, 1964) and is expressed as a fimction 
of protein concentration, which was measured by the method of Lowry (Lowry et 
al, 1951). CYPlAl- and CYP1 A2-dependent dealkylation of ethoxy- and methoxy- 
resomfin was measured fiuorimetrically by monitoring the production of resomfin as 
previously described (Burke and Mayer, 1974; Lubet et al., 1988). Methods are 
described in more detail in Chapter 2.
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4.2.3. Measurement of microsomal N-hydroj^lation o f  2- 
aminoanthracene
The formation of N-hydroxy-aminoanthracene was determined by the Co l o rimetric 
method of Vanderslice et al, (1987). Each incubation contained 25pmoles of 2- 
aminoanthracene. Methodology is described fully in chapter 2.
4.2.4. Mutagenicity testing
The bacterial mutagenicity of 2-aminoanthracene was determined using the Ames 
test. The Salmonella typhimurium strain used in these investigations was TA98, a 
strain sensitive to ffameshift mutations. To mutagen and bacteria were added 
activation mixtures containing 10%(v/v) of subcellular fractions with either NADPH 
(8mM) or NADH (8mM). Molten top agar (2ml) was added and, after vortexing 
thoroughly, the mixture was poured onto minimal agar plates. After incubation for 48 
hours at 37°C, the number of revertant bacterial colonies were counted. A 
spontaneous reversion rate for the bacteria was obtained using DMSO (lOOpl). All 
experiments were performed in triplicate.
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4.3. Results
4.3.1. The mutagenicity of 2-aminoanthracene in the 
presence of Aroclor 1254-pretreated subcellular fractions
2-Aminoanthracene is used as a positive control in mutagenicity studies because it is 
converted to mutagenic metabolites by microsomes in the presence of NADPH. 
However, recently the metabolism of 2AA to mutagenic intermediates has also been 
demonstrated by microsomes in the presence of NADH, and by hepatic cytosol, from 
rats pretreated with Aroclor 1254 (Ayrton et a l, 1992). The current investigation was 
undertaken to investigate the NADH-dependent bioactivation of 2AA to mutagenic 
intermediates over a range of concentrations, to determine the importance of this 
cofactor in the bioactivation of 2AA in comparison to NADPH-dependent 
activation.
The microsomal bioactivation of 2AA to mutagens was achieved in the presence of 
NADPH (8mM) and, more efficiently, NADH (8mM). In contrast, substantial 
cytosolic bioactivation of 2AA was recorded in the presence of NADPH but not 
NADH. Cytosolic bioactivation was lower than bioactivation in the presence of the 
microsomal firaction but the absence of bioactivation in the presence of NADH 
demonstrates cytosolic activation cannot be a consequence of contamination with 
microsomes (figure 4.1).
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Figure, 4,1, Bioactivation of 2-aminoanthracene by microsomes and 
cytosol in the presence of either NADPH or NADH
The Ames test was performed using 10%(v/v) activation mixtures, S. typhimurium strain TA98 and 
2AA. Activation mixtures contained either microsomes and NADPH (Oj, microsomes and NADH 
(M), cytosol and NADPH (<>) or cytosol and NADH (^ ). Results are presented as the mean ± 
standard deviation of triplicates. The spontaneous reversion rate was 13 ± 3 and has already been 
subtracted.
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4.3.2. 2-Aminoanthracene mutagenicity mediated by 
Aroclor 1254-pretreated subcellular fractions in the 
presence of NADH and NADPH
A range of cofactor concentrations were employed to compare the effectiveness of 
NADH and NADPH in supporting the bioactivation of 2AA to mutagens.
At various concentrations of NADH (4-lOmM), hepatic cytosol remained unable to 
metabolise 2AA (Ipg/plate) to mutagenic intermediates (figure 4.2). In contrast, the 
incorporation of NADH into the microsomal activation system provoked the highest 
mutagenic response of any system investigated (figure 4.2). NADPH-dependent 
bioactivation by microsomes and cytosol and the NADH-dep^ent microsomal 
activation of 2AA were not markedly increased by rises in cofactor concentration 
above 4mM (figure 4.2). Therefore concentrations of both NADH and NADPH 
(8mM) used in the other studies are in excess. The similar microsome-mediated 
mutagenic responses with NADPH and NADH demonstrates NADH can support 
2AA bioactivation as effectively as NADPH (figure 4.2).
4.3.3. The effect of preincubation on the bioactivation of 2- 
aminoanthracene by Aroclor 1254-pretreated subcellular 
fractions
Preincubation at 37°C is usually employed to facilitate the metabolism of poorly 
metabolised mutagens. Here preincubation was employed to establish whether 
NADH
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Figure» 4.2. The effect of cofactor concentration on the bioactivation 
of 2~aminoanthracene
2-Ammoanthracene (l\ig/plate), and Salmonella typhimurium strain TA98 were mixed with 
activation mixtures (10% v/v) containing either microsomes and NADPH (HI), microsomes and 
NADH (tÊ), cytosol and NADPH fOJ or cytosol and NADH (^). Results are expressed as mean ± 
standard deviation of triplicates
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Figure, 4.3. The effect o f preincubation on 2-aminoanthracene 
mutagenicity
2AA (l\Lg/plate), Salmonella typhimurium TA98 and activation mixture (10% v/v) were incubated 
together in a shaking waterbath at 37'^ C, molten agar (2ml) was then added, mixed and plated out. 
Activation mixtures contained either microsomes and NADPH (D), microsomes and NADH (M), 
cytosol and NADPH (0) or cytosol and NADH (^). Results are the mean ± standard deviation of  
triplicates
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Figure.4.4. The effect o f microsomal protein concentration on 2- 
aminoanthracene mutagenicity
Microsomes were obtained from rats pretreated with Aroclor 1254. 2AA (l\Lg/plate) and 
Salmonella typhimurium strain TA98 were mixed with activation mixtures containing a range o f 
microsomal concentrations (0.5-20%v/v) and either NADPH or NADH (M).Results are the 
mean ± Standard deviation of triplicates. The spontaneous reversion rate was 14 ± 2 and has 
already been subtracted.
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-dependent bioactivation of 2AA could be detected in the cytosol, and to observe its 
effect upon NADH- and NADPH-dependent microsomal bioactivation systems.
Mutagenicity of 2-aminoanthracene (Ipg/plate) decreased linearly with time whether 
microsomes with NADPH (8mM) or NADH (8mM), or c^osol with NADPH 
(8mM), were employed (figure 4.3).
After a 60 minute preincubation at 37 “ C, the mutagenic response catalysed by the 
microsomal fraction in the presence of either NADH or NADPH was reduced by 
more than 60% (figure 4.3). Cytosolic NADPH-dependent bioactivation was reduced 
by 80% after preincubation, but preincubation had no effect on NADH-dependent 
activation in this firaction i.e. NADH was unable to support any activation in the 
cytosol even after a 60 minute preincubation.
4.3.4. Dependence of the bioactivation of 2- 
aminoanthracene on protein concentration
In investigating the NADPH- and NADH-dependent mutagenicity of 2AA it is so far 
unclear whether the two activities are performed by the same enzyme or whether 
NADH-dependent activity involves a distinct enzyme. Ames test studies were 
performed, employing different microsomal protein concentrations, to demonstrate 
whether the two microsomal bioactivating systems behave differently under these 
conditions, and therefore whether they are likely to be independent activities.
By changing the concentration of microsomal protein in the activation mixture, 
marked differences were observed in the mutagenic response in the presence of
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NADPH (8mM), or NADH (8mM). At lower protein concentrations (l%v/v), the 
mutagenic response induced by NADPH and NADH differed by as much as 20-fold 
(figure 4.4). Bioactivation supported by NADPH was superior at protein 
concentrations up to 5%(v/v), but the elicited mutagenic response dropped rapidly 
when the concentration was increased (10%v/v) (figure 4.4). In the presence of 
NADH, 2-aminoanthracene mutagenicity was insubstantial at low protein 
concentrations but increased to give a maximum effect at about 5-10%(v/v).
At the highest protein concentrations, both the NADPH- and the NADH-dependent 
activities declined (figure 4.4). In the presence of NADH, mutagenicity was reduced 
to around 75%, whereas NADPH-dependent mutagenicity declined to only about 
30% of the maximum mutagenic response observed with this cofactor (figure 4.4).
4.3.5. Bioactivation of 2-aminoanthracene by hepatic 
microsomes: the effect of pretreatment with cytochrome 
P450 inducers
The cytochromes P450 are responsible for the majority of hepatic microsomal 
metabolism of aromatic amines in the presence of NADPH with, in most cases, the 
CYPIA and CYP2B subfamilies being responsible for bioactivation and detoxication 
respectively (Carrière et ah, 1992). In this investigation, the effect of pretreatment 
with cytochrome P450 inducers on the mutagenicity of 2AA, in the presence of 
NADH, was determined. The NADPH-dependent bioactivation was also studied as a 
comparison to highlight differences between the two systems.
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Table.4.L 2-Aminoanthracene bioactivation after treatment with 
various cytochrome P450 inducers
Treatment Cytochrome P450 concentration Histidine Revertants/plate
tnmol/ms protein)
2-Ammoanthracene
(pg/plate)
NADPH NADH
Control
1
0.330
54±9 14±3
2 126 ±3 8± 1
3 121 ± 8 6 ± 2
4 200 ±46 11±4
Aroclor 1254
1
1.354
65 ±13 51 ±13
2 88±7 88 ±14
3 146 ±49 141 ± 5
4 182 ±35 146 ±40
Benzo[a]pyrene
1
0.307
595 ± 74 20 ±10
2 898 ± 56 2 6± 2
3 813 ±52 2 2 ± 6
4 846 ±134 46 ±10
Phenobarbitone
1
0.723
21±8 8 ± 7
2 56 ± 6 1 ± 5
3 114±34 5 ± 2
4 141 ± 15 13±3
Isoniazid
1
0.212
55 ±1 0 ± 2
2 79 ±16 5 ± 3
3 114 ±23 0 ± 3
4 150 ±39 7 ± 4
Dexamethasone
1
0.625
9 ± 5 3 ± 3
2 28 ±15 0 ± 3
3 30±2 8 ± 4
4 44±10 4 ± 6
Clofibrate
1
0.241
30 ±12 0 ± 5
2 33 ± 9 0 ± 5
3 73 ± 2 0 ± 2
4 105 ± 4 9 ± 7
method. The mutagenicity of 2-AA was evaluated using the Ames test employing 10%(v/v) 
activation mixtures, Salmonella typhimurium strain TA98 and either NADPH (8mM) or NADH 
(8mA .^ Results are expressed as the mean ± standard deviation of triplicates. Spontaneous 
reversion rate was 14 ± 4  and has alreacfy been subtracted.
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When NADPH served as the electron donor mutagenicity was evident in the presence 
of all activation systems studied, including untreated animals, and was induced after 
pretreatment with benzo[a]pyrene, with activity increasing more than 10-fold at the 
lower concentrations of 2AA (table 4.1). In contrast, mutagenicity was unaffected by 
pretreatment with Aroclor 1254, despite a marked increase in total cytochrome P450, 
and was suppressed after pretreatment with isoniazid, phenobarbitone, and especially 
clofibrate and dexamethasone (table 4.1).
There was no 2AA bioactivation to mutagens catalysed by microsomes derived from 
untreated animals in the presence of NADH or after any pretreatment, except Aroclor 
1254 and, to a modest degree, benzo[a]pyrene (table 4.1). Therefore the enzyme(s) 
responsible for the bioactivation of 2AA in the presence of NADH are unlikely to be 
responsible for the bioactivation in the presence of NADPH.
4.3.6. The effect of pretreatment with cytochrome P450 
inducers on the N-hydroxylation of 2-aminoanthracene
The first, and rate-limiting step, in the activation of aromatic amines is N- 
hydroxylation catalysed by the cytochrome P450 and flavin-containing 
monooxygenases. In this study the N-hydroxylation of 2-AA was investigated in 
hepatic microsomal fractions, prepared from rats pretreated with cytochrome P450 
inducers, so that it can be correlated with mutagenicity data to determine if  N- 
hydroxylation is responsible for the bioactivation of 2AA in the presence of NADPH 
or NADH.
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In the presence of either NADPH or NADH the highest N-hydroxyiating activities 
were demonstrated by hepatic microsomes from animals pretreated with either 
Aroclor 1254 or benzo[a]pyrene (table 4.2). Pretreatment with clofibrate and, to a 
much lesser extent dexamethasone, inhibited the NADPH-dependent N- 
hydroxylation of 2AA. When NADH was used as the cofactor, activity was 
detectable only in the presence of microsomes from benzo[a]pyrene and Aroclor 
1254-treated animals.
Table.4.2. N-Hydroxy-2-aminoanthracene formation in hepatic 
microsomes pretreated with cytochrome P450 inducers
N-Hydroxylation Activity 
pmoles formed min ' mg^ protein
Pretreatment Microsomes + NADPH Microsomes + NADH
Control 1.382 nd.
Aroclor 1254 15.844 1.862
Benzo[a]pyrene 10.491 0.663
Phenobarbitone 1.622 nd.
Isoniazid 1.462 nd.
Dexamethasone 1.063 nd.
Clofibrate 0.024 nd.
incubation contained microsomal suspension (20\il), either NADPH (8mM) or NADH (8mNQ, and 
2-aminoanthracene (25\imol). Determinations were performed in duplicate afier 10 minutes 
incubation at 37°C in a shaking waterbath. Concentration of N-hydroxy-2-aminoanthracene was 
calculated using hydroxylamine standard, nd. = No N-hydroxylation detected.
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4.3.7. Microsomal CYPlAl- and CYPlA2-dependent O- 
deallq^lase activity in the presence of NADH and NADPH
The 0-dealkylation of alkoxyresorafins is used as an indicator of the activity of 
individual cytochrome P450 isoforms. Ethoxy- and methoxy-resorufin 0-dealkylase 
activities are specific for CYPlAl and CYP1A2 respectively (Namkung et a l, 
1988).
Table 4,3, Microsomal ethoxyresorufin and methoxyresorufin O- 
dealkylase activity in the presence o f NADH and NADPH
nmols resorufin formed min^ mg*^  protein
Substrate concentration NADPH NADH
(nmol)
Ethoxyresorufin
2.50 8.94 0.57
6.25 10.94 1.12
12.50 7.49 1.13
Methoxyresorufin
5.00 2.01 0.06
12.50 2.24 0.07
25.00 1.46 0.15
EROD and MROD respectively.Incubation mixtures contained either lOpl (EROD) or 20\il 
(MROD) of microsomal suspension (25%w/v) from Aroclor 1254-induced rat and the assay was 
initiated by the addition of lOyd of either NADPH or NADH (50mM in 1% NaHCOs). The results 
are the average of duplicates.
Aroclor 1254-treated microsomes in the presence of NADH and NADPH converted 
2-aminoanthracene to mutagenic intermediates in the Ames test (figure 4.1), and 
formed the N-hydroxylamine (table 4.2). N-Hydroxylation of 2AA was induced by
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pretreatment with Aroclor 1254 and benzo[a]pyrene (table 4.2) suggesting that 
isoforms of cytochrome P450 belonging to the CYPIA subfamily are responsible. 
However, eventhough NADH can supply the second electron to cytochrome P450, 
following oxygen incorporation in the substrate-enzyme complex, there is no 
evidence that it can support oxidation by cytochrome P450 in the absence of 
NADPH. In this study the ability of NADH to support the dealkylation of ethoxy- 
and methoxy-resorufin was investigated in comparison to activity in the presence of 
NADPH.
Both NADPH and, to a lesser extent, NADH can support the 0-dealkylation of 
ethoxy- and methoxy-resorufin by Aroclor 1254-treated microsomes. In the presence 
of either cofactor ethoxyresorufin 0-deethylase was markedly greater than 
methoxyresorufin 0-demethylase activity. Also noticeable, at the concentrations of 
substrate employed, is that eventhough both EROD and MROD did not increase with 
an increase in substrate concentration in the presence of NADPH, a rise in substrate 
concentration did produce an increase in activity in the presence of NADH. 
Therefore using NADPH the enzyme activity is already at Vmax i.e., the enzyme has 
a maximum turnover not increased by a rise in substrate concentration, whereas 
enzyme activity has not reached Vmax in the presence of NADH.
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43.8. The effect of streptozotocin-induced diabetes on the 
hepatic bioactivation of aromatic amines
In addition to inducing insulin-dependent diabetes by selectively destroying 
pancreatic B-cells, treatment with streptozotocin has previously been demonstrated to 
increase the S9-mediated bioactivation of nitrosopiperidine, nitrosopyrrolidine, Glu- 
P-1, Trp-P-1, Trp-P-2 and MelQ and to reduce the bioactivation of 2AF (loannides et 
a l, 1988; Flatt et al, 1989; Yamazoe et a l, 1988). The mechanism through which 
streptozotocin achieves these changes is thought to be due to a change in the hepatic 
cytochrome P450 isoform composition (loannides et al., 1988). Indeed, PROD, 
EROD, ethoxycoumaiin 0-deethylase, aniline p-hydroxylase and NADPH- 
cytochrome P450 reductase activities are stimulated by pretreatment with 
streptozotocin. This investigation was undertaken to observe whether streptozotocin- 
treatment similarly perturbed the bioactivation of 2AA and 2AF by isolated 
microsomes in the presence of either NADPH or NADH.
Except for the microsomal NADPH-dependent mutagenic responses, which were 
increased, especially at low mutagen concentrations, induction of diabetes with 
streptozotocin-pretreatment had no major effect on the mutagenic responses of 2AA 
or 2AF (table 4.4).
The total cytochrome P450 concentration in control and streptozotocin-treated 
animals was 0.33 and 0.29nmols mg'* protein respectively.
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Table 4.4. The bioactivation o f 2-aminoanthracene and 2- 
aminofluorene by untreated and streptozotocin-pretreated hepatic
microsomal fractions
Histidine revertants/plate
Treatment
Mutagen
concentration
(pg/plate)
Microsomes + 
NADPH
Microsomes + 
NADH
Untreated 2-Aminoanthracene
1 48±9 8±8
2 76 ±19 34±5
3 215 ±54 45±6
4 397 ±95 82 ±15
Untreated 2-Aminofluorene
1 83 ±14 4± 4
2 164 ±21 2± 4
3 263 ± 50 18±3
4 389 ±53 39±7
Streptozotocin 2-Aminoanthracene
1 181 ±37 14±1
2 257 ±42 29±8
3 304 ±37 59±8
4 442 ±46 101 ±21
Streptozotocin 2-Aminofluorene
1 160 ±7 12 ±10
2 294 ±16 23 ± 10
3 386 ±26 41±4
4 552 ±92 53 ±1
Ames tests were performed using 10%(v/v) activation mixture, and S.typhimurium strain TA98. The 
results are expressed as mean ± standard deviation of triplicates. The spontaneous reversion rate 
was 23 ± 5  and has been subtracted from these values, nd = a mutagenic response lower than the 
spontaneous reversion rate.
4.3.9. Bioactivation of aromatic amines in the presence of 1- 
aminobenzotriazole (ABT)
1-Aminobenzotriazole (ABT) is a suicide substrate of cytochrome P450 (Ortiz de 
Montellano and Mathews, 1981). Oxidation of ABT by cytochrome P450 isoforms, 
yields benzyne which irreversibly binds to haem protoporphyrin IX inactivating these
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enzymes and chloroperoxidase (Ortiz de Montellano et al., 1984).This study was 
carried out to determine whether ABT can inhibit the bioactivation of the aromatic 
amines 2AA, 2AF and 6AC, and of the heterocyclic amine IQ, catalysed by 
microsomes in the presence of NADPH or NADH.
Addition of ABT (lOmM) to Aroclor 1254-pretreated microsomes caused an 87% 
reduction in cytochrome P450 concentration, from 1.39 to 0.18nmoles mg"^  protein, 
following 3 minutes preincubation at 37°C in the presence of NADPH (ImM).
Table, 4.5, The effect o f 1-aminohenzotriazole (ABT) on aromatic 
amine mutagenicity
Histidine revertants/plate
Activation system 
and mutagen
Mutagen
concentration
(lig/plate)
-ABT + ABT
Microsomes + NADPH
2-Aminoanthracene 4 1088 ±47 767 ±27
2-Aminofluorene 4 112±14 91 ±23
6-Aminochrysene 0.25 1561 ±43 683 ± 9
IQ 0.04 311 ±73 33 ±10
Microsomes + NADH
2-Aminoanthracene 4 360 ±52 532 ±133
2-Aminofluorene 4 320 ±50 193 ±16
6-Aminochrysene 0.25 411 ±95 233 ±31
IQ 0.04 465 ± 30 45 ± 10
ABT was dissolved in DMSO, added to activation mixtures and incubated at 37°C for 3 minutes. An 
equal volume of DMSO was added to the -ABT samples. Salmonella typhimurium strain TA98, 
mutagen and molten agar were added, vortexed thoroughly, and poured onto minimal agar plates. 
Results are expressed as the mean ± standard deviation of triplicates. The spontaneous reversion 
rate was 19 ± 6  and has already been subtracted
When a higher concentration of ABT (20mM) was added to the activation mixtures 
containing microsomes in the presence of NADPH the mutagenicity of 2AA and, to a
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greater extent, 6AC was reduced whereas the bioactivation of 2AF was unaffected. 
However the mutagenic response observed with IQ was completely abolished. IQ is 
exclusively metabolised by cytochrome P450 oxidases and the complete removal of 
the bioactivation of IQ, but not 2AA, 6AC or 2AF, suggests that enzymes other than 
the cytochromes P450 participate in the bioactivation of aromatic amines. This 
observation is in agreement with the absence of any effect induced by Aroclor 1254- 
treatment on 2AA mutagenicity (table 4.1) and the reduction in 6AC mutagenicity 
(table 3.13).
In the presence of NADH, Aroclor 1254-treated microsomes can convert IQ to 
mutagenic intermediates as effectively as in the presence of NADPH. This has not 
been observed previously and the exclusive metabolism of IQ by members of the 
cytochrome P450 oxidases, in the presence of NADPH, suggests these enzymes may 
also be responsible for NADH-dependent bioactivation. Similarly to NADPH- 
dependent bioactivation, only the mutagenic response of IQ was completely removed 
by the addition of ABT implying other enzymes are concerned with the bioactivation 
of aromatic amines especially 2AA, which was unaffected by ABT. ABT inhibits 
other haem-containing enzymes such as chloroperoxidase so, a non-haem containing 
enzyme, possibly flavin monooxygenase, is responsible for residual activity after the 
addition of ABT. The mutagenicity of 2AF and 6AC was reduced but not abolished 
after the addition of ABT.
157
4.3.10. Inhibition of aromatic amine bioactivation by 
cytochrome c
Cytochrome P450 accepts electrons from NADPH through the flavoprotein 
cytochrome P450 reductase. Cytochrome c also functions as an electron acceptor 
from NADPH cytochrome P450 reductase and therefore inhibits cytochrome P450 
activity as a result of competition for the electrons. Cytochrome c was used in the 
present studies to compare its effect on NADPH- and NADH-dependent microsomal 
bioactivation of aromatic amines.
Table 4.6. Inhibition o f the mutagenicity of aromatic amines by
cytochrome c
Histidine revertants/ plate
Mutagen Cytochrome c (O.lmM)
Microsomes + 
NADPH
Microsomes + 
NADH
2-Aminoanthracene - 214 ±45 2134 ±158
+ 68 ±38 1743 ± 174
2-Aminofluorene - 871 ± 64 245 ± 19
+ 376 ±27 216 ±7
6-Aminochrysene - 1216 ±17 1965 ± 73
+ 363 ± 17 2879 ±266
Mutagenicity tests were performed with S. typhimurium strain TA98 and 10% (v/v) activation 
mixtures from Aroclor 1254-induced animals. The results are expressed as mean ± standard 
deviation of triplicates. The spontaneous reversion rate for TA98 was 14 ± 4 and has been 
subtracted.
Cytochrome c (O.lmM) decreased considerably the mutagenic response of 2AA 
(5pg/plate), 2AF (5pg/plate) and 6AC (Ipg/plate) in microsomes, in the presence of 
NADPH (table 4.6). The effect of cytochrome c on the microsomal NADH-
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dependent bioactivation of aromatic amines was marginal in the case of 2AA and 
2AF, and in the case of 6AC an overall increase was observed.
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Figure 4.5, Inhibition of 2~aminoanthracene bioactivation by (+)- 
catechin
(+)-Catechin was mixed with 2-aminoanthracene (S^^plate), S. typhimurium strain TA98 and 
activation mixtures (10% v/v) employing either microsomes + NADPH (□), or microsomes + 
NADH (■),. Results are expressed as mean ± standard deviation of triplicates. The spontaneous 
reversion rate was 31 ± 4  and has already been subtracted.
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4.3.11. Inhibition of 2-aminoanthracene bioactivation by 
(+)-catechin in hepatic microsomal fractions from Aroclor 
1254-pretreated rats
(+)-Catechin is an inhibitor of NADPH-cytochrome P450 reductase and consequently 
depresses cytochrome P450 activity (Steele et al., 1985). The effect of (+)-catechin 
on the 2AA mutagenicity in microsomes, in the presence of NADH or NADPH, was 
investigated to determine whether cytochrome P450, or other en^mes which also 
function through a reductase and, therefore, may also be susceptible to inhibition by 
(+)-catechin, are involved in the metabolism of 2AA to mutagenic intermediates.
Microsomal bioactivation of 2AA in the presence of NADPH or NADH was 
unaffected at the lowest (+)-catechin concentration (10"® M), but was virtually 
completely inhibited at the highest (+)-catechin concentration (lO"^  M) (figure 4. 5).
4.3.12. Inhibition of 2-aminoanthracene bioactivation by 
inhibitory anti-NADPH-cytochrome P450 reductase 
antibody
The purpose of this study was to establish whether cytochrome P450 reductase is 
involved in the microsomal NADH-dependent activation of aromatic amines. 
Microsomal NADPH-dependent bioactivation of 2-aminoanthracene was markedly 
inhibited by the anti-P450-reductase antiserum, (table 4.7). However, the 
bioactivation of 2AA by microsomes in the presence of NADH was unaffected by the 
presence of the same antibody.
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Table 4.7. Inhibition of microsomal 2-aminoanthracene bioactivation 
by rat anti-cytochrome P450 reductase
Histidine revertant s/plate
Cofactor Normal serum Antiserum
NADPH 1311 ±189 179 ±26
NADH 571 ±45 521 ±59
temperature, in duplicates, with either goat anti-rat NADPH-cytochrome P450 reductase antiserum 
or normal goat serum (50\d/100\ig protein). To each subcellular fraction was added 80mM 
magnesium chloride (0.05ml), 0.33Mpotassium chloride (0.05ml), an NADPH generating system, 
or NADH (8mM) and made up to 0.5ml with 0.2Mphosphate buffer pH 7.4. To this activation 
mixture was added 2-aminoanthracene (10\i^ and TA98 bacterial suspension (0.1ml), and 
incubated for 3 minutes at 37  ^C. After incubation, 2ml o f molten agar were added, mixed and 
plated out on minimal agar plates. Spontaneous reversion rate was 20 ± 5 and has alreacfy been 
subtracted. Results are the mean ± standard deviation of duplicates.
4.3.13. The effect of dimethyl sulphoxide on 2- 
aminoanthracene bioactivation by hepatic microsomes
Dimethyl sulphoxide (DMSO) is a free radical scavenger and may be used to 
demonstrate the existence of free radical mechanisms in the bioactivation of 2AA to 
mutagenic intermediates. The effect of DMSO on the bioactivation of 2AA by 
hepatic microsomal preparations was investigated in the presence of NADPH or 
NADH.
In the presence of either NADPH or NADH, the addition of DMSO had only 
Tninimal effects on the mutagenic response of 2AA with microsomes (table 4.8). 
DMSO produced a moderate decrease in 2AA mutagenicity in the presence of 
NADPH, and a rise in mutagenicity with NADH.
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Table.4.8. The effect o f dimethyl sulphoxide on 2-aminoanthracene 
bioactivation
Histidine revertants/plate
DMSO (1x1) 0 50 100 200
Activation system
1654 ±84 
1089 ±144
1684 ±116 
1436 ±267
1582 ±108 
1461 ±116
1258 ±202 
1774 ±161
Microsomes + NADPH 
Microsomes + NADH
(5\ig/plate) and 10% (v/v) activation mixtures from Aroclor 1254-induced animals. The results are 
expressed as mean ± standard deviation of triplicates. The spontaneous reversion rate was 15 ± 3  
and has alrea^ been subtracted
4.3.14. The effect of reduced glutathione on 2- 
aminoanthracene mutagenicity
Strong electrophiles react with reduced glutathione to form non-toxic conjugates, the 
reaction being catalysed by glutathione-S-transferase. This is an important 
detoxication mechanism for many mutagens. The TA98 tester strain has significant 
amounts of glutathione and glutathione-S-transferase (Meijer et a l, 1980), and 
therefore bacterial enzymes may be responsible for further metabolism of mutagenic 
intermediates formed by S9 in the Ames test. Rat cytosol also has high 
concentrations of glutathione, and glutathione-S-transferase is induced by Clophen 
A50, and to a lesser extent, phenobarbitone and 3-methylcholanthrene (Summer et 
a l, 1980). Addition of glutathione lowers the mutagenic responses of 2AAF, 2AF 
and N-hydroxy-2AAF (Hongslo et a l, 1983), but increases the mutagenicity of Trp- 
P-2 and N-hydroxy-Trp-P-2 (Saito et al, 1983).
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To determine whether glutathione interacts with microsome-generated metabolites of 
2AA, the mutagenicity of 2AA was investigated in the presence and absence of 
glutathione. Differential response to glutathione by the two activation systems would 
suggest that different mutagenic intermediates are produced.
Reduced glutathione itself was non-mutagenic in the presence of subcellular fractions 
from Aroclor 1254-pretreated rats (table 4.9). However, it has a potentiating effect on 
2AA mutagenicity, which was more marked in the presence of NADH (table 4. 9).
Table 4.9. Potentiation of 2-aminoanthracene mutagenicity in Aroclor 
1254-induced microsomes by glutathione
Histidine revertants/plate
2-Ammoaiithracene and glutathione 
concentrations
Microsomes + 
NADPH
Microsomes + 
NADH
Glutathione (lOmM)
2-AA (5pg)
2AA (5pg) + glutathione (1.25mM) 
2AA (Spg) + glutathione (2.5mM) 
2AA (5pg) + glutathione (S.OmM) 
2AA (5pg) + glutathione (lO.OmM)
nd 
386±113 
321 ± 87 
426 ±104 
716 ±104 
698 ±17
6±4  
256 ±124 
440 ±154 
485 ±231 
825 ± 82 
785 ± 34
Salmonella typhimurium strain TA 98. The spontaneous reversion rate was 17 ± 6  and has already 
been subtracted. Results are expressed as mean ± standard deviation of triplicates, nd = where the 
number o f histidine revertants is less than the spontaneous reversion rate.
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4.3.15. Mutagenicity of aromatic amines in an N ,0- 
acetyltransferase deficient Salmonella typhimurium strain 
(TA98-1,8-DNP6)
TA98-1,8-DNP6 is a Salmonella typhimurium test strain with reduced N,0- 
acetyltransferase activity (McCoy et a l, 1983). N-Hydroxylation of 2-aminofluorene 
is followed by 0-acetylation to generate the mutagenic acetoxyaminofluorene 
(Bartsch, et al 1972), which spontaneously breaks down to release the highly 
electrophilic nitrenium ion. This strain was used to investigate the importance of 
bacterial N,0-acetyltransferase to the mutagenic response of aromatic amines in the 
presence of microsomes, and consequently whether these amines are N-hydroxylated 
by this subcellular fraction in the presence of NADH and NADPH.
2AA, 2AF and 6AC displayed a markedly lower mutagenic response with the N,0- 
acetyltransferase-deficient, TA98-1,8-DNPô strain compared with the equivalent, 
non-deficient, TA98 strain (table 4.10). When TA98 was used as the tester strain, the 
mutagenicity of 6AC and 2AA was much higher in the presence of NADH than 
NADPH but the situation was reversed when 2AF served as the premutagen.
In all cases the mutagenic response was much lower when the acetyltransferase- 
deficient bacterial strain was used implicating the presence of hydroxylamines. The 
fact that a significant mutagenic response is still evident in this strain, suggests that 
other mutagenic intermediates may be present e.g., diol epoxides of 6AC.
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Table 4.10. Aromatic amine mutagenicity in Salmonella typhimurium 
TA98 and the N,0-acetyltransferase-deficient TA98-1,8-DNP6
Histidine revertants/plate
Activation system Mutagen(pg/plate) TA98 TA98-1,8-DNP6
Microsomes + NADPH
2-Aminoanthracene 5 707 ±97 238 ± 32
2-Aminofluorene 5 620 ±74 90±5
6-Aminochrysene 1 533 ± 5 295 ±21
Microsomes + NADH
2-Aminoanthracene 5 1276 ±101 218 ±34
2-Aminofluorene 5 189 ±18 17±11
6-Aminochrysene 1 1699 ±327 255 ± 36
from Aroclor 1254-treated rat. Results are expressed as mean ± standard deviation o f triplicates. 
The spontaneous reversion rates were 25 ± 5 for TA98 and 25 ± 4 for TA98-1,8-DNP6, and have 
already been subtracted.
4.3.16. The effect of 3’-phosphoadenosine-5’-phospho 
sulphate on the bioactivation of aromatic amines
Conjugation of hydroxylamines by cytosolic sulphotransferase requires 3' 
phosphoadenosine-5'-phosphosulphate (PAPS) as a source of sulphate. Sulphate 
conjugation is thought to be one mechanism by which hydroxylamines are further 
metabolised to form unstable esters that break down forming the ultimate 
carcinogen, the nitrenium ion. This investigation was undertaken to demonstrate that 
bioactivation, in both the microsomes and cytosol, involves an initial N- 
hydroxylation and to determine whether conjugation with sulphate is potentiating the
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mutagenic response, and therefore is a possible route of bioactivation for 2AA, 2AF 
and 6AC.
Table 4.11. Modulation o f aromatic amine bioactivation by PAPS
Histidine revertants/plate
Mutagen (jig/plate) 89 + NADPH 89 + NADH
2-AA (5) 1135 + 119 1244 ± 6
2-AA (5) + PAPS 1323 ±47 1027 ±150
2-AF(5) 339 ±15 143 ± 13
2-AF(5) + PAPS 426 ±17 252 ±13
6-AC (0.6) 369 ± 67 862 ±99
6-AC (0.6) + PAPS 62±2
_ j  —- .I—  / i n o y  CO /
98±3
with 5% v/v cytosol because bioactivation of 6AC by cytosol is inhibited in the presence o f  
microsomes, see chapter 3) from Aroclor 1254-treated rats. Salmonella typhimurium strain TA98 
and 3'-phosphoadenosine-5'-phosphosulphate (PAPS,0.1mg/plate). Results are expressed as mean 
± standard deviation of triplicates. The spontaneous reversion rate 27 ± 5 has alreacfy been
subtracted
The addition of PAPS had only minimal effects on the mutagenicity of 2AA (table 
4.11). In contrast, 2AF mutagenicity was increased by the addition of PAPS to a 
similar extent in the presence of either NADPH or NADH. However, the mutagenic 
response observed in the presence of each activation system with 6AC was 
depressed, especially when employing NADH of cofactor (table 4.11).
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4.4. Discussion
The frequent use 2-aminoanthracene as a positive control in mutagenicity testing is 
disproportionate to the information available on its metabolism, both activating and 
deactivating. A role in the bioactivation of 2AA for the cytochromes P450 oxidases 
is however not disputed, in particular the CYPIA subfamily (Steele and loannides, 
1986; Lubet et ah, 1989; Carrier et a l, 1992). In mutagenicity testing, metabolism of 
2AA to mutagenic intermediates by S9 is always undertaken in the presence of 
NADPH; however, a marked mutagenic response has recently been reported in 
microsomes from Aroclor 1254-treated rats in the presence of NADH, with 2AF 
(Leist et a l, 1992), 2AA (Ayrton et a l, 1992) and 6-aminochrysene (Chapter 3).
In the current studies, the bioactivation of 2-aminoanthracene to mutagenic 
intermediates has been further investigated in the presence of NADH, and compared 
to bioactivation in the presence of NADPH. Both systems were investigated for the 
effects of preincubation, in cofactor requirements, dependence on microsomal protein 
concentrations and modulation by pretreatment with inducers of cytochrome P450. 
The observations indicate that enzymes responsible for the bioactivation of 2AA in 
the presence of NADH have different characteristics to those concerned with 
bioactivation in the presence of NADPH.
Enzyme characteristics of the NADPH- and NADH-dependent 
microsomal activities responsible for the bioactivation o f aromatic 
amines
The bioactivation of 2AA in the presence of NADPH is expressed at low cofactor 
and protein concentrations, and is more pronounced than 2AA bioactivation in the
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presence of NADH (figures 4.2 and 4.4). Therefore the NADH system is less 
efficient and, consequently, in vivo the NADPH-dependent activity probably 
predominates. At protein concentrations of 10% (v/v) 2AA is metabolised to toxic 
levels of intermediates in the presence of NADPH. This toxicity may explain why, at 
this concentration of NADPH, previous observations found NADH had no additive 
effect on the NADPH-dependent mutagenicity of aromatic amines (Ayrton et al., 
1992; Leist et al., 1992; Chapter 3). The same enzymes may be involved in both the 
NADPH- and NADH-dependent activation of aromatic amines but have a greater 
affinity for NADPH; however, the markedly different responses to pretreatment with 
various monooxygenase inducers, does not support this hypothesis.
DT-Diaphorase, an oxidoreductase able to utilise both NADPH and NADH, exists in 
two forms, one of which is found within the microsomes and is induced by 
benzo[a]pyrene and TODD (Raflell and Blomberg, 1980). This enzyme, though 
normally concerned with detoxication, is sometimes involved in bioactivation, for 
example, the activation of mitomycin C (Begleiter and Leith, 1993). Amines are not 
substrates for reduction by this enzyme and any involvement would require an initial 
N-hydroxylation to form the hydroxylamine. Moreover, the cytosolic firaction, the 
major source of DT-diaphorase, was unable to support any NADH-dependent 
activation.
Flavin-containing monooxygenases also catalyse the N-hydroxylation of aromatic 
amines, including 2AA and 2AF (Pelroy and Gandolfi, 1980) and can utilise either 
NADPH or NADH (Poulsen and Zieger, 1979). The Km (Michaelis constant) for 
NADH is however 10-fold higher than for NADPH, i.e. the enzyme is saturated at a
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tenth the concentration of NADPH than NADH, and therefore NADPH is the 
preferred substrate. If flavin-containing monooxygenase were responsible for 
bioactivation in this system it may explain why the NADPH-dependent mutagenicity 
is considerably higher at lower protein concentrations. However, no evidence exists 
for the induction of flavin-containing monooxygenase by Aroclor 1254. In addition, 
microsomes obtained from pig liver have previously demonstrated only limited 
microsomal NADPH-dependent bioactivation of 2-aminoanthracene and 6- 
aminochrysene (Chapter 3), even though this tissue is rich in this enzyme system. In 
addition, microsomes were able to support the dealkylation of methoxyresorufm and 
ethoxyresorufrn using NADPH and NADH even though these are not substrates for 
this enzyme system. Consequently, it may be inferred that the role of the flavin 
monooxygenases in the activation of the aromatic amines studied is limited.
NADH can, via NADH-cytochrome bs reductase, supply electrons to the cytochrome 
P450 catalytic cycle. It is currently believed that it can furnish the second electron, 
following the incorporation of oxygen to the substrate-enzyme complex. However, 
there is no evidence that NADH alone can support cytochrome P450 oxidation. 
Moreover, antibodies to NADPH cytochrome P450 reductase, failed to inhibit the 
NADH-mediated bioactivation of 2AA but inhibited it when NADPH served as the 
source of electrons (table 4.7). Clearly these findings demonstrate that NADH does 
not supply electrons to cytochrome P450 through the NADPH cytochrome P450 
reductase. Indeed, when cytochrome c is used as an external electron acceptor, 
NADH cannot catalyse its reduction in the presence of microsomes (Williams and 
Kamin, 1962). In this investigation cytochrome c suppressed microsomal NADPH-
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dependent activation of 2AA, 2AF and 6AC but had no effect upon their NADH- 
dependent microsomal activation (table 4.6). Thus, it is unlikely that NADH- 
mediated metabolism of aromatic amines is catalysed by a conventional form of 
cytochrome P450. If NADPH cytochrome P450 reductase is not involved in NADH- 
dependent bioactivation of aromatic amines it is conceivable that the NADH- 
dependent system involves either a non-CYP protein or a non-conventional CYP 
which can accept electrons from an alternative reductase. The effect of decreases in 
reductase activity were also investigated using (+)-catechin. Addition of (+)-catechin 
almost completely abolished both the NADPH- and NADH-dependent microsomal 
metabolism of 2AA to mutagenic intermediates (figure 4.5.). The inhibition of 
NADH-dependent 2AA bioactivation by (+)-catechin contradicts the effects observed 
with reductase antibodies and cytochrome c. However (+)-catechin does not only 
alter NADPH cytochrome P450 reductase activity, it also inhibits lipooxygenase and 
cyclooxygenase activity and lipid peroxidation (Nakayama et al, 1993), is an 
antioxidant and free radical scavenger (Steele et a l, 1985; Fraga et a l, 1987), and 
can interact directly with proximate carcinogens (Steele et al, 1985). Therefore 
inhibition of NADH-dependent bioactivation of 2AA by (+)-catechin may be 
unrelated to inhibition of cytochrome P450 reductase.
Although no evidence exists for the complete support of cytochrome P450 oxidations 
by NADH, it did support both CYPlAl-dependent ethoxyresorufrn 0-deethylase 
(EROD) and CYP 1 A2-dependent methoxyresorufm 0-deethylase (MROD) activity 
in Aroclor 1254-induced microsomes. The activity of both enzymes was considerably 
lower than in the presence of NADPH and so compared favourably with 2AA
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mutagenicity at lower protein concentrations (figure 4.4) and N-hydroxylating 
activity. Interestingly, EROD and MROD activity in the presence of NADH 
increased in response to increases in substrate concentration but NADPH-dependent 
0-dealkylation did not. Therefore the enzyme activity concerned with NADPH- 
dependent dealkylation is at Vmax but NADH-dependent enzyme activity is not. 
Further investigation would indicate that the Km for each system is different i.e. the 
substrate concentration where enzyme activity is at half maximum. Whether this is an 
indication that different enzymes are concerned with NADPH- and NADH- 
dependent bioactivation of 2AA is uncertain. The NADH-dependent bioactivation of 
IQ has never before been demonstrated but it provides further evidence that NADH 
can be utilised by cytochrome P450 isoforms in the absence of NADPH for the 
bioactivation of aromatic amines because this mutagen undergoes bioactivation 
catalysed exclusively by CYP1A2. Flavin-containing monooxygenase also has a 
much higher Km value for NADH than NADPH (Poulsen and Zieger, 1979) and 
purified FMO is responsible for marked 2AA bioactivation (Pelroy and Gandolfi, 
1980). However, microsomal NADH-dependent EROD and MROD activity was also 
found to require higher concentrations of substrate to reach Vmax and therefore has a 
higher Km value than NADPH (table 4.3) and therefore, because these are not 
substrates for FMO, it is unlikely that NADH-dependent mutagenicity is a 
consequence of activation by FMO.
To investigate fiirther the role of cytochrome P450 in the bioactivation of aromatic 
amines microsomes were incubated in vitro with 1-aminobenzotriazole (ABT), a 
suicide substrate for cytochrome P450 which is metabolised to benzyne which binds
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to, haem protoporphyrin IX inactivating the enzyme (Ortiz de Montellano and 
Mathews, 1981). The mutagenicity of aromatic amines and the heterocyclic amine 
IQ, catalysed by microsomes, was investigated after incubation with ABT. In the 
presence of NADPH or NADH, the mutagenic response of IQ was reduced by 
approximately 90% in the presence of ABT, a reduction comparable to the decrease 
in total cytochrome P450 (87%). The effect of ABT on the bioactivation of aromatic 
amines is less pronounced. Although ABT inhibits all cytochrome P450 isoforms it 
preferentially inhibits some isoforms, for example CYP2B is inhibited more than 
CYPlAl, CYP1A2 or CYP3A (Knickle and Bend, 1992). 6-Aminochrysene 
bioactivation proceeds via two pathways, CYPl A-dependent diol-epoxide formation 
and CYP2B-dependent N-hydroxylation (Yamazaki et al, 1993) which may make it 
more resistant to inhibition by ABT. It is conceivable that the other aromatic amines 
are also substrates for more than one isoform. However IQ is exclusively 
bioactivated by the cytochrome P450 oxidases, and the mutagenicity of this amine 
was completely inhibited by ABT treatment. It is possible that under conditions 
where cytochrome P450 is not functioning the bioactivation of aromatic amines is 
taken over by flavin-containing monooxygenase.
There was a mixed response to the addition of the free radical scavenger DMSO, 
NADPH-dependent microsomal bioactivation was modestly reduced but, in the 
presence of NADH bioactivation was increased considerably. Therefore, the 
metabolism of 2AA by microsomes in the presence of NADPH, may involve, to 
some extent, the production of free radicals.
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Interestingly, microsomal and cytosol activating mechanisms were reduced linearly 
after incubation at 37 °C, an observation similar to that demonstrated for the 
activation of 2-aminoanthracene by trout microsomes (Johnson, 1990). Why 
incubation should suppress the mutagenicity is unclear, because incubation is 
expected to increase the rate of 2AA metabolism. It is possible that preincubation 
produces an increase in mutagenic intermediates to concentrations toxic to the 
bacteria, probably through DNA damage, or that further metabolism of the N- 
hydroxylamine occurs forming less mutagenic ring hydroxylated metabolites. It is 
also possible that a decrease in mutagenicity is a consequence of loss of cofactors 
because of the absence of a generating system in these studies. However, if this were 
responsible the mutagenic response would be expected to reach a plateau, but should 
not be decreased. Another possibility is that the cytochrome P450 isoforms involved 
are not stable under preincubation conditions, but once again, in the absence of 
cofactors for conjugation enzymes, the mutagenic response would be expected to 
reach a plateau and not to decrease. A loss of cytochrome P450 function is also 
unlikely because the stability of cytochrome P450 for more than 60 minutes has been 
demonstrated on numerous occasions, for example the preincubation of nitrosamines 
in the presence of microsomes from Aroclor 1254-treated rat requires a 60 minute 
preincubation at 37°C to demonstrate a mutagenic response in the Ames test (Ayrton 
eta l, 1987).
Modulation o f the NADH- and NADPH-dependent activation o f  
aromatic amines by cytochrome P450 inducers
In agreement with other studies employing CYPlA-inducers, benzo[a]pyrene- 
pretreatment produced a marked induction of 2AA mutagenicity in the presence of
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NADPH (Carrière et al, 1992) demonstrating the importance of this isoform in the 
bioactivation of 2AA. However, the CYPIA proteins are present only at low 
concentrations in untreated hepatic microsomes, comprising less than 5% of total 
cytochrome P450 (loannides and Parke, 1993) and so cannot account for the marked 
mutagenicity demonstrated by this hepatic fraction. This substantial bioactivation of 
2AA by microsomes from untreated rats indicates a possible role for constitutive 
forms of cytochrome P450 in the bioactivation of 2AA. Also in agreement with 
previous investigations on aromatic amine mutagenicity is the decreased 
mutagenicity observed after pretreatment with phenobarbitone and dexamethasone, 
demonstrating that CYP2B and CYP3A subfamilies are responsible for detoxication 
of 2AA (Carrière et al, 1992; Yamazaki et a l, 1992). It is also possible that 
treatment with phenobarbitone and dexamethasone induces CYP2B and CYP3A at 
the expense of CYPIA, thus decreasing CYP 1 A-mediated activation possibly by 
competition for electrons from NADPH cytochrome P450 reductase (loannides and 
Parke, 1990). Pretreatment with Aroclor 1254 had no effect, possibly because this 
treatment induces both enzymes concerned with activation (CYPIA) and 
deactivation (CYP2B). In studies employing reconstituted cytochrome P450 proteins, 
only CYP1A2 was capable of N-hydroxylation of aromatic amines such as 2- 
naphthylamine, and only CYPlAl and to a lesser extent CYP1A2 were responsible 
for the majority of N-hydroxylation of 2-aminofluorene (Astrom and DePierre, 1985; 
Hammons et a l, 1985), whereas CYP2B and CYP3A could only catalyse ring- 
hydroxylation, thus producing non-mutagenic products (Astrom and DePierre, 1985;
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Hammons et al., 1985). Therefore pretreatment with phenobarbitone and 
dexamethasone can direct the metabolism of aromatic amines towards detoxication.
In marked contrast, NADH-dependent bioactivation of 2-aminoanthracene was only 
expressed after pretreatment with Aroclor 1254 and, to a lesser degree, 
benzo[a]pyrene. The minor mutagenic response with microsomes firom 
benzo[a]pyrene-treated animals, which gave an extremely marked mutagenic 
response in the presence of NADPH, may be explained by contamination of the 
NADH with trace amounts of NADPH. However there is no evidence to support this 
hypothesis. The suppliers of NADH, though they could not completely rule out the 
possibility of trace amounts of NADPH, were unable to detect any NADPH using 
standard assay techniques (Sigma Chemical Co, personal communication). Both of 
these treatments induce CYPIA isoforms, and the absence of a mutagenic response 
in untreated microsomes, may be a consequence of the low expression of this 
subfamily in these microsomes. The involvement of a cytochrome P450 isoform in 
the NADH-dependent bioactivation of 2AA and other amines is speculative because 
NADH has not previously been demonstrated to support cytochrome P450 oxidation 
in the absence of NADPH however, in this investigation we have demonstrated both 
CYPlAl- and CYP 1 A2-dependent activity in the presence of NADH in the absence 
of any measurable amounts of NADPH.
Insulin-dependent diabetes, induced by streptozotocin-pretreatment, modulates the 
bioactivation of mutagens by hepatic microsomes by changing the population of 
cytochrome P450 isoforms (loannides et al, 1988). Streptozotocin increases the 
expression of many isoforms including CYP1A2, CYP2B, CYP2E and CYP4A and
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increases the activity of NADPH cytochrome P450 reductase (loannides et al., 1988). 
In contrast to the decrease in 2AF mutagenicity observed previously with S9 (Flatt et 
al, 1989), microsomes supported a modest increase in 2-aminofluorene mutagenicity 
after streptozotocin-treatment. There was no change in 2-aminoantbracene 
mutagenicity and similar observations have been made previously where, even 
though CYPIA expression is elevated, the bioactivation of polycyclic aromatic 
hydrocarbons, e.g., benzo[a]pyrene, were also unaffected by streptozotocin- 
pretreatment (Flatt et al, 1989; loannides et al, 1988; Peng et a l, 1983). However 
these compounds are bioactivated to mutagens primarily by CYPlAl and so are 
unaffected because streptozotocin does not induce this isoform. However CYP1A2, 
the isoform primarily involved in the bioactivation of aromatic amines, is induced by 
streptozotocin (Barnett et a l, 1990) and the absence of any major increase in 
mutagenicity in this study suggests other enzymes are involved in the bioactivation 
of these amines. Pretreatment with streptozotocin is responsible for an increase in 
flavin monooxygenase (Rouer et a l, 1988), epoxide hydrolase and glutathione S- 
transferase (Rouer et a l, 1981), and increases or decreases in the activity of UDP- 
glucuronyltransferase dependent upon the substrate (Rouer et a l, 1981; Price and 
follow, 1982). Streptozotocin-treatment also induces enzymes in a non diabetes- 
dependent mechanism, /.e., the effects are not reversed by treatment with insulin, for 
example, the increased glutathione S-transferase activity (Agius and Gidari, 1985). 
Therefore, because streptozotocin-treatment modifies the expression of so many 
enzymes concerned with both the bioactivation and detoxication of aromatic amines 
it is prudent only to conclude that the overall effect of induction by streptozotocin
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was unable to increase the bioactivation of these aromatic amines to mutagenic 
intermediates.
NADH- and NADPH-dependent N-hydroxylation o f aromatic amines
Microsomal N-hydroxylation of 2-aminoanthracene, in the presence of NADH, by
preparations from animals pretreated with cytochrome P450 inducers was determined 
and found to correspond well with NADH-dependent mutagenicity i.e., only 
microsomes from animals pretreated with Aroclor 1254 and, to a lesser extent, 
benzo[a]pyrene demonstrated any N-hydroxylating activity. Aroclor 1254 and 
benzo[a]pyrene treatments demonstrated a marked induction of NADH- and also 
NADPH-dependent N-hydroxylation, and it would appear therefore that induction of 
CYPIA is responsible for an increase in N-hydroxylation activity and consequently, 
an increase in mutagenicity. However, microsomes from untreated animals, which 
have significantly lower N-hydroxylase activity, in the presence of NADPH display a 
comparable mutagenic response when compared to microsomes from animals 
pretreated with Aroclor 1254 indicating that, at least in untreated animals, other 
enzymes or cytochrome P450 forms play an important role in the bioactivation of 
2AA. Although Aroclor 1254 is a potent inducer of N-hydroxylase it also induces a 
number of enzymes concerned with detoxication such as CYP2B and this may reduce, 
the effect of any increased N-hydroxylation by leading to increased rin^  Similarly, if 
detoxication activity is lower in microsomes from untreated animals, the low levels 
of NADPH-dependent N-hydroxylase activity may be sufficient to elicit the observed 
mutagenicity.
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Bacteria deficient in N,0-acetyltransferase (TA98-1,8-DNP6) can be used to 
demonstrate whether the amino group is hydroxylated or still intact. Without this 
enzyme hydroxylamines cannot be further converted to the highly mutagenic acetoxy 
compounds that spontaneously break down to release the nitrenium ion. Mutagenic 
response(s) in the presence of the microsomes was less pronounced with the N,0- 
acetyltransferase-deficient strain, suggesting that bioactivation does proceed via the 
hydroxylamine. However, a sufficient mutagenic response was observed using the 
deficient strain to suggest that bioactivation of aromatic amines may also occur via 
other mechanisms e. g., the diol epoxide in the case of 6AC.
The effect of PAPS can also be employed to demonstrate that 2AF undergoes N- 
hydroxylation in the presence of microsomes and either NADPH or NADH, because 
sulphate conjugation of the hydroxylamine to the sulphate ester is responsible for an 
increase in mutagenicity. Indeed, an increase in 2AF mutagenicity was observed with 
the addition of PAPS to microsomes supplemented with cytosol in the presence of 
NADPH or NADH. However, under identical conditions the mutagenicity of 6AC 
was markedly decreased in the presence of either cofactor suggesting that the 
microsomes are mainly responsible for ring oxidation of 6AC with subsequent 
sulphate conjugation yielding non-mutagenic metabolites or, that sulphate 
conjugation of the hydroxylamine is a route of detoxication.
The absence of any effect on the mutagenicity of 2AA by PAPS suggests that either 
the hydroxylamine is more mutagenic than the conjugate, that the sulphate conjugate 
is very unstable so breaks down before it can enter the bacteria and bind to DNA, or 
that N-hydroxylation is not as important to the bioactivation of this amine. However,
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problems experienced previously in the investigation of sulphotransferase-mediated 
mutagenicity of aromatic amines in bacterial systems make it difficult to draw too 
many conclusions firom this study. Even though there is increased sulphotransferase- 
mediated DNA binding of N-hydroxy-2AAF and N-hydroxy-2AF (Mulder et ah, 
1977; Abu-Zeid et a l, 1992; Chou et al., 1995), when PAPS is incorporated with rat 
hepatic S9 or sulphotransferase in mutagenicity assays the mutagenicity of N- 
hydroxy-2AAF is suppressed (Stout et al., 1976; Mulder et a l, 1977; Schut and 
Thorgeirsson, 1978; Wirth and Thorgeirsson, 1981).
One route for the detoxication of carcinogens is conjugation with glutathione. 
Glutathione is present at high concentrations in Salmonella typhimurium tester 
strains, and glutathione S-transferase, though not as prevalent as in mammalian 89, is 
also present in significant quantity (Meijer et al, 1980; Summer e ta l ,  1980), and 
the presence of functional levels of glutathione usually leads to an increase in 
deactivation and consequently a decrease in mutagenicity (Kerklaan et al, 1985). In 
agreement with previous studies, glutathione itself is not mutagenic at the 
concentrations employed in these investigations, but addition of reduced glutathione 
was responsible for an increase in mutagenicity in the presence of microsomes, 
especially with NADH, (table 4.9.). Certain classes of xenobiotic are activated by 
glutathione e.g. halomethanes, and 1,2 dihaloethanes (Anders, 1991) but this has not 
been demonstrated previously with 2AAF or 2AF (Hongslo et a l, 1983). The nature 
of the glutathione conjugation is important however, because conjugations at 
different positions are responsible for both the activation and deactivation of 
mutagens (Saito et a l, 1983; Kato, 1986). The heterocyclic amine Trp-P-2 is
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metabolised by glutathione S-transferase and rat liver cytosol to three conjugates, 
two are completely inactive but the third is even more mutagenic than N-hydroxy- 
Trp-P-2, the proposed identity of the mutagenic metabolite being the N^-conjugate 
(Kato, 1986). Alternatively, glutathione may be acting simply as a reducing agent 
causing the reduction of oxidised metabolites to more mutagenic intermediates. For 
example the weaker nitroso or nitro mutagens may be reduced to the N- 
hydroxylamine.
Implications for mutagenicity testing o f a NADH-dependent 
microsomal mechanism responsible for the bioactivation o f  
promutagens
The relevance of these results to mutagenicity testing are uncertain. The lower 
efficiency of NADH-dependent activation of 2AA, and the absence of expression in 
either untreated animals or after pretreatment with monooxygenase inducers, 
indicates the relative unimportance of this system compared to mutagenic activation 
with NADPH. However, the possibility that other substrates may be preferentially 
metabolised by this enzyme system demands further investigation.
The bioactivation of 2AA is less efficient in the presence of NADH than NADPH, 
therefore the incorporation of NADH into the Ames test is of little consequence 
unless carcinogens are preferentially metabolised by the NADH-dependent enzyme. 
These mutagens would not normally be detected, so testing in the presence of NADH 
could be very important to conclusively test for the mutagenic potential of a suspect 
mutagen. Moreover, because the tissue distribution of NADH-dependent aromatic 
amine bioactivation is unknown it is possible that in extrahepatic tissues this system 
is of more importance.
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4.5. Conclusions
Understanding of 2-aminoanthracene mutagenicity remains far from complete, but 
from these investigations several conclusions may be drawn:
i) 2-Aminoanthracene is bioactivated by at least three independent systems present in 
Aroclor 1254-pretreated hepatic S9; the microsomal NADPH-dependent, microsomal 
NADH-dependent and NADPH-dependent cytosolic bioactivation.
ii) The two activities responsible for the bioactivation of 2AA in the microsomes 
involve different enzymes. They possess different optimum protein concentrations, 
and respond differently to mixed-function oxidase inducers and inhibitors.
iii) NADH-dependent activity is not expressed constitutively but is induced by 
treatment with either Aroclor 1254 and to a lesser extent benzo[a]pyrene and is 
therefore possibly a CYPlA-type monooxygenase.
iv) Both microsomal activities can catalyse the N-hydroxylation of 2AA, a process 
frequently associated with the CYPIA subfamily of cytochrome P450 
monooxygenases. However, no evidence exists that NADH supports any cytochrome 
P450 oxidation activity.
The relevance of these investigations to mutagenicity testing are unclear. If NADH- 
dependent activity is the result of a novel enzyme in chemical bioactivation, safety 
evaluation of chemicals may require analysis of NADH-dependent metabolism in 
addition to the current system, which employs NADPH alone.
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CHAPTERS
Induction of the cytosol-mediated bioactivation of 
aromatic amines by polychlorinated biphenyls
182
5.1. Introduction
OhCA,
Polychlorinated biphenyls (PCBs) are aromatic xenobiotics/\used extensively in 
industry, as lubricants, heat-exchange fluids, insulators, plasticizers, synthetic resins 
and plastics. The extensive use of PCBs has led .to an estimated total production in 
the USA, the worlds largest producer, of 1.4 x 10  ^pounds. Consequently, though the 
‘open’ use of PCBs was discontinued in the 1970s and ‘closed’ use, in capacitors and 
transformers, in 1978, almost every component of the global ecosystem has 
detectable levels of PCB contamination. For example, the majority of humans have 
significant PCB burdens, mainly within adipose tissues (O.l-l.Oppm). The 
persistence of PCBs in biological systems is because PCBs accumulate as a result of 
their lipophilicity and resistance to metabolism.
The metabolism of PCBs involves ring hydroxylation to more polar metabolites, but 
highly chlorinated PCB congeners which have no adjacent unsubstituted ring 
positions, are resistant to metabolism and, consequently, accumulate in tissues. The 
most toxic PCB congeners contain five or six chlorine groups. The microsomal 
enzymes responsible for the hydroxylation of PCBs are the cytochrome P450 mixed- 
function oxidases, in particular the CYPIA and CYP2B subfamilies (Alvares et al, 
1973). CYPIA isoforms are primarily responsible for the hydroxylation of coplanar 
PCBs, whereas CYP2B1 preferentially hydroxylates non-coplanar, polyorf/zo 
chlorinated isomers (Kaminsky et al, 1982).
The induction of CYPIA specific enzyme activities such as aryl-hydrocarbon 
hydroxylase (AHH) or ethoxyresorufin 0-deethylase (BROD) demonstrates that
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PCBs are ligands for the cytosolic aryl-hydrocarbon (Ah) receptor. The extent of 
binding to the Ah receptor and consequent induction is dependent upon the 
lipophilicity, electron affinity, entropy and electronic energy gaps of the individual 
PCB. Congeners which possess a higher electron affinity, and lower lipophilicity and 
entropy than 3,3',4,4' tetrachlorobiphenyl are good ligands for the Ah receptor, and 
congeners with higher binding affinity and smaller energy gaps than 3,3',4,4- 
tetrachlorobiphenyl are potent inducers of AHH and EROD (Kafafi et al, 1993). 
Consequently, aryl hydrocarbon hydroxylase induction and receptor binding of PCBs 
increases with the degree of chloro-substitution and planarity. Therefore, coplanar 
PCBs are the best inducers of CYPIA expression followed by mono-ortho 
substituted PCBs which are, in turn, better inducers than di-ortho substituted PCBs 
(Safe et al., 1985). Non-planar PCB congeners are, however, better inducers of 
CYP2B; moreover, pretreatment with commercial PCB mixtures induces other 
phase I and some phase II enzymes, including DT-diaphorase, glutathione-S- 
transferase, epoxide hydrolase and UDP-glucuronyltransferase.
Recently, it has been demonstrated that Aroclor 1254-pretreatment induces activity 
within hepatic cytosol responsible for the metabolism of some aromatic amines to 
mutagenic intermediates in the Ames test (Forster et a l, 1981a and b; Leist et al, 
1992; Ayrton et al, 1992). In the studies described in chapter 3 it was clearly 
demonstrated that Aroclor 1254 was the only effective inducer of the cytosolic amine 
oxidase activity. Aroclor 1254 is a mixture composed of tetra- (11%), penta- (49%), 
hexa- (34%) and hepta-chlorobiphenyls (6%), but the specific congeners responsible 
for the induction of this cytosolic activity have not been identified. In this
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investigation, the pretreatment of rats with individual coplanar and non-coplanar 
PCB congeners with different degrees of chlorination was used to determine which 
congeners are responsible for the induction of aromatic amine bioactivation catalysed 
by hepatic cytosol. Induction was monitored by the bioactivation of two model 
aromatic amine substrates, 2-aminoanthracene and 2-aminofluorene. The 
mutagenicity of the aromatic amines was compared with microsomal EROD, MROD 
and PROD activities to provide further evidence that microsomal contamination is 
not responsible for the cytosolic activity, and with cytosolic N-hydroxylation of 2AA 
and 2AF to demonstrate that the formation of the N-hydroxylamine is responsible for 
the mutagenic response evident in the presence of cytosol.
.//
Figure.5.L lUPAC labelling o f the biphenyl ring
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5:2. Methods
5.2.1. Pretreatment o f animals
Male Wistar albino rats (170-220g) were purchased from The Experimental Biology 
Unit (University of Surrey, Guildford), and received a single intraperitoneal injection 
of either Aroclor 1254 (500mg/kg) or a single PCB congener (70mmol/kg), in com 
oil. Animals were sacrificed on the fifth day after injection, and the livers excised 
and homogenised in four volumes of ice-cold potassium chloride (1.15%). S9 was 
prepared, as previously described (Chapter 2), and stored at -20 °C. Microsomes and 
cytosol were prepared, by two 60-minute centrifiigations at 105,000g, on the day of 
use.
5.2.2. Determination o f total microsomal cytochrome P450 
concentration
The carbon monoxide-difference spectra method (Omura and Sato, 1964) was used to 
determine the total microsomal cytochrome P450 concentration in all samples. The 
concentrations are expressed as nmoles per mg protein, with protein concentrations 
determined using the Lowry method (Lowry ef al, 1951).
5.2.3. Dealkylation o f alkoxyresorufins by microsomal 
cytochrome P450 isoforms
The 0-dealkylation of the three alkoxyresorufins was measured to determine the 
activity of specific cytochrome P450 isoforms (Burke and Mayer, 1975). The
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dealkylation of ethoxyresorufin, methoxyresorufin and pentoxyresorufin were 
utilised as probes to measure CYPIAI, CYP1A2 and CYP2B activity respectively 
(Namkung et al., 1988; Lubet et a l, 1985). The methodology is described fully in 
Chapter 2.
5.2.4. Determination o f the N-hydroxylation o f aromatic 
amines by hepatic cytosol
The metabolism of 2-aminofiuorene and 2-aminoanthracene to N-hydroxylamines 
was measured by the c o \ q rimetric method of Vanderslice et al., (1987), and 
quantified using hydroxylamine (0-2.5pmoles) standards. The activity was expressed 
as nmoles of hydroxylamine formed min* per mg protein, where protein 
concentration was determined by the Lowry procedure (Lowry et al, 1951). The 
methodology is described in detail in Chapter 2. ^
5.2.5. Mutagenicity tests
Induction of the cytosolic activity responsible for the bioactivation of aromatic 
amines was determined using the Ames mutagenicity test, employing 2- 
aminoanthracene (O-lOpg/plate) or 2-aminofiourene (O-lOpg/plate) as model 
substrates. Tests employed the Salmonella typhimurium strain TA98, and 10%(v/v) 
activation mixtures. Results are represented as the mean ± standard deviation of 
histidine revertant colonies on three plates. The method used is described in Chapter 
2.
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5.3. Results
5.3.1. Microsomal cytochrome P450 activity in animals 
treated with PCB congeners
The induction of specific microsomal enzyme activities was used to demonstrate the 
effect of PCB-pretreatment upon the expression of cytochrome P450 isoforms 
concerned with the metabolism of aromatic amines. Subsequently, these microsomal 
activities are compared vdth the mutagenic response of aromatic amines provoked in 
the presence of cytosol, to demonstrate whether contamination by microsomal 
enzymes participates in the cytosolic activity.
Table.5.1. Microsomal cytochrome P450 concentrations and activities 
after pretreatment with PCB congeners
Treatment
Cytochrome
P450
concentration
(nmol/mg
nroteinl
MROD
(nmol/mln/nmol
F450)
EROD
(nmol/min/nmol
P450)
PROD
(pmol/mln/nmol
P450)
Control 0.658 0.313 0.069 28.08
Aroclor 1254 2.175 1.609 2.346 92.54
2,2'-DichIoroblphenyl 0.637 0.070 0.081 13.94
4,4'-Dichlorobiphenyl 0.631 0.662 0.083 13.96
2,2',5-TrichIorobiphenyl 0.370 0.206 0.077 11.14
3,4,4'-Trlch!oroblphenyl 0.511 1.478 0.073 17.33
2,2',4,4’-TetrachIorobiphenyI 0.979 0.610 1.441 69.10
2,2',4,5,5'-PentachIorobiphenyl 0.541 1.106 1.574 115.86
3,3*,4,4',5-Pentachlorobiphenyl 0.584 2.135 1.570 100.38
2,2’,4,4',5,5’-HexachlorobiphenyI 0.808 0.994 1.912 69.14
3 ^ ’,4,4',5,5'-HexachIorobiphenyI 0.791 1.230 1.466 61.70
samples and gave comparable results.
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Table 5.1 shows the microsomal cytochrome P450 content, MROD, EROD, and 
PROD activities of the livers used in the mutagenicity studies derived from rats 
treated with various PCB congeners.
5.3.2. The in vitro effect of Aroclor 1254 on the bioactivation 
of aromatic amines by cytosol
Cytosol-mediated bioactivation of aromatic amines is only detectable after Aroclor 
1254-pretreatment (Chapter 3). The induced bioactivation in the cytosol is 
accompanied by a reduction in the mutagenic response catalysed by microsomes 
(Chapter 3). It is, therefore, possible that the loss of activity from microsomes to 
cytosol may be the effect of solubilisation of cytochrome P450 or other microsomal 
enzymes. To test this hypothesis Aroclor 1254 (250pg/ml S9) was added to untreated 
and to Aroclor 1254-pretreated S9, mixed for 30 seconds and left to stand on ice for 
15 minutes before ultracentrifugation. The ability of the cytosol prepared from these 
samples to metabolise aromatic amines to mutagenic intermediates was compared 
with fractions exposed to com oil, the vehicle for Aroclor 1254.
Hepatic cytosolic fractions from untreated rats could not readily activate any of the 
three aromatic amines tested; moreover incorporation of Aroclor 1254 did not have a 
major effect (table 5.2). As expected, Aroclor 1254-pretreated cytosol converted all 
three promutagens to their genotoxic intermediates. Introduction of Aroclor 1254 to 
the hepatic cytosol did not influence the mutagenic response.
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Table 5.2 Effect o f in vitro Aroclor 1254-treatment on the 
bioactivation o f aromatic amines by hepatic cytosol
Histidine revertants/plate
Sample Concentration
(ug/plate)
Corn oil Aroclor 1254
Untreated
2-Aminoanthracene 5 14±3 36 ± 6
2-Ammofluorene 5 4 i  4 7 ± 5
6-Ammochiysene 1 9±15 16 ± 6
Aroclor 1254
2-Ammoanthracene 5 1048 ±190 1507 ±63
2-Amînofluorene 5 160 ±44 118 ±26
6-Aminochrysene 1 1142 ± 267 1571± 506
activation mixtures. The results are expressed as mean ± standard deviation of three observations. 
The spontaneous reversion rate was 7P ± 5 and has already been subtracted.
5.3.3. The bioactivation of aromatic amines by hepatic 
cytosol from rats pretreated with PCB congeners
The extent of induction of cytochrome P450 activities with the degree of 
chlorosubstitution of PCB congeners is well documented (Kaminsky et al., 1982; 
Kafafi et al., 1993) but the role of PCB congeners in the induction of the hepatic 
cytosol-mediated bioactivation of aromatic amines has not been addressed. The 
mutagenic response of 2AA and 2AF in the presence of hepatic cytosolic fractions 
isolated from animals pretreated with individual PCB congeners was investigated to 
demonstrate which confcjpiers are responsible for the induction of the cytosolic
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bioactivation observed using Aroclor 1254Jdentifying the particular PCB congeners 
responsible, will help the understanding of the induction processes involved in the 
expression of cytosolic activity. A comparison between the induction of microsomal 
enzymes and the cytosol-mediated bioactivation of aromatic amines was used to 
demonstrate whether the former is a factor in the cytosolic activation.
No cytosol-catalysed mutagenic response was observed with 2-aminofluorene after 
pretreatment with polychlorinated biphenyls with fewer than five chlorine atoms and, 
only cytosol from animals treated with Aroclor 1254 or hexachlorobiphenyls, 
especially the 3,3',4,4',5,5'-isomer demonstrated clear 2AF bioactivation (table 5.3).
All PCB congeners induced the cytosolic activity so that a mutagenic response was 
observed, at least at the higher concentrations of 2-aminoanthracene (table 5.4) but 
PCB congeners containing fewer than four chlorines only induced modest 
mutagenic responses. Of the highly chlorinated PCB congeners, the greatest 
mutagenic response was observed after pretreatment with the coplanar PCB 
congeners, 3,3',4,4',5 pentachlorobiphenyl and 3,3',4,4',5,5' hexachlorobiphenyl 
(table 5.4).
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Table. 5.3. Bioactivation of 2-aminofluorene by hepatic cytosol after
pretreatment with PCB congeners
Pretreatment 2-Aminoflourene(pg/plate)
Histidine
revertants/plate
Control 2.5 nd
5.0 10±2
7.5 10±5
10.0 19±5
Aroclor 1254 2.0 25 ±14
4.0 57 ±18
6.0 67 ±16
8.0 146 ±31
2^'-DichIorobiphenyI 2.5 10±2
5.0 7 ± 6
7.5 10±7
10.0 8 ± 6
4,4*-DichIorobiphenyl 2.5 7 ± 6
5.0 8± 3
7.5 9 ± 5
10.0 13 ± 5
2,2%5-TrichIorobiphenyl 2.5 14±4
5.0 nd
7.5 5 ± 3
10.0 13±3
3,4,4'-TrichIorobiphenyI 2.5 20±1
5.0 10 ± 7
7.5 13±6
10.0 16±8
2,2*,4,4*-Tetrachlorobiphenyl 2.5 nd
5.0 3 ± 4
7.5 10±6
10.0 17±8
2,2',4,5,5'-PentachIorobiphenyl 2.5 5 ± 9
5.0 2 ± 4
7.5 nd
10.0 14±11
3^*,4,4’,5-PentachlorobiphenyI 2.5 12±6
5.0 16±9
7.5 17±6
10.0 41 ± 7
2,2’,4,4*,5,5'-Hexachlorobiphenyl 2.5 8 ± 4
5.0 1 ± 6
7.5 21 ± 6
10.0 33 ±3
3,3’,4,4*,5,5*-Hexachlorobiphenyl 2.5 49 ±13
5.0 49±5
7.5 64 ±17
10.0 76± 9
Mutagenicity tests employed 10%(v/v) activation mixtures containing an NADPH-generating 
system, mutagen and Salmonella typhimurium strain TA98. The results are expressed as mean ± 
standard deviation of triplicates. The spontaneous reversion rate was 19 ± 4  and has already been 
subtracted, nd = a reversion rate lower than the spontaneous reversion rate.
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Table.5.4. Bioactivation of 2-aminoanthracene by hepatic cytosol after
pretreatment with PCB congeners
P re tre a tm e n t
2-Aminoanthracene
(pg/plate)
Histidine
revertants/plate
Control 2.5 21 ± 3
5.0 18±3
7.5 19±8
10.0 2 9 ± 6
Aroclor 1254 1.0 192 ±39
2.0 237 ±65
3.0 462 ±72
4.0 665 ±112
2,2*-D:chlorobiphenyl 2.5 16± 4
5.0 31 ±13
7.5 28 ±19
10.0 39 ± 7
4,4'-Dlchlorobiphenyl 2.5 42 ± 7
5.0 47 ±3
7.5 5 1± 6
10.0 58 ±10
2,2',5-Trichlorobiphenyl 2.5 20 ± 8
5.0 45± 12
7.5 47 ±25
10.0 59 ±10
3,4,4*-Trichlorobiphenyl 2.5 46 ± 3
5.0 41 ± 10
7.5 4 4 ± 5
10.0 62 ±17
2,2*,4,4'-Tetrachlorobiphenyl 2.5 71 ±11
5.0 67 ±19
7.5 102 ±21
10.0 106 ±18
2,2',4,5,5*-Pentachlorobiphenyl 2.5 52 ±17
5.0 61 ±23
7.5 79 ±18
10.0 136 ± 25
3,3' ,4,4' ,5-Pentachlorobiphenyl 2.5 280 ±39
5.0 222 ± 108
7.5 328 ± 143
10.0 500 ± 62
2,2',4,4',5,5'-Hexachlorobiphenyl 2.5 71 ±13
5.0 91 ± 7
7.5 106 ±25
10.0 183 ±18
3,3',4,4',5,5'-Hexachlorobiphenyl 2.5 469 ± 64
5.0 624 ± 91
7.5 710 ±194
10.0 850 ±186
typhimurium strain TA98. The results are expressed as mean ± standard deviation o f triplicates. 
The spontaneous reversion rate was 18 ± 2  and has been subtracted.
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5.3.4. N-Hydroxylation activity in cytosolic fractions from 
rats treated with PCB congeners
In the microsomes, the bioactivation of planar aromatic amines involves N- 
hydroxylation. Previous investigation of the substrate specificity of the Aroclor 
1254-induced cytosolic activity responsible for the bioactivation of aromatic amines 
also indicated the importance of the amino group (Chapter 3). Consequently, the N- 
hydroxylamine is assumed to be the mutagenic intermediate produced by cytosolic 
metabolism
Table. 5.5. The cytosolic N-hydroxylation o f aromatic amines after 
pretreatment with polychlorinated biphenyls
N-hydroxylation activity 
(nmols formed min^ per mg protein)
SAMPLE 2-Aminoanthracene 2-Aminofluorene
Com Oil 29.54 38.89
Aroclor 1254 72.32 60.14
2,2' Dichlorobiphenyl 56.27 44.89
4,4' Dichlorobiphenyl 48.04 39.19
2,2',5 Trichlorobiphenyl 55.14 53.52
3,4,4' Trichlorobiphenyl 55.60 53.11
2,2',4,4' Tetrachlorobiphenyl 70.84 65.86
2,2',4,5,5' Pentachlorobiphenyl 76.23 48.34
3,3',4,4',5 Pentachlorobiphenyl 68.88 56.32
2,2',4,4',5,5' Hexachlorobiphenyl 71.62 65.28
3,3',4,4',5,5' Hexachlorobiphenyl 103.31 62.07
Incubation mixtures contained cytosol (0.4mg protein) and aromatic amine (SOpA ,^ and the 
reaction was initiated by the addition of NADPH (2mM). The mixtures were incubated for. ten 
minutes at 37 in a shaking waterbath and the absorbance measured at 595nm at the end of the 
incubation.. The quantity of N-hydroxylamine formed was calculated using a standard curve 
generated using hydroxylamine (r = 0.999).Each incubation was performed in duplicate and the 
results are expressed as the mean of the two observations.
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This investigation aims to verify this route of bioactivation by correlating the N- 
hydroxylation of 2AF and 2AA with their mutagenic responses in cytosol, after 
pretreatment with different PCB congeners.
In general terms the N-hydroxylation of both 2-aminoanthracene and 2- 
aminofluorene by hepatic cytosol from PCB-pretreated rats increased in relation to 
the degree of chlorosubstitution (table 5.5); the higher the number of chlorine atoms 
the greater the induction of cytosolic N-hydroxylation. These studies were, however, 
undertaken in order to correlate N-hydroxylase activity with mutagenic response and 
the purpose was not to study induction of N-hydroxylase activity by PCB congeners.
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5.4. Discussion
The cytosol-mediated bioactivation of mutagenic aromatic amines, including 2- 
aminofluorene, 2-aminoanthracene and 6-aminochrysene, has previously been 
demonstrated in livers from Aroclor 1254-pretreated rats (Forster et al., 1981a and b; 
Leist et al, 1992; Ayrton et al, 1992). This activity exhibits major differences to 
that activity expressed by the microsomes, implying that the cytosolic activity is an 
independent system and not the consequence of microsomal contamination. 
Furthermore, treatment with Aroclor 1254 in vitro appears not to cause any 
solubilisation of microsomal enzymes, which could account for an increase in 
aromatic amine bioactivation by cytosol (table 5.2). Aroclor 1254 is a commercial 
mixture of both coplanar and non-coplanar PCB congeners consisting m ^ y  of 
tetra- (11%), penta- (49%), hexa- (34%) and hepta-chlorobiphenyls (6%). Coplanar 
and non-coplanar PCB congeners are CYPIA and CYP2B inducers respectively 
(Kaminsky et al, 1992), making it difficult to assign any structure relationship to the 
induction of cytosolic activity, or to understand how this activity is regulated. Planar 
aromatic compounds usually induce CYPIA, and other enzymes, via the aryl- 
hydrocarbon receptor, but non-planar compounds are poor ligands for this receptor. 
To illustrate the relevance of planarity and the extent of chlorosubstitution on the 
induction of the enzyme(s) responsible for the bioactivation of aromatic amines, 
cytosol from rats receiving pretreatment with a range of PCB congeners was 
investigated for the ability to activate 2AA and 2AF to mutagens in the Ames test 
and to form the N-hydroxylamine intermediate.
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The highest degree of induction of the hepatic cytosolic bioactivation of aromatic 
amines was achieved after pretreatment with highly chlorinated planar PCB 
congeners and, there was a good correlation between the mutagenic response and the 
N-hydroxylation of aromatic amines in the presence of cytosol. This finding provides 
further evidence that the bioactivation of aromatic amines by cytosol involves N- 
hydroxylation.
Cytosol-mediated mutagenicity of aromatic amines after pretreatment 
with polychlorinated biphenyl confomers
The extent of induction of the cytosol-mediated bioactivation of 2AA and 2AF
increased with the degree of chlorosubstitution of the PCB inducer and was greater
using cytosol from animals treated with coplanar PCB congeners. 2-Aminofluorene,
and to a greater extent, 2-aminoanthracene demonstrated their highest mutagenic 
in ffùM
response pretreatment with 3,3',4,4',5-pentachlorobiphenyl and 3,3',4,4',5,5- 
hexachlorobiphenyl. 2-Aminoanthracene elicited a mutagenic response in cytosol 
after pretreatment with all PCB congeners, but the response was modest with the 
lower molecular weight PCBs. Therefore, a high degree of chlorosubstitution was the 
most important structural characteristic required for a PCB to induce the system 
responsible for the bioactivation of aromatic amines by cytosol. A comparison of 
isomeric PCB congeners revealed coplanar PCB congeners induced more effectively 
than the non-planar PCB isomers. A preference for induction by coplanar PCBs is 
indicative of induction processes employing the Ah receptor, and therefore the Ah- 
receptor is probably concerned with the induction of the cytosolic enzyme(s) 
responsible for the bioactivation of aromatic amines. Furthermore, the affinity of 
PCB congeners for the Ah receptor also increases with their molecular weight (Kafafi
197
et al, 1993), which would explain the increased mutagenic response after 
pretreatment with PCBs containing five or six chlorine atoms.
There is a good correlation between microsomal CYP1 Al -dependent ethoxyresorufin 
0-deethylase (EROD) activity and cytosol-dependent 2AA mutagenicity (R = 0.709), 
but this may be an artefact since both enzymes are regulated by the Ah receptor and it 
is unlikely that CYPlAl is responsible for the bioactivation of aromatic amines 
because CYPlAl is more specific for polycyclic aromatic hydrocarbons, such as 
benzo[a]pyrene which is not bioactivated by the cytosolic fraction (Forster et a l, 
1981b). Also, pretreatment with benzo[a]pyrene, a CYPlAl inducer, does not induce 
cytosolic bioactivation of 2AAF, 2AA or 6AC (Forster et a l, 1981a and b; Chapter 
3). Cytosol-mediated metabolism of 2AA to mutagenic intermediates correlates 
poorly with CYP 1 A2-dependent microsomal methoxyresorufin 0-demethylase 
(MROD) (R = 0.475), eventhough this enzyme is also believed to be under the 
control of the Ah-receptor, and is the cytochrome P450 isoform primarily concerned 
with the bioactivation of aromatic amines. Pentoxyresorufin 0-depentylase (PROD) 
activity also correlates poorly with 2AA mutagenicity (R = 0.597).
Highly chlorinated PCB congeners are more resistant to hydroxylation and are 
subsequently more highly retained (Borlakoglu and Wilkins, 1993) and 3,3',4,4’,5,5'- 
hexachlorobiphenyl, 2,2',4,4',5,5'-hexachlorobiphenyl, 3,3 ',4,4',5-pentachloro 
biphenyl, and to a lesser extent 2,2',4,5,5'-pentachlorobiphenyl, are the only 
conformers, in this study expected to be retained in tissues (Safe, 1989). These 
compounds are retained because they do not have adjacent unsubstituted meta- and 
pflrra-carbons, the ring positions favoured for hydroxylation. Therefore by the fifth
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day after treatment the majority of the lesser chlorinated congeners have probably 
been eliminated fi’om the body, but the majority of the hexa- and 
pentachlorobiphenyl congeners are retained. The longer residence time of these 
congeners might allow greater induction and may explain the noticeably greater 
mutagenicity observed in liver cytosol from animals pretreated vrith these congeners.
Induction of aromatic amine bioactivation especially by PCB congeners which are 
most suited to biological accumulation is of concem. The previously widespread use 
of Aroclor 1254 in Europe and the USA, and the resistance to metabolism of these 
PCB congeners, may have a prolonged effect on health, especially considering the 
position of man at the head of the food chain. Indeed, the bioactivation of 2AA and 
6AC has already been demonstrated by human hepatic cytosol (Chapter 2).However, 
exposure to highly chlorinated congeners, responsible for the most marked cytosolic 
induction, is extremely low accounting for less than 1% of the total accumulated 
PCBs when rats are pretreated with Aroclor 1254.
N-Hydroxylation o f 2-aminoanthracene and 2-aminofluorene by 
hepatic cytosol from rats pretreated with polychlorinated biphenyl 
congeners
Mutagenic aromatic amines are dependent upon N-hydroxylation for the expression 
of their mutagenicity. A significant correlation exists (R=0.847) between the N- 
hydroxylation and mutagenicity of 2-AA in the presence of cytosol (figure 5.2)
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pretreated with polychlorinated biphenyls
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Bioactivation of 2AF however has only a moderate correlation (R=0.522) 'with N- 
hydroxylation (figure 5.2) possibly because the mutagenic response vdth this amine 
was limited after most pretreatments, thus not allowing for a proper correlation to be 
established. The expression of N-hydroxylating activity within the cytosolic firaction 
may indicate the presence of a CYPlA-type enzyme. Cytosolic CYPlAl-type 
activity has previously been demonstrated, using the dééthylation of ethoxyresorufin, 
by human foetal hepatic tissue (Yang et al, 1995). The activity under investigation in 
these studies may be related to this foetal enzyme.
5.5. Conclusions
These investigations have demonstrated that:
(I). The bioactivation of aromatic amines by cytosol is induced preferentially by 
3,3',4,4',5,5'-hexachlorobiphenyl and 3,3',4,4',5-pentachlorobiphenyl, and to a lesser 
extent by 2,2',4,4',5,5-hexachlorobiphenyl, 2,2',4,5,5'-pentachlorobiphenyl, 2,2',4,4'- 
tetrachlorobiphenyl and other PCB congeners le., the best inducers are highly 
chlorinated congeners especially the coplanar isomers.
(ii). Bioactivation involves a cytosol-mediated N-hydroxylation, probably regulated 
by the cytosolic Ah receptor.
(iii) Even though the induction of cytosolic oxidation, and microsomal MROD, 
EROD and PROD activities all increase with the degree of chlorination of the PCB 
inducer, the correlation between the bioactivation of aromatic amines by cytosol and
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the microsomal cytochrome P450 activities is not sufficient to prove cytosolic 
activity is a consequence of microsomal contamination in view of the extensive 
evidence against this hypothesis. However, this does not rule out the possibility of 
contamination with microsomal flavin-containing monooxygenase.
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CHAPTER 6
Bioactivation of aromatic amines: association with
the Ah receptor
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6.1. Introduction
The aryl-hydrocarbon (Ah) receptor is a cytosolic, 2 subunit protein which binds 
avidly, but non-covalently, with xenobiotics including aryl-hydrocarbons and PCBs. 
Ligand-binding increases the affinity of the Ah receptor for DNA and the ligand- 
receptor complex enters the nucleus, binds to DNA activating xenobiotic-responsive 
elements (XREs) which are upstream sequences responsible for the regulation of 
several genes. Binding to an XRE is responsible for the derepression of the gene and 
consequently increases synthesis of a number of proteins including the Ah receptor 
subunits, CYPIA isoforms, CYPIBI, protein kinase C and UDP-glucuronyl 
transferase (see Chapter 1).
Two inbred mouse strains, C57BL6 and DBA2, have contrasting responses to 
induction by aryl hydrocarbons. The C57BL6 strain responds to pretreatment with 
large increases in the synthesis of CYPIA (Daujat et a l, 1991) and other proteins 
whereas the DBA2 strain is described as ‘non-responsive’ because treatment with 
aryl hydrocarbons causes only minimal induction compared with the ‘responsive’ 
mouse strain. The ‘responsiveness’ of these strains is a consequence of different 
binding affinities of their Ah receptors; for example, DBA2 mice have receptors with 
a ten-fold weaker binding affinity for the potent CYPIA inducer 2,3,7,8- 
tetrachlorodibenzo-^-dioxin (TCDD) (Li et al, 1994).
The aromatic amine carcinogens, 2-aminoanthracene (2AA), 2-aminofluorene (2AF), 
and 6-aminochrysene (6AC) are metabolised to mutagenic intermediates in the Ames 
test by hepatic microsomal (Phillipson and loannides, 1983; El-Bayoumy et a l, 
1989) and cytosolic (Forster et al, 1981a and 1981b; Ayrton et a l, 1992; Leist et a l.
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1992; Chapter 3) fractions from Aroclor 1254-pretreated rats. The bioactivation of 
aromatic amines by microsomes is associated primarily with the cytochromes P450, 
especially the CYP1A2 isoform, which is believed to be under the regulation of the 
Ah receptor. Bioactivation of aromatic amines by CYP1A2 involves the formation of 
the N-hydroxylamine; however the same pathway is also catalysed by the flavin- 
containing monooxygenase (Frederick et al, 1982) which has not been linked to the
Ah receptor.
Coplanar polychlorinated biphenyls are more effective than non-coplanar isomers at 
inducing the cytosolic activation of aromatic amines to mutagenic intermediates 
(Chapter 5). Coplanar isomers also display a greater affinity for the Ah-receptor 
(Safe et a l, 1985) and consequently regulation of the cytosol-mediated oxidation of 
aromatic amines may be under the control of the Ah-receptor.
A PCB-inducible NADH-dependent microsomal activity responsible for the 
bioactivation of 2-aminoanthracene has been proposed in the rat (Ayrton et a l, 1992; 
Leist et a l, 1992; Chapter 4). In this study the two inbred mouse strains will be 
employed to determine the relevance of the Ah-receptor to bioactivation of aromatic 
amines by the microsomes, in the presence of NADPH or NADH, and the cytosol.
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6.2. Methods
6.2.1. Pretreatment o f animals
Nine adult C57BL6 and DBA2 mice were purchased from B & K Universal Ltd,
(Hull, North Humberside). Three mice of each strain were pretreated with a single 
intraperitoneal injection of Aroclor 1254 (SOOmg/kg in com oil) and were sacrificed a f t c T  
5 days; a further three animals received benzo[a]pyrene (25mg/kg in com oil) 
intraperitoneally on three consecutive days and were killed 24 hours after the last 
injection, whereas the remaining mice received no treatment. The livers from three 
animals were pooled for the preparation of S9, as previously described (Chapter 2). 
Microsomal and cytosolic subcellular fractions were prepared on the day of use by 
ultracentrifugation at 105,000g for 2 x 60 minutes.
Male Wistar albino rats (180-200g) were also pretreated with either Aroclor 1254 
(500mg/kg body weight intraperitoneally) or benzo[a]pyrene (25mg/kg body weight 
intraperitoneally), and hepatic subcellular fractions were also prepared as described 
in Chapter 2.
6.2.2. Microsomal enryme studies
Microsomal fractions were prepared by ultracentrifugation and total cytochrome 
P450 concentration, and the activities of ethoxyresomfin-O-deethylase and 2- 
aminofiuorene-N-hydroxylase were determined as previously described (Chapter 2).
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6.2.3. Mutagenicity studies
All Ames mutagenicity tests employed the Salmonella typhimurium strain TA98 and 
activation mixtures (10% v/v), containing either NADPH (8mM) or NADH (8mM). 
All experiments were performed in triplicate using the methodology described in 
Chapter 2.
6.2.4. SDS PAGE and Western blot analysis o f hepatic cytosol 
for CYPIA proteins
Rat hepatic cytosolic proteins were separated by SDS PAGE using the method of 
Laemmli (1970), as described in chapter 2. In these investigations a model SB400 
vertical slab apparatus was employed using 10% polyacrylamide gels (120mm x 
110mm X 15mm). The cytosolic proteins were transferred to nitrocellulose sheets, 
and the presence of CYPIA proteins investigated using sheep anti-rat CYTIA, and 
peroxidase-linked donkey anti-sheep antibodies, as described in chapter 2.
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6.3. Results
6.3.1. Cytochrome P450 activities in ‘responsive’ and ‘non- 
responsive’ mice treated with Aroclor 1254 and 
benzo[a]pyrene
Total cytochrome P450 concentration and EROD activity were used to verify the 
presence of a fully functioning Ah receptor in the C57BL6 strain, and to compare the 
effectiveness of Aroclor 1254 and benzo[a]pyrene as inducers. Moreover, if  the level 
of CYPlAl induction by the two inducing agents is similar the fact that only Aroclor 
1254 enhances cytosol-mediated aromatic amine bioactivation (Chapter 3) may be 
interpreted as showing that the cytosolic system is not due to contamination with the 
microsomal CYPIA proteins.
Table.6,1. Cytochrome P450 concentration andethoxyresorufin-O- 
deethylase activity in C57BL6 and DBA2 mice
Strain Treatment Cytochrome P450 concentration (nmol per 
mg protein)
Ethoxyresorufin-O- 
deethylase activity 
(pmol/min per mg 
protein)
Untreated 0.61 8.25
DBA2 Benzo[a]pyrene 0.42 9.39
Aroclor 1254 0.72 10.66
Untreated 0.44 18.44
C57BL6 Benzo[a]pyrene 0.89 72.26
Aroclor 1254 1.69 112.4
EROD results are expressed as the mean of two observations.
In the ‘responsive’ mouse strain two- and four-fold increases in total cytochrome 
P450 concentration were observed after pretreatment with benzo[a]pyrene and
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Aroclor 1254 respectively, but in the ‘non-responsive’ strain only a modest increase 
in total cytochrome P450 concentration was observed after either pretreatment (table 
6.1).
Both strains responded to benzo[a]pyrene and, to a greater extent, Aroclor 1254- 
pretreatment, as exemplified by the ethoxyresorufin-O-deethylase activity (table 6.1); 
however, the degree of induction was markedly higher in the responsive mice. For 
example, following Aroclor 1254-pretreatment, EROD activity was only induced 
1.25-fold in DBA2 microsomes compared to 6-fold in microsomes derived firom 
C57BL6 mice (table 6.1). Therefore it is obvious from these observations that, as 
expected, the two mouse strains respond very differently to induction by either 
benzo[a]pyrene or Aroclor 1254. The DBA2 strain only demonstrates modest 
induction of EROD and total cytochrome P450, whereas both are induced markedly 
in the C57BL6 strain.
6.3.2. Microsomal bioactivation of 2-aminoanthracene by 
Ah ‘responsive’ and ‘non-responsive’ mice: effect of 
treatment with Aroclor 1254
Metabolism of aromatic amines to mutagenic intermediates, through N- 
hydroxylation, is carried out by the cytochrome P450 oxidases, in particular the 
CYP1A2 isoform (loannides and Parke, 1990), and the flavin-containing 
monooxygenases (Pelroy and Gandolfi, 1980). CYPIA isoforms are induced via the 
Ah receptor and in this study mouse strains which are either responsive (C57BL6) or 
non-responsive (DBA2) to induction were used to investigate the role of the Ah
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receptor in the induction of 2AA bioactivation after pretreatment with Aroclor 1254. 
In the rat, Aroclor 1254-treatment induces an NADH-dependent mechanism which 
can convert 2AA to mutagenic intermediates (Ayrton et a l, 1992). The presence of 
this system in mouse, its inducibility by Aroclor 1254 and its dependence upon the 
Ah receptor were also investigated.
Tahle.6.2. The effect o f Aroclor 1254-pretreatment on the NADPH 
and NADH-dependent bioactivation o f 2-aminoanthracene by 
microsomes from Ç57BL6 and DBA2 mice
Histidine revertants/plate
Strain and 
treatment
2-AA
concentration
(pg/plate)
NADPH NADH
DBA 1 38±9 nd
Untreated 2 42 ±14 12±8
3 43±9 10±8
4 36 ±12 32 ±6
DBA 1 51 ±16 23 ±18
Aroclor 1254 2 89±11 49 ±26
3 114±8 32 ±49
4 130±8 59 ±21
C57BL6 1 34±2 nd
Untreated 2 55 ±15 14 ±10
3 63 ± 6 21 ±12
4 74 ±29 55 ±9
C57BL6 1 60 ±17 361 ±47
Aroclor 1254 2 175 ±42 990 ±51
3 295 ±112 1107 ±49
4 422 ±264 1568 ±466
(10% v/v) containing either NADPH (8mM) or NADH (8mM). and Salmonella typhimurium strain 
TA98. The results are expressed as the mean ± standard deviation of triplicates. The spontaneous 
reversion rate of 16 ± 2 has already been subtracted, nd = fewer revertant colonies than the 
spontaneous reversion rate.
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In the presence of either NADPH or NADH, the greatest mutagenic response was 
observed in Aroclor 1254-induced C57BL6 mice, and, to a very much lower extent 
by Aroclor 1254-pretreated DBA2 mice (table 6.2). A very poor mutagenic response 
was observed using microsomes prepared from untreated DBA2 and C57BL6 mice.
After Aroclor 1254-pretreatment, the modest bioactivation of 2-aminoanthracene in 
the ‘non-responsive’ DBA2 mice was greatest in the presence of NADPH. In 
contrast, there was a significant increase in the bioactivation of 2AA in C57BL6 
microsomes, especially in the presence of NADH where a 28-fold increase in the 
number of revertant colonies was observed (at 4pg/plate), 4-fold greater than the 
NADPH-dependent 2AA activation (table 6.2). Therefore, both an NADPH- and, 
especially, an NADH-dependent system responsible for the bioactivation of 2AA are 
induced by Aroclor 1254 by a mechanism dependent upon the Ah receptor.
6.3.3. The cytosolic bioactivation of aromatic amines by 
cytosol from Ah-receptor ‘responsive’ and ‘non-responsive’ 
mouse strains: effect of treatment with Aroclor 1254
In addition to microsomal enzymes, cytosol from Aroclor 1254-treated rat liver is 
also able to metabolise 2AA to mutagenic intermediates in the Ames test (Ayrton et 
al, 1992). This activity is only expressed after induction by Aroclor 1254 or 
individual polychlorinated biphenyl congeners (Chapters 3 and 5). However, the 
mechanism by which this enzyme is induced by Aroclor 1254 is unknown.
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Induction of the cytosol-mediated bioactivation of aromatic amines is greater after 
pretreatment with coplanar highly chlorinated PCB congeners which may be an 
indication that induction proceeds via the Ah receptor. The involvement of the Ah 
receptor in the induction of the cytosol-mediated bioactivation of 2AA, 2AF and 
6AC was investigated using DBA2 and C57BL6 mouse strains.
Table.6.3. Cytosol-mediated bioactivation o f aromatic amines by 
untreated and Aroclor 1254-pretreated C57BL6 and DBA2 mice
Histidine revertants/plate
DBA2 C57BL6
Mutagen
(pg/plate)
Untreated Aroclor
1254
Untreated Aroclor
1254
2-Ammoanthracene
1 nd nd 7 ± 7 227 ±38
2 nd 7± 3 nd 344 ±45
3 nd nd 7 ± 1 474 ±73
4 nd 5±1 9 ± 3 615 ±54
2-Ammofluorene
1 nd 6±  6 nd 13 ± 8
3 1± 4 4 ± 5 4 ± 5 14±7
5 1± 7 nd nd 39± 8
10 25 ± 8 nd nd 52± 9
6-Ammochiysene
0.5 nd nd nd 46± 9
1.0 ; 8 ± 4 13±3 12 ±1 75 ±33
2.0 25 ±13 14±8 33 ±11 147 ±13
3.0 19±11 19±2 45 ±23 281 ±11
Ames tests were performed with W%(v/v) activation mixtures and S. typhimurium strain TA98. 
Results are expressed as the mean ± standard deviation of three observations. The spontaneous 
reversion rate was 19 ± 4 and has been subtracted, nd = a reversion rate lower than the 
spontaneous reversion rate.
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No mutagenic response was observed with any aromatic amine in the presence of 
cytosol from DBA2 mice or from untreated C57BL6 mice (table 6.3). However, 
cytosol from the Ah-receptor ‘responsive’ strain after pretreatment with Aroclor 1254 
did support the bioactivation of all three amines to mutagens (table 6.3). 2- 
Aminoanthracene was responsible for the largest mutagenic response followed by 6- 
aminochrysene and 2-aminofluorene (table 6.3). This, the first demonstration of this 
cytosolic activity in the mouse, shows that the Ah receptor is involved in the 
regulation of this system.
6.3.4. The effect of treatment with benzo[a]pyrene on the 
bioactivation of 2-aminoanthracene by Ah receptor 
‘responsive’ and ‘non-responsive’ mice
The bioactivation of 2AA in the microsomal fraction is assumed to proceed via N- 
hydroxylation catalysed by either the CYPIA subfamily of the cytochrome P450 
monooxygenase system or by flavin-containing monooxygenase. Aroclor 1254- 
pretreatment increases 2AA mutagenicity in mouse microsomes, in the presence of 
NADH and NADPH (table 6.2), and in cytosol (table 6.3). Aroclor 1254 is an 
inducer of both CYPIA and CYP2B and also of a number of other enzymes 
concerned with xenobiotic metabolism. In this investigation, the involvement of 
CYPIA in microsomal bioactivation was demonstrated using mouse microsomes 
after pretreatment with benzo[a]pyrene an inducer of the CYPlAl subfamily. The 
bioactivation of 2AA to mutagenic intermediates was also investigated in cytosolic
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fractions, to demonstrate further that cytosolic activity is not a consequence of 
contamination by microsomal components.
Table.6.4. Bioactivation o f 2-aminoanthracene by hepatic subcellular 
fractions from untreated and benzo[a]pyrene-pretreated C57BL6 and 
DBA2 mice
Histidine revertants/plate
MICROSOMES CYTOSOL
Strain and 
treatment
2-AA
concentration
(pg/plate)
NADPH
(8mM)
NADH
(8mM)
NADPH
(8mM)
1 7 ± 4 nd nd
DBA2 2 13±9 nd nd
Untreated 3 26±4 15±2 nd
4 27±9 17±5 3 ± 0
1 17±7 nd nd
DBA2 2 37±4 11±1 5 ± 4
Benzo[a]pyrene 3 35±4 5±3 11±4
4 66 ±17 19±6 2 ± 0
1 20±1 3±1 nd
C57BL6 2 64±1 10±9 nd
Untreated 3 83 ±16 17±3 nd
4 87 ±18 23±6 nd
1 24 ±13 72 ±37 nd
C57BL6 2 84 ±27 912 ±60 7 ± 3
Benzo[a]pyrene 3 197 ±15 1628 ±323 7 ± 3
4 238 ±38 2090 ±268 15±5
(8mM), S. typhimurium strain TA98 and 2-aminoanthracene (2AA). The results are expressed as 
the mean ± standard deviation of triplicates. The spontaneous reversion rate was 23 ± 5 and has 
already been subtracted, nd = fewer revertant colonies than the spontaneous reversion rate.
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Microsomal fractions in the presence of NADPH elicited only modest bioactivation 
of 2-aminoanthracene in either untreated C57BL6 or benzo[a]pyrene-pretreated 
DBA2 mice (table 6.4). In contrast, benzo[a]pyrene-pretreatment of the ‘responsive’, 
C57BL6 mice induced an almost 4-fold increase in 2AA bioactivation (table 6.4). 
Microsomes from untreated DBA2 mice did not exhibit any mutagenic response at 
these mutagen concentrations.
In the presence of NADH, 2-aminoanthracene was metabolised to mutagenic 
intermediates by microsomes from benzo[a]pyrene pretreated C57BL6 mice (table 
6.4). This, NADH-dependent, mechanism provoked a strong mutagenic response, 9- 
fold greater than with NADPH, demonstrating that this system is particularly induced 
by benzo[a]pyrene-pretreatment.
Neither strain could support the bioactivation of 2-aminoanthracene by hepatic 
cytosol, whether animals were untreated or received benzo[a]pyrene-pretreatment 
(table 6.4), indicating that microsomal contamination is not responsible for the 
activity demonstrated by Aroclor 1254-treated cytosol.
6.3.5. 2-Aminofluorene N-hydroxylation by microsomes 
from Ah-receptor ‘responsive’ and ‘non-responsive’ mouse 
strains
The enzymes concerned with N-hydroxylation of 2AF are primarily the cytochrome 
P450 monooxygenases, particularly the CYPlAl and CYP1A2 isoforms (Hammons 
et ah, 1985), and flavin-containing monooxygenase. CYPIA isoforms are induced 
via the Ah receptor. This investigation was carried out to determine whether
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pretreatment with Aroclor 1254 or benzo[a]pyrene-pretreatments can induce N- 
hydroxylating activity in microsomes in the presence of either NADPH or NADH.
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Figure.6.1. N-Hydroxylation o f 2-aminofluorene by DBA2 and 
CS7BL6 mice
Incubations were carried out in duplicate and contained microsomal suspension (0.1 mg), 2- 
aminofluorene (SOyjnol) and either 2mM NADPH (O) or 2mM NADH (t )^ in 2ml o f 0.1 M  
phosphate buffer pH  7.4. Mixtures were incubated at 37°C for 10 minutes.
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Microsomes isolated from C57BL6 mice after pretreatment with Aroclor 1254 or 
benzo[a]pyrene could N-hydroxylate 2-aminofluorene in the presence of NADPH or 
NADH (figure 6.1). N-Hydroxylation, in the presence of NADH, was modest in all 
other anitnal groups but, in addition to treated C57BL6 mice, only microsomes from 
Aroclor 1254-pretreated DBA2 mice supported N-hydroxylation in the presence of 
NADPH (figure 6.1).
After treatment with benzo[a]pyrene, the N-hydroxylation of 2AF in DBA2 mice 
only occurred in the presence of NADH; however, in the C57BL6 mice, NADPH 
supported N-hydroxylation somewhat more efficiently than NADH. After treatment 
with Aroclor 1254 the reverse was apparent with NADPH being the preferred 
cofactor in DBA2 mice while NADH was preferred by microsomes from C57BL6 
mice but the differences are modest (figure 6.1).
6.3.6. CYPIA apoprotein levels in rat hepatic cytosol
The induction of enzymatic activity in hepatic cytosol responsible for the 
bioactivation of aromatic amines by Aroclor 1254 suggests the presence of either a 
unique cytosolic enzyme, a CYPlA-type enzyme or microsomal contamination. 
Yang et aï., (1995) observed CYPlAl-dependent ethoxyresorufin 0-deethylase 
(EROD) activity in hepatic cytosol isolated from human foetus, and to a lesser extent 
the rat conceptus, far in excess of microsomal EROD activity. It is possible that adult 
rat hepatic cytosol also contains an enzyme related to CYPlAl responsible for the 
bioactivation of aromatic amines. However, pretreatment with benzo[a]pyrene, a
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potent inducer of CYPlAl, had no effect upon the bioactivation of aromatic amines 
by cytosol (Chapter 3).
To investigate the possible existence of a CYPlA-type enzyme, cytosolic fractions 
isolated from rats pretreated with Aroclor 1254 and benzo[a]pyrene were analysed 
immunologically employing antibodies to rat CYPIA (Rodrigues et al, 1987).
Figure 6.2. Western blot o f hepatic cytosols for rat CYPIA proteins
SDS-PAGE electrophoresis was employed to separate microsomal (15\ig) and cytosolic (75- 
150\ig) proteins as described previously (Chapter 2). The proteins were transferred to a 
nitrocellulose sheet and the presence of CYPIA proteins determined by Western blot incorporating 
sheep anti-rat CYPIA antibodies. The procedures are described fully in chapter 2. Lanes 1-8 were 
loaded with 1. Aroclor1254-induced cytosol (150\ig), 2. benzofajpyrene-treated cytosol (150]ig). 3. 
control cytosol (150\ng), 4. markers, 5. Aroclor 1254-treated microsomes (15\ig), 6. Aroclor 1254- 
treated cytosol (7 5\ig), 7. benzofajpyrene-treated cytosol (75\xg). and 8. control cytosol (75\ig).
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From figure 6.2 it can clearly be seen that Aroclor 1254-treated microsomes have by 
far the greater CYPIA content than any of the cytosolic fractions (loaded at higher 
protein concentrations), but Aroclor 1254-treated cytosol also has discernible 
amounts of proteins recognised by anti-CYPlA antibodies. No such proteins were 
observed in cytosol from either benzo[a]pyrene-treated or untreated rats. Thus, after 
Aroclor 1254-treatment of rats either a CYPlA-type protein is induced in rat hepatic 
cytosol or, there is some solubilisation of microsomal proteins. Whichever 
mechanism is responsible, this system is not simply a result of microsomal 
contamination because no CYPlA-type proteins were found in cytosol from 
benzo[a]pyrene-pretreated rats even though benzo[a]pyrene was responsible for 
marked induction of microsomal CYPIA (table 6.5).
6.3.7. Ethoxyresorufin O-deethylase activity in rat 
microsomes and cytosol
Previously EROD activity has been demonstrated in hepatic cytosol isolated from the 
human foetus and rat conceptus (Yang et a l, 1995), and CYPlA-type proteins have 
been demonstrated in the cytosol of rats pretreated with Aroclor 1254 (see above). To 
investigate this further, EROD activity was measured in hepatic microsomes and 
cytosol from rats pretreated with Aroclor 1254 and benzo[a]pyrene. This study was 
undertaken to demonstrate differences between the induction of EROD activity in 
microsomes and cytosol and to investigate whether EROD activity correlates with 
aromatic amine mutagenicity and with the presence of CYPIA proteins.
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Table 6.5. EROD activity in rat hepatic microsomes and cytosol
EROD activity pmoles formed min * per mg protein
Treatment Microsomes Cytosol
Untreated 9.45 nd
Benzo[a]pyrene 415 nd
Aroclor 1254 751 0.39
Cytosolic incubations also contained dicoumarol (10\iM). Results are the mean of duplicates, nd -  
no detectable EROD activity.
In the microsomes both Aroclor 1254- and benzo[a]pyrene-treatment of rats 
markedly induced CYPlAl-dependent EROD activity. Also, as observed 
immunologically (figure 6.2), whereas Aroclor 1254-pretreated cytosol contains 
bands immunologically related to microsomal CYPIA, cytosol from benzo[a]pyrene- 
treated animals did not. EROD activity in Aroclor 1254-treated cytosol was very low, 
being about 0.05% of the activity expressed by microsomes from the same animal. If 
this activity is a result of microsomal contamination, the activity is not sufficient to 
explain the comparable mutagenic responses observed in the presence of microsomes 
and cytosol.
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6.4. Discussion
Planar aryl compounds can induce the expression of xenobiotic-metabolising 
enzymes via the Ah receptor. Planar compounds bind directly to the receptor, in the 
cytosol, forming a ligand-Ah receptor complex which then enters the nucleus. The 
ligand-receptor complex activates genes by binding to upstream regulatory sequences 
termed ‘xenobiotic-responsive elements’ (XREs). Genes regulated this way encode 
proteins essential for both the activation and deactivation of many chemical 
carcinogens, including CYPlAl and CYP1A2 (Hankinson, 1993). Certain mouse 
strains, such as DBA2, are less responsive to aryl hydrocarbon induction. DBA2 
mice are homozygous (Ah** Ah**) for a gene which encodes an Ah receptor ligand 
binding subunit (ALBS) with reduced affinity for aryl hydrocarbons (Hankinson, 
1993). C57BL6 mice are also homozygous (Ah*’ Ah**) but the ALBS found in this 
strain has normal ligand binding affinities. These two mouse strains are used 
routinely to investigate the significance of the Ah receptor in the carcinogenic and 
toxic potential of xenobiotics. In this investigation, an efficiently functioning Ah 
receptor was found to be important for the induction of enzymes responsible for the 
bioactivation of aromatic amines to mutagenic intermediates in mouse microsomes, 
in the presence of NADPH or NADH, and is also essential for Aroclor 1254- 
induction of a cytosolic mechanism which also metabolises aromatic amines to 
mutagenic intermediates.
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Induction o f cytochrome P450 by Aroclor 1254- and benzo[a]pyrene- 
treatment o f C57BL6 and DBA2 mice
Pretreatment with benzo[a]pyrene, an inducer of CYPlAl, and with Aroclor 1254, a 
mixed-type inducer responsible for the induction of CYPIA and 2B isoforms (Okey, 
1990), produced the expected increase in ethoxyresorufin O-deethylase (EROD) 
activity. EROD is used as a marker enzyme for CYPlAl activity (Namkung et a l, 
1988), and is most effectively induced here after Aroclor 1254-pretreatment. As 
expected, the induction of EROD was marginal in DBA2 mice but was marked in the 
C57BL6 strain, demonstrating quantitatively the greater affinity for ligand binding of 
the Ah receptor in this strain. Higher CYPlAl expression in the C57BL6 strain was 
also apparent before treatment, with EROD activity being 2-fold higher than is 
observed with untreated DBA2 mice. Strain differences before pretreatment illustrate 
that there are also constitutive differences responsible for enhanced CYPlAl activity 
in this strain. Constitutive expression of CYPlAl is regulated by a single upstream 
G.C-box sequence, referred to as the basal transcription element (Yanagida et al, 
1990), which binds zinc-finger proteins not the Ah-receptor. Therefore, differences in 
the two mouse strains before treatment may be a demonstration of differences in 
zinc-finger proteins in these strains in addition to differences in Ah receptor 
responsiveness.
Microsome-mediated bioactivation o f 2AA after pretreatment with 
Aroclor 1254 and benzofajpyrene
Bioactivation of aromatic amines proceeds via N-hydroxylation, catalysed primarily 
by the CYPIA subfamily of the cytochrome P450 mixed-function oxidases 
(loannides and Parke, 1990), but also by the flavin-containing monooxygenase 
(Frederick et al, 1982). In the presence of either NADPH (8mM) or NADH (8mM),
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hepatic microsomes from C57BL6 mice demonstrate markedly greater bioactivation 
of 2AA than microsomes fiom DBA2 mice. The increased bioactivation in the Ah 
receptor responsive strain was observed after pretreatment with either benzo[a]pyrene 
or Aroclor 1254.
A good correlation exists between the microsome-mediated bioactivation of 2AA, m 
the pre sence of NADPH, and EROD activity; C57BL6 microsomes support a higher 
mutagenic response and have higher EROD activity than the corresponding DBA2 
microsomes. Furthermore, microsomes from animals pretreated with Aroclor 1254 
induce a stronger mutagenic response and greater EROD activity, than animals 
receiving benzo[a]pyrene-pretreatment.
The activation of 2AAt?*iinduced in DBA2 microsomes after both benzo[a]pyrene- 
and Aroclor 1254-pretreatment, but as reported previously with TCDD, activation 
considerably weaker than in C57BL6 microsomes (Li et al, 1994). Induction of 2AA 
bioactivation in DBA2 mice is either a consequence of induction of the CYPIA 
subfamily via the less efficient Ah receptor or regulation by a non-Ah receptor 
pathway. The existence of a non Ah receptor-dependent route of induction has 
previously been demonstrated in the mouse with tricyclic hydrocarbons, such as 
anthracene, which induced CYP1A2, but not CYPlAl (Chaloupka et a l, 1994). It is 
pertinent to point out that a 4S polycyclic aromatic hydrocarbon-binding protein has 
been identified which can regulate the expression of CYPlAl in mouse hepatoma 
cells with reduced or inactive Ah receptor (Sterling et al, 1994).
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Comparison between NADH- and NADPH-mediated bioactivation
In untreated C57BL6 mice the microsomal bioactivation of 2AA is more pronounced
in the presence of NADPH than NADH (table 6.2). However, after pretreatment with 
Aroclor 1254 or benzo[a]pyrene, the mutagenic response in the presence of NADH is 
extremely marked and is considerably greater than mutagenicity in the presence of 
NADPH. The level of CYPlAl and CYP1A2 isoforms may be responsible for these 
observations because NADH and NADPH can both support the CYPlAl-dependent 
EROD and CYP1 A2-dependent MROD activity (Chapter 5). Moreover, the 
constitutive expression of hepatic CYP1A2 is greater than CYPlAl in mice 
(Diliberto et al., 1995), but after TCDD-pretreatment of mice (Diliberto et al., 1995) 
and Aroclor 1254-treatment of rats (Chapter 5) induction of CYPlAl is greater than 
CYP1A2. These observations suggest that microsomal NADPH-dependent 
bioactivation of 2AA is performed primarily by CYP1A2 but NADH-dependent 
bioactivation may involve mainly CYPlAl. However, even though NADH can 
donate the second electron to the cytochrome P450-substrate complex, oxidation by 
NADH, in the absence of NADPH has not previously been demonstrated in mice. In 
rats however, the CYPlAl and CYP 1 A2-dependent EROD and MROD activities 
were supported by Aroclor 1254-induced microsomes in the presence of either 
NADPH or NADH demonstrating that NADH can support oxidation in the absence 
of NADPH. In addition, in the presence of NADH CYPlAl was greater than 
CYP1A2 activity implying that CYPlAl is more important than CYP1A2 in the 
NADH-dependent bioactivation of 2AA. However, CYPlAl is primarily concerned 
with the bioactivation of polycyclic aromatic hydrocarbons not aromatic amines and, 
in contrast to mutagenicity data, NADPH-dependent EROD and MROD were 10-fold
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greater than NADH-dependent activity. The increased mutagenicity in the presence 
of NADH may be because this cofactor is not used as extensively in the detoxication 
of aromatic amines whereas NADPH is readily employed by isoforms responsible for 
both activation and deactivation.
In addition to the CYPIA subfamily a novel, closely related, subfamily designated 
CYP IB has been identified in mouse (Savas et a l, 1994), rat (Walker et a l, 1995) 
and human (Sutter et al. 1994). The Ah receptor is also involved in the induction of 
this isoform and, similar to CYPlAl, CYPIBI is expressed mainly in extrahepatic 
tissues, but hepatic expression is markedly induced after pretreatment with PAHs and 
TCDD (Savas et a l, 1994). The considerable expression of CYPIBI in breast 
tumours (McKay et a l, 1995) has suggested a role for this isoform m the 
bioactivation of procarcinogens in a way similar to other members of the CYPl 
family. Therefore, it is possible that Aroclor 1254 and benzo[a]pyrene-pretreatments 
induce CYPIBI expression in the liver and consequently, because of the absence of 
both CYPIBI expression and 2AA mutagenicity before pretreatment, this isoform 
may be, at least partly, responsible for the observed bioactivation of 2AA in the 
presence of NADH. The possible role of CYPIBI in the bioactivation of aromatic 
amines in the presence of NADH has not been studied however, the bioactivation of 
many aiylamine mutagens, including 2AA, 2AF and 6AC, has been observed by 
human CYPIBI expressed in Saccharomyces cerevisiae (Shimada et a l, 1996)
Inter-strain differences in cofactor preference for the bioactivation of 2AA to 
mutagens are also evident i.e., microsomes firom Aroclor 1254-pretreated DBA2 
have a preference for NADPH whereas microsomes from C57BL6 mice prefermice
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NADH. The cofactor preferences of C57BL6 before and after Aroclor 1254- 
pretreatment are similar to those observed in Wistar albino rats (Chapter 4), which is 
not unexpected because the Ah receptor of laboratory rats (Sprague-Dawley) and 
C57BL6 mice have previously been reported to be extremely similar (Denison et a l, 
1986). The considerable increase in the NADH-dependent mutagenicity of 2AA 
suggests NADH-dependent bioactivation is induced very strongly via the Ah 
receptor. The very low mutagenic response of 2AA in the presence of NADH in 
untreated mice, and the considerable increase in 2AA mutagenicity after treatment 
with Aroclor 1254 and benzo[a]pyrene only in samples with efficient Ah receptors, 
also demonstrates the Ah receptor is involved in the induction of NADH-dependent 
bioactivation of aromatic amines. In contrast, NADPH-dependent 2AA mutagenicity 
is present in untreated animals, is induced in both ‘responsive’ and ‘non-responsive’ 
mice and induction produces no more than a 5-fold increase in 2AA mutagenicity in 
‘responsive’ mice. Therefore this activity may also be regulated in a non-Ah 
receptor-dependent fashion.
N-Hydroxylation of 2AF by microsomes from Ah receptor responsive 
and non-responsive mice
In this investigation the mutagenicity of 2AA in the two strains after Aroclor 1254- 
pretreatment correlates with the N-hydroxylation of 2AF, even in the subtleties of 
cofactor preferences. In corroboration with mutagenicity data, N-hydroxylation of 
2AF is less marked in the DBA2 strain, NADPH is the preferred cofactor in the 
DBA2 strain, and C57BL6 microsomes prefer NADH. Therefore the bioactivation of 
2AA in the presence of either NADH or NADPH probably involves N- 
hydroxylation, and the induction of this activity is under the control of the Ah
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receptor. It has previously been demonstrated that C57BL6 and DBA2 mice differ in 
their expression of CYPIA isoforms, in that C57BL6 hepatic microsomes express 
both CYPlAl and CYP1A2 but DBA2 mice only express CYP1A2 (Thomas et al, 
1984). It is conceivable therefore that 2AA bioactivation by DBA2 mice involves 
CYP1A2 but in C57BL6 microsomes both CYPlAl and CYP1A2 proteins 
participate. Furthermore, it has already been demonstrated in the rat that NADH is 
utilised more efficiently by CYPlAl than CYP1A2 (Chapter 4) which would explain 
why C57BL6 microsomes, which express CYPlAl, prefer NADH but DBA2 
microsomes, which do not express CYPlAl, prefer NADPH.
Flavin monooxygenase is also known to carry out the N-hydroxylation of aromatic 
amines and can use NADPH and NADH. However, the regulation of this enzyme has 
not been linked to the Ah receptor and the FMO inhibitor methimazole has been 
demonstrated to have no effect on the bioactivation of 2AA in Aroclor 1254-induced 
rat S9 (Rodriguez-Ariza, et ah, 1995).
In C57BL6 mice pretreatment with Aroclor 1254 or benzo[a]pyrene markedly 
induced the N-hydroxylation of 2AF in the presence of NADH or NADPH. 
However, the similar N-hydroxylation activity observed with NADH and NADPH 
contrast with the markedly higher mutagenicity of 2AA in the presence of NADH. 
The metabolism of 2AA has not been investigated sufficiently to identify the 
mutagenic intermediates and therefore it is possible N-hydroxylation may not be the 
only pathway responsible for the bioactivation of 2AA. Furthermore, the increased 
rate of N-hydroxylation following treatment with Aroclor 1254 and benzo[a]pyrene 
does not necessarily indicate that bioactivation proceeds entirely via this route of
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activation. Exposure of hépatocytes to TCDD has been reported to give rise to a 25- 
fold increase in N-hydroxylation of 2AAF but also an increased C-hydroxylation 
such that both before and after treatment N-hydroxylation only accounted for 10% of 
all metabolism and consequently there was only a moderate increase in DNA damage 
(Moller et a l, 1984). A similar effect may be responsible for the absence of a good 
correlation between 2AF N-hydroxylation and 2AA mutagenicity.
Bioactivation o f aromatic amines by hepatic cytosol from Ah 
responsive and non-responsive mice
When the bioactivation of 2AA was investigated in hepatic cytosolic fractions, only 
cytosol obtained from Aroclor 1254-treated C57BL6 mice could generate a 
mutagenic response. The absence of cytosolic bioactivation by cytosol from similarly 
treated DBA2 mice suggests this cytosolic system is also under the control of the Ah- 
receptor /.e., the gene encoding the cytosolic enzyme(s) responsible for this activity 
has a XRE region where ligand-Ah receptor complexes can regulate gene expression. 
Of the three aromatic amine carcinogens investigated, 2AA displayed the greatest 
mutagenic response followed by 6-aminochrysene and 2-aminofluorene.
Interestingly, although benzo[a]pyrene and Aroclor 1254 both induce several 
enzymes via the Ah receptor, and the Ah receptor appears to be responsible for 
induction of the cytosolic oxidase, benzo[a]pyrene-treatment does not induce 
bioactivation by cytosol. It is possible, but unlikely, that there is induction of 
bioactivation by benzo[a]pyrene but it is insufficient to compete against detoxication 
reactions present in cytosol. Alternatively, the existence of more than one subtype of 
Ah receptor with different ligand specificity would also account for the absence of 
induction by benzo[a]pyrene. Indeed, two forms of receptor have been identified in
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rat cytosol, Ah(alpha) and Ah(beta), with only Ah(beta) able to bind to XREs 
(Denison et a l, 1992). A second ‘inducible’ population of Ah receptor, in rats, has 
also been identified after phénobarbital treatment (Benedetti et al, 1994) and after a 
combination of TCDD and 2,2',4,4',5,5'-hexachlorobiphenyl treatment (Landers et 
a l, 1991). Two functionally distinct Ah receptor subtypes have also been described 
in human cell lines (Perdew and Hollenback, 1995). In addition to subtypes of Ah 
receptor, there is also more than one XRE for them to bind with, for example 
CYPlAl and CYP1A2 have non-identical XREs (Quattrochi and Tukey, 1989). It is 
possible that the XRE of the cytosolic enzyme gene is substrate specific and does not 
interact with the benzo[a]pyrene-Ah receptor complex. The Ah receptor can also 
function independently of the nucleus (Enana and Matsumura, 1995), demonstrated 
by a rapid increase in protein kinase activity in nuclews-free subcellular homogenate 
after TCDD-treatment; which was removed by Ah receptor blockers (Enana and 
Matsumura, 1995). The absence of the nucleus makes this induction of protein kinase 
by TCDD distinct from the conventional system and, it is possible that the regulation 
of the cytosolic enzyme(s) by the Ah receptor also proceeds by a nuclear-free 
mechanism.
The absence of a mutagenic response after benzo[a]pyrene-treatment represents a 
marked difference between the bioactivation of aromatic amines by the microsomes 
and cytosol, which rules out contamination with microsomes as the cause of 
cytosolic activity. Indeed, the NADPH-dependent bioactivation of 2AA by Aroclor 
1254-treated C57BL6 cytosol is as marked as the activity present in the microsomes, 
which would not be expected for low levels of microsomal contamination. The
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presence of EROD activity and the detection of CYPlA-type proteins by Western 
blot analysis in cytosol from Aroclor 1254-treated rat would, however, seem to 
suggest that microsomal contamination of the cytosol is responsible for the observed 
activity in this subcellular fraction. However, EROD activity and CYPIA proteins 
are both much lower in cytosol than microsomes, yet the bioactivation of aromatic 
amines by cytosol is comparable to bioactivation by the microsomes thus arguing 
against the cytosolic activity being the result of contamination with microsomes. 
Finally, benzo[a]pyrene-pretreatment induces microsomal EROD activity markedly, 
yet neither cytosolic EROD activity nor any cytosolic CYPIA proteins were detected 
after this pretreatment. It is possible that the low level of CYPIA in cytosol 
determined by immunoblotting only represents the apoprotein on its way to interact 
with haem during the synthesis of CYPIA. Consequently, the reason why no 
CYPlA-apoprotein was detected in benzo[a]pyrene-induced cytosol is because 
microsomal CYPlAl activity this treatment was only 55% of that induced by 
Aroclor 1254-treatment. Therefore it is possible that Aroclor 1254-treatment induces 
a truly cytosolic enzyme responsible for the bioactivation of aromatic anunes which 
is not induced by other CYPIA inducers like benzo[a]pyrene.
6.5. Conclusions
C57BL6 and DBA2 mice demonstrated marked differences in the bioactivation of 
2AA to mutagenic intermediates. These differences are consequences of the 
contrasting efficiency of the Ah receptor-dependent induction processes in these two
strains.
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The current investigation has demonstrated that;
(i). Pretreatment of animals with Aroclor 1254 or benzo[a]pyrene induced 
microsomal CYPlAl-dependent EROD activity and the bioactivation of 2- 
aminoanthracene by microsomes and cytosol from C57BL6 mice, but not in DBA2 
mice. Therefore, the bioactivation of aromatic amines by hepatic microsomes and 
cytosol are both induced via the Ah receptor.
(ii). Microsome-mediated mutagenicity of 2AA in the presence of NADPH or NADH 
parralels the N-hydroxylation of 2AF and bioactivation, therefore, probably proceeds 
along this pathway.
(iii). Aroclor 1254-pretreated microsomes have similar 2AF-N-hydroxylase activity 
in the presence of NADPH and NADH, but markedly different 2AA mutagenicities 
being higher in the former. This may be a consequence of additional bioactivating 
pathways induced by this pretreatment.
(iv). Strain differences in CYPIA expression and 2AA mutagenicity suggest 
NADPH-dependent mutagenicity is carried out mainly by CYP1A2 with CYPlAl 
responsible for NADH-dependent 2AA bioactivation. However no known 
cytochrome P450 isoforms have been demonstrated to function with NADH in the 
absence of NADPH, though EROD and MROD have been demonstrated using 
NADH in Aroclor-induced rats (Chapter 4).
(v). The cytosol-mediated bioactivation of 2AA, 2AF and 6AC is induced in C57BL6 
mice by pretreatment with Aroclor 1254 but not benzo[a]pyrene.
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CHAPTER?
Metabolism of 2-acetylaminofluorene and
2-aminofluorene by rat hepatic subcellular fractions
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7.1. Introduction
2-Acetylaminofluorene (2AAF) and 2-aminofluorene (2AF) are used extensively as 
model substrates for the investigation of aromatic amine bioactivation. Both 2AAF 
and 2AF are metabolised by microsomal enzymes to a number of metabolites, the 
majority of which are ring hydroxylated and less mutagenic (Weisburger and 
Weisburger, 1958). Enzymes involved in this metabolism are the cytochrome P450 
mixed-function oxidases (loannides and Parke, 1990), and flavin-containing 
monooxygenase (Pelroy and Gandolfl, 1980). 2AF, but not 2AAF, is also 
metabolised by extrahepatic prostaglandin H synthase (Eling et al, 1988).
Extensive metabolism of 2AAF and 2AF by the cytochrome P450 oxidases involves 
ring hydroxylation at the 1-, 3-, 5-, 7-, and 9-positions, and also N-hydroxylation of 
the amino group (Thorgeirsson et al, 1983). Several isoforms are involved in this 
metabolism and, in general, are responsible for hydroxylation at more than one 
position. Metabolism of 2AF is carried out by purified rat CYPlAl, CYP1A2, 
CYP2B1, CYP2B2, CYP2C11 and CYP3A1 (Hammons et al, 1985; Âstrom and 
DePierre, 1985) of which CYP2B1, CYPlAl and CYP1A2 are the most active. CYP 
isoforms primarily concerned with the bioactivation of 2AF and 2AAF to mutagenic 
N-hydroxylamines are CYPlAl and CYP1A2 (Hammons et ah, 1985) with CYP3A1 
responsible for low levels of N-hydroxylation (Astrom and DePierre, 1985). The 
major product of 2AAF metabolism by CYPlAl is 3-hydroxy AAF and, in addition 
to N-hydroxy AAF this isoform also produces 5-, 7-, and 9-hydroxylated metabolites. 
Similarly, 2AAF is mainly hydroxylated at position 7 by CYP1A2 but 3-, 5-, 9-, and
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N^hydroxylated metabolites are also formed by this isoform (Goldstein et al, 1984). 
Whether the majority of N-hydroxylation is catalysed by CYPlAl or CYP1A2 
(Astrom and DePierre, 1985; Goldstein et al, 1984) is dependent upon the tissues 
and whether animals receive any pretreatment.
In untreated rats, the majority of hydroxylation of 2AAF by the cytochromes P450 is 
at the 7-position. After pretreatment with TCDD the formation of all metabolites is 
increased and 7-hydroxy 2AAF remains the major metabolite however, N-, 3-, and 5- 
hydroxylation being particularly induced (Smith and Thorgeirsson, 1981). 3- 
Methylcholanthrene and phenobarbitone pretreatments have similar effects (Lotlikar 
eta l, 1967; Lenk and Rosenbauer-Thilmann, 1993).
Another system of microsomal enzymes responsible for the metabolism of 2AF is the 
flavin-containing monooxygenases (Hammons et al, 1985). These enzymes are 
capable of the N-hydroxylation of amines but not ring hydroxylation. However, it has 
previously been reported that his enzyme does not play a major role in 2AF 
metabolism by rat liver (Hammons et al, 1985).
In addition to potentiating the NADPH-dependent bioactivation of 2AAF by 20-30% 
(Lotlikar et al, 1967) NADH, in the absence of NADPH, also supports the 
bioactivation of aromatic amines by microsomes from animals treated vyith Aroclor 
1254 (Ayrton et a l, 1992; Leist et al, 1992). The NADH-dependent bioactivation of 
aromatic amines appears to be distinct from bioactivation mediated by NADPH but 
nevertheless resembles the latter system in probably forming the N-hydroxylamine 
(Chapter 4). However, no identification of metabolites generated solely in the 
presence of NADH has yet been undertaken.
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Liver cytosol from Aroclor 1254-induced rat is also responsible for the metabolism 
of 2AAF and 2AF to mutagenic intermediates (Forster et al, 1981; Leist et al, 1992) 
but, very little is known about the ability of this fraction to catalyse phase I 
metabolism. Bioactivation by the cytosol requires NADPH and molecular oxygen, is 
specific for a limited number of mutagenic aromatic amines, is unaffected by 
repeated ultracentrifiigation, or by the addition of inhibitors of the molybdenum 
oxidases; aldehyde oxidase and xanthine oxidase, or by superoxide dismutase, 
catalase or ascorbic acid (Ayrton et a l, 1992; Leist et al, 1992; Chapter 3). The 
metabolism of 2AAF by cytosol has been demonstrated in untreated rats and yields 
2AF, 7-hydroxy 2AAF, 9-hydroxy 2AAF and AAF-9-one metabolites, though, 
cytosol was prepared by only a single 60 minute centrifugation at 90,000g and 
therefore there is a possibility of microsomal contamination (Lenk and Rosenbauer- 
Thilmann, 1993). These metabolites are all non-mutagenic and may explain why 
untreated rats do not demonstrate any cytosolic bioactivation of either 2AAF or 2AF 
in the Ames test.
In these investigations, metabolism of 2AAF and 2AF by hepatic cytosol was studied 
in untreated and Aroclor 1254-pretreated rats with the aim of identifying the 
mutagenic metabolites produced by cytosolic and microsomal metabolism and to 
demonstrate that there is no microsomal contamination of the cytosol. Microsomal 
NADH-dependent metabolism of 2AAF and 2AF was also investigated and 
compared to metabolism in the presence of NADPH. Metabolites generated by the 
cytosol were investigated for their mutagenicity and attempts were made to 
determine their identity.
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7.2. Methods
7.2.1. Pretreatment o f animals and preparation o f subcellular 
fractions
Male Wistar albino rats (150-200g) were purchased from the Experimental Biology 
Unit (University of Surrey, Guildford), and were pretreated with a single 
intraperitoneal injection of Aroclor 1254 (500mg/kg) and killed 5 days later. The 
livers were excised, washed and homogenised in 4 volumes of ice-cold KCl 
(1.15%w/v), and the S9 fraction prepared by centriftigation (9,000g) as previously 
described (Chapter 2). The hepatic S9 was stored at -20°C and microsomal and 
cytosolic fractions were prepared by ultracentrifugation at 105,000g for 2 x 60 
minutes on the day of use.
7.2.2. Deacetylation o f ^ H] 2-acetylaminofluorene
Radiolabelled 2AAF was deacetylated by the method of Miller and McQueen (1985). 
A toluene solution of pH] 2AAF (728 mCi/mmol) was evaporated to dryness under 
nitrogen and the radiolabel was diluted 1:100 with unlabelled 2AAF. 2AAF was 
subsequently refluxed in 2N HCl for 2 hours under nitrogen and then allowed to cool 
to room temperature. The 2-AF was extracted twice with dichloromethane (50ml) 
after the solution was neutralised with NaHCOa. The dichloromethane was dried over 
magnesium sulphate, evaporated to dryness and the identity of the product was 
verified by NMR in deuterated chloroform. The chloroform was evaporated under
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vacuum and the 2AF was resuspended in DMSO to give a concentration of lOmg/ml. 
Recovery of the radiolabel was 65% and only a single peak was observed by hplc.
7.25. Metabolism of 2-acetylaminofluorene and 2- 
aminofluorene
In a 250ml conical flask, radiolabelled carcinogen (Img, 32pCi) was incubated with 
either cytosol (4ml of a 25% w/v fraction) or resuspended microsomes (4ml of a 25% 
w/v fraction), an NADPH-generating system (147mg NADP, 76mg glucose-6- 
phosphate, plus 20units glucose-6-phosphate dehydrogenase when microsomal 
incubations were used) or NADH (8mM), and was made up to a total volume of 
10ml with phosphate buffer O.IM, pH7.4. Reaction mixtures were incubated at 37°C 
for 2 hours in a shaking waterbath. Metabolism was stopped by placing the vessel on
ice.
7.2.4. Separation and quantification o f radioactive 
metabolites.
The reaction mixture was extracted six times with equal volumes of ice-cold ethyl 
acetate. The extracts were pooled and dried over magnesium sulphate before being 
evaporated to dryness under reduced pressure in a rotary evaporator. Samples were 
resuspended in 250pl of DMSO. The radioactive content was determined, in 
duplicate, to calculate the efficiency of extraction of the radiolabel.
Metabolites were separated on either a partisil lO-ODS or a Beckman CDS column 
using a linear methanol gradient of 30-100% over one hour followed by 100%
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methanol for 30 minutes. Metabolite peaks were collected and aliquots (lOpl) were 
added to 5ml of scintillant (Optiphase ‘safe’) and the radioactivity was measured in a 
Wallac 14110 scintillation counter.
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7.25. Identification of metabolites
Authentic 1-, 3-, 5-, 7-, 8-, 9-, and N-hydroxy-2AAF (Midwest research Institute, 
Kansas, Missouri) and 1-, 3-, 7-, and N-hydroxy-2AF (Prof. JW Gorrod, Kings 
College, London) were employed in the tentative identification of metabolites after 
incubation of 2AAF and 2AF with hepatic subcellular fractions. The purity of all the 
2AAF metabolites was greater than 90%, and was verified by the presence of only a 
single peak after hplc. The purity of 1-, 3-, 7-, and N-0H-2AF was also investigated 
and 1-, 7-, and N-0H-2AF produced only single major peaks after hplc. 3-OH-2AF 
was impure and gave two major peaks but to determine the correct retention time the
3-OH-2AF peak was identified by UV spectra.
Where possible metabolites were tentatively identified by comparison with the 
retention time and UV absorbance spectra of authentic metabolites. A shift in UV 
absorbance after the addition of 0.5M NaOH was also employed to verify the identity 
of hydroxylated metabolites. Where these methods could not identify the metabolites, 
the identity of the major cytosol-generated metabolites was determined by mass 
spectrometry. For the latter analysis, metabolites collected after multiple injections 
were pooled, the methanol was evaporated under vacuum and the remaining aqueous 
solution was removed by freeze drying. The residue was resuspended in methanol for 
analysis, kindly carried out by Derek Hillbeck at Hoechst laboratories at Milton 
Keynes
239
7.2.6. Mutagenicity studies
The concentration of metabolites collected after multiple hplc runs were determined 
by scintillation counting. The samples were then evaporated to dryness and 
resuspended in sufficient DMSO to give, where possible, lOpg/ml solutions. The 
mutagenicity tests employed Salmonella typhimurium strain TA98 and in the absence 
and presence of two activation mixtures; microsomes with an NADPH-generating 
system and cytosol vyith an NADPH-generating system. No preincubation was 
employed and results are expressed as the mean ± standard deviation of duplicates. 
The spontaneous reversion rate was determined using baseline fractions eluted firom 
the hplc column.
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7.3. Results
7.3.1. Identification o f 2AF and 2AAF metabolites formed 
after incubation with Aroclor 1254-treated cytosol
Where possible the tentative identity of metabolites was determined by comparison 
with the hplc retention times and UV spectra of authentic metabolites. Furthermore, 
the identity of hydroxylated metabolites was confirmed by the shift in UV 
absorbance with the addition of NaOH (0.5M). However, the identity of several 
compounds could not be determined using these methods i.e. UV spectra did not 
resemble the spectra of known metabolites or no spectra were observed because of 
low concentration.
Table 7.1. Retention time and UV absorbance maxima o f authentic
2AAF and 2AF metabolites
Compound Retention time (min) UV maxima 
(alkaline shift)
2AAF 51 288nm
2AF 49 286nm
2NF 60 329nm
1-OH-2AAF 40 278nm(263,299,329nm)
3-OH-2AAF 41 273nm (290,352, 346nm)
5-OH-2AAF 47 282nm (288nm)
7-OH-2AAF 39 291nm(311nm)
8-OH-2AAF 39 288nm (292nm)
9-OH-2AAF 38 293nm (294nm)
N-OH-2AAF 46 290nm (303nm)
1-OH-2AF 46 294nm (306,263nm)
3-OH-2AF 42 279nm(319nm)
7-OH-2AF 40 284nm (298nm)
N-OH-2AF 52 289nm
flow rate o f 2ml/mm. UV maxima were determined using authentic metabolites dissolved in 
methanol and the shift in absorbance was achieved by the addition ofO.SMNaOH (0.1ml)
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Table 7.2. Retention time o f 2AF metabolites
Compound Retention time (min)
2AF 40
2AAF 41
1-0H-2AF 33
3-OH-2AF 35
7-OH-2AF 22
N-OH-2AF 39
l.SmVmin.
To determine the identity of the unknown metabolites they were collected after 
multiple separations by hplc and evaporated to dryness to allow analysis by mass 
spectrometry. Unfortunately, the necessity for having this analysis performed ^a tis  
has meant it could not be performed before the submission date for this thesis. 
However, the analysis will be performed in the near future and will, hopefully, be 
included as an appendix.
7.3.2. Metabolism of 2-acetylammofluorene by rat hepatic 
microsomes and cytosol
Ring-pH] 2-acetylaminofluorene (7.28mCi/mmol) was incubated in the presence of 
an NADPH-generating system to demonstrate differences between metabolism by 
microsomes and cytosol, and to identify the mutagenic intermediates of cytosol- 
mediated metabolism. Microsomal 2AAF NADH-dependent metabolism was also 
undertaken for comparison with microsomal 2AAF metabolism supported by
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NADPH. Incubations with subcellular fractions isolated from both Aroclor 1254- 
treated and untreated rats were undertaken, with the aim of identifying why the 
bioactivation of 2AAF in these two treatment groups is different. Incubations were 
also performed in the absence of cofactors where more than 98% of recovered 
radioactivity was present as a single peak identified as 2AAF.
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Figure 7.1. Metabolism of 2AAF by Aroclor 1254-pretreated 
microsomes in the presence o f an NADPH-generating system
Separation -was achieved using a Whatman ODS column, a methanol gradient o f30-100% over 60 
minutes at a flow rate of2ml/min.
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Retention times and UV spectra tentatively identified peaks 1,4, 5,6, 7, 8 and 9 as 7- 
0H-2AAF, 1-0H-2AAF, 3-OH-2AAF, N-0H-2AAF, 5-OH-2AAF, 2AF and 2AAF 
respectively. The overall metabolism of 2AAF by Aroclor-1254 induced 
microsomes, determined by hplc of recovered radiolabel, was less than untreated rat. 
However, the extraction efficiency of the radiolabel from Aroclor 1254-induced 
microsomes (52%) was less than that from incubation mixtures containing untreated 
microsomes (66%). After Aroclor 1254-treatment there was a marked increase in 
metabolism to the N-hydroxylated metabolite (table 7.3), a modest rise in peaks 12 
and 15 and a decrease in 7-, 1- and 5-OH-AAF and 2AF.
Table 7.3. 2AAF metabolism by untreated and Aroclor 1254- 
pretreated microsomes in the presence of an NADPH-generating
system
% of total recovered radioactivity
Peak number UV maxima 
(alkaline shift)
Untreated Aroclor 1254
1 291nm (305nm) 6.37 3.04
2 281nm - 0.77
3 286nm - 0.97
4 278nm 1.53 0.86
5 287nm 1.53 1.99
6 287nm (303nm) 0.84 22.25
7 281nm(288nm) 38.91 10.42
8 287nm 7.08 2.00
9 287nm 15.08 39.34
10 287nm 11.29 3.30
11 288nm 3.49 1.39
12 281,313,346nm 2.27 3.38
13 313nm(346nm) 2.88 3.21
14 314,354nm 3.30 2.30
sum of minor 
metabolites
5.43 4.78
at 37° C. The concentration of metabolites was estimated by collecting the peaks as they eluted from 
the hplc and measuring the radioactivity of an aliquot (lOpl). Results are presented as the mean of  
two determinations
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Table 7.4. 2AAF metabolism by untreated and Aroclor 1254- 
pretreated microsomes in the presence of NADH
% of total radioactivity
Peak number UV maxima 
(alkaline shift)
Untreated Aroclor 1254
1 291nm (297nm) 3.43 1.86
2 277nm 1.19 1.30
3 270nm 1.81 2.42
4 293nm (309nm) 2.92 13.32
5 283nm (289nm) 12.38 7.70
6 313,357nm - 2.84
7 286nm 8.53 12.65
8 287nm 11.27 7.44
9 313,346nm 6.20 8.24
10 346nm 10.37 9.88
11 347nm 8.91 7.81
12 356nm 11.03 12.58
13 356nm 6.80 7.20
14 352nm 4.28 4.76
Sum of minor 
metabolites
11.54 0.00
measuring the radioactivity in two aliquots (10\xl). Results are presented as the mean of two 
determinations.
After the incubation of 2AAF with microsomes and NADH, tentative identification 
of peaks 1, 5, 7 and 8 as 7-OH-2AAF, 1-0H-2AAF, 3-OH-2AAF, N-0H-2AAF, 5- 
0H-2AAF, 2AF and 2AAF was achieved by comparison to retention time and UV 
spectra of authentic metabolites. Total metabolism of 2AAF in the presence of 
NADH, as determined by the hplc of extracted metabolites, was modestly increased 
though, as with NADPH, N-hydroxylation of 2AAF was considerably increased and 
7- and 5-OH-2AAF were decreased. The amounts of all other metabolites were not 
significantly modified. The efficiency of extraction of the radiolabel after incubation
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with NADH was low, but was comparable between Aroclor-1254-treated (38%) and 
untreated (35%) microsomal incubations.
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Figure 7.2. NADH-dependent metabolism o f 2AAF by Aroclor 1254-
pretreated microsomes
Separation was achieved using a Whatman ODS column, a methanol gradient o f 30-100% over 60 
minutes at a flow rate of 2ml/min..
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Figure 7.3. Metabolism of 2AAF by Aroclor 1254-pretreated hepatic 
cytosol
Separation was achieved using a Whatman ODS column, a methanol gradient of 30-100% over 60 
minutes at a flow rate oflml/min.
Neither Aroclor 1254-induced nor untreated cytosol could metabolise 2AAF as 
effectively as the microsomal fractions. Recovery of radiolabel from the incubation 
mixture was very efficient after incubation with Aroclor 1254-induced (79%) or
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untreated (84%) cytosolic fractions and the majority of recovered radiolabel was 
present as the parent compound. However, both Aroclor 1254-induced and untreated 
cytosol metabolised 2AAF to a number of metabolites and Aroclor 1254- 
pretreatment was responsible for a modest increase in 2AAF metabolism to give an 
increase in peaks 1,4,7 and, most noticeably, peak 6.
Table 7.5.2AAF metabolism by untreated and Aroclor 1254-
pretreated cytosol
% of total radioactivity
Peak number UV maxima 
(alkaline shift)
Untreated Aroclor 1254
1 278nm 0.02 0.10
2 275nm 0.09 0.07
3 - 0.07 0.05
4 290nm 0.27 1.27
5* 287nm 93.65 88.03
C 337nm 0.97 6.74
7" 351nm 0.32 1.36
Sum of minor 
metabolites
4.61 2.38
measuring the radioactivity in two aliquots (10\il). Results are presented as the mean of two 
determinations.
The metabolite profiles observed after incubation of 2AAF with microsomes and 
cytosol from Aroclor 1254-induced rat were markedly different. In the cytosol, 
2AAF metabolism was only modest and the major metabolite was an unidentified 
less polar metabolite responsible for peak 6 on the chromatogram (figure 7.3). Small 
amounts of more polar metabolites were also detected in the cytosol. The major polar 
metabolite (peak 4) had UV spectra and retention time which tentatively identified it 
as 7-OH-2AAF and its formation was induced by Aroclor 1254-treatment (table 7.5). 
The major cytosolic metabolites of 2AAF were however less polar than the parent
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compound (figure 7.3) and metabolism of 2AAF to both of these polar metabolites 
(peaks 6 and 7) was induced by Aroclor 1254-treatment. No N-hydroxylated 
metabolite was identified.
7.3.3. Metabolism of 2AF by hepatic microsomes and 
cytosol
Similar to 2AAF, 2AF is converted to mutagens in the Ames test in the presence of 
not only microsomes but also cytosol from Aroclor 1254-pretreated rats (Forster et 
al, 1981b; Leist et a l, 1992) however, 2AF has a greater mutagenic response than its 
acetylated derivative (Leist et ah, 1992). Metabolism of 2AF by Aroclor 1254- 
induced and untreated cytosolic fractions was investigated to determine why 2AF is 
mutagenic in the presence of the former but not the latter subcellular fraction. 
Incubation of 2AF with Aroclor 1254-treated microsomes was also carried out in the 
presence of an NADPH-generating system so that differences between microsomal 
and cytosolic metabolism could be used to further illustrate that cytosolic 
bioactivation of 2AF is not a consequence of microsomal contamination. 2AF is also 
metabolised to mutagenic intermediates by Aroclor 1254-pretreated microsomes in 
the presence of NADH (Leist et a l, 1992). Metabolite profiles produced after 
NADH- and NADPH-dependent metabolism were also compared to determine 
whether metabolism involving these cofactors involves two independent systems.
249
0,40 — Absorbance 
- - -R ad ioac tiv ity
0,00
70605030 40200 10
r -  30
«N 
20 0
>
10 o  
0) 
0
es
P4
Time (minutes)
Figure 7.4. NADPH-dependent metabolism o f 2AF by Aroclor 1254-
pretreated microsomes
Separation was achieved using a Beckman ODS column and a 30-100% methanol gradient over 60 
minutes, at a flow rate of l.Sml/min.
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Table 7.6. 2AF metabolism by Aroclor 1254-pretreated microsomes: 
Comparison of NADH- and NADPH-dependent metabolism
% of total recovered radioactivity
Peak number UV maxima NADPH NADH
1 242nm 1.11 -
2 - 6.03 0.91
3 - 1.21 0.22
4 - - 1.27
5 277nm 4.51 1.68
6 270nm 2.09 1.67
7 - 2.52 0.17
8 - 1.48 -
9 289nm 19.82 0.24
10 286nm 25.38 36.17
11 325mn 10.61 3.70
12 347nm 13.04 14.06
13 349nm - 3.25
14 341nm 1.00 1.59
15 351nm - 7.73
16 223,348nm 4.12 9.32
17 241,275,375nm 1.41 2.39
18 276nm - 5.15
Sum of minor 
metabolites
5.67 10.48
Metabolites were collected as they eluted from the hplc and the concentration was estimated by 
counting the radioactivity in two aliquots (10\il). Results are presented as the mean o f two 
determinations
The noticeably different metabolite profiles produced after NADH and NADPH- 
dependent metabolism of 2AF (figures 7.4 and 7.5) may be an indication that these 
activities are performed by different enzyme(s) systems. However, the unavailability 
of authentic metabolites made the identification of metabolites impossible. Using 
authentic metabolites which were available it was possible to tentatively identify 
peaks 5,9,10 and 11 as 3-OH-2AF, N-0H-2AF, 2AF and 2NF.
251
0,70
— Absorbance 
---R ad ioac tiv ity
0,60
,50
V 0,40
0,30
0 0,20
0,10
456
' / /—
0,00
8050 7060403020100
-  30
Time (min)
20
fld
0
Ch
0
%-w
£
« I
o
cd
Figure 7,5, NADH-dependent metabolism of 2AF by Aroclor 1254- 
pretreated microsomes
Separation of metabolites was achieved using a Beckman ODS column and a 30-100% methanol 
gradient over 60 minutes, at a flow rate of l.Sml/min.
The overall metabolism of 2AF and its metabolism to more polar metabolites, 
especially the N-hydroxylamine, was greater in the presence of NADPH than NADH. 
Furthermore, less radiolabel was extracted after NADPH-dependent metabolism
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(43%) than NADH-dependent metabolism (67%) implying the formation of larger 
amounts of protein-binding intermediates in the presence of this cofactor. In contrast, 
NADH-dependent metabolism yielded much higher concentrations of the less polar 
metabolites (peaks 11-18).
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Figure 7.6. Metabolism of 2AF by Aroclor 1254-pretreated cytosol
Separation was achieved using a Beckman ODS column and a 30-100% methanol gradient over 60 
minutes, at a flow rate of 1.5ml/min.
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No difference was demonstrated in the retrieval of radiolabel after incubation of 2AF 
with Aroclor 1254-treated (67%) and untreated cytosol (65%). 2AF (peak 5) is 
extensively metabolised by both untreated and Aroclor 1254-induced cytosolic 
fractions (table 7.7). However, no N-hydroxylated metabolite was identified. In both 
untreated and Aroclor 1254-induced cytosol the majority of the metabolites are less 
polar than parent compound. The major difference between metabolism by the two 
cytosolic fractions is the production of the metabolite corresponding to peak 6. Peak 
6 represents the predominant metabolite of Aroclor 1254-induced cytosolic 
metabolism but is not a product of metabolism by untreated cytosol (table 7.7). In 
contrast, the predominant metabolite of 2AF after incubation with untreated cytosol 
corresponded to peak 7, which was the second most abundant metabolite formed 
after incubation with cytosol from animals treated with Aroclor 1254.
Table 7.7. Metabolism of 2AF by untreated and Aroclor 1254-
pretreated cytosol
% of total recovered radioactivity
Peak number UV maxima Untreated Aroclor 1254
1 270nm - 1.85
2 1.91 -
3 - 1.33 -
4 - 3.36 -
5 285nm 32.19 39.53
6 285nm - 35.40
7 330nm 37.40 14.28
8 349nm 2.38 0.78
9 352nm 3.57 2.07
10 350nm 7.93 2.83
11 344nm 1.11 0.45
12 - 0.72 1.41
Sum of minor 
metabolites
8.10 1.40
counting the radioactivity in two aliquots (10\il). Results are presented as the mean of two 
determinations.
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7.3.4. Mutagenicity of 2AAF and 2AF metabolites formed 
after incubation with Aroclor 1254-treated cytosol
This investigation was undertaken to identify which of the metabolites produced by 
Aroclor 1254-treated cytosol are mutagenic. Peaks eluting from the hplc column 
were collected and evaporated to dryness under vacuum, resuspended in DMSO and 
incorporated into the Ames mutagenicity test.
Table 7.8. Mutagenicity o f 2AAF metabolites
Histidine revertants/plate
Peak number and 
concentration (|xg/plate)
Without activation With activation
Spontaneous reversion rate 15±5 15±5
2-Aminoanthracene (5.0) - 202 d: 72
1 (1.0) 13 ± 8 25 ± 5
2 (1.0) 13 ± 8 45 ±10
3 (1.0) 7 ± 6 4 2 ± 4
4 (1.0) 10±1 37± 2
5 (2.0) 14±2 48± 9
6 (1.0) 12±5 117±10
7 (1.0) 11±5 71 ±13
phosphate buffer (0.5ml) or 10% (v/v) activation mixtures containing cytosol from Aroclor 1254- 
treated rats and an NADPH-generating system.
At the concentrations employed in the Ames test no cytosolic 2AAF metabolites 
were mutagenic in the absence of an activation system. In contrast, in the presence of 
an activation system all except the sample collected from peak 1 gave a positive 
mutagenic response. However, metabolites corresponding to peaks 7 and, in
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particular, peak 6 were the only metabolites to produce a marked mutagenic response 
(table 7.8).
Table 7.9. Mutagenicity of 2AF metabolites
Histidine revertants/plate
Metabolite (ng/plate) No activation + Microsomes + Cytosol
Spontaneous reversion rate 19±6 11 ± 0 13 ± 4
2-Nitrofluorene (5.0) 76±6 - -
2-Aminoanthracene (5.0) - 296 ±63 288 ±11
1 (0.5) 7 ± 5 119±16 28± 2
5 (1.0) 8 ± 0 124±11 32±9
6 (5.0) 31±3 161 ± 8 45 ±5
7 (2.5) 13 ± 2 192 ±23 48 ± 2
8 (1.0) 11 ±10 118±11 32 ±13
9 (0.5) 9 ± 5 124 ±20 9 ± 1
10 (2.5) 13 ± 6 225 ±16 28 ±1
11 (0.5) 14 ±12 152 ±10 29±5
12 (0.5) 26 ± 5 122 ± 6 21 ±1
(0.5ml) or 10% (v/v) activation mixtures containing microsomes or cytosol from Aroclor 1254- 
treatedrats an, an NADPH-generating system. Metabolites were collected after multiple injections 
onto a Beckman ODS reverse-phase column. Concentrations were estimated by radioactive content 
and the metabolites were evaporated to dryness and resuspended in DMSO to give the highest 
possible concentration per plate.
In the absence of an activation system no 2AF metabolites could support a doubling 
of the spontaneous reversion rate. However, one metabolite (peak 6) did give a 
noticeably higher number of revertants than any other metabolite (table 7.9). This 
may be an indication that this is a direct acting mutagen but that the concentration 
employed was too low to demonstrate a clear mutagenic response. In the presence of 
a cytosolic activation system metabolites corresponding to peaks 6 and 7 gave a 
modest mutagenic response whereas, in the presence of a microsomal activation 
system all metabolites tested gave a positive mutagenic response (table 7.9). In the
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latter system the metabolites collected as peaks 10 and 7 were responsible for the 
highest mutagenic response.
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7.4. Discussion
Investigation of 2AF bioactivation by Aroclor 1254-induced hepatic subcellular 
fractions has demonstrated three distinct activities; microsomal NADPH-dependent, 
microsomal NADH-dependent and cytosolic NADPH-dependent bioactivation (Leist 
et a l, 1992). Two enzyme systems responsible for the bioactivation of arylamines 
have so far been identified in hepatic microsomes; the cytochrome P450 oxidases 
(loannides and Parke, 1990) and flavin-containing monooxygenase (Pelroy and 
Gandolfi, 1980). One or both of these enzyme systems may be responsible for 
NADPH-dependent bioactivation of arylamines. The role of these enzymes in 
NADH-dependent bioactivation is, however, less certain (Chapter 4). It does appear, 
from mutagenicity studies, that both NADPH- and NADH-dependent activation 
involves oxidation of the amino group (Chapter 3 and 4). The identity of the 
cytosolic enzyme responsible for bioactivation of arylamines is unknown but, it too 
appears to involve oxidation of the amino group (Chapter 3).
To compare microsome- and cytosol-mediated activating metabolism of aromatic 
amines, the metabolism of 2AF and the amide 2AAF by control and Aroclor 1254- 
induced hepatic subcellular fractions was investigated.
The metabolite profiles obtained after incubation of 2AAF or 2AF with hepatic
cytosolic fractions were markedly different to microsomal profiles implying that
/
contamination with microsomes is not the cause of cytosolic bioactivation.
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Metabolism o f 2AAF by hepatic subcellular fractions isolated from  
untreated and Aroclor 1254-induced rat
MICROSOMAL 2AAF METABOLISM
The metabolism of 2AAF by untreated microsomes in the presence of NADPH is 
well documented and is responsible mainly for 7-hydroxylation (Thorgeirsson et a l, 
1983). Pretreatment with TCDD, 3-methylcholanthrene or phenobarbitone increases 
the overall metabolism and particularly enhances the N-, 3- and 5-hydroxylation of 
2AAF (Smith and Thorgeirsson, 1981; Lotlikar et al., 1967; Lenk and Rosenbauer- 
Thilmann, 1993).
Although the metabolism of 2AAF in the presence of NADPH, as demonstrated by 
the hplc of extracted metabolites, was lower in Aroclor 1254-treated microsomes, the 
degree of N-hydroxylation was considerably induced (table 7.1). This increase in N- 
hydroxylation is in agreement with metabolism of 2AAF after induction with other 
CYPIA inducers e.g. 3-methylcholanthrene (Lotlikar et ah, 1967; Thorgeirsson et 
a l, 1983). However, in contrast to observations after 3-methylcholanthrene-treatment 
(Thorgeirsson et a l, 1983), metabolism of 2AAF to other hydroxylated metabolites 
was decreased by Aroclor 1254-treatment. The amount of the less polar metabolites 
of 2AAF were either unaffected or lowered by Aroclor 1254-treatment (table 7.1). 
After extraction of metabolites from the incubation mixture a higher concentration of 
radiolabel remained in the aqueous fraction containing Aroclor 1254-induced 
microsomes. This implies that metabolites produced by Aroclor 1254-treated 
microsomes are responsible for an increase in protein-binding.
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NADH-dependent metabolism of 2AAF was modestly increased in Aroclor 1254- 
induced microsomes but, as observed with NADPH-dependent metabolism, N- 
hydroxylation was noticeably induced and 5- and 7-hydroxylation were depressed 
(table 7.4). The formation of some of the less polar metabolites (peaks 9 and 12) was 
slightly increased by Aroclor 1254-pretreatment but the relevance of these 
metabolites to the mutagenicity of 2AAF is unknown
The degree of non-specific deacetylation was higher in the presence of NADH and 
was modestly induced by Aroclor 1254-treatment (table 7.4) in agreement with 
previous investigations involving treatment with Aroclor 1254 (Schut et al., 1978), 
and 3-methylcholanthrene (Lotlikar et al, 1967; Thorgeirsson and Nelson, 1976). 
However, in the presence of NADPH there was a decrease in the amount of 2AF 
formed after induction with Aroclor 1254. This decrease in the amount of 2AF may 
be an indication that 2AF is further metabolised more effectively in the presence of 
NADPH. Investigation of 2AF metabolism demonstrated that metabolism of 2AF is 
greater in the presence of NADPH than NADH (table 7.6). Deacetylase activity in 
hepatic microsomes is of great interest because deacetylation of 2AAF and N-OH- 
2AAF are the most important reactions in 2AAF mutagenicity (Schut et a l, 1978).
2AAF METABOLISM BY CYTOSOLIC FRACTIONS
In the presence of Aroclor 1254-induced cytosol 2AAF is modestly mutagenic in the 
Ames test (Forster et a l, 1981b; Leist et a l, 1992). Incubation of 2AAF vdth 
untreated cytosol has previously been undertaken and was found to yield 2AF, 7-OH- 
AAF, 9-OH-2AAF and AAF-9-one (Lenk and Rosenbauer-Thilmann, 1993). 
However, cytosol employed in this earlier investigation was prepared by a single 60-
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results
minute centrifugation at 90,000g and thereforey^ay be a consequence of microsomal 
contamination. Metabolism of 2AAF by untreated and Aroclor 1254-induced cytosol 
was undertaken in the present studies employing cytosol prepared by 2 x 60-minute 
centrifugations at 105,000g to ensure that microsomal contamination was minimised.
Even after extended centrifugation untreated cytosol was responsible for metabolism 
of 2AAF to more polar metabolites including 7-OH-2AAF (table 7.5). However, the 
quantity of these metabolites was very small and the overall metabolism of 2AAF 
was minimal. The major metabolite peak produced by untreated cytosol was peak 6 
(see figure 7.3). Unlike the microsomal fraction, the overall metabolism of 2AAF 
was increased by Aroclor 1254-treatment though overall metabolism remained 
modest. The formation of 7-OH-2AAF, metabolites corresponding to peaks 1, 7 and, 
most noticeably, peak 6 were increased (table 7.5). The extraction of radiolabel from 
cytosolic incubation mixtures was more efficient than from microsomes and was 
comparable between Aroclor 1254-treated and untreated cytosol. This implies 
covalent-binding of reactive intermediates to protein is considerably lower after 
incubation with cytosol compared to microsomes.
Investigation of the mutagenicity of the 2AAF metabolites failed to identify any 
direct acting mutagens (table 7.8). In the presence of an activation system containing 
Aroclor 1254-induced cytosol (10% v/v) 2AAF (peak 5) did give a modest 
mutagenic response but a higher mutagenic response was obtained with metabolites 
corresponding to peak 6 and, to a lesser extent, peak 7 (table 7.8). Therefore not only 
does Aroclor 1254-treatment increase the metabolism of 2AAF to peaks 6 and 7 but
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these metabolites are more mutagenic than the parent compound and their formation 
therefore constitutes bioactivation.
Metabolism of 2AF by hepatic subcellular fractions from Aroclor 
1254-induced rat
MICROSOMAL 2AF METABOLISM
The major product of 2AF metabolism by Aroclor 1254-induced microsomes in the 
presence of NADPH was tentatively identified as the N-hydroxylamine (table 7.4). 
N-0H-2AF is probably responsible for the observed mutagenicity of 2AF in the 
presence of this subcellular fraction in the Ames test and, induction of N- 
hydroxylation activity explains the increase in 2AF mutagenicity in microsomes from 
animals treated with Aroclor 1254 (Leist et al., 1992).
Interestingly, though 2AF is metabolised to the hydroxylamine in the presence of 
NADH, it is only a minor metabolite (table 7.6). This is however in agreement with 
previous spectrophotometric investigations where the N-hydroxylation of 2AA was 
much lower in the presence of NADH than NADPH (Chapter 4) and may explain the 
weaker mutagenic response observed with 2AF using this cofactor (Leist et al., 
1992). As observed with 2AAF, NADH-dependent 2AF metabolism yielded more of 
the unidentified less polar metabolites than NADPH-dependent metabolism. Once 
marked differences between NADH- and NADPH-dependent metabolism 
suggests the metabolism of arylamines employing these cofactors probably involves 
two different enzyme systems.
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METABOLISM OF 2AF BY HEPATIC CYTOSOL
The overall metabolism of 2AF was much higher than 2AAF in accordance with the 
fact that 2AF is more mutagenic than 2AAF in the presence of cytosol in the Ames 
test (Leist et a l, 1992). Interestingly the total metabolism of 2AF by untreated 
cytosol was fractionally higher than by Aroclor 1254-induced cytosolic fraction 
(table 7.5). However, marked differences were apparent between metabolism by 
untreated and Aroclor 1254-induced cytosol. Only untreated cytosol metabolised 
2AF to metabolite peaks 2,3 and 4 (table 7.7). The majority of 2AF metabolism was 
however to metabolites constituting peaks 7 and 10. In contrast, Aroclor 1254- 
induced cytosol did not metabolise 2AF to give peaks 2,3 and 4, and produced lower 
concentrations of peaks 7 and 10. However, the major metabolite produced by 
Aroclor 1254-treated cytosol corresponded to peak 6 and was not a product of 
metabolism by untreated cytosol (table 7.7). The only other metabolites increased in 
cytosol pretreated with Aroclor 1254 corresponded to peaks 1 and 12 (table 7.7).
How these metabolite profiles relate to mutagenicity is difficult to determine 
because, as observed with 2AAF metabolites, none of the metabolites could induce a 
doubling in the number of revertant in the absence of an activation system (table 7.9) 
and their identity has not yet been determined. However, metabolites corresponding 
to peaks 6 and 7 were both weakly mutagenic in the presence of Aroclor 1254-treated 
cytosol (table 7.9). This is confusing because metabolite peak 7 appears more 
mutagenic than peak 6 in the presence of an activation system, yet the former is more 
abundant in untreated cytosol which does not bioactivate arylamines in the Ames test 
(Chapter 3). However, the metabolite corresponding to peak 6 did give a slight 
positive mutagenic response (but not double the spontaneous reversion rate) in the
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absence of an activation system (table 7.9). Alternatively, it is possible that the 
intermediate responsible for mutagenicity is unstable and therefore mutagenicity data 
obtained here may be falsely low because the mutagen has degraded. The absence of 
a clearly mutagenic metabolite after 2AF metabolism by Aroclor 1254-induced 
cytosol suggests that the active metabolite(s) are perhaps not extracted but remain 
covalently-bound to cytosolic protein. However, the amount of radiolabel not 
extracted after incubation with Aroclor 1254-induced cytosol (33%) and untreated 
cytosol (35%) was not noticeably different.
Interestingly no N-0H-2AF was identified after cytosolic metabolism of 2AF, even 
though N-hydroxylation of 2AF has been detected using a spectrophotometric assay 
(Chapter 5). However, this assay is based upon the ability of hydroxylamines to 
reduce ferric ions to ferrous ions so it is possible that other metabolites are formed 
which can also reduce ferric ions and give a positive observation. Alternatively, N- 
0H-2AF may be further metabolised to one of the unidentified metabolites or, 
remains covalently-bound to protein.
The mutagenicity of the products of cytosolic metabolism was also tested in the 
presence of Aroclor 1254-induced microsomes. All metabolites elucidated a 
mutagenic response. Interestingly, the more polar metabolite, probably a ring-phenol, 
could still be converted to mutagens, possibly via N-hydroxylation. The most potent 
mutagenic response was, however, observed with metabolites corresponding to peaks 
7 and 10, the two metabolites most abundant after metabolism by untreated cytosol 
(table 7.7). The use of a microsomal activation mechanism may be, however, 
misleading because it is not known whether these metabolites produced in the cytosol
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will be able to access the microsomal enzymes. Furthermore, a potentiation of 
control microsomal and S9 bioactivation of 2AAF by cytosol isolated from rats 
treated with Aroclor 1254, 3-methylcholanthrene or phenobarbitone has previously 
been demonstrated (Forster et al, 1981a). Moreover, this cytosolic potentiation 
system of microsomal metabolism has markedly different substrate specificity to 
purely cytosol-mediated bioactivation (Forster et a l, 1981a). The large mutagenic 
response observed with metabolites corresponding to peak 7 and peak 10 in the 
presence of the microsomal fraction may, therefore, be a consequence of the 
uncharacterised potentiation mechanism whereas, metabolite peak 6 represents a 
metabolite more important in the microsome-independent cytosolic bioactivation of 
arylamines.
A better understanding of the bioactivation processes responsible for the 
bioactivation of 2AF and 2AAF by cytosol will be available when the identity of the 
metabolites has been determined. Attempts are currently being undertaken to identify 
these metabolites by mass spectrometry.
7.5. Conclusions
1. Both NADPH- and NADH-dependent metabolism of 2AF and 2AAF by Aroclor 
1254-induced microsomes yield hydroxylamines responsible for the increase in 
mutagenic response by this subcellular preparation.
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2. Cytosol-mediated metabolism of 2AF and 2AAF is markedly different to that 
mediated by the microsomal fraction.
3. Metabolites of 2AAF and 2AF formed by the cytosol, which are less polar than the 
parent, are more mutagenic.
4. The cytosolic metabolites responsible for the observed mutagenicity of 2AAF 
appear to be those responsible for peaks 6 and 7.
5. The cytosolic 2AF metabolite corresponding to peak 6 is probably responsible for 
the mutagenicity of this amine in the Ames test.
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CHAPTERS
Partial purification of a cytosolic enzyme responsible 
for the bioactivation of aromatic amines
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8.1. Introduction
In 1981, a novel activity responsible for the bioactivation of 2-acetylaminofluorene, 
2-aminofluorene and 2-aminoanthracene to mutagens, was demonstrated in hepatic 
cytosol from rats pretreated with Aroclor 1254 (Forster et al., 1981b). This activity 
was not investigated thoroughly at the time but subsequently it has been shown to be 
protein in nature, to have a requirement for NADPH and molecular oxygen, and to be 
unaffected by oxygen radical generating systems (Ayrton et al., 1992; Leist et al., 
1992). Moreover, the metabolism of 2AF, 2AA and 6AC to mutagenic intermediates 
by cytosol has been demonstrated to have very different characteristics to 
bioactivation by the microsomal fraction (Ayrton et al., 1992; Leist et al., 1992; 
Chapters).
Initially, contamination of the soluble fraction with microsomal enzymes was 
thought to be responsible for the bioactivation of aromatic amines by cytosol from 
Aroclor 1254-pretreated rats. However, extensive experimental evidence has shown 
this is not tme. Firstly, activity within the cytosol is resistant to repeated 
ultracentrifugation (Ayrton et al., 1992; Leist et al., 1992; Chapter 3), and the 
activity of cytosol is equally effective at inducing a mutagenic response as the 
microsomal fraction thus excluding minor contamination from being responsible for 
the cytosolic activity (Ayrton et al., 1992; Chapter 3). The bioactivation of aromatic 
amines by microsomal and cytosolic fractions also respond differentially to changes 
in protein and cofactor concentrations; cytosol cannot utilise NADH, though this 
cofactor is employed very effectively by the microsomal fraction (Leist et a l, 1992; 
Chapter 4). Furthermore, the substrate specificity of the microsomal and cytosolic
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systems are very different. Cytosol is responsible for the bioactivation of only a 
limited number of aromatic amines such as 2AAF, 2AF, 2AA (Forster et al., 1981b) 
and 6-aminochrysene (Chapter 3), and did not bioactivate other amines which elicit 
marked mutagenic responses in the presence of the microsomes (Chapter 3). 
Moreover, the bioactivation of aromatic amines by the cytosol was not expressed in 
untreated rats or in rats pretreated with inducers of cytochrome P450 oxidases, where 
as microsomes can bioactivate aromatic amines constitutively (Ayrton et ah, 1992; 
Leist et ah, 1992; Chapter 3).
To unequivocally demonstrate the existence of a novel enzyme in the cytosol 
requires the purification of this protein and demonstration of its activity in 
reconstituted systems, so that it may be fully characterised and identified. In this 
investigation the partial purification of the cytosolic enzyme was undertaken by gel 
chromatography with the active fraction(s) identified using the bioactivation of 2AA 
to mutagens in the Ames test. The molecular weight of the protein was determined 
by elution time and protein electrophoresis in comparison with molecular weight 
markers. The presence of CYPIA isoforms, and therefore contamination by the 
microsomes, was investigated by Western blot analysis of concentrated eluent 
fractions. Furthermore, the ability of the active fraction to metabolise 2AF was 
investigated using radiolabelled substrate and analysis of metabolites by high 
performance liquid chromatography.
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8.2. Methods
8.2.1. Animal pretreatment and cytosol preparation
Male Wistar albino rats (180-200g) received a single intraperitoneal injection of 
Aroclor 1254 (500mg/kg) and were killed five days later. The livers were excised, 
then washed and homogenised in ice-cold KCl (1.15% w/v). Either 25% or 50% 
(w/v) homogenates were prepared, and centrifuged at 9000g for 20 minutes. The 
supernatant was stored at -20°C and cytosol was prepared on the day of use by two 
60-minute centrifiigations at 175,000g to ensure there is no microsomal 
contamination.
8.2.2. Chromatography
Partial purification of cytosolic proteins was achieved using a Pharmacia 50cm x 
3cm column packed with Sephacryl 300HR. Fractions were eluted using a mixture 
comprising sodium phosphate buffer (15mM, pH 7.4), magnesium chloride (8mM), 
potassium chloride (33mM) and p-mercaptoethanol (0.25ml/l). The flow rate of 
buffer was Iml/min and the absorbance of the eluent at 206nm was monitored using 
a LKB Bromma 2138 uvicord S. Fractions were collected every five minutes using a 
LKB Bromma 2070 ultrorac II firaction collector.
8.2.3. Protein determination
The protein contents of each fraction were determined by the Lowry procedure 
(Lowry et ah, 1951). Eluent (0.5ml) was diluted 1:1 with sodium hydroxide (0.5M).
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To this was added 5ml of copper reagent [copper sulphate (1% w/v), sodium 
potassium tartrate (2% w/v), and sodium carbonate (2% w/v) mixed 1:1:100] and left 
to stand at room temperature for ten minutes; Folin-Ciocalteu phenol reagent (0.5ml 
of 1:1 solution with distilled water) was then added and the mixture immediately 
vortexed. A blue colour develops over 30 minutes at room temperature and the 
absorbance was measured at 720nm. Standard curves (0-250pg/ml) employed bovine 
serum albumin (Fraction V) solution (500pg/ml). Analysis was carried out in 
triplicate.
8.2.4. Discontinuous SDS-PAGE
The separation of proteins in the eluent fractions was performed by the method of 
Laemmli (1970), as described in Chapter 2. Electrophoresis was carried out with a 
constant current of 20mA until the bromophenol blue band reached the lower gel, at 
which point the current was increased to 45mA. Once the bromophenol blue band 
reached the bottom of the gel, the current was switched off, and the gel was placed in 
fixing solution for 30 minutes, before staining with coomasie blue R-250 solution 
overnight. After washing with distilled water, the gel was destained using 
trichloracetic acid (10% w/v) until the background was colourless. Once destained, 
the gel was photographed and scaimed for UV absorbance at 600nm using a 
Shimadzu CS-9000 dual wavelength flying spot scarmer.
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8.2.5. Western blot analysis of CYPIA proteins
After the separation of proteins by SDS-PAGE, proteins were transferred to 
nitrocellulose sheets electrophoretically, and were tested for the presence of CYPIA 
proteins by immunological staining (Towbin et al, 1979). Transfer was achieved as 
described in Chapter 2 and the presence of CYPIA proteins was investigated using 
sheep anti-rat CYPIA primary antibodies and a peroxidase linked donkey anti-sheep 
secondary antibody. A positive result was visualised by the addition of 3-3' 
diaminobenzidine (0.1% w/v in tris-HCl O.IM, pH7.5) and 30% hydrogen peroxide 
(40pl).
8.2.6. Mutagenicity testing
The presence of the cytosolic protein in the eluent fractions was determined by the 
mutagenic response of 2 aminoanthracene in the Ames test. To molten agar (2ml) 
were added 2AA (lOpg/plate), Salmonella typhimurium strain TA98 and activation 
mixture (1ml). The activation mixture comprised 1.6ml of eluent and 0.4ml of 
cofactor solution (14.7mg/ml NADP\ 7.6mg/ml glucose-6-phosphate, and 1 
unit/plate glucose-6-phosphate dehydrogenase). Mixtures were vortexed thoroughly 
before plating out onto minimal agar plates. Tests were performed in duplicate and 
the number of revertant colonies were counted after incubation for 48 hours at 37°C.
8.2.7. Metabolism o f 2-aminofluorene
The metabolism of [^H]2AF by eluent fractions was determined in incubation 
mixtures containing eluent fraction (6ml), Img of [^H]2AF (7.281mCi/mmol) and an
272
NADPH-generating system (NADP^ 147mg, glucose-6-phosphate 76mg, glucose-6- 
phosphate dehydrogenase 20units) in 4ml of phosphate buffer (O.IM, pH 7.4). 
Incubation took place in a 250ml conical flasks in a shaking waterbath at 37°C for 2 
hours and the reaction was stopped by placing the flask on ice. Metabolites were 
extracted six times with equal volumes of ice-cold ethyl acetate, and the extracts 
were dried over magnesium sulphate before being evaporated to dryness in a rotary 
evaporator. The metabolites were resuspended in 250pl of DMSO and aliquots 
(15|xl) were separated on a Beckman ultrasphere ODS reverse phase column (25cm x 
4.6mm) as described in Chapter 2. Metabolite peaks were collected and the 
concentration was determined by the amount of radioactivity, which was measured in 
aliquots (20pl), in Optiphase safe scintillation cocktail (5ml).
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83. Results
8.3.1. Partial purification of a cytosolic enzyme responsible
for the bioactivation of 2 aminoanthracene
The partial purification of hepatic cytosolic proteins, fi*om Aroclor 1254-pretreated 
rat, was accomplished using a Sephacyl 300HR column and an eluent flow of 
1 ml/minute. Fractions were collected every 5 minutes after loading 2ml cytosol 
(25%w/v), and the amine oxidase activity in each protein-containing firaction was 
monitored by the ability to metabolise 2AA (lOpg/plate) to mutagenic intermediates 
in the Ames test.
The fraction collected 85-90 minutes after loading the cytosol was responsible for 
metabolism of 2AA to give the greatest mutagenic response in the Ames test. Even 
though this fraction had one of the highest mutagenic responses it also had one of the 
highest protein concentrations. Fractions containing very low protein concentrations j 
also had very high specific activities, even though their mutagenic responses were 
barely above double the spontaneous reversion rate (table 8.1).
The procedure was repeated but with the incorporation of a 5 minute preincubation 
step at 37°C in the Ames test, in an attempt to increase the mutagenic response. 
Longer preincubation was not used because previous investigation has shown that 
this leads to a decrease in mutagenic response (Chapter 4).
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Figure 8.L Bioactivation of 2~aminoanthracene by eluent fractions 
from Aroclor 1254-pretreated rat hepatic cytosol.
Mutagenicity data (^) are expressed as the mean ± standard deviation of duplicates. Tests 
employed either no incubation (A) or 5 minutes at 37°C (B). The spontaneous reversion rate was 8 
± 3 and has been subtracted. The positive control employed whole cytosol (10% v/v), stored at 4 °C 
during the purification, and elicited a mutagenic response o f296 ± 12. Tests employed activation 
mixture (1 ml/plate). Salmonella typhimurium TA98, and 2-aminoanthracene (10\ig/plate). Protein 
concentration is expressed as the mean of duplicates (M).
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Once again the fraction collected between 85 and 90 minutes, after loading 2ml of 
Aroclor 1254-treated cytosol (25% w/v) produced the highest mutagenic response, 
though it was not significantly increased by the preincubation step. When the results 
were expressed as specific activities, fractions containing low protein concentrations 
again appeared to be more active, even though the mutagenic response was only just 
double the spontaneous reversion rate.
Table 8.1. The bioactivation of 2-aminoanthracene by eluentfractions,
caressed as specific activity
Histidine revertants/mg’^ protein
Elution time 
(minutes)
No incubation Preincubation
60-65 190 188
65-70 150 126
70-75 134 109
75-80 167 144
80-85 134 170
85-90 174 186
90-95 131 163
95-100 132 106
100-105 158 79
105-110 116 114
Mutagenicity tests were performed in duplicate and employed Salmonella typhimurium strain TA98 
and 2-aminoanthracene (lOpg/plate). Preincuhation was at 37 'C  for 5 minutes. Results are 
expressed as the mean number of histidine revertants per mg protein The spontaneous reversion 
rate was 8 ±  3 and was subtracted before calculating the specific activity. The mutagenicity of2AA 
in the presence of complete cytosol (10% v/v) was 201 histidine revertants per mg protein.
Electrophoresis was carried out to determine the number of proteins present in the 
most active eluant fractions and, whether any obvious differences are apparent
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between this fraction from Aroclor 1254-treated hepatic cytosol and untreated hepatic 
cytosol.
Table 8.2. UV absorbance of protein bands after electrophoresis o f  
untreated and Aroclor 1254-pretreated cytosol
Peak area
Approximate molecular 
weight (kDa)
Untreated
cytosol
Aroclor
1254
cytosol
Untreated
fraction
Aroclor
1254
fraction
202.0 877 - - -
187.0 - 976 618 -
173.0 1764 - - -
160.0 - - - 1327
148.0 196 563 - -
137.0 356 378 - -
126.0 592 - 698 -
117.0 nil 1271 - -
108.0 1693 - - 943
96.0 1492 1008 - -
85.0 1221 857 - -
75.0 2099 1429 1188 917
65.0 - - 1995 2066
63.0 7142 5067 - -
58.0 2091 2091 - -
54.0 - - - 1934
46.0 2835 3816 505 1514
41.0 7586 6855 1560 1512
38.0 4054 2542 963 1251
33.0 3121 4384 803 1047
30.0 3406 5336 1448 1675
26.0 1228 3020 - 752
18.0 11783 21689 2980 4816
15.0 5231 26390 947 4253
molecular weights were estimated by comparison with the mobility of protein standards
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Western blot analysis was run in parallel to ascertain whether any CYPIA proteins 
are present in the fraction demonstrating the greatest bioactivation of 2AA and 
consequently whether cytosolic activity is, at least in part, a result of contamination 
with microsomal protein.
Figure 8.2. Separation of cytosolic proteins by SDS-PAGE
Sample wells contained ZOOpg of cytosolic protein or 20jig ofprotein from eluant fractions. Lanes 
1-5 were loaded with 85-90 minute fraction from control cytosol, 85-90 minute fraction from 
Aroclor 1254-induced cytosol, whole control cytosol, whole Aroclor 1254-induced cytsol and 
molecular weight markers respectively.
Protein staining with coomasie blue demonstrated about ten major protein bands in 
the active fraction from Aroclor 1254-induced rat cytosol. When compared with a 
fraction collected at the same point after injection of untreated cytosol, marked 
differences were apparent, which were also observed in whole cytosol. Protein bands 
corresponding to molecular weights of approximately 160, 65, 54, 46, 18, and 
especially 15kDa were induced by Aroclor 1254-treatment.
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Western blot analysis of microsomes (lOOpg) and cytosols (400pg) and active eluant 
fraction (lOOpg) from Aroclor 1254-treated rat demonstrated an abundance of 
CYPIA protein in microsomes, a modest amount of CYPIA proteins in cytosol but 
no detectable CYPIA in the eluent fraction (figure 8.3).
Figure 8.3. Western blot of Aroclor 1254-induced microsomes, cytosol,
and cytosolic fractions.
Lanes 1-3 were loaded with Aroclor 1254-induced microsomes (100\Lg), Aroclor 1254-induced 
cytosol (400\ig), and active fraction from Aroclor 1254-induced cytsol (100\ig)
8.3.2. Partial purification of a cytosolic protein responsible 
for the bioactivation of 2-aminoanthracene, using 
concentrated cytosol (50%w/v)
To obtain greater activity in eluent fractions and to demonstrate that activity 
increases with an increase in protein concentration, more concentrated cytosol, 
prepared from 50% (w/v) homogenates, was fractionated and tested for the ability to 
bioactivate 2AA.
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Figure 8.4. Protein concentration and 2-aminoanthracene 
mutagenicity infractions from Aroclor 1254-treated cytosol (50% w/v)
Mutagenicity is expressed as mean ± standard deviation of triplicates (^). The spontaneous 
reversion rate was 17 ± 3 and has already been subtracted Ames tests employed 2- 
aminoanthracene (lOpg/plate), Salmonella typhimurium TA98, an NADPH-generating system, 
including glucose-6-phosphate dehydrogenase (1 unit per plate), and O.Sml/plate of eluant 
fractions. Protein concentration was determined in duplicate by the Lowry procedure (M).
Using this system a positive mutagenic response was only observed in three eluant 
fractions collected 80-85, 85-90, and 90-95 minutes after loading Aroclor 1254- 
induced cytosol onto the column (figure 8.4). These fractions had specific mutagenic 
responses of 680, 804 and 514 revertants per mg of protein respectively. Therefore, as 
observed previously with 25%(w/v) cytosol, the strongest mutagenic response was 
observed in the fraction collected from 85-90 minutes after injection. The specific
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activity was also considerably higher using this cytosol preparation (50% w/v) than 
the original (25% w/v).
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Figure 8.5. Electrophoresis gel o f active fractions collected after the 
partial purification ofAroclor 1254-pretreated cytosol (50%w/v)
Wells 1-4 were loaded with molecular weight markers and eluent fractions (10\ig) collected 
between 55-60,80-85,85-90 and 90-95 minutes after loading cytosol (2ml of 50% v/v) respectively.
The three active fractions, collected from 50%(w/v) cytosol (2ml), were separated 
into component proteins by electrophoresis to demonstrate the number of proteins 
per fraction and to identify possible candidates for the active protein by comparing 
the UV absorbance of protein bands and the mutagenic activities in the three 
fractions.
The fraction demonstrating the greatest mutagenic response contained 15 protein 
bands. The majority of proteins were found in each of the three active fractions but at 
different concentrations. If the UV absorbance of protein bands in the three fractions 
is compared to the mutagenic responses a good positive correlation (r  ^ > 0.7) is 
observed for 6 of the protein bands corresponding to molecular weights of; 70.0,
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65.5, 58.0, 35.5, 31.5, and 21.5kDa. The best correlations were with protein bands at 
21.5kDa (r^  = 0.9975), 31.5kDa (r^  = 0.9547) and 65.5kDa (r  ^ = 0.9504) therefore 
these are the best candidates for the protein responsible for the bioactivation of 2- 
aminoanthracene.
Table 8.3. UV absorbance o f protein bands after electrophoresis o f
active eluent fractions
Peak area
Approximate 
molecular weight 
(kDa)
80-85 85-90 90-95
107.0 2035 2011 1304
84.0 5848 1609 1706
70.0 1078 2184 471
65.5 2444 3497 1489
61.5 1603 - -
58.0 1422 4474 742
54.5 - - 918
51.5 9186 - 818
45.5 1409 1555 1977
42.5 - 846 -
40.0 1336 1936 -
, 35.5 3426 3839 2881
31.5 1472 2236 754
28.0 2123 4208 -
24.5 8078 9584 9485
21.5 13846 16212 7476
17.0 650 1016 877
14.0 2206 2444 -
estimatedfrom the mobility o f protein standards
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8.3.3. Partial purification of cytosolic proteins using a 
second column
Using Sephacryl 300HR it was only possible to partially purify the cytosolic protein 
responsible for the bioactivation of aromatic amines (figures 9.3 and 9.5). Some of 
the candidate proteins responsible for this activity have low molecular weiglits (17- 
21.5 kDa), so active fi-actions (85-90 minutes) firom eight injections of 50% (w/v) 
cytosol (2ml) were collected, freeze-dried, resuspended in 3ml of eluent buffer, and 
loaded (2ml) onto a second column. This second column was packed with Sephacryl 
lOOHR, which should readily separate the low molecular weight from higher 
molecular weight proteins.
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Figure 8.6. Electrophoresis gel o f active fraction collected after the 
partial purification of Aroclor 1254-pretreated cytosol (50% w/v) using 
Sephacryl 300HR and lOOHR columns
Sample well was loaded with protein (20]ig) collected 30-40 minutes after loading concentrated 
protein onto a Sephacryl lOOHR column.
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No fractions collected from the Sephacryl lOOHR column demonstrated any 
significant 2AA bioactivation. However, the fraction collected between 30 and 40 
minutes after loading did produce a modest mutagenic response. On fiirther 
investigation of this fraction it was found that it contained the majority of the protein 
and that passing cytosolic fraction through this column had not lowered the number 
of proteins. Therefore Sephacryl lOOHR columns are of little use to the further 
purification of cytosol.
Table 8.4. Protein concentration and bioactivation o f  2- 
aminoanthracene by eluent fractions from a Sephacryl lOOHR column
Time (minutes)
Protein concentration 
(pg/ml)
Histidine
revertants/plate
20-30 16 nd
30-40 357 34 ±20
40-50 175 1 ± 4
50-60 41 5± 3
typhimurium TA98 and an NADPH-generating system. The spontaneous reversion rate was 17 àz 4 
and has already been subtracted.. The experiment was performed in duplicate.
8.3.4. Metabolism of 2-aminofluorene by eluent fractions 
after partial purification of Aroclor 1254-pretreated cytosol 
(50% w/v)
The metabolism of 2-aminofluorene was employed to demonstrate that the mutagenic 
responses obtained in the Ames test are a consequence of metabolism and, that eluent 
fractions with the greatest mutagenic responses are also active in the metabolism of 
2AF.
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Table 8,5. UV absorbance of protein bands in the active eluent 
fraction after separation using Sephacryl 1OOHR
Approximate molecular weight 
(kDa)
Peak area
94.5 955
85.0 631
78.5 624
72.0 3958
69.5 912
66.5 2145
58.0 934
52.5 4284
44.0 1939
40.5 630
38.5 2190
33.5 3727
30.0 2371
26.5 4289
23.5 9002
21.5 12482
were estimated from the mobility of protein standards
Radiolabelled [3H]2AF (7.281mCi/mmol) was incubated with eluent fractions, 
collected between 55-60 (fraction 12) and 85-90 minutes (fraction 18) after loading, 
in the presence and absence of an NADPH-generating system.
Both fractions metabolised 2AF in the presence of an NADPH-generating system. 
However, fraction 18 was responsible for greater overall metabolism than fraction 
12, being responsible for the metabolism of 75% of the parent compound compared
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to only 46% in fraction 12. There was very little degradation of parent compound in 
each fraction in the absence of cofactors with 2AF making up 91 and 86% of total 
radioactivity in fractions 12 and 18 respectively. Therefore both fractions are able to 
metabolise 2AF but both require an NADPH-generating system (figure 8.7).
Table 8.6. Metabolism o flA F  by eluent fractions collected during the 
partial purification o f cytosol after treatment with Aroclor 1254
Percentage of recovered radioactivity
Fraction 12 Fraction 18
Retention 
Time (mins) - Cofactors + Cofactors
- Cofactors + Cofactors
43 91.499 57.796 92.973 29.480
46 2.346 9.899 - 11.61
47 - 5.708 - 12.391
52 0.211 17.321 0.230 28.674
58 - 0.564 - 2.157
61.5 0.310 0.269 0.249 2.440
induced cytosol for 2 hours either with or without an NADPH-generating system. Metabolite peaks 
were collected as they eluted from the hplc and the radioactivity in aliquots (2 x 10\il) was 
measured and used to calculate the concentration of metabolite.
The metabolites formed are less polar than the parent compound and the hplc 
chromatograms resemble those obtained with whole cytosol. Comparison of these 
chromatograms with those of whole cytosol (Chapter 7) suggests the major 
metabolites correspond to the more mutagenic metabolites (peaks 6 and 7).
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Figure 8.7. HPLC chromatograms after incubation o f 2- 
aminofluorene with cytosolic eluant fraction
2-Aminofluorene (Img) was incubated for 2 hours at 37°C with eluant fraction (6ml) collected 
between 85-90 minutes after loading 2ml of Aroclor 1254-induced liver cytosol (50% w/v). 
Incubations were undertaken in the absence (A) and presence (B) ofan NADPH-generating system
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8.4. Discussion
The presence of an hepatic cytosolic system responsible for the bioactivation of the 
aromatic amines 2AAF and 2AF to mutagens in Aroclor 1254-induced rats was first 
demonstrated in 1981 (Forster et al., 1981b). More detailed research was not 
undertaken until 1992 when the activation of 2AF was investigated in greater detail 
(Leist et al., 1992). These studies demonstrated marked differences between 
cytosolic and microsomal bioactivation of this amine indicating that the cytosolic 
activity could not be a consequence of microsomal contamination. Moreover, the 
cytosolic activation was as marked as activation with microsomes, which is not 
indicative of contamination, and was resistant to repeated centrifugation (Leist et al., 
1992). However, investigation of bioactivation by the cytosolic and microsomal 
fractions also demonstrate some similarities; both systems require NADPH and O2 
and are abolished by 9-hydroxyellipticine and a-naphthoflavone. Furthermore, 
microsomes and cytosol both express EROD activity and have immunologically 
detectable CYPl A proteins . but both
CYPl A activity and concentration were much higher in the microsomes (Chapter 6), 
and cytosolic bioactivation is impaired by cytochrome c and (+)-catechin, though not 
as significantly as microsomal activation (Chapter 3), and is completely removed by 
the cytochrome P450 suicide substrate 1ABT (Chapter 3). Therefore, even though the 
majority of evidence from mutagenicity tests indicates the existence of a unique 
cytosolic enzyme this cannot be unequivocally proven using these techniques. To 
demonstrate, inarguably, the existence of a cytosolic enzyme responsible for the
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bioactivation of aromatic amines demands its purification and investigation of the 
purified enzyme.
In this investigation the cytosolic protein responsible for the activation of aromatic 
amines in Aroclor 1254-induced rats was partially purified and was able to 
bioactivate 2AA to mutagens without the addition of NADPH-cytochrome P450 
reductase, required for activity using purified cytochrome P450 isoforms. 
Furthermore, the proteins present in the eluent fraction expressing the greatest 
mutagenic response were found not to be immunologically related to microsomal 
CYPl A isoforms. Therefore the protein responsible for the bioactivation of aromatic 
amines, in Aroclor 1254-induced cytosol, is not a cytochrome P450 related to 
CYPl A or, a contaminant from the microsomal fraction but is truly of a cytosolic 
nature.
Bioactivation o f 2-aminoanthracene by fractions from Aroclor 1254- 
treated cytosol
After the loading of Aroclor 1254-induced cytosol onto a Sephacryl 3OOHR column, 
the firaction collected between 85 and 90 minutes consistently yielded the greatest 
mutagenic response when employed as the activation mixture in the Ames test using 
2AA as the promutagen (figure 8.1, 8.2 and 8.4). This firaction, however, despite 
containing one of the highest protein concentrations, still had a higher specific 
mutagenic activity than most other firactions (table 8.1); however, fractions 
containing low protein concentrations also appeared to have very good specific 
mutagenic activities. The relevance of these low protein firactions is difficult to 
interpret, since the increase in histidine revertants over the spontaneous reversion rate 
WA$ low.
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Interestingly, when the metabolism of 2AF was compared in the fraction which 
produced the highest mutagenic response and a second fraction having only low 
protein concentrations, but high specific activity, both supported marked metabolism. 
Once again the firaction collected after 85-90 minutes had the greatest metabolic 
activity, with 70% of parent compound being metabolised compared to 42% in the 
low protein fraction. However, because of the much lower protein concentration in 
the latter, it exhibited the greatest specific activity.
The problem with using the Ames test for the detection of the cytosolic activating 
enzyme was the low sensitivity. Consequently, a small increase in revertant colonies 
when using fractions containing low protein concentrations to bioactivate 2AA gave 
very high specific activities. Future investigations may benefit from the use of a 
Salmonella strain (NM2009) which is 0-acetyltransferase over-expressing and the 
more sensitive umu test (Yamazaki and Shimada, 1992).
In an attempt to increase the sensitivity of the Ames test a preincubation step was 
included (5 minutes at 37°C), but had no effect on the mutagenic response. This short 
preincubation step was included because longer periods of incubation are responsible 
for decreases in mutagenic response (Chapter 4). However, the use of more 
concentrated cytosol preparations (50% w/v) was more successful and produced a 
very marked mutagenic response (figure 8.4), residing in the same fractions as 
previously observed with the more dilute cytosol. This addressed the problem where 
eluent fractions containing low protein concentrations demonstrated high specific 
mutagenicity even though 2AA mutagenicity was barely double the spontaneous
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reversion rate, because lower eluent volumes could be employed which decreased the 
specific mutagenicity of these fractions.
The existence of bioactivating activity in these firactions demonstrates that the 
microsomal cytochrome P450 oxidases cannot be responsible because they require 
other components of the mixed-fimction oxidase system e.g., NADPH cytochrome 
P450 reductase. Since the Ames test was not supplemented with reductase the 
activation cannot be attributed to cytochrome P450 unless microsomes, and therefore 
the mixed-fimction oxidase system, are intact. Furthermore, the size of intact 
microsomes would mean that they are not retained on the column and would 
therefore elute immediately after the void volume. Since the firaction containing the 
greatest activity elutes much later than the void volume it is probably a consequence 
of a truly cytosolic enzyme.
Purification o f a cytosolic enzyme responsible for the bioactivation o f  
aromatic amines
The eluent firaction which induces the greatest mutagenic response contains 15 
proteins of which 6 are present in significant quantities (tables 8.2, 8.3 and 8.6). 
When this firaction was concentrated by freeze drying and analysed for CYPl A 
isoforms immunologically, no CYPl A was detected; therefore, neither microsomal 
CYPl A isoforms nor immunologically related cytosolic enzymes are responsible for 
the bioactivation of 2AA. When this fi-action was compared with the corresponding 
firaction collected at the same time-point, but after loading cytosol firom control 
animals, marked differences were observed, with several proteins expressed more in 
Aroclor 1254-induced cytosol (table 8.2). In particular the lower molecular weight
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proteins and a protein with an estimated molecular weight of 46kDa were expressed 
far more in Aroclor 1254-induced cytosol.
Using concentrated cytosol (50% w/v) three fractions, when used as activation 
systems in the presence of 2AA, expressed considerably higher mutagenicity than all 
other fractions (table 8.3) and, in addition, displayed marked differences in protein 
bands after electrophoresis. Good correlations were obtained between the 
concentration of some of these proteins, determined by UV absorbance, and the 
mutagenicity observed in the three fractions. Three proteins with estimated molecular 
weights of 21.5, 31.5, and 65.5kDa demonstrated the best correlations between 
mutagenicity and protein concentrations with correlation coefficients of 0.9975, 
0.9547 and 0.9504 respectively.
The inhibition of cytosolic bioactivation by ABT, cytochrome c, methylene blue and
(+)-catechin suggest the enzyme responsible for the bioactivation of aromatic amines
receives electrons, possibly through a flavin-containing enzyme, or that this
prosthetic group forms part of the cytosolic enzyme (Chapter 3). Similar observations
have already been made with other cytosolic enzymes, for example nitric oxide
synthase has a protoporphyrin IX prosthetic group and both FMN and FAD (White
and Marietta, 1992). NOS is a monomeric protein of molecular weight 130 kDa. Any
U a5Soc4o.tcd«
enzyme containing haem,jits own reductase would be expected to be
quite large therefore, of the three the 65.5 kDa protein is the most acceptable 
candidate for the cytosolic enzyme but is still small. However, the cytosolic enzyme 
may not be monomeric and therefore in the presence of SDS will break down into
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individual polypeptides and consequently more than one protein band may be 
expected for the cytosolic enzyme.
In an attempt to separate the 3 most likely candidates for the cytosolic enzyme, 
fractions were collected between 85-90 minutes after loading 8 x 2ml of cytosol 
(50% w/v) onto the Sephacryl 300HR column and were pooled, concentrated and 
then loaded onto a Sephacryl lOOHR column. Unfortunately, under the conditions 
employed, there was no separation of these proteins and the mutagenic response 
induced was poor. Therefore, the enzyme appears to be quite unstable under these 
conditions and it cannot be discounted that the lower molecular weight proteins are 
products of degradation. This may explain why such a large range of molecular 
weight proteins are found in each eluent fraction.
8.5. Conclusions
Although the purification of, and therefore the identification of, the cytosolic enzyme 
responsible for 2AA-bioactivation was not achieved in this study, the demonstration 
of a mutagenic response in the Ames test shows that this enzyme does continue to 
fimction after some degree of purification. The residence time on the column 
suggests this activity is not the consequence of contaminating microsomes or of an 
intact mixed-ftmction oxidase system. The cytosolic enzyme cannot be a CYPIA- 
related protein because immunological analysis for CYPl A was negative.
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CHAPTER 9
General discussion and conclusions
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9.1. Introduction
The aiylamines are a group of chemicals, many of which are carcinogenic, found as 
intermediates in the dye and plastics industries, as agricultural chemicals, products 
from the combustion of fossil fuels, components of cigarette smoke and as pyrolysis 
products in cooked foods. Several aromatic amines have been recognised as the 
causative agents responsible for urinary bladder cancer (Case et al., 1954).
As indirect-acting carcinogens, arylamines require metabolism before they can 
interact with DNA. The bioactivation of arylamines to reactive intermediates takes 
place primarily in the liver and is catalysed by the cytochrome P450 oxidases 
(loannides and Parke, 1990), and the flavin-containing monooxygenases (Pelroy and 
Gandolfi, 1980). Both these enzyme systems form highly reactive N-hydroxylamine 
proximate carcinogens. Prostaglandin H synthase is another enzyme responsible for 
the bioactivation of arylamines but this extrahepatic mechanism is not responsible for 
N-hydroxylation (Eling and Curtis, 1992). The principal objectives of this project are 
two-fold, (a) To characterise the cytosolic bioactivation of aromatic amines and 
establish whether microsomal contamination plays a role in this activity, (b) To 
investigate in detail the NADH-dependent microsomal activation of aromatic amines.
9.2. Cytosol-mediated bioactivation of aromatic amines
The bioactivation of aromatic amines by Aroclor 1254-induced hepatic cytosol, in 
the absence of microsomes, was demonstrated by Forster et al., (1981b), when they
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reported the cytosol-mediated mutagenicity of 2AA, 2AF and 2AAF. Additional 
studies have also reported the bioactivation of 2-naphthylamine and 2,7- 
diaminofluorene (Ami et al., 1980; Leist et al., 1992). This cytosol-mediated 
mutagenicity requires NADPH and oxygen, is protein in nature and demonstrates 
marked differences in substrate and cofactor requirements to the microsome- 
mediated bioactivation of mutagens (Forster g/ al., 1981b; Leist et al., 1992; Ayrton 
et a l, 1992).
9.2.1. Cytosol-mediated bioactivation of aromatic amines is not a 
consequence of contamination with microsomal enzymes
One possible explanation of the cytosol-mediated bioactivation of aromatic amines is 
contamination with enzymes from the microsomal fraction however, sufficient 
evidence is now available which makes this proposal extremely unlikely. 
Bioactivation by the cytosolic system was not removed by repeated centrifugation, 
instead the mutagenic response with 2AF and 2AA increased after further 
centrifugations (Leist et al., 1992; Ayrton et al., 1992; Chapter 3). In addition, the 
bioactivation of 6AC by cytosol was considerably decreased by the addition of 
microsomal fraction (Chapter 3).
6-Aminochrysene mutagenicity in the presence of cytosol was not supported by 
NADH, a cofactor effectively utilised by the microsomal fraction (Chapter 3), was 
absent from control cytosol and was not induced by pretreatment with any prototype 
CYP inducers (Chapter 3). Moreover, the cytosolic fraction demonstrated substrate 
specificity distinct from that of the microsomal fraction with some very potent 
microsome-mediated bacterial mutagens being non-mutagenic in the presence of 
cytosol (Chapter 3). Furthermore, incubation of 2AF or 2AAF with cytosol produced
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metabolite profiles completely unlike those generated after incubation with the 
microsomal fraction (Chapter 7). Finally, partially purified cytosolic proteins 
produced mutagenic intermediates from 2AA without the addition of exogenous 
NADPH-cytochrome P450 reductase, which would be required by purified CYP 
(Chapter 8).
9.2.2. Bioactivation of promutagens; substrate specificity of the 
cytosolic fraction
All substrates for the cytosolic bioactivation system have an exocyclic amino group 
(Chapter 3) and, of the amines investigated so far, only 2-aminoanthracene, 2- 
aminofluorene, 2,7-diaminofluorene, 2-acetylaminofiuorene, 6-aminochrysene, 2- 
aminochrysene, 2-naphthylamine, MelQ and 2,3-diaminonaphthylene form 
mutagenic intermediates in the presence of Aroclor 1254-induced cytosol (Forster et 
a l, 1981b; Leist et a l, 1992; Ayrton et a l, 1992; Ami et a l, 1980; Chapter 3). 
Investigation of the dimensions of these compounds showed that not only the depth 
of the mutagen i.e., its degree of planarity, but also the length and width of the 
molecule were important determinants of the susceptibility of these compounds to 
metabolism by the cytosolic fraction. Compounds less than 4.2Â in depth, more than 
12Â in length and less than 9Â in width were the best substrates for bioactivation by 
cytosol (Chapter 3). However, several compounds which were non-mutagenic in the 
presence of Aroclor 1254-induced cytosol also meet these criteria. It appears, 
therefore, that in addition to size and planarity, the position of the amino group and 
the presence of other functional groups in close proximity are also important factors 
in determining the potential of a compound to undergo bioactivation by the cytosolic 
oxidase. If substrates of the cytosolic oxidase have to be planar it is possible that.
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similar to CYPlAl, this cytosolic enzyme has an access channel which acts like a 
sieve for planar molecules (Lewis et a l, 1994). It has also been suggested that the Ah 
receptor has a similar binding site (Lewis et al., 1986), and therefore substrates for 
the cytosolic enzyme could also access the binding site of the Ah receptor. Indeed, 
the involvement of the Ah receptor in the induction of cytosol-mediated bioactivation 
of aromatic amines has been demonstrated (Chapter 6).
9.2.3. Characterisation of the cytosolic oxidase
PCB-induced hepatic cytosol can N-hydroxylate aromatic amines (Chapter 5) by a 
mechanism under the control of the Ah-receptor (Chapter 6). This N-hydroxylation is 
crucial for the bioactivation of aromatic amines, as demonstrated by the loss of 
mutagenicity when N,0-acetyltransferase-deficient bacteria were employed in the 
Ames test (Chapter 3) and the absence of a mutagenic response with chiysene or 2- 
and 6-methylchrysene (Chapter 3). However, no N-hydroxylamine was detected by 
hplc after incubation of Aroclor 1254-induced cytosol with 2AF (Chapter 7). The 
enzyme involved in the bioactivation of arylamines is possibly a haemoprotein, and 
may also contain FMN and FAD responsible for electron transport to haem (Chapter 
3), and has a molecular weight of about 65.5kDa (Chapter 8).
The cytosolic bioactivation of aromatic amines is restricted to the liver (Chapter 3) 
though activity with a similar substrate specificity has been demonstrated in cytosol 
from red blood cells (Duverger-Van Bogaert et al., 1991). Hepatic activity cannot be 
a consequence of contamination with blood because all hepatic samples were 
prepared the same way yet only cytosol firom animals treated with Aroclor 1254 
demonstrated the bioactivation of aromatic amines (Chapter 3). Also methylene blue.
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required by the red blood cell cytosol, inhibited bioactivation in hepatic cytosol 
(Chapter 3).
Slight differences in substrate specificity were observed for Wistar albino and 
Sprague Dawley rat hepatic cytosols (Chapter 3) suggesting the cytosolic enzyme 
may demonstrate some degree of polymorphism. There was also considerable 
variation in the ability of human hepatic cytosol to bioactivate 2AA (Chapter 3). The 
small sample size (3) however makes it impossible to attach any significance to this 
variation, especially without the medical history of the individuals. However, what is 
significant is that human cytosol provoked a mutagenic response thus making the 
investigation of cytosol-mediated bioactivation relevant to human health. Many 
aromatic amines exist in the environment and their metabolism to genotoxic 
intermediates by the cytosol in addition to microsomes, increases the potential for 
DNA damage and tumourogenesis.
9.3. Microsomal NADH-dependent bioactivation
Cytochrome P450 and flavin-containing monooxygenase are both involved in the 
microsome-mediated bioactivation of aromatic amines. In the Ames test, this activity 
is routinely supported by an NADPH-generating system. However, evidence is also 
available that demonstrates the bioactivation amines by Aroclor 1254-induced 
microsomes in the presence of NADH. Previous investigations have shown that, in 
the absence of NADPH, microsomes firom Aroclor 1254-treated rats supplemented 
with NADH metabolised 2AF, dimethylnitrosamine, nitrosopiperidine and 2AA to 
mutagenic intermediates (Leist et a l, 1992; Fong et a l, 1982; Ayrton et al., 1992).
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With each of these mutagens, the mutagenic response was lower in the presence of 
NADH than NADPH but was still substantial.
In this thesis the NADH-dependent bioactivation of aromatic amines, particularly 
2AA, was investigated further to provide evidence that this activity is independent of 
NADPH-dependent metabolism, may involve a novel cytochrome P450 oxidase and 
is induced by PCBs via the Ah receptor.
9.3.1. NADH-dependent microsomal bioactivation of aromatic 
amines; comparison with the NADPH-dependent system
At protein concentrations used in the Ames test (10% v/v activation mixture) only 
modest differences were observed between NADH- and NADPH-dependent 
bioactivation of 2AA (Chapter 4). However, at lower protein concentrations the 
mutagenic response was considerably higher in the presence of NADPH (Chapter 4). 
The two systems also responded very differently to treatment with prototype CYP 
inducers. The NADH-dependent bioactivation of 2AA was only demonstrated after 
treatment with Aroclor 1254 and, to a much lower degree, benzo[a]pyrene, whereas 
NADPH-dependent bioactivation was expressed constitutively, was not induced by 
Aroclor 1254-treatment but was considerably induced after treatment with 
benzo[a]pyrene (Chapter 4). Induction processes involved with NADH- and 
NADPH-dependent bioactivation required the Ah receptor but, 2AA mutagenicity 
with the NADH system in Ah receptor responsive mice was induced to a greater 
extent than the NADPH system in the same strain (Chapter 6).
300
9.3.2. Possible role of cytochrome P450 in the NADH-dependent 
bioactivation of arylamines
Aroclor 1254-induced microsomes supported the N-hydroxylation of 2AA, 2AAF, 
and 2AF (Chapters 4 and 7), which may be catalysed by either cytochrome P450 
(loannides and Parke, 1990), or flavin-containing monooxygenases (Pelroy and 
Gandolfi, 1980). Both these systems employ NADPH as a source of electrons though 
FMO can also use NADH. However, though NADH could supply the second 
electron to the cytochrome P450 cycle via cytochrome bs-reductase, prior to these 
investigations no evidence had been reported for NADH-dependent oxidation of 
xenobiotics by CYP in the absence of NADPH. Although FMO can utilise NADH, 
the Km for NADPH is a tenth that of NADH, and consequently the FMO activity is 
lower with NADH. Similarly, at low protein concentrations, NADH-dependent 2AA 
mutagenicity is markedly lower than in the presence of NADPH (Chapter 4), 
therefore suggesting FMO may play a role in the bioactivation of 2AA by Aroclor 
1254-induced microsomes. However, hepatic microsomes from pig liver, a tissue rich 
in FMO, was unable to catalyse any significant bioactivation of 6AC in the presence 
of NADPH (Chapter 3) and methimazole, an inhibitor of FMO, does not effect the 
bioactivation of 2AA in Aroclor 1254-treated rat microsomes (Rodriguez-Ariza et 
a l, 1995). It is still possible, however, that FMO is responsible for only NADH- 
dependent bioactivation of 2AA especially, as mentioned above, because no evidence 
has previously demonstrated that oxidation of xenobiotics by CYP can occur in the 
presence of only NADH. However, in this thesis, CYPl Al -dependent EROD and 
CYPl A2-dependent MROD activity have been demonstrated in Aroclor 1254-treated 
microsomes in the presence of NADH (Chapter 4). Furthermore, NADH-dependent
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bioactivation of 2AA was only found in microsomes after treatment with Aroclor 
1254 which is a CYPl A and CYP2B inducer and does not induce FMO (Chapter 4). 
However, 2AA did not elicit a mutagenic response in the presence of NADH and 
microsomes from phenobarbitone-treated rat liver. Modest NADH-dependent 2AA 
mutagenicity was also observed in microsomes from benzo[a]pyrene- but not 
phenobarbitone-treated animals (Chapter 4). This suggests that the CYPl A 
subfamily, and not CYP2B, is responsible for NADH-dependent activity. Moreover, 
like CYPIA isoform^ induction of NADH-dependent bioactivation of 2AA is 
achieved via the Ah receptor (Chapter 6). The positive mutagenic response observed 
with IQ in the presence of NADH is further evidence of a role for CYPl isoforms in 
NADH-dependent bioactivation because the bioactivation of IQ is catalysed by 
members of the CYPl family but not FMO.
Even though (+)-catechin, an inhibitor of NADPH-cytochrome P450 reductase, 
decreased 2AA bioactivation in the presence of NADH, neither cytochrome c nor 
inhibitory antibodies to NADPH-cytochrome P450 reductase had any effect on this 
bioactivation system (Chapter 4). This is not unexpected however, because NADH 
supplies electrons to CYP via NADH-cytochrome bs reductase which is unaffected 
by cytochrome c.
A novel CYPl subfamily, namely CYPIB, has recently been described in mice, rat 
and human tissues (Savas et al., 1994; Spink et al., 1994; Sutter et al., 1994, Walker 
et a l, 1995). This subfamily is induced by pretreatment with TCDD, 
benz[a]anthracene, p-naphthoflavone and benzo[a]pyrene (Savas et al., 1994; Shen et 
al., 1994), but induction by PCBs has not been investigated. Expression of CYPIB 1
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is found mainly in extrahepatic tissues such as adrenal glands and testes (Walker et 
a l, 1995), and after induction with p-naphthaflavone is found in lung, liver, kidney 
and uterus (Savas et a l, 1994). The involvement of CYPIB 1 in the activation of 
various promutagens, using human CYPIB 1 expressed in Saccharomyces cerevisiae, 
compared to activation by purified CYPIA isoforms, in a reconstituted system, has 
recently been investigated (Shimada et a l, 1996). CYPIB 1 was better at the 
bioactivation of Trp-P-1, 2AA, 3-methoxy-4-aminoazobenzene and many other 
mutagens in the umu test than CYPIA isoforms and, also catalysed the activation of, 
amongst others, IQ, MelQ, 2AF and 6AC (Shimada et a l, 1996). The level of 
activation of 2AF and 6AC by CYP IB 1 was comparable to bioactivation by 
CYP1A2 and CYPlAl respectively. It is possible that the involvement of CYPIB I 
in the bioactivation of aromatic amines is responsible for differences between 
NADPH- and NADH-dependent bioactivation in the Ames test. However, no 
investigation of NADH-mediated CYPIB 1 activity has been undertaken and, 
comparisons between CYPIA and CYPIB 1 activity cannot be made because, in this 
report, these isoforms were investigated in different expression systems. The 
preferential activation of 2AA by human CYPIB 1 in the presence of NADPH 
(Shimada et al., 1996) does suggest that this isoform, and not CYP1A2 or CYPlAl, 
is responsible for the majority of bioactivation by microsomes which is agreement 
with previous investigations where no correlation was obtained between aryl 
hydrocarbon hydroxylase activity and 2AA mutagenicity (Zieger et a l, 1979). 
NADH-dependent EROD and MROD activity suggest CYPlAl and CYP1A2 are 
responsible for NADH-dependent 2AA mutagenicity however, EROD is also 
catalysed by CYP IB 1 (Gentest Corporation, personal communication) and therefore
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the greater EROD activity with NADPH may be the consequence of metabolism by 
CYPIBI, in addition to CYPlAl. NADH-dependent CYP IB 1 activity has not been 
investigated but this isoform was unable to metabolise dimethylnitrosamine, which 
does undergo NADH-dependent bioactivation (Fong et al., 1982), to mutagenic 
intermediates in the presence of NADPH (Shimada et al., 1996).
It is possible that more than one enzyme is responsible for NADH-dependent 
bioactivation of mutagenic amines because of the structural diversity of mutagens 
which undergo bioactivation by this system. 2AA, 2AF, 6AC and nitrosopiperidine 
are all converted to mutagenic intermediates in the presence of NADH by Aroclor 
1254-induced microsomes. However, in the presence of NADPH, the major CYP 
isoforms responsible for the bioactivation of these amines are CYPIBI, CYPIAl/2, 
CYP2B1/2 and CYP2E1 respectively (Shimada et al., 1996; Yamazaki et al., 1993; 
Kokkinakis et al, 1985; Yang et a l, 1985). Therefore, it is unlikely that one enzyme 
can metabolise such a variety of substrates. However, flavin-containing 
monooxygenase can conceivably metabolise a large number of substrates because 
oxygen binds to the flavin prosthetic group before the substrate, forming a 
hydroperoxyflavin, such that any compound that can subsequently be oxidised by 
this hydroxyflavin is a possible substrate for FMO. As mentioned earlier, however, 
FMO differs firom this NADH-dependent system in that it is not induced by Aroclor 
1254-treatment and is not under the regulation of the Ah receptor (Chapter 4).
In conclusion, the NADH-dependent bioactivation of aromatic amines appears to be 
distinct firom activation with NADPH, and demonstrates similarities, but also several 
differences, to both the CYP and flavin-containing monooxygenase systems. Thus,
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on the basis of available data, it cannot be established unequivocally whether either 
of these systems or a novel enzyme is responsible for this activity. However, it is 
clear that this enzyme is induced via the Ah receptor (Chapter 6) and is responsible 
for the N-hydroxylation of aromatic amines (Chapter 4).
9.4. Future work
9.4.1. Further investigation of the cytosolic enzyme
Although this thesis has shown cytosolic bioactivation of arylamines to be
independent of microsomes (Chapter 3), has increased the understanding of how it is 
induced (Chapter 6), determined its substrate specificity (Chapter 3) and its 
distribution in different tissues, strains, and species some aspects still demand further 
investigation.
Attempts were made to purify the cytosolic protein responsible for the bioactivation 
of amines but only partial purification was obtained and, though a protein of 65.5kDa 
molecular weight was identified as the most likely candidate for this enzyme, the 
identity of the enzyme could not be proven (Chapter 8). Difficulties arose in the 
detection of activity in the eluent firaction. The Ames test was employed but specific 
activities were difficult to interpret because results are only considered to be positive 
if the number of revertants is at least double the spontaneous reversion rate. 
Therefore, at low protein concentrations the sensitivity of the assay was low. 
Moreover, the required 48 hours incubation of plates was too time consuming. The 
stability of this enzyme has not been studied to ensure that it does not degrade under
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the conditions of storage. As polycyclic aromatic hydrocarbons tend to be highly 
fluorescent, it would be preferable to develop a rapid fluorimetric method for the 
measurement of metabolism of substrates such as 6AC and 2AA.
The requirement of the aromatic amine bioactivation system for bacterial N ,0- 
acetyltransferase has been demonstrated using bacteria deficient in this enzyme 
(Chapter 3 and 4). An increased mutagenic response with aromatic amines has also 
been observed using a strain of Salmonella typhimurium (NM2009) which is O- 
acetyltransferase over-expressing because of the introduction of an O- 
acetyltransferase gene (Yamazaki et al., 1992). This bacterial strain is, therefore 
more sensitive to aromatic amine-mediated mutagenesis (Yamazaki et al., 1992) and 
would be superior at detecting activity in eluent fractions. Furthermore, this bacterial 
strain is employed in the umu test, a more sensitive assay for mutagenicity which 
also has the benefit of being less time consuming than the Ames test. Further 
attempts to purify the cytosolic enzyme may therefore employ NM2009 and the umu 
test system to screen firactions for bioactivating activity. The fractions containing the 
highest specific activity can than undergo further purification either using the same 
column but changing the conditions e.g., pH, concentration of the mobile phase, 
temperature, or, using a different packing material. Once purified the cytosolic 
protein may be used to raise antibodies which may be employed in immunodetection 
of the cytosolic enzyme.
The presence of cytosol-mediated 2AA bioactivation has been demonstrated in three 
human hepatic samples (Chapter 3). However, the relevance of this finding to human 
cancer is unknown and, the inadequate supply of human tissues makes investigation
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difficult. If polyclonal antibodies raised to the rat cytosolic enzyme cross-reactive 
with the human form of this enzyme then only small amounts of human tissues 
would be required to establish the presence of this enzyme by immunoblotting. This 
may allow the investigation of larger numbers of individuals and also comparisons 
between healthy individuals and those with cancer or, comparisons between 
individuals who are smokers, alcoholics, or exposed occupationally to aromatic 
amines, with relevant controls. These studies would determine the relevance of the 
cytosolic enzyme to human carcinogenesis.
In the absence of antibodies to the cytosolic enzyme, the relevance of the cytosol- 
mediated bioactivation may be investigated further in experimental animals e.g., 
whether this activity is induced by cigarette smoke, high-fat diets, alcohol or 
exposure to heterocyclic amines in cooked meats. Indeed, a modest but significant 
(p<0.01) increase in cytosol-mediated bioactivation of 2AA and 2AAF has been 
demonstrated by rats fed ethanol for 30 days (Traynor et al., 1991).
In the present investigations the substrate specificity of the cytosolic enzyme was 
investigated and it was found that the best substrates were amines that are less than 
4.2Â in depth, 9Â in vddth but more than 12Â in length (Chapter 3) yet other amines 
with comparable dimensions were non-mutagenic in the presence of the cytosolic 
fraction. However, only a limited number of amines were investigated, at 
considerably different concentrations and mutagenicity was not determined in the 
same study to ensure strict comparability. To investigate the structure-activity 
relationship, and consequently gain an insight into the binding site of the cytosolic 
enzyme, it is necessary that a larger number of amines is investigated concurrently, at
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the same concentration or, at a range of concentrations to give a linear response, so 
that specific activity can be expressed as revertants per mg of mutagen, to allow 
better comparison between mutagens.
9.4.2. Further investigation of the microsomal NADH-dependent 
enzyme
The identity of microsomal enzymes which utilise NADH as cofactor in the 
bioactivation of amines to mutagens has not been determined. The involvement of 
the cytochrome P450 oxidases or flavin-containing monooxygenases may be 
investigated using specific inhibitors e.g., a-naphthofiavone, metyrapone, 
methimazole, or inhibitory antibodies. Furthermore, investigation of NADH- 
mediated bioactivation by reconstituted purified CYP or FMO would also 
demonstrate which, if any, of these enzymes is responsible for this activity.
The importance of NADH-dependent bioactivation to mutagenicity testing and 
human carcinogenesis are unknown. NADH-dependent activation, of the limited 
number of substrates so far investigated, is lower than activation in the presence of 
NADPH (Fong et al., 1982; Leist et a l, 1992; Ayrton et a l, 1992; Chapter 4), and 
has not been demonstrated for any compound which is non-mutagenic in the 
presence of NADPH. Therefore, to determine the importance of this enzyme to 
mutagenicity testing requires that the substrate specificity be thoroughly investigated, 
using both known bacterial mutagens and compounds non-mutagenic in the presence 
of NADPH-containing activation mixtures, but for which carcinogenicity and/or 
mutagenicity in in vivo tests has been determined. It is also essential that the presence 
of the NADH-dependent system is demonstrated in human hepatic microsomes. 
Finally, if  after thorough investigation the NADH-dependent activity cannot be
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attributed to an existing enzyme system, then the purification of the active protein 
and in vitro reconstitution are essential.
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Appendix I
Analysis of hepatic cytosol-generated 2AAF and 2AF 
metabolites by mass spectrometry
Methods
2AAF and 2AF metabolism and isolation o f their metabolites
Ring-labelled [^H]2AAF (Img, 32]aCi) or ring-labelled fH]2AF (Img, 32pCi) were 
incubated at 37° C for 2 hours in the presence of hepatic cytosol (4ml of a 25%w/v 
fraction), the metabolites were extracted using ice-cold ethyl acetate and separated by 
hplc as described in Chapter 7. Incubations were performed in duplicate and 
metabolites were collected after multiple injections; the amount of each metabolite 
was determined by scintillation counting. The methanol was evaporated under 
vacuum and the remaining aqueous phase was removed by freeze drying. Metabolites 
were stored dried at 4 ° C in the dark until they could be analysed.
Mass Spectrometry
All mass spectrometry was kindly performed by Derek Hillbeck (Hoechst Marion 
Roussel, Walton Milton Keynes).
GCiMS
GC:MS analysis was performed using a modified method of that previously employed 
by Boyd et ah, (1983). Samples were introduced onto a Hewlett Packard HP-1 
dimethyl silicon (0.33pM) colunrn (12m long x 0.2mm internal diameter) with a 
helium flow rate of 36cmVsecond. The GC column was maintained at 180°C for 1 
min, and the temperature was subsequently increased linearly to 280 °C at a rate of 
16°C/min. The GC was interfaced directly with a Kratos MS80RFA mass
spectrometer. MS conditions were: 70eV electron impact ionisation, lOOpA trap 
current, a source temperature of 220° C and full scanning was carried out between 600 
and 25 mass units.
LC:MS
Aliquots (10-30pg) were added to lOOpl of mobile phase (70% methanol: 30% 5mM 
ammonium acetate) and injected onto the column. Separation was achieved using a 
flow rate of 0.2ml/min. The flow was directed into the Turbolonspray interface of a 
Sciex API300 mass spectrometer. Full scanning was carried out from 30-400 mass 
units in 0.2 mass unit increments.
Results
Authentic 2-aminofluorene, 2-acetylaminofluorene and 2-nitrofluorene were 
employed as standards and produced the expected spectra, demonstrating molecular 
ions with masses of 181, 223 and 211 mass units respectively. Analysis of metabolites 
by GC:MS was only able to confirm that the compounds were derived from 2AAF 
and 2AF. This was possibly a consequence of the analysis only being carried out 
under routinely employed conditions as np optimisation of the procedure could be 
undertaken. Improved analysis could be achieved given time by modification of the 
analysis conditions and authentic metabolites could have been used to ensure their 
stability during analysis. Furthermore, the published methodology for the GC:MS of 
related compounds does not volunteer information on the injection technique
employed. It is possible that these metabolites thermally decompose under these 
injection conditions. The absence of any detectable components for 2AF metabolite 7 
may support this hypothesis. Therefore each metabolite was also analysed by LC:MS. 
Unfortunately LC:MS was also only able to identify molecular ions corresponding to 
2AAF and 2AF and not molecular ions corresponding to any of the expected 
metabolites. Consequently, the absence of any useful information is, probably, the 
result of sample degradation prior to analysis.
Table 1, Molecular ions identified for metabolites of 2AF and 2AAF 
formed after incubation with Aroclor 12544nduced cytosol
Sample Major molecular ion
Standards
2-Aminofluorene 181
2-Acetylaminofluorene 223
2-Nitrofluorene 211
2-AF metabolites
1 181
5 181
6 181
7 289,246
9 181
10 181
2-AAF metabolites
3 not 2-AAF related
4 not 2AAF related
5 223
6 181
7 not 2AAF related
Metabolites are numbered as described in Figures 7.3 and 7.6.
After LC:MS analysis of 2AF metabolite 7, the major molecular ions were detected 
had masses of 289 and 246 implying the compound is non-parent related. However 
the large amount of radioactivity in this sample indicates otherwise. A weak signal 
was detected for a molecular ion of mass 165, which corresponds to the fluorene 
nucleus and consequently the difficulties observed with the analysis of this metabolite 
may be a result of the presence of large amounts of contaminants, particularly 
phthalates, a common contaminant, which have very stable fragment ions responsible 
for strong MS signals.
Only molecular ions with sufficient stability to reach the ion collector of the mass 
spectrometer are detected. It is possible, though unlikely, that these metabolites are 
unstable under the conditions employed. It is more likely that whilst awaiting analysis 
the metabolites have degraded even though all samples were stored in the dark at 
4°C.
With hindsight, improved analysis could have been achieved by on-line LC:MS 
analysis of the metabolites immediately following extraction from the incubation 
mixture. Unfortunately, neither time nor access to equipment allowed this to be 
investigated.
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6-Aminochrysene was converted into mutagen(s), in the Ames 
test in the presence of Aroclor 1254-induced hepatic S9, 
microsomal and cytosolic fractions, the first being the least 
and the last the most efficient activation system. The cytosolic 
activation of 6-aminochrysene decreased in the presence of 
increasing amounts of microsomes. The Aroclor 1254-induced 
rat microsomal and cytosolic systems differed markedly in 
a number of properties, including their cofactor requirements 
and responses to prototype inducers of the cytochrome 
P450-dependent mixed-function oxidase system. The cytosolic 
activation system could also convert 2-aminochrysene to 
mutagens but not 2- and 6-methylchrysene. Human hepatic 
cytosol could convert 6-aminochrysene and 2-aminoanthracene 
to mutagens in the Ames test. It is concluded that a hepatic 
cytosolic oxygenase exists, totally different from the 
microsomal oxygenases, which metabolizes aminopolycyclic 
aromatic hydrocarbons to mutagens, presumably through 
N-oxidation. This oxygenase activity appears to be present 
in human hepatic cytosol.
Introduction
Chemical carcinogens containing an exocyclic amino group 
express their carcinogenicity/mutagenicity through highly reactive 
intermediates, believed to be nitrenium ions. These are formed 
metabolically, the first step being an N-hydroxylation; the 
resulting hydroxylamines are spontaneously converted under 
acidic conditions or following the formation of 0-esters, to their 
corresponding nitrenium ions.
The N-hydroxylation of aromatic amines is catalysed by at least 
two NADPH-dependent enzyme systems, the FAD-monooxygen- 
ase system (Ziegler, 1990) and the cytochrome P450-dependent 
mixed-function oxidases (Guengerich, 1988). An NADH- 
pathway has also been described (Ayrton et al. , 1992; Leist et 
al. , 1992). Of the various cytochrome P450 families, the CYPl 
appears to be the most important catalyst of the N-hydroxylation 
of aromatic amines (Masson et al. , 1983; Hammons et al. , 1985; 
loannides and Parke, 1990). This family comprises a single 
subfamily that contains two proteins, namely CYPlAl and 
CYP1A2, and it is the latter which is more closely associated 
with the N-hydroxylation of aromatic amines.
Following the initial observations of Forster et al. (1981), the 
presence of a cytosolic oxygenase in the liver, capable of 
activating some aromatic amines such as 2-aminofluorene and 
its derivatives, and 2-aminoanthracene has been described 
(Traynor et a l ,  1991; Ayrton et al. , 1992; Leist et al. , 1992). 
The cytosolic system, however, failed to activate carcinogens 
such as 4-aminobiphenyl, benzidine and the highly mutagenic 
heterocyclic amine IQ (2-amino-3-methylimidazole[4,5-f]- 
quinoline), a food mutagen (Abu-Shakra et al. , 1986; Leist et al. ,
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1992). This system is NADPH-dependent and its characteristics 
are consideraWy different from those of the microsomal enzymes; 
experimental evidence has been provided to show that the 
cytosolic system does not constitute microsomal contamination.
The present study was undertaken in order to: (i) evaluate the 
possible role of cytosol in the activation of aminopolycyclic 
aromatic hydrocarbons, such as 6-aminochrysene, an important 
class of environmental contaminants; (ii) compare the capacities 
of hepatic microsomal and cytosolic preparations in bioactivating 
these chemicals; (iii) establish whether the microsomal and 
cytosolic activation systems are inducible by cytochrome P450 
prototype inducing agents; (iv) to investigate whether human 
hepatic cytosol is also capable of activating aromatic amines.
Materials and methods
2-Aminochiysene and 6-aminochrysene (Koch Light Laboratories, Bucks, UK) 
2- and 6-methylchrysene (Community Bureau of Reference, Commission of the 
European Communities, Brussels, Belgium), 2-aminoanthracene (Ralph and 
Emmanuel, Middlesex, UK), Aroclor 1254 (Robens Institute, University of 
Surrey), phenobarbitone (BDH, Dorset, UK), benzo(a)pyrene, isoniazid, 
dexamethasone-21-phosphate and all cofactors (Sigma Co., Dorset, UK) were 
all purchased. The Salmonella typhimurium strain TA98 was a gift from Professor 
B.N.Ames, Berkeley, CA, USA.
Male Wistar albino rats (150—200 g), male golden Syrian hamsters 
(1 0 0 -1 2 0  g), and a male albino ferret (1500 g), were used in the studies. Fresh 
male pig liver was obtained from the local abattoir and the human hepatic cytosolic 
samples were a gift from Dr A.Boobis, Royal Postgraduate Medical School, 
London, UK.
Induction of the mixed-ftmction oxidases was achieved by administration of 
single daily intraperitoneal (i.p.) injections o f benzo(a)pyrene (25 mg/kg), 
phenobarbitone (80 mg/kg), clofibrate (80 mg/kg), and dexamethasone 
(100 mg/kg) and isoniazid (100 mg/kg) intragastrically for 3 days, all animals 
being killed 24 h after the last administration. Aroclor 1254 was administered 
as a single i.p. injection (500 mg/kg), the animals being killed on the 5th day 
following administration.
Livers were immediately excised and postmitochondrial (S9), microsomal and 
cytosolic fractions were prepared as previously described (loannides and Parke, 
1975) and were stored at —70°C until use. Microsomal and cytosolic fractions 
were prepared on the day of use. Unless otherwise stated, the cytosol was decanted 
and recentrifuged at 105 000 g for 1 h in order to remove any contaminating 
microsomes. Total cytochrome P450 (Omura and Sato, 1964) and protein (Lowry 
et a l ,  1951) were determined in the microsomal preparations.
Mutagenicity was determined using the Ames test (Maron and Ames, 1983) 
employing Salmonella typhimurium strain TA98 and 10% (v/v) hepatic preparations 
as activation systems, unless otherwise stated. When microsomes were used, the 
activation system was supplemented with glucose 6-phosphate dehydrogenase 
(1 unit/plate). When postmitochondrial preparations were compared with 
microsomes and cytosol as activation systems, the postmitochondrial fraction was 
separated into its components, i.e. microsomes and cytosol, and then 
rehomogenized so as to take into consideration any effects due to centrifugation.
Results
6-Aminochrysene was converted to mutagens in the Ames test 
by all three hepatic fractions, S9, microsomal and cytosolic, 
derived from rat pretreated with Aroclor 1254. The cytosolic 
system was by far the most efficient metaboliser, whereas S9 
displayed the poorest degree of activation (Table I). In order to 
further investigate the mechanism responsible for the poor 
mutagenic response observed with the S9 preparations, 
microsomes (10% v/v) and cytosol (10% v/v) were mixed 
with increasing amounts of cytosol and microsomes respectively
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Table I. Bioactivation of 6-aminochrysene by rat hepatic fractions
Histidine revertants/plate
(/tg/plate) S9 Microsomes Cytosol
Spontaneous reversion rate 23 ±  1 18 ±  7 21 ±  4
0.05 33 ±  7 17 ±  7 129 ±  11
0.10 29 ±  1 16 ±  3 349 ±  34
0.20 34 ±  7 36 ±  13 703 ±  28
0.30 105 ±  26 329 ±  45 1125 ±  76
0.40 600 ±  131 944 ±  216 1124 ±  71
The test was carried out using Salmonella typhimurium strain TA98 and 
10% (v/v) activation systems from Aroclor 1254 induced rats. When 
isolated microsomes were used, the activation system was supplemented 
with glucose 6-phosphate dehydrogenase (1 unit/plate). Results are presented 
as mean ±  SD of triplicates. The test was repeated using hepatic samples 
from another, similarly-treated animal with similar results.
Table II. Influence of the interactions o f microsomes and cytosol in the
bioaetivation of 6-aminochrysene
Mierosomes (10%) Histidine
revertants/plate
Cytosol (%) 
0
2.5
5.0
7.5
10.0
144 ±  29 
206 ±  22 
218 ±  14 
166 ±  5 
125 ±  2
Cytosol (10%) Histidine
revertants/plate
Microsomes (%) 
0
2.5
5.0
7.5
10.0
1277 d= 126 
2771 ±  294 
844 d= 99 
389 ±  50 
164 ±  34
The test was performed using Salmonella typhimurium strain TA98, 
6-aminochrysene (0.6 ftg) as the promutagen and hepatic fractions from 
Aroclor 1254-induced rats. The spontaneous reversion rate was 20 ±  7. 
Under the same conditions S9 (10% v/v) activation produced 166 ±  15 
revenants. Results are presented as mean ±  SD of triplicates. The study 
was repeated using different, but similarly-treated, activation systems with 
similar results.
Table HI. Effect o f repeated centrifugation on the cytosolic mutagenicity of 
6-aminochrysene
No. o f centrifugations Histidine
revertants/plate
Spontaneous reversion rate 20 ±  3
1 1932 ±  465
2 859 ±  261
3 992 ±  257
The test was carried out using Salmonella typhimurium strain TA98, 
6-aminochrysene (0.8 ^g) as the promutagen and hepatic cytosol (10% v/v) 
as the activation system. The cytosol was repeatedly centrifuged at 105 (X)0 
g for 1 h and carefully decanted. Results are presented as mean ±  SD of 
triplicates.
(Table H). The microsome-induced mutagenicity of 6-amino­
chrysene was not significantly influenced by the presence of 
cytosol but, in contrast, cytosol-induced mutagenicity, after an 
initial rise, was markedly inhibited by the presence of increasing 
amounts of microsomes (Table II).
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Fig. 1. Cofactor requirements for the hepatic microsomal and cytosolic 
activation of 6-aminochrysene. The study was carried out using Salmonella 
typhimurium strain TA98, 6-aminochrysene (0.8 /tg) and 10% (v/v) hepatic 
activation systems from Aroclor 1254-treated rats. The cofactor 
concentrations used were: NADPH (5 mM glucose 6-phosphate and 4 mM 
NADP, supplemented with 1 unit/plate glucose 6-phosphate dehydrogenase 
in the case o f microsomes): NADP (4 mM) and NADH (8 mM). The 
spontaneous reversion rates were 24 ±  5 and 27 ±  6 for microsomes and 
cytosol respectively. Each study represents the mean of triplicates.
In order to eliminate any contribution of microsomal activation 
to the cytosolic activation, the cytosol was further centrifuged. 
An additional centrifugation resulted in a drop in the mutagenic 
response, but further centrifugation had no significant effect 
(Table HI). Consequently, in all studies cytosol was recentrifuged 
to remove any microsomal contamination.
The microsomal activation of 6-aminochrysene was supported 
by both NADPH and NADH but only the former supported the 
cytosolic activation (Figure 1). Increasing the concentration of 
the cytosolic fraction increased mutagenic response up to at least 
20% (v/v), but when microsomes were used as the activation 
system maximum mutagenic response was seen at 10% (v/v) 
concentration, and this declined markedly when the concentra­
tion of microsomes was increased to 20% (v/v) (Figure 2).
Methylene blue could not effectively support the cytosol- 
mediated mutagenic response of 6-aminochrysene when compared 
to an NADPH-generating system (Table IV). It is believed that 
methylene blue maintains haemoglobin in its reduced oxygenated 
form.
Aroclor 1254-induced rat hepatic microsomal and cytosolic 
preparations clearly converted 6-aminochrysene and its 2-isomer 
to mutagenic intermediates in the Ames test, but when 6-methyl­
chrysene and its 2-isomer were used as the promutagens no 
positive mutagenic response was evident (Figure 3).
Microsomes from untreated rats were very efficient in 
converting 6-aminochrysene to mutagens whereas cytosol gave 
rise to a weak mutagenic effect (Table V). Treatment of rats with 
Aroclor 1254 markedly enhanced cytosohc activation of 6-amino- 
chrysene whereas, in contrast, microsomal activation was 
markedly reduced despite the much higher cytochrome P450 
levels. Pretreatment with benzo(a)pyrene decreased microsome- 
mediated mutagenic response but had no influence on the degree 
of mutagenicity in the presence of the cytosolic activation system
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Fig. 2. Dependence of the cytosolic and microsomal activation of 
6-aminochrysene on the concentration of the activation system. The study 
was carried out using Salmonella typhimurium strain TA98, 6-aminochrysene 
(0.8 /tg) and Aroclor 1254-induced hepatic preparations. The spontaneous 
reversion rates o f 24 ±  3 and 22 ±  4 for microsomes and cytosol 
respectively have already been subtracted. Each point represents the mean 
±  SD of triplicates. ( □ ,  Microsomes; ■ ,  cytosol.)
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Table IV. Bioactivation of 6-aminochrysene 
blue
in the presence of methylene
Activation system Histidine
revertants/plate
Spontaneous reversion rate 12 ± 2
NADP (4 mM) -h G6P (5 mM) 754 ±  16
Methylene blue (1.33 ftM) 49 ±  7
The test was performed using hepatic cytosol (10%, v/v) from Aroclor 
1254-induced rats, Salmonella typhimurium strain TA98 and 
6-aminochrysene (0.6 pg). Results are expressed as mean ±  SD of 
triplicates. The experiment was repeated using as activation system a hepatic 
fraction from another, similarly-treated animal, with similar results. G6P, 
glucose 6-phosphate.
(Table V). Pretreatment of rats with phenobarbitone, isoniazid, 
dexamethasone and clofibrate caused only minimal effects on the 
microsomal activation of 6-aminochrysene. Similarly, cytosolic 
activation was not drastically altered by these pretreatments, but 
a modest increase and decrease in mutagenicity was observed 
with animals treated with phenobarbitone and clofibrate 
respectively (Table V). It is appreciated that, when microsomes 
were used as the activation system, with some activation systems 
maximum activation had already been achieved at the lowest 
promutagen concentrations making comparisons between 
inducing agents difficult. However, use of lower promutagen 
concentrations would make mutagenic response difficult to detect 
with the cytosolic and some microsomal preparations.
Untreated rat, and to a lesser extent, hamster microsomes could 
readily transform 6-aminochrysene to mutagens but ferret and 
pig microsomes provoked only a weak mutagenic response 
(Figure 4). Cytosolic preparations from the above animal species 
produced very weak or no mutagenic response (Table VI). When 
2-aminoanthracene was used as the promutagen, microsomes
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Fig. 3. Bioactivation of 2- and 6-aminochrysene and of their methyl 
analogues to mutagens in the Ames test. The study was carried out using 
Salmonella typhimurium strain TA98 and 10% (v/v) hepatic activation 
systems from Aroclor 1254-induced rats. Each point represents the mean 
±  SD for triplicates. ( ■ ,  2-Aminochrysene; □ ,  6-aminochrysene; T, 
2-methylchrysene; O , 6-methylchrysene.)
from rat and hamster gave rise to a clear mutagenic response 
but cytosolic preparations could not provoke a positive response 
(Figure 5 and Table VI). Cytosolic preparations from three 
different human livers converted both 6-aminochrysene and 
2-aminoanthracene to mutagens in the Ames test (Table VII).
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Fig. 4. Species differences in the hepatic microsomal activation of 6-amino­
chrysene to mutagens. The study was carried out using Salmonella 
typhimurium strain TA98, 6-aminochrysene (1.0 pg) and 10% (v/v) hepatic 
microsomal activation systems from untreated animals. The spontaneous 
reversion rates of 16 ±  3, 29 ±  6, 20 ±  7 and 14 ±  1 for the rat, 
hamster, ferret and pig respectively, have already been subtracted. Each 
point represents the mean ±  SD for triplicates. ( ■ ,  Rat; • ,  hamster; O , 
ferret; ▼, pig.)
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Fig. 5. Species differences in the hepatic microsomal bioactivation of 
2-aminoanthracene to mutagens in the Ames test. The study was carried out 
using Salmonella typhimurium strain TA98, 2-aminoanthracene (5.0 /rg) and 
10% (v/v) activation systems from untreated animals. The spontaneous 
reversion rates are shown in the legend to Figure 4 and have already been 
subtracted. Each value represents the mean ±  SD for triplicates.
T able V. Effect of cytochrome P450 induction on i 
6-aminochrysene by hepatic preparations
the bioactivation of
Inducing agent Cytochrome P450 Histidine revertants/plate
and 6-amino (nmol/mg protein) cytosol microsomes
chrysene
concentration
(/xg/plate)
Control 0.79
0.25 16 ±  3 1867 ± 22
0.50 40 ±  12 1819 ± 248
0.75 46 d= 4 1613 ± 165
1.00 42 ±  5 1197 165
Aroclor 1254 3.15
0.25 186 ±  17 4 ± 2
0.50 361 ±  34 16 ± 9
0.75 401 ±  27 28 ± 14
1.00 535 ±  20 154 ± 21
Benzo(a)pyrene 1.18
0.25 13 ±  4 4 ± 3
0.50 41 ±  6 35 ± 6
0.75 38 ±  12 119 ± 4
1.00 44 ±  3 296 ± 30
Phénobarbital 1.12
0.25 44 ±  15 1309 ± 140
0.50 62 ±  4 1175 ± 174
0.75 95 ±  3 867 ± 42
1.00 101 ±  3 673 ± 46
Isoniazid 0.71
0.25 18 ±  8 759 ± 176
0.50 31 ±  10 1171 ± 71
0.75 56 ±  7 1379 ± 79
1.00 48 ±  4 1190 ± 125
Dexamethasone 0.81
0.25 33 ±  5 1009 ± 33
0.50 65 ±  20 1422 ± 213
0.75 82 ±  11 1893 ± 260
1.00 69 ±  6 1895 ± 160
Clofibrate 0.72
0.25 1 ±  1 960 ± 215
0.50 9 ±  3 1497 ± 216
0.75 17 ±  11 1665 ± 153
1.00 28 ±  3 2186 ± 97
Test was carried out using Salmonella typhimurium strain TA98 and 10% 
(v/v) rat hepatic activation systems supplemented with glucose 6-phosphate 
dehydrogenase (1 unit/plate) in the case of microsomes. The spontaneous 
reversion rate of 20 ±  5 has already been subtracted. The study was 
repeated utilising different samples, from similarly-treated animals with 
similar results.
Discussion
6-Aminochrysene can conceivably be activated through two 
distinctly different metabolic pathways. The first involves 
formation of the bay-region dihydrodiol-epoxides, as 
demonstrated for the parent hydrocarbon chrysene and its methyl 
derivatives (Amin et al., 1985; Hecht et al., 1987). Alternatively, 
in analogy to other aromatic amines, it may undergo N-oxygena- 
tion to yield the hydroxylamine that leads to the formation of 
the nitrenium ion, a potent electrophile. In the Ames test, in the 
presence of Aroclor 1254-induced hepatic microsomes, 2- and 
4-methylchrysene elicited no positive mutagenic response, 
whether microsomes or cytosol served as activating system, in 
agreement with previous studies (Cheung et al. , 1993). Chrysene 
did elicit a positive mutagenic response but at much higher 
concentrations than those employed in the present study with the 
various promutagens (Cheung et a l ,  1993). In contrast, under
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Table VI. Species differences in the cytosolic activation of 6-aminochrysene 
and 2-aminoanthracene to mutagens
Animal Promutagen Mutagenicity
species (Atg/plate) (histidine revertants/plate)
Rat 6-AC (0.6) 26 ±  7
6-AC (1.0) 29 ±  3
2-AN (5.0) 26 ±  9
Hamster 6-AC (0.6) 20 ±  8
6-AC (1.0) 25 ±  4
2-AN (5.0) 30 ±  8
Ferret 6-AC (0.6) 20 ±  2
6-AC (1.0) 14 ±  3
2-AN (5.0) 11 ± 1
Pig 6-AC (0.6) 25 ±  9
6-AC (1.0) 37 ±  8
2-AN (5.0) 24 ±  2
The test was carried out using 10% (v/v) cytosolic preparations from 
untreated animals and Salmonella typhimurium strain TA98. The 
spontaneous reversion rate was 16 ±  5. Results are presented as mean 
±  SD of triplicates. 6-AC, 6-aminochrysene; 2-AN, 2-aminoanthracene.
Table VU. Metabolic activation of 2-aminoanthracene and 6-aminochrysene 
to mutagens in the Ames test by human hepatic cytosol
Carcinogen Histidine revertants/plate
sample 1 sample 2 sample 3
Spontaneous reversion rate 17 ±  1 21 ±  1 26 ±  5
6-Aminochrysene (1 ftg/plate) 37 ±  3 84 ±  23 68 ±  5
2-Aminoanthracene (5.0 /tg/plate) 217 ±  59 166 ±  53 326 ±  47
The test was carried out using 10% (v/v) hepatic cytosolic preparations and 
Salmonella typhimurium strain TA98. Results are presented as mean ±  SD 
for triplicates.
the same conditions, 2- and 6-aminochrysene both induced a 
strong mutagenic response. These observations indicate that the 
aminochrysene-induced mutagenicity is most likely to reflect 
activation through N-oxygenation rather than arene oxidation. 
Indeed the hepatic DNA adducts formed by 6-aminochrysene are 
primarily derived from the hydroxylamine (Delclos et al., 1987).
6-Aminochrysene induced a positive mutagenic response in the 
presence of Aroclor 1254-induced cytosol, isolated microsomes 
and postmitochondrial rat hepatic preparations, the first being 
the most and the last the least effective activation system. It has 
been demonstrated that Aroclor 1254-induced cytosol could 
activate other aromatic amines such as 2-aminoanthracene and 
2-aminofluorene and its derivatives (Traynor et al. , 1991; Ayrton 
et al. , 1992; Leist et al. , 1992). The fact that the best mutagenic 
response was achieved with the cytosolic system whereas the S9 
preparation (microsomes +  cytosol) induced a poor response, 
raised the possibility that the cytosol-generated mutagens could 
be deactivated by microsomal enzymes. In order to elucidate the 
responsible mechanism, cytosol was mixed with increasing levels 
of microsomes and used as activation system. Following an initial 
increase, microsomes caused a concentration-dependent decrease 
in the cytosol-mediated mutagenicity of 6-aminochiysene so that 
at the 10% concentration, used routinely in our assays, 
microsomes decreased the mutagenic response by some 90%. 
In contrast, microsome-induced mutagenicity of 6-aminochrysene 
was not significantly affected by the presence of increasing 
amounts of cytosol. These results indicate that the poor mutagenic 
response in die presence of hepatic S9 is due to the fact that the
cytosol-derived mutagenic intermediate(s) are deactivated by 
microsomal enzymes.
When the cytosol, in the absence of microsomes, activates a 
promutagen it is inevitably argued that this may be due to 
contamination with microsomes. However, this possibility can 
be confidently ruled out for a number of reasons, following strong 
experimental evidence, (i) After an initial drop in 6-amino- 
chiysene-induced mutagenicity following repeated centrifiigation 
of the cytosol at 105 000 g for 1 h, further centrifugation did 
not alter mutagenic response which remained marked, 
(ii) Increasing the concentration of the hepatic fraction in the 
activation system, in the case of the microsomal system maximum 
mutagenic response was seen at about 5 % (v/v) but a dramatic 
decline in mutagenicity was evident when the concentration was 
further raised to 20% (v/v). In contrast cytosolic activation 
increased with increasing cytosol concentration up to at least 20% 
(v/v). These observations indicate that the characteristics of the 
cytosolic and microsomal activating systems are different, (iii) In 
the same study, especially at the higher concentration activation 
systems, e.g. 10% and 20% (v/v), the activation by the cytosol 
was far higher than that attained by the corresponding micro­
somal preparations, incompatible with minor contamination of 
the cytosol with microsomes. (iv) The microsomal activation 
system could be supported by botii NADPH and NADH, whereas 
only the former reduced nucleotide could support the cytosolic 
activation, demonstrating different cofactor requirements by the 
two systems.
In order to obtain further evidence as to the properties of the 
two hepatic systems, the mutagenicity of 6-aminochrysene was 
studied in the presence of activation systems isolated from rats 
treated with prototype cytochrome P450 inducing agents. Control 
microsomes were effective in bioactivating 6-aminochrysene, 
demonstrating that constitutive forms of cytochrome P450 or 
other enzyme systems such as the FAD-monooxygenase are the 
major catalysts of the N-hydroxylation of this amine. No marked 
increase in mutagenic response was evident following treatment 
of the animals with the selective cytochrome P450 inducers 
benzo[fl]pyrene (CYPIA), phenobarbitone (CYP2B), Aroclor 
1254 (CYPIA and CYP2B), isoniazid (CYP2E), dexamethasone 
(CYP3A), and clofibrate (CYP4A), demonstrating that the 
xenobiotic-inducible cytochrome P450 proteins are not major 
catalysts of the 6-aminochrysene bioactivation. An important facet 
of the induction studies is that CYP3A induction by dexa­
methasone failed to influence the mutagenicity of 6-amino- 
chrysene, whereas the orthologous human protein is an important 
catalyst of the bioactivation of this mutagen (Shimada et al. , 
1989), further illustrating the marked difference in substrate 
specificity between the human and rodent CYP3A proteins. 
Another relevant observation is that the microsome-mediated 
mutagenicity of 6-aminochrysene is inhibited by the treatments 
with Aroclor 1254, benzo[a]pyrene and to a lesser extent 
phénobarbital, indicating that CYPl and CYP2B induction occurs 
at the expense of the constitutive forms of cytochrome P450 
involved in the activation of this promutagen. It must be pointed 
out, however, that other workers found that, using a Salmonella 
typhimurium strain in which an 0-acetyltransferase gene has been 
incorporated and the umu gene expression system was used, all 
the inducible cytochrome P450 families/subfamilies investigated 
could enhance to some extent the bioactivation of 6-amino­
chrysene (Yamazaki and Shimada, 1992). The CYP4A subfamily 
was not studied. However, when the parent bacterial strain, 
lacking the 0-acetyltransferase gene, was used, the effects of 
these inducing agents were much less pronounced. Further studies
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with purified proteins led these workers to conclude that the 
CYP2B proteins are the best catalysts. The contribution of these 
proteins in the activation of this promutagen by preparations from 
untreated animals was not studied. Using the conventional TA98 
Salmonella typhimurium strain and employing rat hepatic S9 
activation systems, it was found that treatment with pheno­
barbitone enhanced the activation of 6-aminochrysene to mutagens 
only when low levels of S9 protein were used, whereas at high 
S9 protein levels, S9 from 3-methylcholanthrene-induced rats was 
the most effective activation system, while phenobarbitone- 
induced was less effective than control at these S9 levels (Lubet 
et al., 1989). Clearly, the role of cytochrome P450 proteins in 
the microsomal bioactivation of 6-aminochrysene is complex, 
possibly involving more than one protein. However, caution must 
be exercised in interpreting data when S9 preparations are used, 
since the cytosol itself may substantially contribute to the 
mutagenicity of this carcinogen. In recent studies, using the same 
mutagenicity system and employing purified human liver proteins, 
CYP1A2 was the major catalyst followed by CYP3A4 and 
possibly CYP2B6 (Yamazaki et al., 1993).
In contrast to the observations with the microsomal prepara­
tions, the only cytosolic preparation that effectively activated 
6-aminochrysene was that derived from the rats treated with 
Aroclor 1254. These observations provide further unequivocal 
evidence that the microsomal and cytosolic activation systems 
are distinct, and the cytosolic activation cannot be accounted for 
in terms of microsomal contamination. Since the cytosolic 
activation of 2-aminoanthracene and 2-aminofluorene are also 
inducible by treatment with Aroclor 1254 (Traynor et al., 1991 ; 
Ayrton et al., 1992; Leist et al., 1992), it may be inferred that 
these three aromatic amines are metabolized by the same, or at 
least very closely related enzyme systems.
As previous studies have alluded to the possibility that aromatic 
amines may be activated by red blood cells in the cytosol in the 
presence of methylene blue (Duverger-van Boaget et al., 1991) 
it was considered pertinent to establish whether it makes a 
significant contribution to the hepatic cytosolic activation. 
Although slight activation was noted in the presence of methylene 
blue, this constituted only 5% of the mutagenic response seen 
in the presence of NADPH.
In order to investigate whether the cytosolic activation system 
was characteristic of the rat, or is also present in other animal 
species, hepatic preparations from untreated animals were 
employed as activation systems of the two promutagens 2-amino­
anthracene and 6-aminochrysene. Microsomes from rat and 
hamster activated both amines effectively; no activation was, 
however, evident with the ferret and pig microsomes. As the latter 
species is endowed with high FAD-monooxygenase activity, it 
may be inferred That this enzyme system is not a major catalyst 
of the N-hydroxylation of these two amines. Cytosolic prepara­
tions from these animals provoked either a weak or no mutagenic 
response. These findings further support the view that the 
cytosolic and microsomal systems are different.
Using human hepatic cytosolic activation systems the muta­
genicity of both amines was investigated. All three cytosolic 
samples clearly activated 2-aminoanthracene. A modest 
mutagenic response was also obtained for 6-aminochrysene. 
Thus, human hepatic cytosolic preparations are capable of 
catalysing the activation of these promutagens i
In conclusion, the present studies show that; (i) 6-amino­
chrysene can be activated to mutagens by hepatic microsomal 
and cytosolic activation systems; (ii) the microsonlal metabolism 
of 6-aminochrysene is likely to be mediated by constitutive
cytochrome P450 forms and the extent of activation is markedly 
diminished by treatment of rats with benzo[a]pyrene and Aroclor 
1254; (iii) the cytosolic activation of 6-aminochtysene is markedly 
inducible by Aroclor 1254; (iv) strong experimental evidence is 
presented that the dytosolic activation system does not represent 
contamination with microsomes; (v) the cytosolic activation 
system is also present in human liver.
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